KIDS Distribution saved on May 04, 2018@09:40:40
Oncology Patch ONC*2.2*9
**KIDS**:ONC*2.2*9^

**INSTALL NAME**
ONC*2.2*9
"BLD",10319,0)
ONC*2.2*9^ONCOLOGY^0^3180504^y
"BLD",10319,4,0)
^9.64PA^165.5^2
"BLD",10319,4,165.5,0)
165.5
"BLD",10319,4,165.5,2,0)
^9.641^165.5^1
"BLD",10319,4,165.5,2,165.5,0)
ONCOLOGY PRIMARY  (File-top level)
"BLD",10319,4,165.5,2,165.5,1,0)
^9.6411^286^5
"BLD",10319,4,165.5,2,165.5,1,24.3,0)
GRADE CLINICAL
"BLD",10319,4,165.5,2,165.5,1,24.4,0)
GRADE PATHOLOGICAL
"BLD",10319,4,165.5,2,165.5,1,24.5,0)
GRADE POST-THERAPY
"BLD",10319,4,165.5,2,165.5,1,285,0)
TEXT-STAGING
"BLD",10319,4,165.5,2,165.5,1,286,0)
TEXT-SITE SPECIFIC DATA ITEMS
"BLD",10319,4,165.5,222)
y^y^p^^^^n^^n
"BLD",10319,4,165.5,224)

"BLD",10319,4,169.3,0)
169.3
"BLD",10319,4,169.3,222)
y^y^f^^n^^y^r^n
"BLD",10319,4,169.3,224)

"BLD",10319,4,"APDD",165.5,165.5)

"BLD",10319,4,"APDD",165.5,165.5,24.3)

"BLD",10319,4,"APDD",165.5,165.5,24.4)

"BLD",10319,4,"APDD",165.5,165.5,24.5)

"BLD",10319,4,"APDD",165.5,165.5,285)

"BLD",10319,4,"APDD",165.5,165.5,286)

"BLD",10319,4,"B",165.5,165.5)

"BLD",10319,4,"B",169.3,169.3)

"BLD",10319,6.3)
3
"BLD",10319,"ABPKG")
n
"BLD",10319,"INI")
ONCUPLPR
"BLD",10319,"INIT")
ONC2PS09
"BLD",10319,"KRN",0)
^9.67PA^779.2^20
"BLD",10319,"KRN",.4,0)
.4
"BLD",10319,"KRN",.401,0)
.401
"BLD",10319,"KRN",.402,0)
.402
"BLD",10319,"KRN",.402,"NM",0)
^9.68A^1^1
"BLD",10319,"KRN",.402,"NM",1,0)
ONCO ABSTRACT-I    FILE #165.5^165.5^0
"BLD",10319,"KRN",.402,"NM","B","ONCO ABSTRACT-I    FILE #165.5",1)

"BLD",10319,"KRN",.403,0)
.403
"BLD",10319,"KRN",.5,0)
.5
"BLD",10319,"KRN",.84,0)
.84
"BLD",10319,"KRN",3.6,0)
3.6
"BLD",10319,"KRN",3.8,0)
3.8
"BLD",10319,"KRN",9.2,0)
9.2
"BLD",10319,"KRN",9.8,0)
9.8
"BLD",10319,"KRN",9.8,"NM",0)
^9.68A^8^8
"BLD",10319,"KRN",9.8,"NM",1,0)
ONCACD1^^0^B70408549
"BLD",10319,"KRN",9.8,"NM",2,0)
ONCODIS^^0^B825697
"BLD",10319,"KRN",9.8,"NM",3,0)
ONCUPLPR^^0^B1000520
"BLD",10319,"KRN",9.8,"NM",4,0)
ONCOTNS^^0^B19790752
"BLD",10319,"KRN",9.8,"NM",5,0)
ONCOPA1^^0^B60892840
"BLD",10319,"KRN",9.8,"NM",6,0)
ONCPCI^^0^B27235694
"BLD",10319,"KRN",9.8,"NM",7,0)
ONC2PS09^^0^B2237612
"BLD",10319,"KRN",9.8,"NM",8,0)
ONCPSD^^0^B8425456
"BLD",10319,"KRN",9.8,"NM","B","ONC2PS09",7)

"BLD",10319,"KRN",9.8,"NM","B","ONCACD1",1)

"BLD",10319,"KRN",9.8,"NM","B","ONCODIS",2)

"BLD",10319,"KRN",9.8,"NM","B","ONCOPA1",5)

"BLD",10319,"KRN",9.8,"NM","B","ONCOTNS",4)

"BLD",10319,"KRN",9.8,"NM","B","ONCPCI",6)

"BLD",10319,"KRN",9.8,"NM","B","ONCPSD",8)

"BLD",10319,"KRN",9.8,"NM","B","ONCUPLPR",3)

"BLD",10319,"KRN",19,0)
19
"BLD",10319,"KRN",19.1,0)
19.1
"BLD",10319,"KRN",101,0)
101
"BLD",10319,"KRN",409.61,0)
409.61
"BLD",10319,"KRN",771,0)
771
"BLD",10319,"KRN",779.2,0)
779.2
"BLD",10319,"KRN",870,0)
870
"BLD",10319,"KRN",8989.51,0)
8989.51
"BLD",10319,"KRN",8989.52,0)
8989.52
"BLD",10319,"KRN",8994,0)
8994
"BLD",10319,"KRN","B",.4,.4)

"BLD",10319,"KRN","B",.401,.401)

"BLD",10319,"KRN","B",.402,.402)

"BLD",10319,"KRN","B",.403,.403)

"BLD",10319,"KRN","B",.5,.5)

"BLD",10319,"KRN","B",.84,.84)

"BLD",10319,"KRN","B",3.6,3.6)

"BLD",10319,"KRN","B",3.8,3.8)

"BLD",10319,"KRN","B",9.2,9.2)

"BLD",10319,"KRN","B",9.8,9.8)

"BLD",10319,"KRN","B",19,19)

"BLD",10319,"KRN","B",19.1,19.1)

"BLD",10319,"KRN","B",101,101)

"BLD",10319,"KRN","B",409.61,409.61)

"BLD",10319,"KRN","B",771,771)

"BLD",10319,"KRN","B",779.2,779.2)

"BLD",10319,"KRN","B",870,870)

"BLD",10319,"KRN","B",8989.51,8989.51)

"BLD",10319,"KRN","B",8989.52,8989.52)

"BLD",10319,"KRN","B",8994,8994)

"BLD",10319,"QUES",0)
^9.62^^
"BLD",10319,"REQB",0)
^9.611^1^1
"BLD",10319,"REQB",1,0)
ONC*2.2*6^2
"BLD",10319,"REQB","B","ONC*2.2*6",1)

"DATA",169.3,26500,0)
CYST, EMBRYONIC^2650/0^^
"DATA",169.3,26630,0)
CYST, NEUROGLIAL-LINED^2663/0^^
"DATA",169.3,33410,0)
CYST, EPITHELIAL INCLUSION^3341/0^^
"DATA",169.3,33790,0)
CYST, COLLOID^3379/0^^
"DATA",169.3,69760,0)
SUSPICIOUS FOR MALIGNANT CELLS^6976/0^^
"DATA",169.3,75500,0)
HAMARTOMA^7550/0^^
"DATA",169.3,80000,0)
NEOPLASM, BENIGN^8000/0^^^^^^9
"DATA",169.3,80000,1,0)
^169.32^2^2
"DATA",169.3,80000,1,1,0)
TUMOR, BENIGN
"DATA",169.3,80000,1,2,0)
UNCLASSIFIED TUMOR, BENIGN
"DATA",169.3,80001,0)
NEOPLASM, UNCERTAIN BENIGN OR MALIGNANT^8000/1^^^^^^9
"DATA",169.3,80001,1,0)
^169.32^4^4
"DATA",169.3,80001,1,1,0)
NEOPLASM, NOS
"DATA",169.3,80001,1,2,0)
TUMOR, NOS
"DATA",169.3,80001,1,3,0)
UNCLASSIFIED TUMOR, BORDERLINE MALIGNANCY
"DATA",169.3,80001,1,4,0)
UNCLASSIFIED TUMOR, UNC BENIGN OR MALIGNANT
"DATA",169.3,80002,0)
NEOPLASM, IN SITU^8000/2^^^
"DATA",169.3,80003,0)
NEOPLASM, MALIGNANT^8000/3^^^^67340^^9
"DATA",169.3,80003,1,0)
^169.32^5^5
"DATA",169.3,80003,1,1,0)
TUMOR, MALIGNANT, NOS
"DATA",169.3,80003,1,2,0)
MALIGNANCY
"DATA",169.3,80003,1,3,0)
CANCER
"DATA",169.3,80003,1,4,0)
UNCLASSIFIED TUMOR, MALIGNANT
"DATA",169.3,80003,1,5,0)
BLASTOMA, NOS
"DATA",169.3,80010,0)
TUMOR CELLS, BENIGN^8001/0^^^^^^9
"DATA",169.3,80011,0)
TUMOR CELLS, UNCERTAIN BENIGN OR MALIGNANT^8001/1^^^^^^9
"DATA",169.3,80011,1,0)
^169.32^1^1
"DATA",169.3,80011,1,1,0)
TUMOR CELLS, NOS
"DATA",169.3,80012,0)
TUMOR CELLS IN SITU^8001/2^^^
"DATA",169.3,80013,0)
TUMOR CELLS, MALIGNANT^8001/3^^^^67340^^9
"DATA",169.3,80022,0)
IN SITU TUMOR, SMALL CELL TYPE^8002/2^^^
"DATA",169.3,80023,0)
MALIGNANT TUMOR, SMALL CELL TYPE^8002/3^^^^67340^^9
"DATA",169.3,80032,0)
IN SITU TUMOR, GIANT CELL TYPE^8003/2^^^
"DATA",169.3,80033,0)
MALIGNANT TUMOR, GIANT CELL TYPE^8003/3^^^^67340^^9
"DATA",169.3,80042,0)
IN SITU TUMOR, SPINDLE CELL TYPE^8004/2^^^
"DATA",169.3,80043,0)
MALIGNANT TUMOR, SPINDLE CELL TYPE^8004/3^^^^67340^^9
"DATA",169.3,80043,1,0)
^169.32^1^1
"DATA",169.3,80043,1,1,0)
MALIGNANT TUMOR, FUSIFORM CELL TYPE
"DATA",169.3,80050,0)
CLEAR CELL TUMOR, NOS^8005/0^^^
"DATA",169.3,80052,0)
CLEAR CELL TUMOR IN SITU^8005/2^^^
"DATA",169.3,80053,0)
MALIGNANT TUMOR, CLEAR CELL TYPE^8005/3^^^^67340
"DATA",169.3,80100,0)
EPITHELIAL TUMOR, BENIGN^8010/0^^^^^^3
"DATA",169.3,80102,0)
CARCINOMA IN SITU, NOS^8010/2^^^^67340^^3
"DATA",169.3,80102,1,0)
^169.32^1^1
"DATA",169.3,80102,1,1,0)
INTRAEPITHELIAL CARCINOMA, NOS
"DATA",169.3,80103,0)
CARCINOMA, NOS^8010/3^^^^67340^^3
"DATA",169.3,80103,1,0)
^169.32^2^2
"DATA",169.3,80103,1,1,0)
EPITHELIAL TUMOR, MALIGNANT
"DATA",169.3,80103,1,2,0)
URACHAL CARCINOMA (C65.9, C66.9, C67._, C68._)
"DATA",169.3,80110,0)
EPITHELIOMA, BENIGN^8011/0^^^^^^3
"DATA",169.3,80112,0)
EPITHELIOMA IN SITU^8011/2^^^
"DATA",169.3,80113,0)
EPITHELIOMA, MALIGNANT^8011/3^^^^67340^^3
"DATA",169.3,80113,1,0)
^169.32^1^1
"DATA",169.3,80113,1,1,0)
EPITHELIOMA, NOS
"DATA",169.3,80122,0)
LARGE CELL CARCINOMA IN SITU^8012/2^^^
"DATA",169.3,80123,0)
LARGE CELL CARCINOMA, NOS^8012/3^^^^67340^^3
"DATA",169.3,80132,0)
LARGE CELL NEUROENDOCRINE CARCINOMA IN SITU^8013/2^^^
"DATA",169.3,80133,0)
LARGE CELL NEUROENDOCRINE CARCINOMA ^8013/3^^^^67340
"DATA",169.3,80133,1,0)
^169.32^1^1
"DATA",169.3,80133,1,1,0)
COMBINED LARGE CELL NEUROENDOCRINE CARCINOMA (C34._, C37.9)
"DATA",169.3,80142,0)
LARGE CELL CA WITH RHABDOID PHENOTYPE IN SITU^8014/2^^^
"DATA",169.3,80143,0)
LARGE CELL CARCINOMA WITH RHABDOID PHENOTYPE^8014/3^^^^67340
"DATA",169.3,80152,0)
GLASSY CELL CARCINOMA IN SITU^8015/2^^^
"DATA",169.3,80153,0)
GLASSY CELL CARCINOMA^8015/3^^^^67340
"DATA",169.3,80202,0)
CARCINOMA IN SITU, UNDIFFERENTIATED^8020/2^^^
"DATA",169.3,80203,0)
CARCINOMA, UNDIFFERENTIATED, NOS^8020/3^^^^67340^^3
"DATA",169.3,80212,0)
CARCINOMA IN SITU, ANAPLASTIC^8021/2^^^
"DATA",169.3,80213,0)
CARCINOMA, ANAPLASTIC, NOS^8021/3^^^^67340^^3
"DATA",169.3,80222,0)
PLEOMORPHIC CARCINOMA IN SITU^8022/2^^^
"DATA",169.3,80223,0)
PLEOMORPHIC CARCINOMA^8022/3^^^^67340^^3
"DATA",169.3,80233,0)
NUT CARCINOMA (C30.0, C31.9, C34._)^8023/3
"DATA",169.3,80233,1,0)
^169.32^3^2
"DATA",169.3,80233,1,1,0)
NUT MIDLINE CARCINOMA (C30.0, C31.9, C34._)
"DATA",169.3,80233,1,3,0)
MIDL CARC OF CHILD & YOUNG ADULTS W/ NUT REARR (C30.0 C31.9 C34._)
"DATA",169.3,80302,0)
GIANT CELL AND SPINDLE CELL CARCINOMA IN SITU^8030/2^^^
"DATA",169.3,80303,0)
GIANT CELL AND SPINDLE CELL CARCINOMA^8030/3^^^^67340^^3
"DATA",169.3,80312,0)
GIANT CELL CARCINOMA IN SITU^8031/2^^^
"DATA",169.3,80313,0)
GIANT CELL CARCINOMA^8031/3^^^^67340^^3
"DATA",169.3,80322,0)
SPINDLE CELL CARCINOMA IN SITU^8032/2^^^
"DATA",169.3,80323,0)
SPINDLE CELL CARCINOMA, NOS^8032/3^^^^67340^^3
"DATA",169.3,80332,0)
PSEUDOSARCOMATOUS CARCINOMA IN SITU^8033/2^^^
"DATA",169.3,80333,0)
PSEUDOSARCOMATOUS CARCINOMA^8033/3^^^^67340^^3
"DATA",169.3,80333,1,0)
^169.32^1^1
"DATA",169.3,80333,1,1,0)
SARCOMATOID CARCINOMA
"DATA",169.3,80342,0)
POLYGONAL CELL CARCINOMA IN SITU^8034/2^^^
"DATA",169.3,80343,0)
POLYGONAL CELL CARCINOMA^8034/3^^^^67340^^3
"DATA",169.3,80352,0)
CARCINOMA WITH OSTEOCLAST GIANT CELLS IN SITU^8035/2^^^
"DATA",169.3,80353,0)
CARCINOMA WITH OSTEOCLAST-LIKE GIANT CELLS^8035/3^^^^67340^^3
"DATA",169.3,80400,0)
TUMORLET, BENIGN^8040/0^^^
"DATA",169.3,80401,0)
TUMORLET, NOS^8040/1^^^^^^3
"DATA",169.3,80412,0)
SMALL CELL CARCINOMA IN SITU^8041/2^^^
"DATA",169.3,80413,0)
SMALL CELL CARCINOMA, NOS^8041/3^^^^67340^^3
"DATA",169.3,80413,1,0)
^169.32^6^6
"DATA",169.3,80413,1,1,0)
RESERVE CELL CARCINOMA
"DATA",169.3,80413,1,2,0)
ROUND CELL CARCINOMA
"DATA",169.3,80413,1,3,0)
SMALL CELL NEUROENDOCRINE CARCINOMA
"DATA",169.3,80413,1,4,0)
HIGH-GRADE NEUROENDOCRINE CARCINOMA (C54._, C55.9)
"DATA",169.3,80413,1,5,0)
NEUROENDOCRINE CARCINOMA, POORLY DIFFERENTIATED (C50._)
"DATA",169.3,80413,1,6,0)
SMALL CELL CARCINOMA PULMONARY TYPE (C56.9)
"DATA",169.3,80422,0)
OAT CELL CARCINOMA IN SITU^8042/2^^^
"DATA",169.3,80423,0)
OAT CELL CARCINOMA^8042/3^^^6734^67340^^3
"DATA",169.3,80423,1,0)
^169.32^^0
"DATA",169.3,80432,0)
SMALL CELL CARCINOMA IN SITU, FUSIFORM CELL^8043/2^^^
"DATA",169.3,80433,0)
SMALL CELL CARCINOMA, FUSIFORM CELL^8043/3^^^^67340^^3
"DATA",169.3,80433,1,0)
^169.32^^0
"DATA",169.3,80442,0)
SMALL CELL CARCINOMA IN SITU, INTERMED CELL^8044/2^^^
"DATA",169.3,80443,0)
SMALL CELL CARCINOMA, INTERMEDIATE CELL^8044/3^^^6734^67340^^3
"DATA",169.3,80443,1,0)
^169.32^1^1
"DATA",169.3,80443,1,1,0)
SMALL CELL CARCINOMA, HYPERCALCEMIC TYPE (C56.9)
"DATA",169.3,80452,0)
COMBINED SMALL CELL CARCINOMA IN SITU^8045/2^^^
"DATA",169.3,80453,0)
COMBINED SMALL CELL CARCINOMA^8045/3^^^6734^67340^^3
"DATA",169.3,80453,1,0)
^169.32^4^4
"DATA",169.3,80453,1,1,0)
MIXED SMALL CELL CARCINOMA
"DATA",169.3,80453,1,2,0)
COMBINED SMALL CELL-LARGE CELL CARCINOMA
"DATA",169.3,80453,1,3,0)
COMBINED SMALL CELL-ADENOCARCINOMA
"DATA",169.3,80453,1,4,0)
COMBINED SMALL CELL-SQUAMOUS CELL CARCINOMA
"DATA",169.3,80462,0)
NON-SMALL CELL CARCINOMA IN SITU^8046/2^^^
"DATA",169.3,80463,0)
NON-SMALL CELL CARCINOMA^8046/3^^^^67340^^
"DATA",169.3,80500,0)
PAPILLOMA, NOS^8050/0^^^6767^^^3
"DATA",169.3,80500,1,0)
^169.32^^0
"DATA",169.3,80502,0)
PAPILLARY CARCINOMA IN SITU^8050/2^^^^^^3
"DATA",169.3,80503,0)
PAPILLARY CARCINOMA, NOS^8050/3^^^^67340^^3
"DATA",169.3,80510,0)
VERRUCOUS PAPILLOMA^8051/0^^^^^^3
"DATA",169.3,80512,0)
VERRUCOUS CARCINOMA IN SITU^8051/2^^^
"DATA",169.3,80513,0)
VERRUCOUS CARCINOMA, NOS^8051/3^^^^67340^^3
"DATA",169.3,80513,1,0)
^169.32^4^4
"DATA",169.3,80513,1,1,0)
VERRUCOUS SQUAMOUS CELL CARCINOMA
"DATA",169.3,80513,1,2,0)
VERRUCOUS EPIDERMOID CARCINOMA
"DATA",169.3,80513,1,3,0)
CONDYLOMATOUS CARCINOMA
"DATA",169.3,80513,1,4,0)
WARTY CARCINOMA
"DATA",169.3,80520,0)
SQUAMOUS CELL PAPILLOMA, NOS^8052/0^^^^^^3
"DATA",169.3,80520,1,0)
^169.32^2^2
"DATA",169.3,80520,1,1,0)
SQUAMOUS PAPILLOMA
"DATA",169.3,80520,1,2,0)
KERATOTIC PAPILLOMA
"DATA",169.3,80522,0)
PAPILLARY SQUAMOUS CELL CA, NON-INVASIVE^8052/2^^^^67340^^3
"DATA",169.3,80522,1,0)
^169.32^1^1
"DATA",169.3,80522,1,1,0)
PAPILLARY SQUAMOUS CELL CA IN SITU
"DATA",169.3,80523,0)
PAPILLARY SQUAMOUS CELL CARCINOMA^8052/3^^^^67340^^3
"DATA",169.3,80523,1,0)
^169.32^2^1
"DATA",169.3,80523,1,2,0)
PAPILLARY EPIDERMOID CARCINOMA
"DATA",169.3,80530,0)
SQUAMOUS CELL PAPILLOMA, INVERTED^8053/0^^^^^^3
"DATA",169.3,80543,0)
CONDYLOMATOUS CARCINOMA (C60.0-C60.2, C60.9)^8054/3
"DATA",169.3,80543,1,0)
^169.32^1^1
"DATA",169.3,80543,1,1,0)
WARTY CARCINOMA (C60.0-C60.2, C60.9)
"DATA",169.3,80600,0)
SQUAMOUS PAPILLOMATOSIS^8060/0^^^^^^3
"DATA",169.3,80600,1,0)
^169.32^1^1
"DATA",169.3,80600,1,1,0)
PAPILLOMATOSIS, NOS
"DATA",169.3,80702,0)
SQUAMOUS CELL CARCINOMA IN SITU, NOS^8070/2^^^^67340^^3
"DATA",169.3,80702,1,0)
^169.32^4^3
"DATA",169.3,80702,1,2,0)
INTRAEPIDERMAL CARCINOMA, NOS
"DATA",169.3,80702,1,3,0)
EPIDERMOID CARCINOMA IN SITU, NOS
"DATA",169.3,80702,1,4,0)
INTRAEPITHELIAL SQUAMOUS CELL CARCINOMA
"DATA",169.3,80703,0)
SQUAMOUS CELL CARCINOMA, NOS^8070/3^^^^67340^^3
"DATA",169.3,80703,1,0)
^169.32^4^3
"DATA",169.3,80703,1,2,0)
EPIDERMOID CARCINOMA, NOS
"DATA",169.3,80703,1,3,0)
SQUAMOUS CARCINOMA
"DATA",169.3,80703,1,4,0)
SQUAMOUS CELL EPITHELIOMA
"DATA",169.3,80712,0)
SQUAMOUS CELL CA IN SITU, KERATINIZING^8071/2^^^
"DATA",169.3,80712,1,0)
^169.32^2^2
"DATA",169.3,80712,1,1,0)
DIFFERENTIATED PENILE INTRAEPITHELIAL NEOPLASIA (C60._)
"DATA",169.3,80712,1,2,0)
DIFFERENTIATED-TYPE VULVAR INTRAEPITHELIAL NEOPLASIA (C51._)
"DATA",169.3,80713,0)
SQUAMOUS CELL CARCINOMA, KERATINIZING, NOS^8071/3^^^^67340^^3
"DATA",169.3,80713,1,0)
^169.32^2^2
"DATA",169.3,80713,1,1,0)
SQUAMOUS CELL CA, LARGE CELL, KERATINIZING
"DATA",169.3,80713,1,2,0)
EPIDERMOID CARCINOMA, KERATINIZING
"DATA",169.3,80722,0)
SQUAMOUS CA IN SITU/LRG CELL, NONKERATINIZING^8072/2^^^
"DATA",169.3,80723,0)
SQUAMOUS CA, LARGE CELL, NONKERATINIZING, NOS^8072/3^^^^67340^^3
"DATA",169.3,80723,1,0)
^169.32^2^2
"DATA",169.3,80723,1,1,0)
SQUAMOUS CELL CARCINOMA, NONKERATINIZING, NOS
"DATA",169.3,80723,1,2,0)
EPIDERMOID CA, LARGE CELL, NONKERATINIZING
"DATA",169.3,80732,0)
SQUAMOUS CA IN SITU/SML CELL, NONKERATINIZING^8073/2^^^
"DATA",169.3,80733,0)
SQUAMOUS CELL CA, SMALL CELL, NONKERATINIZING^8073/3^^^^67340^^3
"DATA",169.3,80733,1,0)
^169.32^1^1
"DATA",169.3,80733,1,1,0)
EPIDERMOID CA, SMALL CELL, NONKERATINIZING
"DATA",169.3,80742,0)
SQUAMOUS CELL CA IN SITU, SPINDLE CELL^8074/2^^^
"DATA",169.3,80743,0)
SQUAMOUS CELL CARCINOMA, SPINDLE CELL^8074/3^^^^67340^^3
"DATA",169.3,80743,1,0)
^169.32^3^2
"DATA",169.3,80743,1,1,0)
EPIDERMOID CARCINOMA, SPINDLE CELL
"DATA",169.3,80743,1,3,0)
SQUAMOUS CELL CARCINOMA, SARCOMATOID
"DATA",169.3,80752,0)
SQUAMOUS CELL CA IN SITU, ADENOID^8075/2^^^
"DATA",169.3,80753,0)
SQUAMOUS CELL CARCINOMA, ADENOID^8075/3^^^^67340^^3
"DATA",169.3,80753,1,0)
^169.32^2^2
"DATA",169.3,80753,1,1,0)
SQUAMOUS CELL CARCINOMA, PSEUDOGLANDULAR
"DATA",169.3,80753,1,2,0)
SQUAMOUS CELL CARCINOMA, ACANTHOLYTIC
"DATA",169.3,80762,0)
SQUAMOUS CELL CA IN SITU W QUES STROMAL INV^8076/2^^^6753^67340^^3
"DATA",169.3,80762,1,0)
^169.32^1^1
"DATA",169.3,80762,1,1,0)
EPIDERMOID CA IN SITU W QUES STROMAL INV
"DATA",169.3,80763,0)
SQUAMOUS CELL CARCINOMA, MICROINVASIVE^8076/3^^^6753^67340^^3
"DATA",169.3,80772,0)
SQUAMOUS INTRAEPITHELIAL NEOPLASIA, GRADE III^8077/2^^^6753^67340^^3
"DATA",169.3,80772,1,0)
^169.32^9^9
"DATA",169.3,80772,1,1,0)
CERVICAL INTRAEPITHELIAL NEOPLASIA, GRADE III
"DATA",169.3,80772,1,2,0)
CIN III, NOS
"DATA",169.3,80772,1,3,0)
CIN III WITH SEVERE DYSPLASIA
"DATA",169.3,80772,1,4,0)
VAIN III
"DATA",169.3,80772,1,5,0)
VIN III
"DATA",169.3,80772,1,6,0)
VAGINAL INTRAEPITHELIAL NEOPLASIA, GRADE III
"DATA",169.3,80772,1,7,0)
VULVAR INTRAEPITHELIAL NEOPLASIA, GRADE III
"DATA",169.3,80772,1,8,0)
ANAL INTRAEPITHELIAL NEOPLASIA, GRADE III
"DATA",169.3,80772,1,9,0)
AIN III
"DATA",169.3,80782,0)
SQUAMOUS CELL CA IN SITU WITH HORN FORMATION^8078/2^^^
"DATA",169.3,80783,0)
SQUAMOUS CELL CARCINOMA WITH HORN FORMATION^8078/3^^^
"DATA",169.3,80802,0)
QUEYRAT ERYTHROPLASIA^8080/2^^^6760^67600^^3
"DATA",169.3,80802,1,0)
^169.32^^0
"DATA",169.3,80812,0)
BOWEN DISEASE ^8081/2^^^6744^67440^^3
"DATA",169.3,80812,1,0)
^169.32^1^1
"DATA",169.3,80812,1,1,0)
INTRAEPIDERMAL SQUAMOUS CELL CA, BOWEN TYPE
"DATA",169.3,80813,0)
BOWEN DISEASE, MALIGNANT^8081/3^^^
"DATA",169.3,80822,0)
LYMPHOEPITHELIAL CARCINOMA IN SITU^8082/2^^^
"DATA",169.3,80823,0)
LYMPHOEPITHELIAL CARCINOMA^8082/3^^^6711^67340^^3
"DATA",169.3,80823,1,0)
^169.32^3^3
"DATA",169.3,80823,1,1,0)
LYMPHOEPITHELIOMA
"DATA",169.3,80823,1,2,0)
LYMPHOEPITHELIOMA-LIKE CARCINOMA
"DATA",169.3,80823,1,3,0)
SCHMINCKE TUMOR
"DATA",169.3,80832,0)
BASALOID SQUAMOUS CELL CARCINOMA IN SITU^8083/2^^^
"DATA",169.3,80833,0)
BASALOID SQUAMOUS CELL CARCINOMA^8083/3^^^^67340
"DATA",169.3,80842,0)
SQUAMOUS CELL CA IN SITU, CLEAR CELL TYPE^8084/2^^^
"DATA",169.3,80843,0)
SQUAMOUS CELL CARCINOMA, CLEAR CELL TYPE^8084/3^^^^67340
"DATA",169.3,80853,0)
SCC, HPV-POS (C01.9 C10.2 C10.3 C10.8 C10.9 C31.0-C31.3 C31.9)^8085/3
"DATA",169.3,80863,0)
SCC, HPV-NEG (C01.9 C10.2 C10.3 C10.8 C10.9 C31.0-C31.3 C31.9)^8086/3
"DATA",169.3,80901,0)
BASAL CELL TUMOR^8090/1^^^6744^67440^^3
"DATA",169.3,80902,0)
BASAL CELL CARCINOMA, IN SITU^8090/2^^^
"DATA",169.3,80903,0)
BASAL CELL CARCINOMA, NOS^8090/3^67340^^6744^67440^^3
"DATA",169.3,80903,1,0)
^169.32^3^3
"DATA",169.3,80903,1,1,0)
PIGMENTED BASAL CELL CARCINOMA
"DATA",169.3,80903,1,2,0)
BASAL CELL EPITHELIOMA
"DATA",169.3,80903,1,3,0)
RODENT ULCER
"DATA",169.3,80912,0)
MULTICENTRIC BASAL CELL CARCINOMA, IN SITU^8091/2^^^
"DATA",169.3,80913,0)
MULTIFOCAL SUPERFICIAL BASAL CELL CARCINOMA^8091/3^^^^67440^^3
"DATA",169.3,80913,1,0)
^169.32^1^1
"DATA",169.3,80913,1,1,0)
MULTICENTRIC BASAL CELL CARCINOMA
"DATA",169.3,80922,0)
INFILTRATING BASAL CELL CARCINOMA IN SITU^8092/2^^^
"DATA",169.3,80923,0)
INFILTRATING BASAL CELL CARCINOMA, NOS^8092/3^^^^67440^^3
"DATA",169.3,80923,1,0)
^169.32^5^4
"DATA",169.3,80923,1,2,0)
INFILTRATING BASAL CELL CA, NON-SCLEROSING
"DATA",169.3,80923,1,3,0)
INFILTRATING BASAL CELL CA, SCLEROSING
"DATA",169.3,80923,1,4,0)
BASAL CELL CARCINOMA, MORPHEIC
"DATA",169.3,80923,1,5,0)
BASAL CELL CARCINOMA, DESMOPLASTIC TYPE
"DATA",169.3,80932,0)
BASAL CELL CARCINOMA IN SITU, FIBROEPITHELIAL^8093/2^^^
"DATA",169.3,80933,0)
BASAL CELL CARCINOMA, FIBROEPITHELIAL^8093/3^67340^^^67440^^3
"DATA",169.3,80933,1,0)
^169.32^5^4
"DATA",169.3,80933,1,2,0)
FIBROEPITHELIOMA OF PINKUS TYPE
"DATA",169.3,80933,1,3,0)
FIBROEPITHELIAL BASAL CELL CA, PINKUS TYPE
"DATA",169.3,80933,1,4,0)
PINKUS TUMOR
"DATA",169.3,80933,1,5,0)
FIBROEPITHELIOMA, NOS
"DATA",169.3,80942,0)
BASOSQUAMOUS CARCINOMA IN SITU^8094/2^^^
"DATA",169.3,80943,0)
BASOSQUAMOUS CARCINOMA^8094/3^67340^^6744^67440^^3
"DATA",169.3,80943,1,0)
^169.32^2^1
"DATA",169.3,80943,1,2,0)
MIXED BASAL-SQUAMOUS CELL CARCINOMA
"DATA",169.3,80952,0)
METATYPICAL CARCINOMA IN SITU^8095/2^^^
"DATA",169.3,80953,0)
METATYPICAL CARCINOMA^8095/3^^^^67440^^3
"DATA",169.3,80953,1,0)
^169.32^^0
"DATA",169.3,80960,0)
INTRAEPIDERMAL EPITHELIOMA OF JADASSOHN^8096/0^^^^67440^^3
"DATA",169.3,80960,1,0)
^169.32^^0
"DATA",169.3,80972,0)
BASAL CELL CARCINOMA IN SITU, NODULAR^8097/2^^^
"DATA",169.3,80973,0)
BASAL CELL CARCINOMA, NODULAR^8097/3^67340^^^67440^^
"DATA",169.3,80973,1,0)
^169.32^1^1
"DATA",169.3,80973,1,1,0)
BASAL CELL CARCINOMA, MICRONODULAR
"DATA",169.3,80982,0)
ADENOID BASAL CARCINOMA IN SITU^8098/2^^^
"DATA",169.3,80983,0)
ADENOID BASAL CARCINOMA^8098/3^^^^67530^^
"DATA",169.3,81000,0)
TRICHOEPITHELIOMA^8100/0^^^6744^67440^^3
"DATA",169.3,81000,1,0)
^169.32^2^2
"DATA",169.3,81000,1,1,0)
BROOKE TUMOR
"DATA",169.3,81000,1,2,0)
EPITHELIOMA ADENOIDES CYSTICUM
"DATA",169.3,81010,0)
TRICHOFOLLICULOMA^8101/0^^^6744^67440^^3
"DATA",169.3,81020,0)
TRICHOLEMMOMA^8102/0^^^6744^67440^^3
"DATA",169.3,81022,0)
TRICHILEMMOCARCINOMA IN SITU^8102/2^^^
"DATA",169.3,81023,0)
TRICHILEMMOCARCINOMA^8102/3^^^^67440^^
"DATA",169.3,81023,1,0)
^169.32^1^1
"DATA",169.3,81023,1,1,0)
TRICHILEMMAL CARCINOMA
"DATA",169.3,81030,0)
PILAR TUMOR^8103/0^^^^67440^^
"DATA",169.3,81030,1,0)
^169.32^2^2
"DATA",169.3,81030,1,1,0)
PROLIFERATING TRICHILEMMAL CYST
"DATA",169.3,81030,1,2,0)
PROLIFERATING TRICHILEMMAL TUMOR
"DATA",169.3,81100,0)
PILOMATRIXOMA, NOS^8110/0^^^^67440^^
"DATA",169.3,81100,1,0)
^169.32^2^2
"DATA",169.3,81100,1,1,0)
CALCIFYING EPITHELIOMA OF MALHERBE
"DATA",169.3,81100,1,2,0)
PILOMATRICOMA, NOS
"DATA",169.3,81102,0)
PILOMATRIX CARCINOMA IN SITU^8110/2^^^
"DATA",169.3,81103,0)
PILOMATRIX CARCINOMA^8110/3^^^6744^67440^^3
"DATA",169.3,81103,1,0)
^169.32^3^3
"DATA",169.3,81103,1,1,0)
PILOMATRIXOMA, MALIGNANT
"DATA",169.3,81103,1,2,0)
PILOMATRICOMA, MALIGNANT
"DATA",169.3,81103,1,3,0)
MATRICAL CARCINOMA
"DATA",169.3,81200,0)
TRANSITIONAL CELL PAPILLOMA, BENIGN^8120/0^^^^^^3
"DATA",169.3,81200,1,0)
^169.32^1^1
"DATA",169.3,81200,1,1,0)
TRANSITIONAL PAPILLOMA
"DATA",169.3,81201,0)
UROTHELIAL PAPILLOMA, NOS^8120/1^^^6767^^^3
"DATA",169.3,81201,1,0)
^169.32^2^2
"DATA",169.3,81201,1,1,0)
PAPILLOMA OF BLADDER
"DATA",169.3,81201,1,2,0)
TRANSITIONAL CELL PAPILLOMA, NOS
"DATA",169.3,81202,0)
TRANSITIONAL CELL CARCINOMA IN SITU^8120/2^^^^^^3
"DATA",169.3,81202,1,0)
^169.32^1^1
"DATA",169.3,81202,1,1,0)
UROTHELIAL CARCINOMA IN SITU
"DATA",169.3,81203,0)
TRANSITIONAL CELL CARCINOMA, NOS^8120/3^^^^67340^^3
"DATA",169.3,81203,1,0)
^169.32^11^10
"DATA",169.3,81203,1,2,0)
UROTHELIAL CARCINOMA, NOS
"DATA",169.3,81203,1,3,0)
TRANSITIONAL CARCINOMA
"DATA",169.3,81203,1,4,0)
LIPID-RICH UROTHELIAL CARCINOMA (C65.9, C66.9, C67._, C68._)
"DATA",169.3,81203,1,5,0)
MICROCYSTIC UROTHELIAL CARCINOMA (C65.9, C66.9, C67._, C68._)
"DATA",169.3,81203,1,6,0)
NESTED UROTHELIAL CARCINOMA (C65.9, C66.9, C67._, C68._)
"DATA",169.3,81203,1,7,0)
SQUAMOTRANSITIONAL CELL CARCINOMA (C53._)
"DATA",169.3,81203,1,8,0)
UROTHELIAL CARC W/ DIVERGENT DIFFERENTIATION (C65.9,C66.9,C67._,C68._)
"DATA",169.3,81203,1,9,0)
UROTHELIAL CARC W SQUAMOUS DIFFERENTIATION (C65.9,C66.9,C67._,C68._)
"DATA",169.3,81203,1,10,0)
UROTHELIAL CARC W TROPHOBLASTIC DIFFERENTIA (C65.9,C66.9,C67._,C68._)
"DATA",169.3,81203,1,11,0)
CLEAR CELL (GLYCOGEN-RICH) UROTHELIAL CARC (C65.9,C66.9,C67._,C68._)
"DATA",169.3,81210,0)
SCHNEIDERIAN PAPILLOMA, NOS^8121/0^67310^^^67300^^3
"DATA",169.3,81210,1,0)
^169.32^5^5
"DATA",169.3,81210,1,1,0)
SINONASAL PAPILLOMA, NOS
"DATA",169.3,81210,1,2,0)
SINONASAL PAPILLOMA, FUNGIFORM
"DATA",169.3,81210,1,3,0)
TRANSITIONAL CELL PAPILLOMA, INVERTED, BENIGN
"DATA",169.3,81210,1,4,0)
TRANSITIONAL PAPILLOMA, INVERTED, BENIGN
"DATA",169.3,81210,1,5,0)
SINONASAL PAPILLOMA, EXOPHYTIC
"DATA",169.3,81211,0)
TRANSITIONAL CELL PAPILLOMA, INVERTED, NOS^8121/1^^^^^^3
"DATA",169.3,81211,1,0)
^169.32^5^5
"DATA",169.3,81211,1,1,0)
TRANSITIONAL PAPILLOMA, INVERTED, NOS
"DATA",169.3,81211,1,2,0)
COLUMNAR CELL PAPILLOMA
"DATA",169.3,81211,1,3,0)
CYLINDRICAL CELL PAPILLOMA
"DATA",169.3,81211,1,4,0)
ONCOCYTIC SCHNEIDERIAN PAPILLOMA
"DATA",169.3,81211,1,5,0)
SCHNEIDERIAN PAPILLOMA, INVERTED
"DATA",169.3,81212,0)
SCHNEIDERIAN CARCINOMA IN SITU^8121/2^^^
"DATA",169.3,81213,0)
SCHNEIDERIAN CARCINOMA^8121/3^67310^^^67300^^3
"DATA",169.3,81213,1,0)
^169.32^1^1
"DATA",169.3,81213,1,1,0)
CYLINDRICAL CELL CARCINOMA
"DATA",169.3,81222,0)
TRANSITIONAL CELL CA IN SITU, SPINDLE CELL^8122/2^^^
"DATA",169.3,81223,0)
TRANSITIONAL CELL CARCINOMA, SPINDLE CELL^8122/3^^^^67340^^3
"DATA",169.3,81223,1,0)
^169.32^3^2
"DATA",169.3,81223,1,2,0)
SPINDLE
"DATA",169.3,81223,1,3,0)
TRANSITIONAL CELL CARCINOMA, SARCOMATOID
"DATA",169.3,81232,0)
BASALOID CARCINOMA IN SITU^8123/2^^^
"DATA",169.3,81233,0)
BASALOID CARCINOMA^8123/3^67340^^6721^67211^^3
"DATA",169.3,81242,0)
CLOACOGENIC CARCINOMA IN SITU^8124/2^^^
"DATA",169.3,81243,0)
CLOACOGENIC CARCINOMA^8124/3^^^6721^67210^^3
"DATA",169.3,81301,0)
PAPILLARY TRANS CELL NEOPLASM OF LOW MALIG^8130/1^^^^67670^^
"DATA",169.3,81301,1,0)
^169.32^1^1
"DATA",169.3,81301,1,1,0)
PAPILLARY UROTHELIAL NEOPLASM OF LOW MALIG
"DATA",169.3,81302,0)
PAPILLARY TRANSITIONAL CELL CA, NON-INVASIVE^8130/2^^^^67670^^3
"DATA",169.3,81302,1,0)
^169.32^1^1
"DATA",169.3,81302,1,1,0)
PAPILLARY UROTHELIAL CARCINOMA, NON-INVASIVE
"DATA",169.3,81303,0)
PAPILLARY TRANSITIONAL CELL CARCINOMA^8130/3^^^^67670^^3
"DATA",169.3,81303,1,0)
^169.32^3^1
"DATA",169.3,81303,1,3,0)
PAPILLARY UROTHELIAL CARCINOMA
"DATA",169.3,81312,0)
TRANSITIONAL CELL CA IN SITU, MICROPAPILLARY^8131/2^^^
"DATA",169.3,81313,0)
TRANSITIONAL CELL CARCINOMA, MICROPAPILLARY^8131/3^^^^67670^^
"DATA",169.3,81400,0)
ADENOMA, NOS^8140/0^^^^^^3
"DATA",169.3,81400,1,0)
^169.32^^0
"DATA",169.3,81401,0)
ATYPICAL ADENOMA^8140/1^^^^^^3
"DATA",169.3,81401,1,0)
^169.32^1^1
"DATA",169.3,81401,1,1,0)
BRONCHIAL ADENOMA
"DATA",169.3,81402,0)
ADENOCARCINOMA IN SITU, NOS^8140/2^^^^^^3
"DATA",169.3,81402,1,0)
^169.32^^0
"DATA",169.3,81403,0)
ADENOCARCINOMA, NOS^8140/3^^^^^^3
"DATA",169.3,81403,1,0)
^169.32^3^3
"DATA",169.3,81403,1,1,0)
MINIMALLY INVASIVE ADENOCARCINOMA, NOS (C34._)
"DATA",169.3,81403,1,2,0)
ENDOCERVICAL ADENOCARCINOMA USUAL TYPE (C53._)
"DATA",169.3,81403,1,3,0)
ACINAR ADENOCARCINOMA (C61.9 ONLY)
"DATA",169.3,81412,0)
SCIRRHOUS ADENOCARCINOMA IN SITU^8141/2^^^
"DATA",169.3,81413,0)
SCIRRHOUS ADENOCARCINOMA^8141/3^^^^^^3
"DATA",169.3,81413,1,0)
^169.32^2^2
"DATA",169.3,81413,1,1,0)
SCHIRRHOUS CARCINOMA
"DATA",169.3,81413,1,2,0)
CARCINOMA WITH PRODUCTIVE FIBROSIS
"DATA",169.3,81422,0)
LINITIS PLASTICA IN SITU^8142/2^^^
"DATA",169.3,81423,0)
LINITIS PLASTICA^8142/3^^^6716^67160^^3
"DATA",169.3,81432,0)
SUPERFICIAL SPREADING ADENOCARCINOMA IN SITU^8143/2^^^
"DATA",169.3,81433,0)
SUPERFICIAL SPREADING ADENOCARCINOMA^8143/3^^^^^^3
"DATA",169.3,81442,0)
ADENOCARCINOMA IN SITU, INTESTINAL TYPE^8144/2^^^
"DATA",169.3,81443,0)
ADENOCARCINOMA, INTESTINAL TYPE^8144/3^^^6716^67160^^3
"DATA",169.3,81443,1,0)
^169.32^4^4
"DATA",169.3,81443,1,1,0)
CARCINOMA, INTESTINAL TYPE
"DATA",169.3,81443,1,2,0)
ENTERIC ADENOCARCINOMA (C34. 0, C65.9, C66.9, C67._, C68._)
"DATA",169.3,81443,1,3,0)
INTESTINAL-TYPE ADENOCARCINOMA (C30.0, C53._)
"DATA",169.3,81443,1,4,0)
MUCINOUS CARCINOMA, INTESTINAL TYPE (C53._)
"DATA",169.3,81452,0)
CARCINOMA IN SITU, DIFFUSE TYPE^8145/2^^^
"DATA",169.3,81453,0)
CARCINOMA, DIFFUSE TYPE^8145/3^^^6716^67160^^3
"DATA",169.3,81453,1,0)
^169.32^1^1
"DATA",169.3,81453,1,1,0)
ADENOCARCINOMA, DIFFUSE TYPE
"DATA",169.3,81460,0)
MONOMORPHIC ADENOMA^8146/0^^^^^^3
"DATA",169.3,81470,0)
BASAL CELL ADENOMA^8147/0^^^6707^^^3
"DATA",169.3,81472,0)
BASAL CELL ADENOCARCINOMA IN SITU^8147/2^^^
"DATA",169.3,81473,0)
BASAL CELL ADENOCARCINOMA^8147/3^^^^^^3
"DATA",169.3,81482,0)
GLANDULAR INTRAEPITHELIAL NEOPLASIA, GR III^8148/2^^^
"DATA",169.3,81482,1,0)
^169.32^2^2
"DATA",169.3,81482,1,1,0)
PROSTATIC INTRAEPITHELIAL NEOPLASIA, GR III
"DATA",169.3,81482,1,2,0)
PIN III
"DATA",169.3,81490,0)
CANALICULAR ADENOMA^8149/0^^^
"DATA",169.3,81500,0)
ISLET CELL ADENOMA^8150/0^^^6725^67250^^3
"DATA",169.3,81500,1,0)
^169.32^3^3
"DATA",169.3,81500,1,1,0)
ISLET CELL TUMOR, BENIGN
"DATA",169.3,81500,1,2,0)
NESIDIOBLASTOMA
"DATA",169.3,81500,1,3,0)
ISLET CELL ADENOMATOSIS
"DATA",169.3,81501,0)
ISLET CELL TUMOR, NOS^8150/1^^^^67250^^
"DATA",169.3,81502,0)
ISLET CELL CARCINOMA IN SITU^8150/2^^^
"DATA",169.3,81503,0)
ISLET CELL CARCINOMA^8150/3^^^6725^67250^^3
"DATA",169.3,81503,1,0)
^169.32^1^1
"DATA",169.3,81503,1,1,0)
ISLET CELL ADENOCARCINOMA
"DATA",169.3,81510,0)
INSULINOMA, NOS^8151/0^^^^67250^^3
"DATA",169.3,81510,1,0)
^169.32^1^1
"DATA",169.3,81510,1,1,0)
BETA CELL ADENOMA
"DATA",169.3,81512,0)
INSULINOMA IN SITU^8151/2^^^
"DATA",169.3,81513,0)
INSULINOMA, MALIGNANT^8151/3^^^6725^67250^^3
"DATA",169.3,81513,1,0)
^169.32^1^1
"DATA",169.3,81513,1,1,0)
BETA CELL TUMOR, MALIGNANT
"DATA",169.3,81521,0)
GLUCAGONOMA, NOS^8152/1^^^6725^67250^^3
"DATA",169.3,81521,1,0)
^169.32^2^2
"DATA",169.3,81521,1,1,0)
ALPHA CELL ADENOMA
"DATA",169.3,81521,1,2,0)
ALPHA CELL TUMOR, NOS
"DATA",169.3,81522,0)
GLUCAGONOMA IN SITU^8152/2^^^
"DATA",169.3,81523,0)
GLUCAGONOMA, MALIGNANT^8152/3^^^6725^67250^^3
"DATA",169.3,81523,1,0)
^169.32^1^1
"DATA",169.3,81523,1,1,0)
ALPHA CELL TUMOR, MALIGNANT
"DATA",169.3,81531,0)
GASTRINOMA, NOS^8153/1^^^^^^3
"DATA",169.3,81531,1,0)
^169.32^2^2
"DATA",169.3,81531,1,1,0)
G CELL TUMOR, NOS
"DATA",169.3,81531,1,2,0)
GASTRIN CELL TUMOR
"DATA",169.3,81532,0)
GASTRINOMA IN SITU^8153/2^^^
"DATA",169.3,81533,0)
GASTRINOMA, MALIGNANT^8153/3^^^^^^3
"DATA",169.3,81533,1,0)
^169.32^3^2
"DATA",169.3,81533,1,1,0)
G CELL TUMOR, MALIGNANT
"DATA",169.3,81533,1,3,0)
GASTRIN CELL TUMOR, MALIGNANT
"DATA",169.3,81542,0)
MIXED ISLET CELL AND EXOCRINE ADENOCA IN SITU^8154/2^^^
"DATA",169.3,81543,0)
MIXED ISLET CELL AND EXOCRINE ADENOCARCINOMA^8154/3^^^6725^67250^^3
"DATA",169.3,81543,1,0)
^169.32^2^2
"DATA",169.3,81543,1,1,0)
MIXED DUCTAL-ENDOCRINE CARCINOMA
"DATA",169.3,81543,1,2,0)
MIXED ACINAR-ENDOCRINE CARCINOMA
"DATA",169.3,81551,0)
VIPOMA, NOS^8155/1^^^
"DATA",169.3,81552,0)
VIPOMA IN SITU^8155/2^^^
"DATA",169.3,81553,0)
VIPOMA, MALIGNANT^8155/3^^^^^^3
"DATA",169.3,81561,0)
SOMATOSTATINOMA, NOS^8156/1^^^
"DATA",169.3,81561,1,0)
^169.32^1^1
"DATA",169.3,81561,1,1,0)
SOMATOSTATIN CELL TUMOR, NOS
"DATA",169.3,81562,0)
SOMATOSTATINOMA IN SITU^8156/2^^^
"DATA",169.3,81563,0)
SOMATOSTATINOMA, MALIGNANT^8156/3^^^
"DATA",169.3,81563,1,0)
^169.32^1^1
"DATA",169.3,81563,1,1,0)
SOMATOSTATIN CELL TUMOR, MALIGNANT
"DATA",169.3,81571,0)
ENTEROGLUCAGONOMA, NOS^8157/1^^^
"DATA",169.3,81572,0)
ENTEROGLUCAGONOMA IN SITU^8157/2^^^
"DATA",169.3,81573,0)
ENTEROGLUCAGONOMA, MALIGNANT^8157/3^^^
"DATA",169.3,81581,0)
ENDOCRINE TUMOR, FUNCTIONING, NOS^8158/1
"DATA",169.3,81581,1,0)
^169.32^1^1
"DATA",169.3,81581,1,1,0)
ACTH-PRODUCING TUMOR
"DATA",169.3,81600,0)
BILE DUCT ADENOMA^8160/0^67240^^6722^67221^^3
"DATA",169.3,81600,1,0)
^169.32^1^1
"DATA",169.3,81600,1,1,0)
CHOLANGIOMA
"DATA",169.3,81602,0)
CHOLANGIOCARCINOMA IN SITU^8160/2^^^
"DATA",169.3,81603,0)
CHOLANGIOCARCINOMA^8160/3^67240^^6722^67221^^3
"DATA",169.3,81603,1,0)
^169.32^2^2
"DATA",169.3,81603,1,1,0)
BILE DUCT CARCINOMA
"DATA",169.3,81603,1,2,0)
BILE DUCT ADENOCARCINOMA
"DATA",169.3,81610,0)
BILE DUCT CYSTADENOMA^8161/0^67240^^^67221^^3
"DATA",169.3,81612,0)
BILE DUCT CYSTADENOCARCINOMA IN SITU^8161/2^^^
"DATA",169.3,81613,0)
BILE DUCT CYSTADENOCARCINOMA^8161/3^67240^^^67221^^3
"DATA",169.3,81613,1,0)
^169.32^^0
"DATA",169.3,81622,0)
KLATSKIN TUMOR IN SITU^8162/2^^^
"DATA",169.3,81623,0)
KLATSKIN TUMOR^8162/3^67240^^6722^67221^^3
"DATA",169.3,81633,0)
PANCREATOBILIARY-TYPE CARCINOMA (C24.1)^8163/3
"DATA",169.3,81633,1,0)
^169.32^1^1
"DATA",169.3,81633,1,1,0)
ADENOCARCINOMA, PANCREATOBILIARY-TYPE (C24.1)
"DATA",169.3,81700,0)
LIVER CELL ADENOMA^8170/0^^^6722^67220^^3
"DATA",169.3,81700,1,0)
^169.32^2^2
"DATA",169.3,81700,1,1,0)
HEPATOCELLULAR ADENOMA
"DATA",169.3,81700,1,2,0)
HEPATOMA, BENIGN
"DATA",169.3,81702,0)
HEPATOCELLULAR CA IN SITU^8170/2^^^
"DATA",169.3,81703,0)
HEPATOCELLULAR CARCINOMA, NOS^8170/3^^^6722^67220^^3
"DATA",169.3,81703,1,0)
^169.32^4^4
"DATA",169.3,81703,1,1,0)
LIVER CELL CARCINOMA
"DATA",169.3,81703,1,2,0)
HEPATOCARCINOMA
"DATA",169.3,81703,1,3,0)
HEPATOMA, MALIGNANT
"DATA",169.3,81703,1,4,0)
HEPATOMA, NOS
"DATA",169.3,81712,0)
HEPATOCELLULAR CA IN SITU, FIBROLAMELLAR^8171/2^^^
"DATA",169.3,81713,0)
HEPATOCELLULAR CARCINOMA, FIBROLAMELLAR^8171/3^^^6722^67220^^3
"DATA",169.3,81713,1,0)
^169.32^^0
"DATA",169.3,81722,0)
HEPATOCELLULAR CA IN SITU, SCIRRHOUS ^8172/2^^^
"DATA",169.3,81723,0)
HEPATOCELLULAR CARCINOMA, SCIRRHOUS ^8172/3^^^^67220^^
"DATA",169.3,81723,1,0)
^169.32^1^1
"DATA",169.3,81723,1,1,0)
SCLEROSING HEPATIC CARCINOMA
"DATA",169.3,81732,0)
HEPATOCELLULAR CA IN SITU, SPINDLE CELL VAR ^8173/2^^^
"DATA",169.3,81733,0)
HEPATOCELLULAR CA, SPINDLE CELL VARIANT ^8173/3^^^^67220^^
"DATA",169.3,81733,1,0)
^169.32^1^1
"DATA",169.3,81733,1,1,0)
HEPATOCELLULAR CARCINOMA, SARCOMATOID
"DATA",169.3,81742,0)
HEPATOCELLULAR CA IN SITU, CLEAR CELL TYPE ^8174/2^^^
"DATA",169.3,81743,0)
HEPATOCELLULAR CARCINOMA, CLEAR CELL TYPE ^8174/3^^^^67220^^
"DATA",169.3,81752,0)
HEPATOCELLULAR CA IN SITU, PLEOMORPHIC TYPE ^8175/2^^^
"DATA",169.3,81753,0)
HEPATOCELLULAR CARCINOMA, PLEOMORPHIC TYPE ^8175/3^^^^67220^^
"DATA",169.3,81802,0)
COMB HEPATOCELLULAR CA/CHOLANGIOCA IN SITU^8180/2^^^
"DATA",169.3,81803,0)
COMB HEPATOCELLULAR CA AND CHOLANGIOCARCINOMA^8180/3^^^6722^67220^^3
"DATA",169.3,81803,1,0)
^169.32^2^2
"DATA",169.3,81803,1,1,0)
MIXED HEPATOCELLULAR AND BILE DUCT CARCINOMA
"DATA",169.3,81803,1,2,0)
HEPATOCHOLANGIOCARCINOMA
"DATA",169.3,81900,0)
TRABECULAR ADENOMA^8190/0^^^^^^3
"DATA",169.3,81902,0)
TRABECULAR ADENOCARCINOMA IN SITU^8190/2^^^
"DATA",169.3,81903,0)
TRABECULAR ADENOCARCINOMA^8190/3^^^^^^3
"DATA",169.3,81903,1,0)
^169.32^1^1
"DATA",169.3,81903,1,1,0)
TRABECULAR CARCINOMA
"DATA",169.3,81910,0)
EMBRYONAL ADENOMA^8191/0^^^^^^3
"DATA",169.3,82000,0)
ECCRINE DERMAL CYLINDROMA^8200/0^^^6744^67440^^3
"DATA",169.3,82000,1,0)
^169.32^2^2
"DATA",169.3,82000,1,1,0)
TURBAN TUMOR
"DATA",169.3,82000,1,2,0)
CYLINDROMA OF SKIN
"DATA",169.3,82002,0)
ADENOID CYSTIC CARCINOMA IN SITU^8200/2^^^
"DATA",169.3,82003,0)
ADENOID CYSTIC CARCINOMA^8200/3^^^^^^3
"DATA",169.3,82003,1,0)
^169.32^5^5
"DATA",169.3,82003,1,1,0)
ADENOCYSTIC CARCINOMA
"DATA",169.3,82003,1,2,0)
CYLINDROMA, NOS
"DATA",169.3,82003,1,3,0)
BRONCHIAL ADENOMA, CYLINDROID
"DATA",169.3,82003,1,4,0)
ADENOCARCINOMA, CYLINDROID
"DATA",169.3,82003,1,5,0)
THYMIC CARCINOMA WITH ADENOID CYSTIC CARCINOMA-LIKE FEATURES (C37.9)
"DATA",169.3,82012,0)
CRIBRIFORM CARCINOMA IN SITU^8201/2^^^^67500^^3
"DATA",169.3,82012,1,0)
^169.32^1^1
"DATA",169.3,82012,1,1,0)
DUCTAL CARCINOMA IN SITU, CRIBRIFORM TYPE
"DATA",169.3,82013,0)
CRIBRIFORM CARCINOMA, NOS^8201/3^^^^^^3
"DATA",169.3,82013,1,0)
^169.32^1^1
"DATA",169.3,82013,1,1,0)
DUCTAL CARCINOMA, CRIBRIFORM TYPE
"DATA",169.3,82020,0)
MICROCYSTIC ADENOMA^8202/0^^^6725^67250^^3
"DATA",169.3,82040,0)
LACTATING ADENOMA^8204/0^^^^67500^^
"DATA",169.3,82100,0)
ADENOMATOUS POLYP, NOS^8210/0^^^^^^3
"DATA",169.3,82100,1,0)
^169.32^1^1
"DATA",169.3,82100,1,1,0)
POLYPOID ADENOMA
"DATA",169.3,82102,0)
ADENOCARCINOMA IN SITU IN ADENOMATOUS POLYP^8210/2^^^^^^3
"DATA",169.3,82102,1,0)
^169.32^5^5
"DATA",169.3,82102,1,1,0)
ADENOCARCINOMA IN SITU IN TUBULAR ADENOMA
"DATA",169.3,82102,1,2,0)
CARCINOMA IN SITU IN ADENOMATOUS POLYP
"DATA",169.3,82102,1,3,0)
ADENOCARCINOMA IN SITU IN A POLYP, NOS
"DATA",169.3,82102,1,4,0)
CARCINOMA IN SITU IN A POLYP, NOS
"DATA",169.3,82102,1,5,0)
ADENOCARCINOMA IN SITU IN POLYPOID ADENOMA
"DATA",169.3,82103,0)
ADENOCARCINOMA ADENOMATOUS IN POLYP^8210/3^^^^^^3
"DATA",169.3,82103,1,0)
^169.32^5^5
"DATA",169.3,82103,1,1,0)
ADENOCARCINOMA IN TUBULAR ADENOMA
"DATA",169.3,82103,1,2,0)
CARCINOMA IN ADENOMATOUS POLYP
"DATA",169.3,82103,1,3,0)
ADENOCARCINOMA IN POLYPOID ADENOMA
"DATA",169.3,82103,1,4,0)
ADENOCARCINOMA IN A POLYP, NOS
"DATA",169.3,82103,1,5,0)
CARCINOMA IN A POLYP, NOS
"DATA",169.3,82110,0)
TUBULAR ADENOMA, NOS^8211/0^^^^^^3
"DATA",169.3,82112,0)
TUBULAR ADENOCARCINOMA IN SITU^8211/2^^^
"DATA",169.3,82113,0)
TUBULAR ADENOCARCINOMA^8211/3^^^^^^3
"DATA",169.3,82113,1,0)
^169.32^1^1
"DATA",169.3,82113,1,1,0)
TUBULAR CARCINOMA
"DATA",169.3,82120,0)
FLAT ADENOMA^8212/0^^^
"DATA",169.3,82130,0)
SERRATED ADENOMA^8213/0^^^^67180^^
"DATA",169.3,82130,1,0)
^169.32^1^1
"DATA",169.3,82130,1,1,0)
MIXED ADENOMATOUS AND HYPERPLASTIC POLYP
"DATA",169.3,82133,0)
SERRATED ADENOCARCINOMA (C18.0, C18.2, C18.9, C19.9, C20.9)^8213/3^^^^^^3
"DATA",169.3,82133,1,0)
^169.32^1^1
"DATA",169.3,82133,1,1,0)
SERRATED ADENOCARCINOMA
"DATA",169.3,82142,0)
PARIETAL CELL CARCINOMA IN SITU^8214/2^^^
"DATA",169.3,82143,0)
PARIETAL CELL CARCINOMA^8214/3^^^^67160^^
"DATA",169.3,82143,1,0)
^169.32^1^1
"DATA",169.3,82143,1,1,0)
PARIETAL CELL ADENOCARCINOMA
"DATA",169.3,82152,0)
ADENOCARCINOMA OF ANAL GLANDS IN SITU^8215/2^^^
"DATA",169.3,82153,0)
ADENOCARCINOMA OF ANAL GLANDS^8215/3^^^^67211^^
"DATA",169.3,82153,1,0)
^169.32^1^1
"DATA",169.3,82153,1,1,0)
ADENOCARCINOMA OF ANAL DUCTS
"DATA",169.3,82200,0)
ADENOMATOUS POLYPOSIS COLI^8220/0^^^6718^67180^^3
"DATA",169.3,82200,1,0)
^169.32^2^2
"DATA",169.3,82200,1,1,0)
FAMILIAL POLYPOSIS COLI
"DATA",169.3,82200,1,2,0)
ADENOMATOSIS, NOS
"DATA",169.3,82202,0)
ADENOCA IN SITU IN FAMILIAL POLYPOSIS COLI^8220/2^^^
"DATA",169.3,82202,1,0)
^169.32^1^1
"DATA",169.3,82202,1,1,0)
ADENOCA IN SITU IN ADENOMATOUS POLYPOSIS COLI
"DATA",169.3,82203,0)
ADENOCARCINOMA IN ADENOMATOUS POLYPOSIS COLI^8220/3^^^6718^67180^^3
"DATA",169.3,82210,0)
MULTIPLE ADENOMATOUS POLYPS^8221/0^^^^^^3
"DATA",169.3,82212,0)
ADENOCA IN SITU IN MULT ADENOMATOUS POLYPS^8221/2^^^
"DATA",169.3,82213,0)
ADENOCARCINOMA IN MULTIPLE ADENOMATOUS POLYPS^8221/3^^^^^^3
"DATA",169.3,82302,0)
DUCTAL CARCINOMA IN SITU, SOLID TYPE^8230/2^^^^67500^^3
"DATA",169.3,82302,1,0)
^169.32^1^1
"DATA",169.3,82302,1,1,0)
INTRADUCTAL CARCINOMA, SOLID TYPE
"DATA",169.3,82303,0)
SOLID CARCINOMA, NOS^8230/3^^^^^^3
"DATA",169.3,82303,1,0)
^169.32^2^2
"DATA",169.3,82303,1,1,0)
SOLID ADENOCARCINOMA WITH MUCIN FORMATION
"DATA",169.3,82303,1,2,0)
SOLID CARCINOMA WITH MUCIN FORMATION
"DATA",169.3,82312,0)
CARCINOMA SIMPLEX IN SITU^8231/2^^^
"DATA",169.3,82313,0)
CARCINOMA SIMPLEX^8231/3^^^^^^3
"DATA",169.3,82401,0)
CARCINOID TUMOR OF UNCERTAIN MALIG POTENTIAL^8240/1^^^6718^67181^^9
"DATA",169.3,82401,1,0)
^169.32^4^4
"DATA",169.3,82401,1,1,0)
CARCINOID TUMOR, NOS, OF APPENDIX
"DATA",169.3,82401,1,2,0)
ARGENTAFFINOMA, NOS
"DATA",169.3,82401,1,3,0)
CARCINOID, NOS, OF APPENDIX
"DATA",169.3,82401,1,4,0)
CARCINOID TUMOR, ARGENTAFFIN, NOS
"DATA",169.3,82402,0)
CARCINOID TUMOR IN SITU^8240/2^^^
"DATA",169.3,82403,0)
CARCINOID TUMOR, NOS^8240/3^^^^^^3
"DATA",169.3,82403,1,0)
^169.32^3^3
"DATA",169.3,82403,1,1,0)
CARCINOID, NOS
"DATA",169.3,82403,1,2,0)
BRONCHIAL ADENOMA, CARCINOID
"DATA",169.3,82403,1,3,0)
TYPICAL CARCINOID
"DATA",169.3,82412,0)
ENTEROCHROMAFFIN CELL CARCINOID IN SITU^8241/2^^^
"DATA",169.3,82413,0)
ENTEROCHROMAFFIN CELL CARCINOID^8241/3^^^^^^3
"DATA",169.3,82413,1,0)
^169.32^4^4
"DATA",169.3,82413,1,1,0)
CARCINOID TUMOR, ARGENTAFFIN, MALIGNANT
"DATA",169.3,82413,1,2,0)
EC CELL CARCINOID
"DATA",169.3,82413,1,3,0)
SEROTONIN PRODUCING CARCINOID
"DATA",169.3,82413,1,4,0)
ARGENTAFFINOMA, MALIGNANT
"DATA",169.3,82421,0)
ENTEROCHROMAFFIN-LIKE CELL CARCINOID, NOS^8242/1^^^
"DATA",169.3,82421,1,0)
^169.32^1^1
"DATA",169.3,82421,1,1,0)
ECL CELL CARCINOID, NOS
"DATA",169.3,82422,0)
ENTEROCHROMAFFIN-LIKE CELL TUMOR IN SITU^8242/2^^^
"DATA",169.3,82423,0)
ENTEROCHROMAFFIN-LIKE CELL TUMOR, MALIGNANT^8242/3^^^^^^3
"DATA",169.3,82423,1,0)
^169.32^1^1
"DATA",169.3,82423,1,1,0)
ECL CELL CARCINOID, MALIGNANT
"DATA",169.3,82432,0)
GOBLET CELL CARCINOID IN SITU^8243/2^^^
"DATA",169.3,82433,0)
GOBLET CELL CARCINOID^8243/3^^^^^^3
"DATA",169.3,82433,1,0)
^169.32^2^2
"DATA",169.3,82433,1,1,0)
MUCOCARCINOID TUMOR
"DATA",169.3,82433,1,2,0)
MUCINOUS CARCINOID
"DATA",169.3,82442,0)
COMPOSITE CARCINOID IN SITU^8244/2^^^
"DATA",169.3,82443,0)
COMPOSITE CARCINOID^8244/3^^^^^^3
"DATA",169.3,82443,1,0)
^169.32^2^2
"DATA",169.3,82443,1,1,0)
COMBINED CARCINOID AND ADENOCARCINOMA
"DATA",169.3,82443,1,2,0)
MIXED CARCINOID-ADENOCARCINOMA
"DATA",169.3,82451,0)
TUBULAR CARCINOID^8245/1^^^
"DATA",169.3,82452,0)
ADENOCARCINOID TUMOR IN SITU^8245/2^^^
"DATA",169.3,82453,0)
ADENOCARCINOID TUMOR^8245/3^^^^^^9
"DATA",169.3,82462,0)
NEUROENDOCRINE CARCINOMA IN SITU^8246/2^^^
"DATA",169.3,82463,0)
NEUROENDOCRINE CARCINOMA, NOS^8246/3^^^^^^3
"DATA",169.3,82463,1,0)
^169.32^1^1
"DATA",169.3,82463,1,1,0)
NEUROENDOCRINE TUMOR, WELL DIFFERENTIATED (C50._)
"DATA",169.3,82472,0)
MERKEL CELL CARCINOMA, IN SITU^8247/2^^^
"DATA",169.3,82473,0)
MERKEL CELL CARCINOMA^8247/3^^^6744^67440^^3
"DATA",169.3,82473,1,0)
^169.32^2^2
"DATA",169.3,82473,1,1,0)
MERKEL CELL TUMOR
"DATA",169.3,82473,1,2,0)
PRIMARY CUTANEOUS NEUROENDOCRINE CARCINOMA
"DATA",169.3,82481,0)
APUDOMA^8248/1^^^^^^3
"DATA",169.3,82492,0)
ATYPICAL CARCINOID TUMOR IN SITU^8249/2^^^
"DATA",169.3,82493,0)
ATYPICAL CARCINOID TUMOR^8249/3^^^
"DATA",169.3,82501,0)
PULMONARY ADENOMATOSIS^8250/1^^^6734^67340^^3
"DATA",169.3,82502,0)
ADENOCARCINOMA IN SITU, NON-MUCINOUS (C34._)^8250/2^^^
"DATA",169.3,82502,1,0)
^169.32^1^1
"DATA",169.3,82502,1,1,0)
BRONCHIOLO-ALVEOLAR ADENOCARCINOMA IN SITU
"DATA",169.3,82503,0)
LEPIDIC ADENOCARCINOMA (C34._)^8250/3^^^6734^67340^^3
"DATA",169.3,82503,1,0)
^169.32^8^6
"DATA",169.3,82503,1,2,0)
ALVEOLAR CELL CARCINOMA
"DATA",169.3,82503,1,3,0)
BRONCHIOLAR CARCINOMA
"DATA",169.3,82503,1,4,0)
BRONCHIOLAR ADENOCARCINOMA
"DATA",169.3,82503,1,5,0)
BRONCHIOLO-ALVEOLAR CARCINOMA, NOS
"DATA",169.3,82503,1,7,0)
LEPIDIC PREDOMINANT ADENOCARCINOMA (C34._)
"DATA",169.3,82503,1,8,0)
BRONCHIOLO-ALVEOLAR ADENOCARCINOMA, NOS
"DATA",169.3,82510,0)
ALVEOLAR ADENOMA^8251/0^^^^67340^^
"DATA",169.3,82512,0)
ALVEOLAR ADENOCARCINOMA IN SITU^8251/2^^^
"DATA",169.3,82513,0)
ALVEOLAR ADENOCARCINOMA^8251/3^^^6734^67340^^3
"DATA",169.3,82513,1,0)
^169.32^1^1
"DATA",169.3,82513,1,1,0)
ALVEOLAR CARCINOMA
"DATA",169.3,82522,0)
BRONCHIOLO-ALVEOLAR CA IN SITU, NON-MUCINOUS^8252/2^^^
"DATA",169.3,82523,0)
BRONCHIOLO-ALVEOLAR CARCINOMA, NON-MUCINOUS^8252/3^^^^67340^^
"DATA",169.3,82523,1,0)
^169.32^2^2
"DATA",169.3,82523,1,1,0)
BRONCHIOLO-ALVEOLAR CARCINOMA, CLARA CELL
"DATA",169.3,82523,1,2,0)
BRONCHIOLO-ALVEOLAR CA, TYPE II PNEUMOCYTE
"DATA",169.3,82532,0)
BRONCHIOLO-ALVEOLAR CA IN SITU, MUCINOUS^8253/2^^^
"DATA",169.3,82532,1,0)
^169.32^2^2
"DATA",169.3,82532,1,1,0)
BRONCHIOLO-ALVEOLAR CA IN SITU, MUCINOUS
"DATA",169.3,82532,1,2,0)
ADENOCARCINOMA IN SITU, MUCINOUS (C34._)
"DATA",169.3,82533,0)
INVASIVE MUCINOUS ADENOCARCINOMA (C34._)^8253/3^^^^67340^^
"DATA",169.3,82533,1,0)
^169.32^2^2
"DATA",169.3,82533,1,1,0)
BRONCHIOLO-ALVEOLAR CA, GOBLET CELL TYPE
"DATA",169.3,82533,1,2,0)
BRONCHIOLO-ALVEOLAR CARCINOMA, MUCINOUS
"DATA",169.3,82542,0)
BRONCHIOLO-ALVEOLAR CA IN SITU, MIXED^8254/2^^^
"DATA",169.3,82543,0)
MIXED INVASIVE MUCINOUS AND NON-MUCINOUS ADENOCARCINOMA (C34._)^8254/3^^^^67340^^
"DATA",169.3,82543,1,0)
^169.32^4^4
"DATA",169.3,82543,1,1,0)
BRONCHIOLO-ALVEOLAR CA, CLARA AND GOBLET CELL
"DATA",169.3,82543,1,2,0)
BRONCHIOLO-ALVEOLAR CA, INDETERMINATE TYPE
"DATA",169.3,82543,1,3,0)
BRONCHIOLO-ALVEOLAR CA, II PNEUMOCYTE/GOBLET
"DATA",169.3,82543,1,4,0)
BRONCHIOLO-ALVEOLAR CA, MIXED MUC AND NON-MUC
"DATA",169.3,82552,0)
ADENOCARCINOMA WITH MIXED SUBTYPES IN SITU^8255/2^^^
"DATA",169.3,82553,0)
ADENOCARCINOMA WITH MIXED SUBTYPES^8255/3^^^
"DATA",169.3,82553,1,0)
^169.32^1^1
"DATA",169.3,82553,1,1,0)
ADENOCARCINOMA COMBINED W OTHER TYPES OF CA
"DATA",169.3,82563,0)
MINIMALLY INVASIVE ADENOCARCINOMA, NON-MUCINOUS (C34._)^8256/3
"DATA",169.3,82573,0)
MINIMALLY INVASIVE ADENOCARCINOMA, MUCINOUS (C34._)^8257/3
"DATA",169.3,82600,0)
PAPILLARY ADENOMA, NOS^8260/0^^^^^^3
"DATA",169.3,82600,1,0)
^169.32^1^1
"DATA",169.3,82600,1,1,0)
GLANDULAR PAPILLOMA
"DATA",169.3,82602,0)
PAPILLARY ADENOCARCINOMA IN SITU^8260/2^^^
"DATA",169.3,82603,0)
PAPILLARY ADENOCARCINOMA, NOS^8260/3^^^^^^3
"DATA",169.3,82603,1,0)
^169.32^2^2
"DATA",169.3,82603,1,1,0)
PAPILLARY RENAL CELL CARCINOMA
"DATA",169.3,82603,1,2,0)
PAPILLARY CARCINOMA OF THYROID
"DATA",169.3,82610,0)
VILLOUS ADENOMA, NOS^8261/0^^^^^^3
"DATA",169.3,82610,1,0)
^169.32^1^1
"DATA",169.3,82610,1,1,0)
VILLOUS PAPILLOMA
"DATA",169.3,82612,0)
ADENOCARCINOMA IN SITU IN VILLOUS ADENOMA^8261/2^^^^^^3
"DATA",169.3,82612,1,0)
^169.32^^0
"DATA",169.3,82613,0)
ADENOCARCINOMA IN VILLOUS ADENOMA^8261/3^^^^^^3
"DATA",169.3,82613,1,0)
^169.32^^0
"DATA",169.3,82622,0)
VILLOUS ADENOCARCINOMA IN SITU^8262/2^^^
"DATA",169.3,82623,0)
VILLOUS ADENOCARCINOMA^8262/3^^^^^^3
"DATA",169.3,82630,0)
TUBULOVILLOUS ADENOMA, NOS^8263/0^^^^^^3
"DATA",169.3,82630,1,0)
^169.32^2^2
"DATA",169.3,82630,1,1,0)
VILLOGLANDULAR ADENOMA
"DATA",169.3,82630,1,2,0)
PAPILLOTUBULAR ADENOMA
"DATA",169.3,82632,0)
ADENOCA IN SITU IN TUBULOVILLOUS ADENOMA^8263/2^^^^^^3
"DATA",169.3,82633,0)
ADENOCARCINOMA IN TUBULOVILLOUS ADENOMA^8263/3^^^^^^3
"DATA",169.3,82633,1,0)
^169.32^4^4
"DATA",169.3,82633,1,1,0)
TUBULOPAPILLARY ADENOCARCINOMA
"DATA",169.3,82633,1,2,0)
PAPILLOTUBULAR ADENOCARCINOMA
"DATA",169.3,82633,1,3,0)
ENDOMETRIOID ADENOCARCINOMA, VILLOGLANDULAR (C54._, C55.9)
"DATA",169.3,82633,1,4,0)
VILLOGLANDULAR CARCINOMA (C53._)
"DATA",169.3,82640,0)
PAPILLOMATOSIS, GLANDULAR^8264/0^^^
"DATA",169.3,82640,1,0)
^169.32^1^1
"DATA",169.3,82640,1,1,0)
BILIARY PAPILLOMATOSIS
"DATA",169.3,82653,0)
MICROPAPILLARY CARCINOMA, NOS (C18._, C19.9, C20.9, C34._)^8265/3
"DATA",169.3,82653,1,0)
^169.32^1^1
"DATA",169.3,82653,1,1,0)
MICROPAPILLARY ADENOCARCINOMA (C34._)
"DATA",169.3,82700,0)
CHROMOPHOBE ADENOMA^8270/0^^^6775^67751^^3
"DATA",169.3,82700,1,0)
^169.32^^0
"DATA",169.3,82702,0)
CHROMOPHOBE CARCINOMA IN SITU^8270/2^^^
"DATA",169.3,82703,0)
CHROMOPHOBE CARCINOMA^8270/3^^^6775^67751^^3
"DATA",169.3,82703,1,0)
^169.32^1^1
"DATA",169.3,82703,1,1,0)
CHROMOPHOBE ADENOCARCINOMA
"DATA",169.3,82710,0)
PROLACTINOMA^8271/0^^^6775^67751^^3
"DATA",169.3,82720,0)
PITUITARY ADENOMA, NOS^8272/0^^^^67751^^
"DATA",169.3,82722,0)
PITUITARY CARCINOMA IN SITU^8272/2^^^
"DATA",169.3,82723,0)
PITUITARY CARCINOMA, NOS^8272/3^^^^67751^^
"DATA",169.3,82800,0)
ACIDOPHIL ADENOMA^8280/0^^^6775^67751^^3
"DATA",169.3,82800,1,0)
^169.32^2^1
"DATA",169.3,82800,1,2,0)
EOSINOPHIL ADENOMA
"DATA",169.3,82802,0)
ACIDOPHIL CARCINOMA IN SITU^8280/2^^^
"DATA",169.3,82803,0)
ACIDOPHIL CARCINOMA^8280/3^^^6775^67751^^3
"DATA",169.3,82803,1,0)
^169.32^3^3
"DATA",169.3,82803,1,1,0)
ACIDOPHIL ADENOCARCINOMA
"DATA",169.3,82803,1,2,0)
EOSINOPHIL CARCINOMA
"DATA",169.3,82803,1,3,0)
EOSINOPHIL ADENOCARCINOMA
"DATA",169.3,82810,0)
MIXED ACIDOPHIL-BASOPHIL ADENOMA^8281/0^^^^67751^^3
"DATA",169.3,82812,0)
MIXED ACIDOPHIL-BASOPHIL CARCINOMA IN SITU^8281/2^^^
"DATA",169.3,82813,0)
MIXED ACIDOPHIL-BASOPHIL CARCINOMA^8281/3^^^^67751^^3
"DATA",169.3,82813,1,0)
^169.32^^0
"DATA",169.3,82900,0)
OXYPHILIC ADENOMA^8290/0^^^6773^67739^^3
"DATA",169.3,82900,1,0)
^169.32^5^5
"DATA",169.3,82900,1,1,0)
ONCOCYTIC ADENOMA
"DATA",169.3,82900,1,2,0)
ONCOCYTOMA
"DATA",169.3,82900,1,3,0)
HURTHLE CELL ADENOMA
"DATA",169.3,82900,1,4,0)
HURTHLE CELL TUMOR
"DATA",169.3,82900,1,5,0)
FOLLICULAR ADENOMA, OXYPHILIC CELL
"DATA",169.3,82902,0)
OXYPHILIC ADENOCARCINOMA IN SITU^8290/2^^^
"DATA",169.3,82903,0)
OXYPHILIC ADENOCARCINOMA^8290/3^^^6773^67739^^3
"DATA",169.3,82903,1,0)
^169.32^5^5
"DATA",169.3,82903,1,1,0)
ONCOCYTIC CARCINOMA
"DATA",169.3,82903,1,2,0)
ONCOCYTIC ADENOCARCINOMA
"DATA",169.3,82903,1,3,0)
HURTHLE CELL CARCINOMA
"DATA",169.3,82903,1,4,0)
HURTHLE CELL ADENOCARCINOMA
"DATA",169.3,82903,1,5,0)
FOLLICULAR CARCINOMA, OXYPHILIC CELL
"DATA",169.3,83000,0)
BASOPHIL ADENOMA^8300/0^^^6775^67751^^3
"DATA",169.3,83000,1,0)
^169.32^2^1
"DATA",169.3,83000,1,2,0)
MUCOID CELL ADENOMA
"DATA",169.3,83002,0)
BASOPHIL CARCINOMA IN SITU^8300/2^^^
"DATA",169.3,83003,0)
BASOPHIL CARCINOMA^8300/3^^^6775^67751^^3
"DATA",169.3,83003,1,0)
^169.32^2^2
"DATA",169.3,83003,1,1,0)
BASOPHIL ADENOCARCINOMA
"DATA",169.3,83003,1,2,0)
MUCOID CELL ADENOCARCINOMA
"DATA",169.3,83100,0)
CLEAR CELL ADENOMA^8310/0^^^^^^3
"DATA",169.3,83102,0)
CLEAR CELL ADENOCARCINOMA IN SITU^8310/2^^^
"DATA",169.3,83103,0)
CLEAR CELL ADENOCARCINOMA, NOS^8310/3^^^^^^3
"DATA",169.3,83103,1,0)
^169.32^2^2
"DATA",169.3,83103,1,1,0)
CLEAR CELL ADENOCARCINOMA, MESONEPHROID
"DATA",169.3,83103,1,2,0)
CLEAR CELL CARCINOMA
"DATA",169.3,83111,0)
HYPERNEPHROID TUMOR^8311/1^^^^^^3
"DATA",169.3,83113,0)
HEREDITARY LEIOMYOMATOSIS & RCC- ASSOCIATED RENAL CELL CARCINOMA (C64.9)^8311/3
"DATA",169.3,83113,1,0)
^169.32^1^1
"DATA",169.3,83113,1,1,0)
MIT FAMILY TRANSLOCATION RENAL CELL CARCINOMA (C64.9)
"DATA",169.3,83122,0)
RENAL CELL CARCINOMA IN SITU^8312/2^^^
"DATA",169.3,83123,0)
RENAL CELL CARCINOMA, NOS^8312/3^^^6764^67649^^3
"DATA",169.3,83123,1,0)
^169.32^4^4
"DATA",169.3,83123,1,1,0)
HYPERNEPHROMA
"DATA",169.3,83123,1,2,0)
RENAL CELL ADENOCARCINOMA
"DATA",169.3,83123,1,3,0)
GRAWITZ TUMOR
"DATA",169.3,83123,1,4,0)
RENAL CELL CARCINOMA, UNCLASSIFIED (C64.9)
"DATA",169.3,83130,0)
CLEAR CELL ADENOFIBROMA^8313/0^^^^67569^^3
"DATA",169.3,83130,1,0)
^169.32^1^1
"DATA",169.3,83130,1,1,0)
CLEAR CELL CYSTADENOFIBROMA
"DATA",169.3,83131,0)
CLEAR CELL ADENOFIBROMA OF BORDERLINE MALIG^8313/1^^^^67569^^
"DATA",169.3,83131,1,0)
^169.32^1^1
"DATA",169.3,83131,1,1,0)
CLEAR CELL CYSTADENOFIBROMA OF BORDERLINE MAL
"DATA",169.3,83132,0)
CLEAR CELL ADENOCARCINOFIBROMA IN SITU^8313/2^^^
"DATA",169.3,83133,0)
CLEAR CELL ADENOCARCINOFIBROMA^8313/3^^^^67569^^
"DATA",169.3,83133,1,0)
^169.32^1^1
"DATA",169.3,83133,1,1,0)
CLEAR CELL CYSTADENOCARCINOFIBROMA
"DATA",169.3,83142,0)
LIPID RICH CARCINOMA IN SITU^8314/2^^^
"DATA",169.3,83143,0)
LIPID RICH CARCINOMA^8314/3^^^^67500^^3
"DATA",169.3,83152,0)
GLYCOGEN-RICH CARCINOMA IN SITU^8315/2^^^
"DATA",169.3,83153,0)
GLYCOGEN-RICH CARCINOMA^8315/3^^^^^^3
"DATA",169.3,83162,0)
CYST-ASSOCIATED RENAL CELL CARCINOMA IN SITU^8316/2^^^
"DATA",169.3,83163,0)
CYST-ASSOCIATED RENAL CELL CARCINOMA^8316/3^^^^67649^^
"DATA",169.3,83163,1,0)
^169.32^2^2
"DATA",169.3,83163,1,1,0)
ACQUIRED CYSTIC DISEASE-ASSOCIATED RENAL CELL CARCINOMA (RCC) (C64.9) 
"DATA",169.3,83163,1,2,0)
TUBULOCYSTIC RENAL CELL CARCINOMA (C64.9)
"DATA",169.3,83172,0)
RENAL CELL CA IN SITU, CHROMOPHOBE TYPE^8317/2^^^
"DATA",169.3,83173,0)
RENAL CELL CARCINOMA, CHROMOPHOBE TYPE^8317/3^^^^67649^^
"DATA",169.3,83173,1,0)
^169.32^1^1
"DATA",169.3,83173,1,1,0)
CHROMOPHOBE CELL RENAL CARCINOMA
"DATA",169.3,83182,0)
RENAL CELL CA IN SITU, SARCOMATOID^8318/2^^^
"DATA",169.3,83183,0)
RENAL CELL CARCINOMA, SARCOMATOID^8318/3^^^^67649^^
"DATA",169.3,83183,1,0)
^169.32^1^1
"DATA",169.3,83183,1,1,0)
RENAL CELL CARCINOMA, SPINDLE CELL
"DATA",169.3,83192,0)
COLLECTING DUCT CARCINOMA IN SITU^8319/2^^^
"DATA",169.3,83193,0)
COLLECTING DUCT CARCINOMA^8319/3^^^^67649^^
"DATA",169.3,83193,1,0)
^169.32^2^2
"DATA",169.3,83193,1,1,0)
BELLINI DUCT CARCINOMA
"DATA",169.3,83193,1,2,0)
RENAL CARCINOMA, COLLECTING DUCT TYPE
"DATA",169.3,83202,0)
GRANULAR CELL CARCINOMA IN SITU^8320/2^^^
"DATA",169.3,83203,0)
GRANULAR CELL CARCINOMA^8320/3^^^^^^3
"DATA",169.3,83203,1,0)
^169.32^1^1
"DATA",169.3,83203,1,1,0)
GRANULAR CELL ADENOCARCINOMA
"DATA",169.3,83210,0)
CHIEF CELL ADENOMA^8321/0^^^^67750^^3
"DATA",169.3,83220,0)
WATER-CLEAR CELL ADENOMA^8322/0^^^^67750^^3
"DATA",169.3,83222,0)
WATER-CLEAR CELL ADENOCARCINOMA IN SITU^8322/2^^^
"DATA",169.3,83223,0)
WATER-CLEAR CELL ADENOCARCINOMA^8322/3^^^^67750^^3
"DATA",169.3,83223,1,0)
^169.32^1^1
"DATA",169.3,83223,1,1,0)
WATER-CLEAR CELL CARCINOMA
"DATA",169.3,83230,0)
MIXED CELL ADENOMA^8323/0^^^^^^3
"DATA",169.3,83232,0)
MIXED CELL ADENOCARCINOMA IN SITU^8323/2^^^
"DATA",169.3,83233,0)
MIXED CELL ADENOCARCINOMA^8323/3^^^^^^3
"DATA",169.3,83240,0)
LIPOADENOMA^8324/0^^^^^^3
"DATA",169.3,83240,1,0)
^169.32^1^1
"DATA",169.3,83240,1,1,0)
ADENOLIPOMA
"DATA",169.3,83250,0)
METANEPHRIC ADENOMA^8325/0^^^^67649^^
"DATA",169.3,83300,0)
FOLLICULAR ADENOMA^8330/0^^^^67739^^3
"DATA",169.3,83301,0)
ATYPICAL FOLLICULAR ADENOMA^8330/1^^^^67739^^
"DATA",169.3,83302,0)
FOLLICULAR ADENOCARCINOMA IN SITU^8330/2^^^
"DATA",169.3,83303,0)
FOLLICULAR ADENOCARCINOMA, NOS^8330/3^^^6773^67739^^3
"DATA",169.3,83303,1,0)
^169.32^1^1
"DATA",169.3,83303,1,1,0)
FOLLICULAR CARCINOMA, NOS
"DATA",169.3,83312,0)
FOLLICULAR ADENOCA IN SITU, WELL DIFF^8331/2^^^
"DATA",169.3,83313,0)
FOLLICULAR ADENOCA, WELL DIFFERENTIATED^8331/3^^^6773^67739^^3
"DATA",169.3,83313,1,0)
^169.32^1^1
"DATA",169.3,83313,1,1,0)
FOLLICULAR CARCINOMA, WELL DIFFERENTIATED
"DATA",169.3,83322,0)
FOLLICULAR ADENOCA IN SITU, TRABECULAR^8332/2^^^
"DATA",169.3,83323,0)
FOLLICULAR ADENOCARCINOMA, TRABECULAR^8332/3^^^6773^67739^^3
"DATA",169.3,83323,1,0)
^169.32^4^3
"DATA",169.3,83323,1,1,0)
FOLLICULAR CARCINOMA, TRABECULAR
"DATA",169.3,83323,1,2,0)
FOLLICULAR ADENOCA, MODERATELY DIFFERENTIATED
"DATA",169.3,83323,1,4,0)
FOLLICULAR CA, MODERATELY DIFFERENTIATED
"DATA",169.3,83330,0)
MICROFOLLICULAR ADENOMA, NOS^8333/0^^^6773^67739^^3
"DATA",169.3,83330,1,0)
^169.32^1^1
"DATA",169.3,83330,1,1,0)
FETAL ADENOMA
"DATA",169.3,83332,0)
FETAL ADENOCARCINOMA IN SITU^8333/2^^^
"DATA",169.3,83333,0)
FETAL ADENOCARCINOMA^8333/3^^^
"DATA",169.3,83340,0)
MACROFOLLICULAR ADENOMA^8334/0^^^6773^67739^^3
"DATA",169.3,83340,1,0)
^169.32^1^1
"DATA",169.3,83340,1,1,0)
COLLOID ADENOMA
"DATA",169.3,83352,0)
FOLLICULAR CARCINOMA IN SITU^8335/2^^^
"DATA",169.3,83353,0)
FOLLICULAR CARCINOMA, MINIMALLY INVASIVE^8335/3^^^^67739^^
"DATA",169.3,83353,1,0)
^169.32^1^1
"DATA",169.3,83353,1,1,0)
FOLLICULAR CARCINOMA, ENCAPSULATED
"DATA",169.3,83360,0)
HYALINIZING TRABECULAR ADENOMA^8336/0^^^^67739^^
"DATA",169.3,83372,0)
INSULAR CARCINOMA IN SITU^8337/2^^^
"DATA",169.3,83373,0)
INSULAR CARCINOMA^8337/3^^^^67739^^
"DATA",169.3,83393,0)
FOLLICULAR THYROID CARCINOMA (FTC), ENCAPSULATED ANGOINVASIVE (C73.9)^8339/3
"DATA",169.3,83402,0)
PAPILLARY CA IN SITU, FOLLICULAR VARIANT^8340/2^^^
"DATA",169.3,83403,0)
PAPILLARY CARCINOMA, FOLLICULAR VARIANT^8340/3^^^6773^67739^^3
"DATA",169.3,83403,1,0)
^169.32^3^3
"DATA",169.3,83403,1,1,0)
PAPILLARY ADENOCARCINOMA, FOLLICULAR VARIANT
"DATA",169.3,83403,1,2,0)
PAPILLARY AND FOLLICULAR ADENOCARCINOMA
"DATA",169.3,83403,1,3,0)
PAPILLARY AND FOLLICULAR CARCINOMA
"DATA",169.3,83412,0)
PAPILLARY MICROCARCINOMA IN SITU^8341/2^^^
"DATA",169.3,83413,0)
PAPILLARY MICROCARCINOMA^8341/3^^^^67739^^
"DATA",169.3,83422,0)
PAPILLARY CARCINOMA IN SITU, OXYPHILIC CELL^8342/2^^^
"DATA",169.3,83423,0)
PAPILLARY CARCINOMA, OXYPHILIC CELL^8342/3^^^^67739^^
"DATA",169.3,83432,0)
PAPILLARY CARCINOMA IN SITU, ENCAPSULATED^8343/2^^^
"DATA",169.3,83432,1,0)
^169.32^6^4
"DATA",169.3,83432,1,1,0)
NON-INVASIVE EFVPTC (C73.9)
"DATA",169.3,83432,1,2,0)
NON-INVASIVE FTP (C73.9)
"DATA",169.3,83432,1,5,0)
NON-INV ENCAPS FOLLIC VAR OF PAP THYR CARC/ NON-INV EFVPTC (C73.9)
"DATA",169.3,83432,1,6,0)
NON-INV FOLLIC THYR NEOPLASM W/ PAP-LIKE NUCL FEATURES / NIFTP (C73.9)
"DATA",169.3,83433,0)
PAPILLARY CARCINOMA, ENCAPSULATED^8343/3^^^^67739^^
"DATA",169.3,83433,1,0)
^169.32^4^2
"DATA",169.3,83433,1,3,0)
ENCAPSULATED FOLLIC VAR OF PAP THYROID CARC, NOS / EFVPTC, NOS (C73.9)
"DATA",169.3,83433,1,4,0)
INV ENCAPSULATED FOLLIC VAR OF PAP THYROID CARC / INV EFVPTC (C73.9)
"DATA",169.3,83442,0)
PAPILLARY CARCINOMA IN SITU, COLUMNAR CELL^8344/2^^^
"DATA",169.3,83443,0)
PAPILLARY CARCINOMA, COLUMNAR CELL^8344/3^^^^67739^^
"DATA",169.3,83443,1,0)
^169.32^1^1
"DATA",169.3,83443,1,1,0)
PAPILLARY CARCINOMA, TALL CELL
"DATA",169.3,83452,0)
MEDULLARY CARCINOMA W AMYLOID STROMA IN SITU^8345/2^^^
"DATA",169.3,83453,0)
MEDULLARY CARCINOMA WITH AMYLOID STROMA^8345/3^^^^67739^^
"DATA",169.3,83453,1,0)
^169.32^2^2
"DATA",169.3,83453,1,1,0)
PARAFOLLICULAR CELL CARCINOMA
"DATA",169.3,83453,1,2,0)
C CELL CARCINOMA
"DATA",169.3,83462,0)
MIXED MEDULLARY-FOLLICULAR CARCINOMA IN SITU^8346/2^^^
"DATA",169.3,83463,0)
MIXED MEDULLARY-FOLLICULAR CARCINOMA^8346/3^^^^67739^^
"DATA",169.3,83472,0)
MIXED MEDULLARY-PAPILLARY CARCINOMA IN SITU^8347/2^^^
"DATA",169.3,83473,0)
MIXED MEDULLARY-PAPILLARY CARCINOMA^8347/3^^^^67739^^
"DATA",169.3,83502,0)
NONENCAPSULATED SCLEROSING CARCINOMA IN SITU^8350/2^^^
"DATA",169.3,83503,0)
NONENCAPSULATED SCLEROSING CARCINOMA^8350/3^^^6773^67739^^3
"DATA",169.3,83503,1,0)
^169.32^3^3
"DATA",169.3,83503,1,1,0)
NONENCAPSULATED SCLEROSING ADENOCARCINOMA
"DATA",169.3,83503,1,2,0)
NONENCAPSULATED SCLEROSING TUMOR
"DATA",169.3,83503,1,3,0)
PAPILLARY CARCINOMA, DIFFUSE SCLEROSING
"DATA",169.3,83601,0)
MULTIPLE ENDOCRINE ADENOMAS^8360/1^^^^^^3
"DATA",169.3,83601,1,0)
^169.32^1^1
"DATA",169.3,83601,1,1,0)
ENDOCRINE ADENOMATOSIS
"DATA",169.3,83610,0)
JUXTAGLOMERULAR TUMOR^8361/0^^^6764^67649^^3
"DATA",169.3,83610,1,0)
^169.32^1^1
"DATA",169.3,83610,1,1,0)
RENINOMA
"DATA",169.3,83700,0)
ADRENAL CORTICAL ADENOMA, NOS^8370/0^^^6774^67740^^3
"DATA",169.3,83700,1,0)
^169.32^2^2
"DATA",169.3,83700,1,1,0)
ADRENAL CORTICAL TUMOR, BENIGN
"DATA",169.3,83700,1,2,0)
ADRENAL CORTICAL TUMOR, NOS
"DATA",169.3,83702,0)
ADRENAL CORTICAL CARCINOMA IN SITU^8370/2^^^
"DATA",169.3,83703,0)
ADRENAL CORTICAL CARCINOMA^8370/3^^^6774^67740^^3
"DATA",169.3,83703,1,0)
^169.32^2^2
"DATA",169.3,83703,1,1,0)
ADRENAL CORTICAL ADENOCARCINOMA
"DATA",169.3,83703,1,2,0)
ADRENAL CORTICAL TUMOR, MALIGNANT
"DATA",169.3,83710,0)
ADRENAL CORTICAL ADENOMA, COMPACT CELL^8371/0^^^^67740^^3
"DATA",169.3,83710,1,0)
^169.32^^0
"DATA",169.3,83720,0)
ADRENAL CORTICAL ADENOMA, PIGMENTED^8372/0^^^6774^67740^^3
"DATA",169.3,83720,1,0)
^169.32^2^2
"DATA",169.3,83720,1,1,0)
BLACK ADENOMA
"DATA",169.3,83720,1,2,0)
PIGMENTED ADENOMA
"DATA",169.3,83730,0)
ADRENAL CORTICAL ADENOMA, CLEAR CELL^8373/0^^^^67740^^3
"DATA",169.3,83740,0)
ADRENAL CORTICAL ADENOMA, GLOMERULOSA CELL^8374/0^^^^67740^^3
"DATA",169.3,83750,0)
ADRENAL CORTICAL ADENOMA, MIXED CELL^8375/0^^^^67740^^3
"DATA",169.3,83800,0)
ENDOMETRIOID ADENOMA, NOS^8380/0^^^6774^67749^^3
"DATA",169.3,83800,1,0)
^169.32^1^1
"DATA",169.3,83800,1,1,0)
ENDOMETRIOID CYSTADENOMA, NOS
"DATA",169.3,83801,0)
ENDOMETRIOID ADENOMA, BORDERLINE MALIGNANCY^8380/1^^^6756^67569^^3
"DATA",169.3,83801,1,0)
^169.32^3^3
"DATA",169.3,83801,1,1,0)
ENDOMETRIOID CYSTADENOMA, BORDERLINE MALIG
"DATA",169.3,83801,1,2,0)
ENDOMETRIOID TUMOR OF LOW MALIGNANT POTENTIAL
"DATA",169.3,83801,1,3,0)
ATYPICAL PROLIFERATIVE ENDOMETRIOID TUMOR
"DATA",169.3,83802,0)
ENDOMETRIOID ADENOCA IN SITU^8380/2^^^
"DATA",169.3,83802,1,0)
^169.32^1^1
"DATA",169.3,83802,1,1,0)
ATYPICAL HYPERPLASIA/ENDOMETRIOID INTRAEPITHELIAL NEOPLASM (C54._)
"DATA",169.3,83803,0)
ENDOMETRIOID ADENOCARCINOMA, NOS^8380/3^^^6756^67569^^3
"DATA",169.3,83803,1,0)
^169.32^2^2
"DATA",169.3,83803,1,1,0)
ENDOMETRIOID CARCINOMA, NOS
"DATA",169.3,83803,1,2,0)
ENDOMETRIOID CYSTADENOCARCINOMA
"DATA",169.3,83810,0)
ENDOMETRIOID ADENOFIBROMA, NOS^8381/0^^^6756^67569^^3
"DATA",169.3,83810,1,0)
^169.32^1^1
"DATA",169.3,83810,1,1,0)
ENDOMETRIOID CYSTADENOFIBROMA, NOS
"DATA",169.3,83811,0)
ENDOMETRIOID ADENOFIBROMA, BORDERLINE MALIG^8381/1^^^6756^67569^^3
"DATA",169.3,83811,1,0)
^169.32^1^1
"DATA",169.3,83811,1,1,0)
ENDOMETRIOID CYSTADENOFIBROMA, BORDERLINE MAL
"DATA",169.3,83812,0)
ENDOMETRIOID ADENOFIBROMA IN SITU^8381/2^^^
"DATA",169.3,83813,0)
ENDOMETRIOID ADENOFIBROMA, MALIGNANT^8381/3^^^6756^67569^^3
"DATA",169.3,83813,1,0)
^169.32^1^1
"DATA",169.3,83813,1,1,0)
ENDOMETRIOID CYSTADENOFIBROMA, MALIGNANT
"DATA",169.3,83822,0)
ENDOMETRIOID ADENOCA IN SITU, SECRETORY VAR^8382/2^^^
"DATA",169.3,83823,0)
ENDOMETRIOID ADENOCA, SECRETORY VARIANT^8382/3^^^
"DATA",169.3,83832,0)
ENDOMETRIOID ADENOCA IN SITU, CILIATED CELL^8383/2^^^
"DATA",169.3,83833,0)
ENDOMETRIOID ADENOCA, CILIATED CELL VARIANT^8383/3^^^
"DATA",169.3,83842,0)
ADENOCARCINOMA IN SITU, ENDOCERVICAL TYPE^8384/2^^^
"DATA",169.3,83843,0)
ADENOCARCINOMA, ENDOCERVICAL TYPE^8384/3^^^
"DATA",169.3,83900,0)
SKIN APPENDAGE ADENOMA^8390/0^^^6744^67440^^3
"DATA",169.3,83900,1,0)
^169.32^2^2
"DATA",169.3,83900,1,1,0)
SKIN APPENDAGE TUMOR, BENIGN
"DATA",169.3,83900,1,2,0)
ADNEXAL TUMOR, BENIGN
"DATA",169.3,83902,0)
SKIN APPENDAGE CARCINOMA IN SITU^8390/2^^^
"DATA",169.3,83903,0)
SKIN APPENDAGE CARCINOMA^8390/3^^^6744^67440^^3
"DATA",169.3,83903,1,0)
^169.32^1^1
"DATA",169.3,83903,1,1,0)
ADNEXAL CARCINOMA
"DATA",169.3,83910,0)
FOLLICULAR FIBROMA^8391/0^^^^67440^^
"DATA",169.3,83910,1,0)
^169.32^3^3
"DATA",169.3,83910,1,1,0)
TRICHODISCOMA
"DATA",169.3,83910,1,2,0)
FIBROFOLLICULOMA
"DATA",169.3,83910,1,3,0)
PERIFOLLICULAR FIBROMA
"DATA",169.3,83920,0)
SYRINGOFIBROADENOMA^8392/0^^^^67440^^
"DATA",169.3,84000,0)
SWEAT GLAND ADENOMA^8400/0^^^6744^67440^^3
"DATA",169.3,84000,1,0)
^169.32^3^3
"DATA",169.3,84000,1,1,0)
SWEAT GLAND TUMOR, BENIGN
"DATA",169.3,84000,1,2,0)
HIDRADENOMA, NOS
"DATA",169.3,84000,1,3,0)
SYRINGADENOMA, NOS
"DATA",169.3,84001,0)
SWEAT GLAND TUMOR, NOS^8400/1^^^^67440^^3
"DATA",169.3,84002,0)
SWEAT GLAND ADENOCARCINOMA IN SITU^8400/2^^^
"DATA",169.3,84003,0)
SWEAT GLAND ADENOCARCINOMA^8400/3^^^^67440^^3
"DATA",169.3,84003,1,0)
^169.32^2^2
"DATA",169.3,84003,1,1,0)
SWEAT GLAND CARCINOMA
"DATA",169.3,84003,1,2,0)
SWEAT GLAND TUMOR, MALIGNANT
"DATA",169.3,84010,0)
APOCRINE ADENOMA^8401/0^^^^^^3
"DATA",169.3,84010,1,0)
^169.32^1^1
"DATA",169.3,84010,1,1,0)
APOCRINE CYSTADENOMA
"DATA",169.3,84012,0)
APOCRINE ADENOCARCINOMA, IN SITU^8401/2^^^
"DATA",169.3,84013,0)
APOCRINE ADENOCARCINOMA^8401/3^^^^^^3
"DATA",169.3,84020,0)
NODULAR HIDRADENOMA^8402/0^^^^67440^^3
"DATA",169.3,84020,1,0)
^169.32^2^2
"DATA",169.3,84020,1,1,0)
ECCRINE ACROSPIROMA
"DATA",169.3,84020,1,2,0)
CLEAR CELL HIDRADENOMA
"DATA",169.3,84022,0)
NODULAR HIDRADENOMA IN SITU^8402/2^^^
"DATA",169.3,84023,0)
NODULAR HIDRADENOMA, MALIGNANT^8402/3^^^^67440^^
"DATA",169.3,84023,1,0)
^169.32^1^1
"DATA",169.3,84023,1,1,0)
HIDRADENOCARCINOMA
"DATA",169.3,84030,0)
ECCRINE SPIRADENOMA^8403/0^^^^67440^^3
"DATA",169.3,84030,1,0)
^169.32^1^1
"DATA",169.3,84030,1,1,0)
SPIRADENOMA, NOS
"DATA",169.3,84032,0)
ECCRINE SPIRADENOMA IN SITU^8403/2^^^
"DATA",169.3,84033,0)
MALIGNANT ECCRINE SPIRADENOMA^8403/3^^^^67440^^
"DATA",169.3,84040,0)
HIDROCYSTOMA^8404/0^^^^67440^^3
"DATA",169.3,84040,1,0)
^169.32^1^1
"DATA",169.3,84040,1,1,0)
ECCRINE CYSTADENOMA
"DATA",169.3,84050,0)
PAPILLARY HIDRADENOMA^8405/0^^^^^^3
"DATA",169.3,84050,1,0)
^169.32^1^1
"DATA",169.3,84050,1,1,0)
HIDRADENOMA PAPILLIFERUM
"DATA",169.3,84060,0)
PAPILLARY SYRINGADENOMA^8406/0^^^^67440^^3
"DATA",169.3,84060,1,0)
^169.32^2^2
"DATA",169.3,84060,1,1,0)
SYRINGOCYSTADENOMA PAPILLIFERUM
"DATA",169.3,84060,1,2,0)
PAPILLARY SYRINGOCYSTADENOMA
"DATA",169.3,84062,0)
PAPILLARY SYRINGADENOCARCINOMA IN SITU^8406/2^^^
"DATA",169.3,84063,0)
PAPILLARY SYRINGADENOCARCINOMA^8406/3^^^
"DATA",169.3,84063,1,0)
^169.32^1^1
"DATA",169.3,84063,1,1,0)
PAPILLARY SYRINGOCYSTADENOCARCINOMA
"DATA",169.3,84070,0)
SYRINGOMA, NOS^8407/0^^^^67440^^3
"DATA",169.3,84072,0)
SCLEROSING SWEAT DUCT CARCINOMA IN SITU^8407/2^^^
"DATA",169.3,84073,0)
SCLEROSING SWEAT DUCT CARCINOMA^8407/3^^^^67440^^
"DATA",169.3,84073,1,0)
^169.32^2^2
"DATA",169.3,84073,1,1,0)
SYRINGOMATOUS CARCINOMA
"DATA",169.3,84073,1,2,0)
MICROCYSTIC ADNEXAL CARCINOMA
"DATA",169.3,84080,0)
ECCRINE PAPILLARY ADENOMA^8408/0^^^^67440^^3
"DATA",169.3,84081,0)
AGGRESSIVE DIGITAL PAPILLARY ADENOMA^8408/1^^^^67440^^
"DATA",169.3,84082,0)
ECCRINE PAPILLARY ADENOCARCINOMA IN SITU^8408/2^^^
"DATA",169.3,84083,0)
ECCRINE PAPILLARY ADENOCARCINOMA^8408/3^^^^67440^^
"DATA",169.3,84083,1,0)
^169.32^1^1
"DATA",169.3,84083,1,1,0)
DIGITAL PAPILLARY ADENOCARCINOMA
"DATA",169.3,84090,0)
ECCRINE POROMA^8409/0^^^^67440^^
"DATA",169.3,84092,0)
ECCRINE POROMA IN SITU^8409/2^^^
"DATA",169.3,84093,0)
ECCRINE POROMA, MALIGNANT^8409/3^^^
"DATA",169.3,84093,1,0)
^169.32^1^1
"DATA",169.3,84093,1,1,0)
POROCARCINOMA
"DATA",169.3,84100,0)
SEBACEOUS ADENOMA^8410/0^^^^67440^^3
"DATA",169.3,84100,1,0)
^169.32^1^1
"DATA",169.3,84100,1,1,0)
SEBACEOUS EPITHELIOMA
"DATA",169.3,84102,0)
SEBACEOUS ADENOCARCINOMA IN SITU^8410/2^^^
"DATA",169.3,84103,0)
SEBACEOUS ADENOCARCINOMA^8410/3^^^6744^67440^^3
"DATA",169.3,84103,1,0)
^169.32^1^1
"DATA",169.3,84103,1,1,0)
SEBACEOUS CARCINOMA
"DATA",169.3,84132,0)
ECCRINE ADENOCARCINOMA IN SITU^8413/2^^^
"DATA",169.3,84133,0)
ECCRINE ADENOCARCINOMA^8413/3^^^^67440^^
"DATA",169.3,84200,0)
CERUMINOUS ADENOMA^8420/0^^^^67442^^3
"DATA",169.3,84202,0)
CERUMINOUS ADENOCARCINOMA IN SITU^8420/2^^^
"DATA",169.3,84203,0)
CERUMINOUS ADENOCARCINOMA^8420/3^^^^67442^^3
"DATA",169.3,84203,1,0)
^169.32^1^1
"DATA",169.3,84203,1,1,0)
CERUMINOUS CARCINOMA
"DATA",169.3,84301,0)
MUCOEPIDERMOID TUMOR^8430/1^^^^^^3
"DATA",169.3,84302,0)
MUCOEPIDERMOID CARCINOMA IN SITU^8430/2^^^
"DATA",169.3,84303,0)
MUCOEPIDERMOID CARCINOMA^8430/3^^^^^^3
"DATA",169.3,84400,0)
CYSTADENOMA, NOS^8440/0^^^^^^3
"DATA",169.3,84400,1,0)
^169.32^1^1
"DATA",169.3,84400,1,1,0)
CYSTOMA, NOS
"DATA",169.3,84401,0)
SEROUS CYSTADENOMA OF UNC MALIGNANT POTENTIAL^8440/1^^^
"DATA",169.3,84402,0)
CYSTADENOCARCINOMA IN SITU^8440/2^^^
"DATA",169.3,84403,0)
CYSTADENOCARCINOMA, NOS^8440/3^^^^^^3
"DATA",169.3,84410,0)
SEROUS CYSTADENOMA, NOS^8441/0^^^6756^67569^^3
"DATA",169.3,84410,1,0)
^169.32^2^2
"DATA",169.3,84410,1,1,0)
SEROUS CYSTOMA
"DATA",169.3,84410,1,2,0)
SEROUS MICROCYSTIC ADENOMA
"DATA",169.3,84412,0)
SEROUS CYSTADENOCARCINOMA IN SITU^8441/2^^^
"DATA",169.3,84412,1,0)
^169.32^3^3
"DATA",169.3,84412,1,1,0)
SEROUS CYSTADENOCARCINOMA IN SITU
"DATA",169.3,84412,1,2,0)
SEROUS ENDOMETRIAL INTRAEPITHELIAL CARCINOMA (C54._, C55.9)
"DATA",169.3,84412,1,3,0)
SEROUS TUBAL INTRAEPITHELIAL CARCINOMA (C57.0)
"DATA",169.3,84413,0)
SEROUS CYSTADENOCARCINOMA, NOS^8441/3^^^6756^67569^^3
"DATA",169.3,84413,1,0)
^169.32^2^2
"DATA",169.3,84413,1,1,0)
SEROUS ADENOCARCINOMA, NOS
"DATA",169.3,84413,1,2,0)
SEROUS CARCINOMA, NOS
"DATA",169.3,84421,0)
SEROUS CYSTADENOMA, BORDERLINE^8442/1^^^6756^67569^^3
"DATA",169.3,84421,1,0)
^169.32^5^2
"DATA",169.3,84421,1,4,0)
SEROUS TUMOR, NOS, OF LOW MALIGNANT POTENTIAL
"DATA",169.3,84421,1,5,0)
ATYPICAL PROLIFERATING SEROUS TUMOR
"DATA",169.3,84430,0)
CLEAR CELL CYSTADENOMA^8443/0^^^^67569^^
"DATA",169.3,84441,0)
CLEAR CELL CYSTIC/BORDERLINE MALIGNANCY^8444/1^^^^67569^^
"DATA",169.3,84441,1,0)
^169.32^1^1
"DATA",169.3,84441,1,1,0)
ATYPICAL PROLIFERATING CLEAR CELL TUMOR
"DATA",169.3,84500,0)
PAPILLARY CYSTADENOMA, NOS^8450/0^^^^67569^^3
"DATA",169.3,84502,0)
PAPILLARY CYSTADENOCARCINOMA IN SITU^8450/2^^^
"DATA",169.3,84503,0)
PAPILLARY CYSTADENOCARCINOMA, NOS^8450/3^^^6756^67569^^3
"DATA",169.3,84503,1,0)
^169.32^3^1
"DATA",169.3,84503,1,3,0)
PAPILLOCYSTIC ADENOCARCINOMA
"DATA",169.3,84511,0)
PAPILLARY CYSTADENOMA, BORDERLINE^8451/1^^^^67569^^
"DATA",169.3,84521,0)
SOLID PSEUDOPAPILLARY TUMOR^8452/1^^^6725^67250^^3
"DATA",169.3,84521,1,0)
^169.32^3^3
"DATA",169.3,84521,1,1,0)
SOLID AND PAPILLARY EPITHELIAL NEOPLASM
"DATA",169.3,84521,1,2,0)
SOLID AND CYSTIC TUMOR
"DATA",169.3,84521,1,3,0)
PAPILLARY CYSTIC TUMOR
"DATA",169.3,84522,0)
SOLID PSEUDOPAPILLARY CARCINOMA IN SITU^8452/2^^^
"DATA",169.3,84523,0)
SOLID PSEUDOPAPILLARY CARCINOMA^8452/3^^^^67250^^
"DATA",169.3,84530,0)
INTRADUCTAL PAPILLARY-MUCINOUS ADENOMA^8453/0^^^^67250^^
"DATA",169.3,84531,0)
INTRADUCTAL PAPILLARY-MUCINOUS/MOD DYSPLASIA^8453/1^^^^67250^^
"DATA",169.3,84532,0)
INTRADUCTAL PAPILLARY-MUCINOUS CA, NON-INV^8453/2^^^^67250^^
"DATA",169.3,84532,1,0)
^169.32^1^1
"DATA",169.3,84532,1,1,0)
INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM W/HIGH-GRADE DYSPLASIA (C25._)
"DATA",169.3,84533,0)
INTRADUCTAL PAPILLARY-MUCINOUS CA, INVASIVE^8453/3^^^^67250^^
"DATA",169.3,84533,1,0)
^169.32^1^1
"DATA",169.3,84533,1,1,0)
INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM (IPMN) W/ASSOC INV CARC (C25._
"DATA",169.3,84540,0)
CYSTIC TUMOR OF ATRIO-VENTRICULAR NODE^8454/0^^^^67380^^
"DATA",169.3,84600,0)
PAPILLARY SEROUS CYSTADENOMA, NOS^8460/0^^^6756^67569^^3
"DATA",169.3,84602,0)
PAPILLARY SEROUS CYSTADENOCARCINOMA IN SITU^8460/2^^^
"DATA",169.3,84602,1,0)
^169.32^3^3
"DATA",169.3,84602,1,1,0)
PAPILLARY SEROUS CYSTADENOCARCINOMA IN SITU
"DATA",169.3,84602,1,2,0)
SEROUS BORDERLINE TUMOR-MICROPAPILLARY VARIANT (C56.9)
"DATA",169.3,84602,1,3,0)
NON-INVASIVE LOW GRADE SEROUS CARCINOMA (C56.9)
"DATA",169.3,84603,0)
PAPILLARY SEROUS CYSTADENOCARCINOMA^8460/3^^^^67569^^3
"DATA",169.3,84603,1,0)
^169.32^4^3
"DATA",169.3,84603,1,2,0)
PAPILLARY SEROUS ADENOCARCINOMA
"DATA",169.3,84603,1,3,0)
MICROPAPILLARY SEROUS CARCINOMA
"DATA",169.3,84603,1,4,0)
LOW-GRADE SEROUS CARCINOMA (C56.9, C48._, C57.0, C57.1-C57.3)
"DATA",169.3,84610,0)
SEROUS SURFACE PAPILLOMA^8461/0^^^^67569^^
"DATA",169.3,84611,0)
SEROUS SURFACE PAPILLOMA OF UNC MALIGNANT POT^8461/1^^^
"DATA",169.3,84612,0)
SEROUS SURFACE PAPILLARY CARCINOMA IN SITU^8461/2^^^
"DATA",169.3,84613,0)
SEROUS SURFACE PAPILLARY CARCINOMA^8461/3^^^^67569^^3
"DATA",169.3,84613,1,0)
^169.32^2^2
"DATA",169.3,84613,1,1,0)
PRIMARY SEROUS PAPILLARY CA OF PERITONEUM
"DATA",169.3,84613,1,2,0)
HIGH-GRADE SEROUS CARCINOMA (C48._, C56.9, C57.0, C57.1-C57.3)
"DATA",169.3,84621,0)
SEROUS PAPILLARY CYSTIC TUMOR, BORDERLINE^8462/1^^^6756^67569^^3
"DATA",169.3,84621,1,0)
^169.32^5^3
"DATA",169.3,84621,1,3,0)
PAPILLARY SEROUS CYSTADENOMA, BORDERLINE MAL
"DATA",169.3,84621,1,4,0)
PAPILLARY SEROUS TUMOR OF LOW MALIGNANT POT
"DATA",169.3,84621,1,5,0)
ATYPICAL PROLIFERATIVE PAPILLARY SEROUS TUMOR
"DATA",169.3,84631,0)
SEROUS SURFACE PAPILLARY TUMOR/BORDERLINE MAL^8463/1^^^^67569^^
"DATA",169.3,84700,0)
MUCINOUS CYSTADENOMA, NOS^8470/0^^^6756^67569^^3
"DATA",169.3,84700,1,0)
^169.32^2^2
"DATA",169.3,84700,1,1,0)
MUCINOUS CYSTOMA
"DATA",169.3,84700,1,2,0)
PSEUDOMUCINOUS CYSTADENOMA, NOS
"DATA",169.3,84701,0)
MUCINOUS CYSTIC TUMOR WITH MODERATE DYSPLASIA^8470/1^^^^67250^^
"DATA",169.3,84702,0)
MUCINOUS CYSTADENOCARCINOMA, NON-INVASIVE^8470/2^^^^67250^^3
"DATA",169.3,84703,0)
MUCINOUS CYSTADENOCARCINOMA, NOS^8470/3^^^6756^67569^^3
"DATA",169.3,84703,1,0)
^169.32^5^3
"DATA",169.3,84703,1,3,0)
PSEUDOMUCINOUS ADENOCARCINOMA
"DATA",169.3,84703,1,4,0)
PSEUDOMUCINOUS CYSTADENOCARCINOMA, NOS
"DATA",169.3,84703,1,5,0)
MUCINOUS CYSTIC TUMOR WITH ASSOCIATED INVASIVE CARCINOMA (C25._)
"DATA",169.3,84710,0)
PAPILLARY MUCINOUS CYSTADENOMA, NOS^8471/0^^^6756^67569^^3
"DATA",169.3,84710,1,0)
^169.32^1^1
"DATA",169.3,84710,1,1,0)
PAPILLARY PSEUDOMUCINOUS CYSTADENOMA, NOS
"DATA",169.3,84712,0)
PAPILLARY MUCINOUS CYSTADENOCARCINOMA IN SITU^8471/2^^^
"DATA",169.3,84713,0)
PAPILLARY MUCINOUS CYSTADENOCARCINOMA^8471/3^^^^67569^^3
"DATA",169.3,84713,1,0)
^169.32^2^1
"DATA",169.3,84713,1,2,0)
PAPILLARY PSEUDOMUCINOUS CYSTADENOCARCINOMA
"DATA",169.3,84721,0)
MUCINOUS CYSTIC TUMOR, BORDERLINE^8472/1^^^6756^67569^^3
"DATA",169.3,84721,1,0)
^169.32^6^4
"DATA",169.3,84721,1,3,0)
MUCINOUS CYSTADENOMA, BORDERLINE MALIGNANCY
"DATA",169.3,84721,1,4,0)
PSEUDOMUCINOUS CYSTADENOMA, BORDERLINE MALIG
"DATA",169.3,84721,1,5,0)
MUCINOUS TUMOR, NOS, LOW MALIGNANT POTENTIAL
"DATA",169.3,84721,1,6,0)
ATYPICAL PROLIFERATIVE MUCINOUS TUMOR
"DATA",169.3,84731,0)
PAPILLARY MUCINOUS CYSTADENOMA, BORDERLINE^8473/1^^^6756^67569^^3
"DATA",169.3,84731,1,0)
^169.32^2^2
"DATA",169.3,84731,1,1,0)
PAPILLARY PSEUDOMUCINOUS CYSTADENOMA/BORDERLN
"DATA",169.3,84731,1,2,0)
PAPILLARY MUCINOUS TUMOR OF LOW MALIGNANT POT
"DATA",169.3,84743,0)
SEROMUCINOUS CARCINOMA (C56.9)^8474/3
"DATA",169.3,84800,0)
MUCINOUS ADENOMA^8480/0^^^^^^3
"DATA",169.3,84801,0)
LOW GRADE APPENDICEAL MUCINOUS NEOPLASM (C18.1)^8480/1
"DATA",169.3,84802,0)
MUCINOUS ADENOCARCINOMA IN SITU^8480/2^^^
"DATA",169.3,84803,0)
MUCINOUS ADENOCARCINOMA^8480/3^^^^^^3
"DATA",169.3,84803,1,0)
^169.32^11^11
"DATA",169.3,84803,1,1,0)
MUCINOUS CARCINOMA
"DATA",169.3,84803,1,2,0)
COLLOID ADENOCARCINOMA
"DATA",169.3,84803,1,3,0)
COLLOID CARCINOMA
"DATA",169.3,84803,1,4,0)
GELATINOUS ADENOCARCINOMA
"DATA",169.3,84803,1,5,0)
GELATINOUS CARCINOMA
"DATA",169.3,84803,1,6,0)
MUCOID ADENOCARCINOMA
"DATA",169.3,84803,1,7,0)
MUCOID CARCINOMA
"DATA",169.3,84803,1,8,0)
MUCOUS ADENOCARCINOMA
"DATA",169.3,84803,1,9,0)
MUCOUS CARCINOMA
"DATA",169.3,84803,1,10,0)
PSEUDOMYXOMA PERITONEI W UNKNOWN PRIMARY SITE
"DATA",169.3,84803,1,11,0)
MUCINOUS TUBULAR AND SPINDLE CELL CARCINOMA (C64.9)
"DATA",169.3,84812,0)
MUCIN-PRODUCING ADENOCARCINOMA IN SITU^8481/2^^^
"DATA",169.3,84813,0)
MUCIN-PRODUCING ADENOCARCINOMA^8481/3^^^^^^3
"DATA",169.3,84813,1,0)
^169.32^3^3
"DATA",169.3,84813,1,1,0)
MUCIN-PRODUCING CARCINOMA
"DATA",169.3,84813,1,2,0)
MUCIN-SECRETING ADENOCARCINOMA
"DATA",169.3,84813,1,3,0)
MUCIN-SECRETING CARCINOMA
"DATA",169.3,84822,0)
MUCINOUS ADENOCA IN SITU, ENDOCERVICAL TYPE^8482/2^^^
"DATA",169.3,84823,0)
MUCINOUS ADENOCARCINOMA, ENDOCERVICAL TYPE^8482/3^^^
"DATA",169.3,84823,1,0)
^169.32^1^1
"DATA",169.3,84823,1,1,0)
MUCINOUS CARCINOMA, GASTRIC TYPE (C53._)
"DATA",169.3,84902,0)
SIGNET RING CELL CARCINOMA IN SITU^8490/2^^^
"DATA",169.3,84903,0)
SIGNET RING CELL CARCINOMA^8490/3^^^^^^3
"DATA",169.3,84903,1,0)
^169.32^1^1
"DATA",169.3,84903,1,1,0)
SIGNET RING CELL ADENOCARCINOMA
"DATA",169.3,85002,0)
DUCTAL CARCINOMA, NONINFILTRATING, NOS^8500/2^^^^^^3
"DATA",169.3,85002,1,0)
^169.32^9^9
"DATA",169.3,85002,1,1,0)
INTRADUCTAL ADENOCA, NONINFILTRATING, NOS
"DATA",169.3,85002,1,2,0)
INTRADUCTAL CARCINOMA, NOS
"DATA",169.3,85002,1,3,0)
DUCTAL CARCINOMA IN SITU, NOS
"DATA",169.3,85002,1,4,0)
DUCTAL INTRAEPITHELIAL NEOPLASIA 3
"DATA",169.3,85002,1,5,0)
DIN 3
"DATA",169.3,85002,1,6,0)
DCIS, NOS
"DATA",169.3,85002,1,7,0)
LOW GRADE CRIBRIFORM CYSTADENOCARCINOMA (LGCCC) (C06.9, C08.9)
"DATA",169.3,85002,1,8,0)
MAMMARY CARCINOMA, IN SITU  (C50._)
"DATA",169.3,85002,1,9,0)
NON-INVASIVE MAMMARY CARCINOMA (C50._)
"DATA",169.3,85003,0)
INFILTRATING DUCT CARCINOMA, NOS^8500/3^^^6750^67500^^3
"DATA",169.3,85003,1,0)
^169.32^9^9
"DATA",169.3,85003,1,1,0)
INFILTRATING DUCT ADENOCARCINOMA
"DATA",169.3,85003,1,2,0)
DUCT ADENOCARCINOMA, NOS
"DATA",169.3,85003,1,3,0)
DUCT CARCINOMA, NOS
"DATA",169.3,85003,1,4,0)
DUCT CELL CARCINOMA
"DATA",169.3,85003,1,5,0)
DUCTAL CARCINOMA, NOS
"DATA",169.3,85003,1,6,0)
SALIVARY DUCT CARCINOMA (C06.9, C08.9)
"DATA",169.3,85003,1,7,0)
INVASIVE CARCINOMA OF NO SPECIAL TYPE (C50._)
"DATA",169.3,85003,1,8,0)
INVASIVE CARCINOMA, NST (C50._)
"DATA",169.3,85003,1,9,0)
INVASIVE MAMMARY CARCINOMA (C50._)
"DATA",169.3,85012,0)
COMEDOCARCINOMA, NONINFILTRATING^8501/2^^^^67500^^3
"DATA",169.3,85012,1,0)
^169.32^2^2
"DATA",169.3,85012,1,1,0)
DUCTAL CARCINOMA IN SITU, COMEDO TYPE
"DATA",169.3,85012,1,2,0)
DCIS, COMEDO TYPE
"DATA",169.3,85013,0)
COMEDOCARCINOMA, NOS^8501/3^^^^67500^^3
"DATA",169.3,85022,0)
JUVENILE CARCINOMA, IN SITU, OF BREAST^8502/2^^^
"DATA",169.3,85023,0)
SECRETORY CARCINOMA OF BREAST^8502/3^^^6750^67500^^3
"DATA",169.3,85023,1,0)
^169.32^1^1
"DATA",169.3,85023,1,1,0)
JUVENILE CARCINOMA OF BREAST
"DATA",169.3,85030,0)
INTRADUCTAL PAPILLOMA^8503/0^^^^^^3
"DATA",169.3,85030,1,0)
^169.32^2^2
"DATA",169.3,85030,1,1,0)
DUCT ADENOMA, NOS
"DATA",169.3,85030,1,2,0)
DUCTAL PAPILLOMA
"DATA",169.3,85032,0)
NONINFILTRATING INTRADUCTAL PAPILLARY ADENOCA^8503/2^^^6750^67500^^3
"DATA",169.3,85032,1,0)
^169.32^7^7
"DATA",169.3,85032,1,1,0)
NONINFILTRATING INTRADUCTAL PAPILLARY CA
"DATA",169.3,85032,1,2,0)
INTRADUCTAL PAPILLARY ADENOCARCINOMA, NOS
"DATA",169.3,85032,1,3,0)
INTRADUCTAL PAPILLARY CARCINOMA, NOS
"DATA",169.3,85032,1,4,0)
DUCTAL CARCINOMA IN SITU, PAPILLARY
"DATA",169.3,85032,1,5,0)
DCIS, PAPILLARY
"DATA",169.3,85032,1,6,0)
INTRADUCTAL PAPILLOMA WITH DUCTAL CARCINOMA IN SITU (C50._)
"DATA",169.3,85032,1,7,0)
INTRADUCTAL TUBULOPAPILLARY NEOPLASM (C25._)
"DATA",169.3,85033,0)
INTRADUCTAL PAPILLARY ADENOCA WITH INVASION^8503/3^^^6750^67500^^3
"DATA",169.3,85033,1,0)
^169.32^3^3
"DATA",169.3,85033,1,1,0)
INFILTRATING PAPILLARY ADENOCARCINOMA
"DATA",169.3,85033,1,2,0)
INFILTRATING AND PAPILLARY ADENOCARCINOMA
"DATA",169.3,85033,1,3,0)
INTRACYSTIC PAPILLARY NEOPLASM W/ASSOCIATED INVASIVE CARCINOMA
"DATA",169.3,85040,0)
INTRACYSTIC PAPILLARY ADENOMA^8504/0^^^^^^3
"DATA",169.3,85040,1,0)
^169.32^1^1
"DATA",169.3,85040,1,1,0)
INTRACYSTIC PAPILLOMA
"DATA",169.3,85042,0)
NONINFILTRATING INTRACYSTIC CARCINOMA^8504/2^^^^^^3
"DATA",169.3,85042,1,0)
^169.32^2^1
"DATA",169.3,85042,1,2,0)
ENCAPSULATED PAPILLARY CARCINOMA (C50._)
"DATA",169.3,85043,0)
INTRACYSTIC CARCINOMA, NOS^8504/3^^^^^^3
"DATA",169.3,85043,1,0)
^169.32^2^2
"DATA",169.3,85043,1,1,0)
INTRACYSTIC PAPILLARY ADENOCARCINOMA
"DATA",169.3,85043,1,2,0)
ENCAPSULATED PAPILLARY CARCINOMA W/INVASION (C50._)
"DATA",169.3,85050,0)
INTRADUCTAL PAPILLOMATOSIS, NOS^8505/0^^^^^^3
"DATA",169.3,85050,1,0)
^169.32^1^1
"DATA",169.3,85050,1,1,0)
DIFFUSE INTRADUCTAL PAPILLOMATOSIS
"DATA",169.3,85060,0)
ADENOMA OF NIPPLE^8506/0^^^6750^67500^^3
"DATA",169.3,85060,1,0)
^169.32^1^1
"DATA",169.3,85060,1,1,0)
SUBAREOLAR DUCT PAPILLOMATOSIS
"DATA",169.3,85072,0)
INTRADUCTAL MICROPAPILLARY CARCINOMA^8507/2^^^^67500^^
"DATA",169.3,85072,1,0)
^169.32^2^2
"DATA",169.3,85072,1,1,0)
DUCTAL CARCINOMA IN SITU, MICROPAPILLARY
"DATA",169.3,85072,1,2,0)
INTRADUCTAL CARCINOMA, CLINGING
"DATA",169.3,85073,0)
INVASIVE MICROPAPILLARY CARCINOMA (C50._)^8507/3^^^^^^3
"DATA",169.3,85073,1,0)
^169.32^1^1
"DATA",169.3,85073,1,1,0)
MICROPAPILLARY CARCINOMA, NOS
"DATA",169.3,85082,0)
CYSTIC HYPERSECRETORY CARCINOMA IN SITU^8508/2^^^
"DATA",169.3,85083,0)
CYSTIC HYPERSECRETORY CARCINOMA^8508/3^^^^67500^^
"DATA",169.3,85092,0)
SOLID PAPILLARY CARCINOMA IN SITU (C50._)^8509/2
"DATA",169.3,85093,0)
SOLID PAPILLARY CARCINOMA WITH INVASION (C50._)^8509/3
"DATA",169.3,85102,0)
MEDULLARY CARCINOMA IN SITU^8510/2^^^
"DATA",169.3,85103,0)
MEDULLARY CARCINOMA, NOS^8510/3^^^6773^67739^^3
"DATA",169.3,85103,1,0)
^169.32^2^2
"DATA",169.3,85103,1,1,0)
MEDULLARY ADENOCARCINOMA
"DATA",169.3,85103,1,2,0)
RENAL MEDULLARY CARCINOMA (C64.9)
"DATA",169.3,85122,0)
MEDULLARY CARCINOMA W LYMPHOID STROMA IN SITU^8512/2^^^
"DATA",169.3,85123,0)
MEDULLARY CARCINOMA WITH LYMPHOID STROMA^8512/3^^^6750^^^3
"DATA",169.3,85132,0)
ATYPICAL MEDULLARY CARCINOMA IN SITU^8513/2^^^
"DATA",169.3,85133,0)
ATYPICAL MEDULLARY CARCINOMA^8513/3^^^^67500^^
"DATA",169.3,85142,0)
DUCT CARCINOMA IN SITU, DESMOPLASTIC TYPE^8514/2^^^
"DATA",169.3,85143,0)
DUCT CARCINOMA, DESMOPLASTIC TYPE^8514/3^^^
"DATA",169.3,85192,0)
PLEOMORPHIC LOBULAR CARCINOMA IN SITU (C50._)^8519/2
"DATA",169.3,85202,0)
LOBULAR CARCINOMA IN SITU, NOS^8520/2^^^6750^67500^^3
"DATA",169.3,85202,1,0)
^169.32^3^3
"DATA",169.3,85202,1,1,0)
LOBULAR CARCINOMA, NONINFILTRATING
"DATA",169.3,85202,1,2,0)
LCIS, NOS
"DATA",169.3,85202,1,3,0)
INTRADUCTAL PAPILLOMA WITH LOBULAR CARCINOMA IN SITU (C50._)
"DATA",169.3,85203,0)
LOBULAR CARCINOMA, NOS^8520/3^^^6750^67500^^3
"DATA",169.3,85203,1,0)
^169.32^8^8
"DATA",169.3,85203,1,1,0)
LOBULAR ADENOCARCINOMA
"DATA",169.3,85203,1,2,0)
INFILTRATING LOBULAR CARCINOMA, NOS
"DATA",169.3,85203,1,3,0)
TUBULOLOBULAR CARCINOMA (C50._)
"DATA",169.3,85203,1,4,0)
INVASIVE LOBULAR CARCINOMA (C50._)
"DATA",169.3,85203,1,5,0)
PLEOMORPHIC LOBULAR CARCINOMA (C50._)
"DATA",169.3,85203,1,6,0)
INVASIVE LOBULAR CARCINOMA, TUBULOLOBULAR VARIANT (C50._)
"DATA",169.3,85203,1,7,0)
INVASIVE LOBULAR CARCINOMA, SOLID TYPE (C50._)
"DATA",169.3,85203,1,8,0)
INVASIVE LOBULAR CARCINOMA, ALVEOLAR TYPE (C50._)
"DATA",169.3,85212,0)
INFILTRATING DUCTULAR CARCINOMA IN SITU^8521/2^^^
"DATA",169.3,85213,0)
INFILTRATING DUCTULAR CARCINOMA^8521/3^^^^67500^^3
"DATA",169.3,85222,0)
INFILTRATING DUCT AND LOBULAR CA IN SITU^8522/2^^^^67500^^
"DATA",169.3,85223,0)
INFILTRATING DUCT AND LOBULAR CARCINOMA^8522/3^^^6750^67500^^3
"DATA",169.3,85223,1,0)
^169.32^4^4
"DATA",169.3,85223,1,1,0)
LOBULAR AND DUCTAL CARCINOMA
"DATA",169.3,85223,1,2,0)
INFILTRATING DUCT AND LOBULAR CA IN SITU
"DATA",169.3,85223,1,3,0)
INTRADUCTAL AND LOBULAR CARCINOMA
"DATA",169.3,85223,1,4,0)
INFILTRATING LOBULAR CA AND DUCTAL CA IN SITU
"DATA",169.3,85232,0)
INFILTRATING DUCT IN SITU W OTHER TYPES OF CA^8523/2^^^
"DATA",169.3,85233,0)
INFILTRATING DUCT MIXED W OTHER TYPES OF CA^8523/3^^^^67500^^
"DATA",169.3,85233,1,0)
^169.32^4^4
"DATA",169.3,85233,1,1,0)
INFILTRATING DUCT AND CRIBRIFORM CARCINOMA
"DATA",169.3,85233,1,2,0)
INFILTRATING DUCT AND MUCINOUS CARCINOMA
"DATA",169.3,85233,1,3,0)
INFILTRATING DUCT AND TUBULAR CARCINOMA
"DATA",169.3,85233,1,4,0)
INFILTRATING DUCT AND COLLOID CARCINOMA
"DATA",169.3,85242,0)
IN SITU LOBULAR MIXED WITH OTHER IN SITU CA^8524/2^^^
"DATA",169.3,85243,0)
INFILTRATING LOBULAR MIXED W OTHER TYPES CA^8524/3^^^^67500^^
"DATA",169.3,85252,0)
POLYMORPHOUS LOW GRADE ADENOCARCINOMA IN SITU^8525/2^^^
"DATA",169.3,85253,0)
POLYMORPHOUS LOW GRADE ADENOCARCINOMA^8525/3^^^
"DATA",169.3,85253,1,0)
^169.32^1^1
"DATA",169.3,85253,1,1,0)
TERMINAL DUCT ADENOCARCINOMA
"DATA",169.3,85302,0)
INFLAMMATORY CARCINOMA IN SITU^8530/2^^^
"DATA",169.3,85303,0)
INFLAMMATORY CARCINOMA^8530/3^^^6750^67500^^3
"DATA",169.3,85303,1,0)
^169.32^1^1
"DATA",169.3,85303,1,1,0)
INFLAMMATORY ADENOCARCINOMA
"DATA",169.3,85402,0)
PAGET DISEASE, MAMMARY, IN SITU^8540/2^^^
"DATA",169.3,85402,1,0)
^169.32^1^1
"DATA",169.3,85402,1,1,0)
PAGET DISEASE IN SITU OF BREAST
"DATA",169.3,85403,0)
PAGET DISEASE, MAMMARY^8540/3^^^^67500^^3
"DATA",169.3,85403,1,0)
^169.32^1^1
"DATA",169.3,85403,1,1,0)
PAGET DISEASE OF BREAST
"DATA",169.3,85412,0)
PAGET DISEASE/INFLT DUCT CA OF BREAST IN SITU^8541/2^^^
"DATA",169.3,85413,0)
PAGET DISEASE/INFILTRATING DUCT CA OF BREAST^8541/3^^^^67500^^3
"DATA",169.3,85422,0)
PAGET DISEASE, EXTRAMAMMARY, IN SITU^8542/2^^^
"DATA",169.3,85423,0)
PAGET DISEASE, EXTRAMAMMARY^8542/3^^^^^^3
"DATA",169.3,85432,0)
PAGET DISEASE/INTRADUCT CA OF BREAST IN SITU^8543/2^^^
"DATA",169.3,85433,0)
PAGET DISEASE AND INTRADUCTAL CA OF BREAST^8543/3^^^^67500^^3
"DATA",169.3,85500,0)
ACINAR CELL ADENOMA^8550/0^^^^^^3
"DATA",169.3,85500,1,0)
^169.32^2^2
"DATA",169.3,85500,1,1,0)
ACINAR ADENOMA
"DATA",169.3,85500,1,2,0)
ACINIC CELL ADENOMA
"DATA",169.3,85501,0)
ACINAR CELL TUMOR^8550/1^^^^^^3
"DATA",169.3,85501,1,0)
^169.32^1^1
"DATA",169.3,85501,1,1,0)
ACINIC CELL TUMOR
"DATA",169.3,85502,0)
ACINAR CELL CARCINOMA IN SITU^8550/2^^^
"DATA",169.3,85503,0)
ACINAR CELL CARCINOMA^8550/3^^^^^^3
"DATA",169.3,85503,1,0)
^169.32^4^4
"DATA",169.3,85503,1,1,0)
ACINIC CELL ADENOCACARCINOMA
"DATA",169.3,85503,1,2,0)
ACINAR ADENOCARCINOMA
"DATA",169.3,85503,1,3,0)
ACINAR CARCINOMA
"DATA",169.3,85503,1,4,0)
ACINAR CELL CARCINOMA
"DATA",169.3,85512,0)
ACINAR CELL CYSTADENOCARCINOMA IN SITU^8551/2^^^
"DATA",169.3,85513,0)
ACINAR CELL CYSTADENOCARCINOMA^8551/3^^^
"DATA",169.3,85513,1,0)
^169.32^1^1
"DATA",169.3,85513,1,1,0)
ACINAR ADENOCARCINOMA (C34._)
"DATA",169.3,85523,0)
MIXED ACINAR DUCTAL CARCINOMA^8552/3
"DATA",169.3,85523,1,0)
^169.32^^0
"DATA",169.3,85600,0)
MIXED SQUAMOUS CELL AND GLANDULAR PAPILLOMA^8560/0^^^
"DATA",169.3,85602,0)
ADENOSQUAMOUS CARCINOMA IN SITU^8560/2^^^
"DATA",169.3,85603,0)
ADENOSQUAMOUS CARCINOMA^8560/3^^^^^^3
"DATA",169.3,85603,1,0)
^169.32^2^2
"DATA",169.3,85603,1,1,0)
MIXED ADENOCARCINOMA AND SQUAMOUS CELL CA
"DATA",169.3,85603,1,2,0)
MIXED ADENOCARCINOMA AND EPIDERMOID CARCINOMA
"DATA",169.3,85610,0)
ADENOLYMPHOMA^8561/0^67080^^6708^67079^^3
"DATA",169.3,85610,1,0)
^169.32^3^2
"DATA",169.3,85610,1,1,0)
PAPILLARY CYSTADENOMA LYMPHOMATOSUM
"DATA",169.3,85610,1,3,0)
WARTHIN TUMOR
"DATA",169.3,85622,0)
EPITHELIAL-MYOPITHELIAL CARCINOMA IN SITU^8562/2^^^
"DATA",169.3,85623,0)
EPITHELIAL-MYOPITHELIAL CARCINOMA^8562/3^^^^^^3
"DATA",169.3,85702,0)
ADENOCARCINOMA W SQUAMOUS METAPLASIA IN SITU^8570/2^^^
"DATA",169.3,85703,0)
ADENOCARCINOMA WITH SQUAMOUS METAPLASIA^8570/3^^^^^^3
"DATA",169.3,85703,1,0)
^169.32^2^2
"DATA",169.3,85703,1,1,0)
LOW GRADE ADENOSQUAMOUS CARCINOMA (C50._)
"DATA",169.3,85703,1,2,0)
ENDOMETRIOID CARCINOMA WITH SQUAMOUS DIFFERENTIATION (C54._, C55.9)
"DATA",169.3,85712,0)
ADENOCA W CARTILAG & OSSEOUS METAPLAS IN SITU^8571/2^^^
"DATA",169.3,85713,0)
ADENOCA W CARTILAGINOUS & OSSEOUS METAPLASIA^8571/3^^^^^^3
"DATA",169.3,85713,1,0)
^169.32^4^4
"DATA",169.3,85713,1,1,0)
CARCINOMA WITH OSSEOUS DIFFERENTIATION (C50._)
"DATA",169.3,85713,1,2,0)
METAPLASTIC CARCINOMA WITH CHONDROID DIFF (C50._)
"DATA",169.3,85713,1,3,0)
METAPLASTIC CARCINOMA WITH OSSEOUS DIFF (C50._)
"DATA",169.3,85713,1,4,0)
CARCINOMA WITH CHONDROID DIFFERENTIATION (C50._)
"DATA",169.3,85722,0)
ADENOCA W SPINDLE CELL METAPLASIA IN SITU^8572/2^^^
"DATA",169.3,85723,0)
ADENOCARCINOMA WITH SPINDLE CELL METAPLASIA^8572/3^^^^^^3
"DATA",169.3,85723,1,0)
^169.32^2^2
"DATA",169.3,85723,1,1,0)
FIBROMATOSIS-LIKE METAPLASTIC CARCINOMA (C50._)
"DATA",169.3,85723,1,2,0)
ACINAR ADENOCARCINOMA, SARCOMATOID (C61.9)
"DATA",169.3,85732,0)
ADENOCA W APOCRINE METAPLASIA IN SITU^8573/2^^^
"DATA",169.3,85733,0)
ADENOCARCINOMA WITH APOCRINE METAPLASIA^8573/3^^^^^^3
"DATA",169.3,85733,1,0)
^169.32^1^1
"DATA",169.3,85733,1,1,0)
CARCINOMA WITH APOCRINE METAPLASIA
"DATA",169.3,85742,0)
ADENOCA W NEUROENDOCRINE DIFF IN SITU^8574/2^^^
"DATA",169.3,85743,0)
ADENOCA WITH NEUROENDOCRINE DIFFERENTIATION^8574/3^^^
"DATA",169.3,85743,1,0)
^169.32^2^2
"DATA",169.3,85743,1,1,0)
CARCINOMA WITH NEUROENDOCRINE DIFFERENTIATION
"DATA",169.3,85743,1,2,0)
ADENOCARCINOMA ADMIXED WITH NEUROENDOCRINE CARCINOMA (C53._)
"DATA",169.3,85752,0)
METAPLASTIC CARCINOMA IN SITU^8575/2^^^
"DATA",169.3,85753,0)
METAPLASTIC CARCINOMA, NOS^8575/3^^^
"DATA",169.3,85753,1,0)
^169.32^3^3
"DATA",169.3,85753,1,1,0)
METAPLASTIC CARCIMONA WITH OTHER TYPES MESEN
"DATA",169.3,85753,1,2,0)
METAPLATIC CARCINOMA OF NO SPECIAL TYPE
"DATA",169.3,85753,1,3,0)
CARCIMONA WITH OTHER TYPES MESENCHYMAL DIFFERENTIATION (C50._)
"DATA",169.3,85762,0)
HEPATOID ADENOCARCINOMA IN SITU^8576/2^^^
"DATA",169.3,85763,0)
HEPATOID ADENOCARCINOMA^8576/3^^^
"DATA",169.3,85763,1,0)
^169.32^1^1
"DATA",169.3,85763,1,1,0)
HEPATOID CARCINOMA
"DATA",169.3,85800,0)
THYMOMA, BENIGN^8580/0^^^^67379^^
"DATA",169.3,85801,0)
THYMOMA, NOS^8580/1^^^6737^67379^^3
"DATA",169.3,85801,1,0)
^169.32^^0
"DATA",169.3,85802,0)
THYMOMA, IN SITU^8580/2^^^
"DATA",169.3,85803,0)
THYMOMA, MALIGNANT, NOS^8580/3^^^6737^67379^^3
"DATA",169.3,85803,1,0)
^169.32^^0
"DATA",169.3,85811,0)
THYMOMA, TYPE A, NOS^8581/1^^^^67379^^
"DATA",169.3,85811,1,0)
^169.32^2^2
"DATA",169.3,85811,1,1,0)
THYMOMA, SPINDLE CELL, NOS
"DATA",169.3,85811,1,2,0)
THYMOMA, MEDULLARY, NOS
"DATA",169.3,85812,0)
THYMOMA, TYPE A, IN SITU^8581/2^^^
"DATA",169.3,85813,0)
THYMOMA, TYPE A, MALIGNANT^8581/3^^^^67379^^
"DATA",169.3,85813,1,0)
^169.32^2^2
"DATA",169.3,85813,1,1,0)
THYMOMA, SPINDLE CELL, MALIGNANT
"DATA",169.3,85813,1,2,0)
THYMOMA, MEDULLARY, MALIGNANT
"DATA",169.3,85821,0)
THYMOMA, TYPE AB, NOS^8582/1^^^^67379^^
"DATA",169.3,85821,1,0)
^169.32^1^1
"DATA",169.3,85821,1,1,0)
THYMOMA, MIXED TYPE, NOS
"DATA",169.3,85822,0)
THYMOMA, TYPE AB, IN SITU^8582/2^^^
"DATA",169.3,85823,0)
THYMOMA, TYPE AB, MALIGNANT^8582/3^^^^67379^^
"DATA",169.3,85823,1,0)
^169.32^1^1
"DATA",169.3,85823,1,1,0)
THYMOMA, MIXED TYPE, MALIGNANT
"DATA",169.3,85831,0)
THYMOMA, TYPE B1, NOS^8583/1^^^^67379^^
"DATA",169.3,85831,1,0)
^169.32^4^4
"DATA",169.3,85831,1,1,0)
THYMOMA, LYMPHOCYTE-RICH, NOS
"DATA",169.3,85831,1,2,0)
THYMOMA, LYMPHOCYTIC, NOS
"DATA",169.3,85831,1,3,0)
THYMOMA, PREDOMINANTLY CORTICAL, NOS
"DATA",169.3,85831,1,4,0)
THYMOMA, ORGANOID, NOS
"DATA",169.3,85832,0)
THYMOMA, TYPE B1, IN SITU^8583/2^^^
"DATA",169.3,85833,0)
THYMOMA, TYPE B1, MALIGNANT^8583/3^^^^67379^^
"DATA",169.3,85833,1,0)
^169.32^4^4
"DATA",169.3,85833,1,1,0)
THYMOMA, LYMPHOCYTE-RICH, MALIGNANT
"DATA",169.3,85833,1,2,0)
THYMOMA, LYMPHOCYTIC, MALIGNANT
"DATA",169.3,85833,1,3,0)
THYMOMA, PREDOMINANTLY CORTICAL, MALIGNANT
"DATA",169.3,85833,1,4,0)
THYMOMA, ORGANOID, MALIGNANT
"DATA",169.3,85841,0)
THYMOMA, TYPE B2, NOS^8584/1^^^^67379^^
"DATA",169.3,85841,1,0)
^169.32^1^1
"DATA",169.3,85841,1,1,0)
THYMOMA, CORTICAL, NOS
"DATA",169.3,85842,0)
THYMOMA, TYPE B2, IN SITU^8584/2^^^
"DATA",169.3,85843,0)
THYMOMA, TYPE B2, MALIGNANT^8584/3^^^^67379^^
"DATA",169.3,85843,1,0)
^169.32^1^1
"DATA",169.3,85843,1,1,0)
THYMOMA, CORTICAL, MALIGNANT
"DATA",169.3,85851,0)
THYMOMA, TYPE B3, NOS^8585/1^^^^67379^^
"DATA",169.3,85851,1,0)
^169.32^2^2
"DATA",169.3,85851,1,1,0)
THYMOMA, EPITHELIAL, NOS
"DATA",169.3,85851,1,2,0)
THYMOMA, ATYPICAL, NOS
"DATA",169.3,85852,0)
THYMOMA, TYPE B3, IN SITU^8585/2^^^
"DATA",169.3,85853,0)
THYMOMA, TYPE B3, MALIGNANT^8585/3^^^^67379^^
"DATA",169.3,85853,1,0)
^169.32^3^3
"DATA",169.3,85853,1,1,0)
THYMOMA, EPITHELIAL, MALIGNANT
"DATA",169.3,85853,1,2,0)
THYMOMA, ATYPICAL, MALIGNANT
"DATA",169.3,85853,1,3,0)
WELL DIFFERENTIATED THYMIC CARCINOMA 
"DATA",169.3,85862,0)
THYMIC CARCINOMA IN SITU^8586/2^^^
"DATA",169.3,85863,0)
THYMIC CARCINOMA, NOS^8586/3^^^^67379^^
"DATA",169.3,85863,1,0)
^169.32^1^1
"DATA",169.3,85863,1,1,0)
THYMOMA, TYPE C
"DATA",169.3,85870,0)
ECTOPIC HAMARTOMATOUS THYMOMA^8587/0^^^
"DATA",169.3,85882,0)
SPINDLE EPITHELIAL TUM W THYMUS ELEM IN SITU^8588/2^^^
"DATA",169.3,85883,0)
SPINDLE EPITHELIAL TUMOR W THYMUS-LIKE ELEM^8588/3^^^
"DATA",169.3,85883,1,0)
^169.32^2^2
"DATA",169.3,85883,1,1,0)
SPINDLE EPITHELIAL TUMOR W THYMUS-LIKE DIFF
"DATA",169.3,85883,1,2,0)
SETTLE
"DATA",169.3,85892,0)
CARCINOMA SHOWING THYMUS-LIKE ELEMENT IN SITU^8589/2^^^
"DATA",169.3,85893,0)
CARCINOMA SHOWING THYMUS-LIKE ELEMENT^8589/3^^^
"DATA",169.3,85893,1,0)
^169.32^2^2
"DATA",169.3,85893,1,1,0)
CARCINOMA SHOWING THYMUS-LIKE DIFFERENTIATION
"DATA",169.3,85893,1,2,0)
CASTLE
"DATA",169.3,85901,0)
SEX CORD-GONADAL STROMAL TUMOR^8590/1^^^^^^2
"DATA",169.3,85901,1,0)
^169.32^4^4
"DATA",169.3,85901,1,1,0)
GONADAL STROMAL TUMOR, NOS
"DATA",169.3,85901,1,2,0)
TESTICULAR STROMAL TUMOR
"DATA",169.3,85901,1,3,0)
OVARIAN STROMAL TUMOR
"DATA",169.3,85901,1,4,0)
SEX CORD TUMOR, NOS
"DATA",169.3,85911,0)
SEX CORD-GONADAL STROMAL TUMOR, INC DIFF^8591/1^^^
"DATA",169.3,85921,0)
SEX CORD-GONADAL STROMAL TUMOR, MIXED FORMS^8592/1^^^
"DATA",169.3,85931,0)
STROMAL TUMOR WITH MINOR SEX CORD ELEMENTS^8593/1^^^^67569^^
"DATA",169.3,85941,0)
MIXED GERM CELL SEX CORD-STROMAL TUMOR, UNCLASSIFIED (C48.2, C56.9, C57.9)^8594/1
"DATA",169.3,86000,0)
THECOMA, NOS^8600/0^^^6756^67569^^2
"DATA",169.3,86000,1,0)
^169.32^1^1
"DATA",169.3,86000,1,1,0)
THECA CELL TUMOR
"DATA",169.3,86002,0)
THECOMA IN SITU^8600/2^^^
"DATA",169.3,86003,0)
THECOMA, MALIGNANT^8600/3^^^^67569^^2
"DATA",169.3,86010,0)
THECOMA, LUTEINIZED^8601/0^^^6756^67569^^2
"DATA",169.3,86020,0)
SCLEROSING STROMAL TUMOR^8602/0^^^6756^67569^^2
"DATA",169.3,86100,0)
LUTEOMA, NOS^8610/0^^^^67569^^
"DATA",169.3,86100,1,0)
^169.32^1^1
"DATA",169.3,86100,1,1,0)
LUTEINOMA
"DATA",169.3,86201,0)
GRANULOSA CELL TUMOR, ADULT TYPE^8620/1^^^6756^67569^^2
"DATA",169.3,86201,1,0)
^169.32^1^1
"DATA",169.3,86201,1,1,0)
GRANULOSA CELL TUMOR, NOS
"DATA",169.3,86202,0)
GRANULOSA CELL TUMOR IN SITU^8620/2^^^
"DATA",169.3,86203,0)
GRANULOSA CELL TUMOR, MALIGNANT^8620/3^^^6756^67569^^3
"DATA",169.3,86203,1,0)
^169.32^3^3
"DATA",169.3,86203,1,1,0)
GANULOSA CELL CARCINOMA
"DATA",169.3,86203,1,2,0)
GRANULOSA CELL TUMOR, SARCOMATOID
"DATA",169.3,86203,1,3,0)
ADULT GRANULOSA CELL TUMOR (C56.9 ONLY)
"DATA",169.3,86211,0)
GRANULOSA CELL-THECA CELL TUMOR^8621/1^^^^67569^^2
"DATA",169.3,86211,1,0)
^169.32^1^1
"DATA",169.3,86211,1,1,0)
THECA CELL-GRANULOSA CELL TUMOR
"DATA",169.3,86212,0)
GRANULOSA CELL-THECA CELL TUMOR IN SITU^8621/2^^^
"DATA",169.3,86213,0)
GRANULOSA CELL-THECA CELL TUMOR, MALIGNANT^8621/3^^^
"DATA",169.3,86221,0)
GRANULOSA CELL TUMOR, JUVENILE^8622/1^^^^67569^^2
"DATA",169.3,86222,0)
JUVENILE GRANULOSA CELL TUMOR IN SITU^8622/2^^^
"DATA",169.3,86223,0)
JUVENILE GRANULOSA CELL TUMOR, MALIGNANT^8622/3^^^
"DATA",169.3,86231,0)
SEX CORD TUMOR WITH ANNULAR TUBULES^8623/1^^^6756^67569^^2
"DATA",169.3,86300,0)
ANDROBLASTOMA, BENIGN^8630/0^^^^^^2
"DATA",169.3,86300,1,0)
^169.32^1^1
"DATA",169.3,86300,1,1,0)
ARRHENOBLASTOMA, BENIGN
"DATA",169.3,86301,0)
ANDROBLASTOMA, NOS^8630/1^^^^^^2
"DATA",169.3,86301,1,0)
^169.32^1^1
"DATA",169.3,86301,1,1,0)
ARRHENOBLASTOMA, NOS
"DATA",169.3,86302,0)
ANDROBLASTOMA IN SITU^8630/2^^^
"DATA",169.3,86303,0)
ANDROBLASTOMA, MALIGNANT^8630/3^^^^^^2
"DATA",169.3,86303,1,0)
^169.32^1^1
"DATA",169.3,86303,1,1,0)
ARRHENOBLASSTOMA, MALIGNANT
"DATA",169.3,86310,0)
SERTOLI-LEYDIG CELL TUMOR, WELL DIFF^8631/0^^^^^^2
"DATA",169.3,86311,0)
SERTOLI-LEYDIG CELL TUMOR, INTERMEDIATE DIFF^8631/1^^^
"DATA",169.3,86311,1,0)
^169.32^1^1
"DATA",169.3,86311,1,1,0)
SERTOLI-LEYDIG CELL TUMOR, NOS
"DATA",169.3,86312,0)
SERTOLI-LEYDIG CELL TUMOR IN SITU, POOR DIFF^8631/2^^^
"DATA",169.3,86313,0)
SERTOLI-LEYDIG CELL TUMOR, POORLY DIFF^8631/3^^^
"DATA",169.3,86313,1,0)
^169.32^1^1
"DATA",169.3,86313,1,1,0)
SERTOLI-LEYDIG CELL TUMOR, SARCOMATOID
"DATA",169.3,86321,0)
GYNANDROBLASTOMA^8632/1^^^^67569^^2
"DATA",169.3,86322,0)
TUBULAR ANDROBLASTOMA IN SITU^8632/2^^^
"DATA",169.3,86323,0)
TUBULAR ANDROBLASTOMA, MALIGNANT^8632/3^^^
"DATA",169.3,86331,0)
SERTOLI-LEYDIG CELL TUMOR, RETIFORM^8633/1^^^
"DATA",169.3,86341,0)
SERTOLI-LEYDIG CELL TUMOR, INT DIFF, HET ELEM^8634/1^^^
"DATA",169.3,86341,1,0)
^169.32^1^1
"DATA",169.3,86341,1,1,0)
SERTOLI-LEYDIG CELL TUMOR, RETIFORM, HET ELEM
"DATA",169.3,86342,0)
SERTOLI-LEYDIG CELL TUMOR IN SITU, HET ELEM^8634/2^^^
"DATA",169.3,86343,0)
SERTOLI-LEYDIG CELL TUMOR, POOR DIFF, HET ELE^8634/3^^^
"DATA",169.3,86401,0)
SERTOLI CELL TUMOR, NOS^8640/1^^^
"DATA",169.3,86401,1,0)
^169.32^4^4
"DATA",169.3,86401,1,1,0)
PICK TUBULAR ADENOMA
"DATA",169.3,86401,1,2,0)
SERTOLI CELL ADENOMA
"DATA",169.3,86401,1,3,0)
TUBULAR ANDROBLASTOMA, NOS
"DATA",169.3,86401,1,4,0)
TESTICULAR ADENOMA
"DATA",169.3,86402,0)
SERTOLI CELL CARCINOMA IN SITU^8640/2^^^
"DATA",169.3,86403,0)
SERTOLI CELL CARCINOMA^8640/3^^^6762^67620^^3
"DATA",169.3,86410,0)
SERTOLI CELL TUMOR WITH LIPID STORAGE^8641/0^^^^^^2
"DATA",169.3,86410,1,0)
^169.32^3^3
"DATA",169.3,86410,1,1,0)
FOLLICULOME LIPIDIQUE
"DATA",169.3,86410,1,2,0)
TUBULAR ANDROBLASTOMA WITH LIPID STORAGE
"DATA",169.3,86410,1,3,0)
LIPID-RICH SERTOLI CELL TUMOR
"DATA",169.3,86421,0)
LARGE CELL CALCIFYING SERTOLI CELL TUMOR^8642/1^^^
"DATA",169.3,86500,0)
LEYDIG CELL TUMOR, BENIGN^8650/0^^^6762^67620^^2
"DATA",169.3,86500,1,0)
^169.32^1^1
"DATA",169.3,86500,1,1,0)
INTERSTITIAL CELL TUMOR, BENIGN
"DATA",169.3,86501,0)
LEYDIG CELL TUMOR, NOS^8650/1^^^^67620^^2
"DATA",169.3,86501,1,0)
^169.32^1^1
"DATA",169.3,86501,1,1,0)
INTERSTITIAL CELL TUMOR, NOS
"DATA",169.3,86502,0)
LEYDIG CELL TUMOR IN SITU^8650/2^^^
"DATA",169.3,86503,0)
LEYDIG CELL TUMOR, MALIGNANT^8650/3^^^6762^67620^^2
"DATA",169.3,86503,1,0)
^169.32^1^1
"DATA",169.3,86503,1,1,0)
INTERSTITIAL CELL TUMOR, MALIGNANT
"DATA",169.3,86600,0)
HILUS CELL TUMOR^8660/0^^^6756^67569^^2
"DATA",169.3,86600,1,0)
^169.32^1^1
"DATA",169.3,86600,1,1,0)
HILAR CELL TUMOR
"DATA",169.3,86700,0)
LIPID CELL TUMOR OF OVARY^8670/0^^^6756^67569^^2
"DATA",169.3,86700,1,0)
^169.32^3^3
"DATA",169.3,86700,1,1,0)
LIPOID CELL TUMOR OF OVARY
"DATA",169.3,86700,1,2,0)
MASCULINOVOBLASTOMA
"DATA",169.3,86700,1,3,0)
STEROID CELL TUMOR, NOS
"DATA",169.3,86702,0)
STEROID CELL TUMOR IN SITU^8670/2^^^
"DATA",169.3,86703,0)
STEROID CELL TUMOR, MALIGNANT^8670/3^^^
"DATA",169.3,86710,0)
ADRENAL REST TUMOR^8671/0^^^^^^8
"DATA",169.3,86800,0)
PARAGANGLIOMA, BENIGN^8680/0^^^
"DATA",169.3,86801,0)
PARAGANGLIOMA, NOS^8680/1^^^^^^8
"DATA",169.3,86802,0)
PARAGANGLIOMA IN SITU^8680/2^^^
"DATA",169.3,86803,0)
PARAGANGLIOMA, MALIGNANT^8680/3^^^^^^8
"DATA",169.3,86811,0)
SYMPATHETIC PARAGANGLIOMA^8681/1^^^^^^8
"DATA",169.3,86821,0)
PARASYMPATHETIC PARAGANGLIOMA^8682/1^^^^^^8
"DATA",169.3,86830,0)
GANGLIOCYTIC PARAGANGLIOMA^8683/0^^^^67170^^8
"DATA",169.3,86901,0)
GLOMUS JUGULARE TUMOR, NOS^8690/1^^^6717^67755^^8
"DATA",169.3,86901,1,0)
^169.32^2^2
"DATA",169.3,86901,1,1,0)
JUGULAR PARAGANGLIOMA
"DATA",169.3,86901,1,2,0)
JUGULOTYMPANIC PARAGANGLIOMA
"DATA",169.3,86911,0)
AORTIC BODY TUMOR^8691/1^^^6775^67755^^8
"DATA",169.3,86911,1,0)
^169.32^2^2
"DATA",169.3,86911,1,1,0)
AORTIC BODY PARAGANGLIOMA
"DATA",169.3,86911,1,2,0)
AORTICOPULMONARY PARAGANGLIOMA
"DATA",169.3,86912,0)
AORTIC BODY TUMOR IN SITU^8691/2^^^
"DATA",169.3,86913,0)
AORTIC BODY TUMOR, MALIGNANT^8691/3^^^
"DATA",169.3,86921,0)
CAROTID BODY TUMOR^8692/1^^^6775^67754^^8
"DATA",169.3,86921,1,0)
^169.32^1^1
"DATA",169.3,86921,1,1,0)
CAROTID BODY PARAGANGLIOMA
"DATA",169.3,86922,0)
CAROTID BODY TUMOR IN SITU^8692/2^^^
"DATA",169.3,86923,0)
CAROTID BODY TUMOR, MALIGNANT^8692/3^^^
"DATA",169.3,86931,0)
EXTRA-ADRENAL PARAGANGLIOMA, NOS^8693/1^^^^^^8
"DATA",169.3,86931,1,0)
^169.32^2^2
"DATA",169.3,86931,1,1,0)
NONCHROMAFFIN PARAGANGLIOMA, NOS
"DATA",169.3,86931,1,2,0)
CHEMODECTOMA
"DATA",169.3,86932,0)
EXTRA-ADRENAL PARAGANGLIOMA IN SITU^8693/2^^^
"DATA",169.3,86933,0)
EXTRA-ADRENAL PARAGANGLIOMA, MALIGNANT^8693/3^^^^^^8
"DATA",169.3,86933,1,0)
^169.32^1^1
"DATA",169.3,86933,1,1,0)
NONCHROMAFFIN PARAGANGLIOMA, MALIGNANT
"DATA",169.3,87000,0)
PHEOCHROMOCYTOMA, NOS^8700/0^^^6774^67741^^8
"DATA",169.3,87000,1,0)
^169.32^5^4
"DATA",169.3,87000,1,2,0)
CHROMAFFINOMA
"DATA",169.3,87000,1,3,0)
CHROMAFFIN TUMOR
"DATA",169.3,87000,1,4,0)
CHROMAFFIN PARAGANGLIOMA
"DATA",169.3,87000,1,5,0)
ADRENAL MEDULLARY PARAGANGLIOMA
"DATA",169.3,87002,0)
PHEOCHROMOCYTOMA IN SITU^8700/2^^^
"DATA",169.3,87003,0)
PHEOCHROMOCYTOMA, MALIGNANT^8700/3^^^6774^67741^^8
"DATA",169.3,87003,1,0)
^169.32^3^2
"DATA",169.3,87003,1,2,0)
PHEOCHROMOBLASTOMA
"DATA",169.3,87003,1,3,0)
ADRENAL MEDULLARY PARAGANGLIOMA, MALIGNANT
"DATA",169.3,87102,0)
GLOMANGIOSARCOMA IN SITU^8710/2^^^
"DATA",169.3,87103,0)
GLOMANGIOSARCOMA^8710/3^^^^^^5
"DATA",169.3,87103,1,0)
^169.32^1^1
"DATA",169.3,87103,1,1,0)
GLOMOID SARCOMA
"DATA",169.3,87110,0)
GLOMUS TUMOR, NOS^8711/0^^^^^^8
"DATA",169.3,87112,0)
GLOMUS TUMOR IN SITU^8711/2^^^
"DATA",169.3,87113,0)
GLOMUS TUMOR, MALIGNANT^8711/3^^^
"DATA",169.3,87120,0)
GLOMANGIOMA^8712/0^^^^^^8
"DATA",169.3,87130,0)
GLOMANGIOMYOMA^8713/0^^^^^^8
"DATA",169.3,87143,0)
PECOMA, MALIGNANT^8714/3
"DATA",169.3,87143,1,0)
^169.32^2^2
"DATA",169.3,87143,1,1,0)
MALIGNANT PERIVASCULAR EPITHELIAL CELL TUMOR
"DATA",169.3,87143,1,2,0)
PERIVASCULAR EPITHELIOID CELL TUMOR, MALIG
"DATA",169.3,87200,0)
PIGMENTED NEVUS, NOS^8720/0^^^6744^67440^^7
"DATA",169.3,87200,1,0)
^169.32^3^3
"DATA",169.3,87200,1,1,0)
NEVUS, NOS
"DATA",169.3,87200,1,2,0)
HAIRY NEVUS
"DATA",169.3,87200,1,3,0)
MELANOCYTIC NEVUS
"DATA",169.3,87202,0)
MELANOMA IN SITU^8720/2^^^^^^7
"DATA",169.3,87203,0)
MALIGNANT MELANOMA, NOS^8720/3^^^^^^7
"DATA",169.3,87203,1,0)
^169.32^2^2
"DATA",169.3,87203,1,1,0)
MELANOMA, NOS
"DATA",169.3,87203,1,2,0)
MENINGEAL MELANOMA (C70._, C71._)
"DATA",169.3,87212,0)
NODULAR MELANOMA, IN SITU^8721/2^^^
"DATA",169.3,87213,0)
NODULAR MELANOMA^8721/3^^^^67440^^7
"DATA",169.3,87220,0)
BALLOON CELL NEVUS^8722/0^^^^67440^^7
"DATA",169.3,87222,0)
BALLOON CELL MELANOMA, IN SITU^8722/2^^^
"DATA",169.3,87223,0)
BALLOON CELL MELANOMA^8722/3^^^^67440^^7
"DATA",169.3,87230,0)
HALO NEVUS^8723/0^^^6744^67440^^7
"DATA",169.3,87230,1,0)
^169.32^1^1
"DATA",169.3,87230,1,1,0)
REGRESSING NEVUS
"DATA",169.3,87232,0)
MELANOMA IN SITU, REGRESSING^8723/2^^^
"DATA",169.3,87233,0)
MALIGNANT MELANOMA, REGRESSING^8723/3^^^^67440^^7
"DATA",169.3,87250,0)
NEURONEVUS^8725/0^^^^67440^^7
"DATA",169.3,87260,0)
MAGNOCELLULAR NEVUS^8726/0^^^^67694^^7
"DATA",169.3,87260,1,0)
^169.32^2^2
"DATA",169.3,87260,1,1,0)
MELANOCYTOMA, EYEBALL
"DATA",169.3,87260,1,2,0)
MELANOCYTOMA, NOS
"DATA",169.3,87261,0)
MELANOCYTOMA OF UNCERTAIN MALIGNANT POTENTIAL^8726/1^^^
"DATA",169.3,87262,0)
MAGNOCELLULAR MELANOMA IN SITU^8726/2^^^
"DATA",169.3,87263,0)
MAGNOCELLULAR MELANOMA^8726/3^^^
"DATA",169.3,87270,0)
DYSPLASTIC NEVUS^8727/0^^^6744^67440^^7
"DATA",169.3,87280,0)
DIFFUSE MELANOCYTOSIS^8728/0^^^^67709^^
"DATA",169.3,87281,0)
MENINGEAL MELANOCYTOMA^8728/1^^^^67709^^
"DATA",169.3,87282,0)
MENINGEAL MELANOMATOSIS IN SITU^8728/2^^^
"DATA",169.3,87283,0)
MENINGEAL MELANOMATOSIS^8728/3^^^^67709^^
"DATA",169.3,87300,0)
NONPIGMENTED NEVUS^8730/0^^^6744^67440^^7
"DATA",169.3,87300,1,0)
^169.32^1^1
"DATA",169.3,87300,1,1,0)
ACHROMIC NEVUS
"DATA",169.3,87302,0)
AMELANOTIC MELANOMA, IN SITU^8730/2^^^
"DATA",169.3,87303,0)
AMELANOTIC MELANOMA^8730/3^^^6744^67440^^7
"DATA",169.3,87303,1,0)
^169.32^^0
"DATA",169.3,87400,0)
JUNCTIONAL NEVUS, NOS^8740/0^^^6744^67440^^7
"DATA",169.3,87400,1,0)
^169.32^2^2
"DATA",169.3,87400,1,1,0)
JUNCTION NEVUS
"DATA",169.3,87400,1,2,0)
INTRAEPIDERMAL NEVUS
"DATA",169.3,87402,0)
MALIGNANT MELANOMA IN SITU/JUNCTIONAL NEVUS^8740/2^^^
"DATA",169.3,87403,0)
MALIGNANT MELANOMA IN JUNCTIONAL NEVUS^8740/3^^^^67440^^7
"DATA",169.3,87412,0)
PRECANCEROUS MELANOSIS, NOS^8741/2^^^6744^67440^^7
"DATA",169.3,87413,0)
MALIGNANT MELANOMA IN PRECANCEROUS MELANOSIS^8741/3^^^6744^67440^^7
"DATA",169.3,87413,1,0)
^169.32^^0
"DATA",169.3,87422,0)
LENTIGO MALIGNA^8742/2^^^6744^67440^^7
"DATA",169.3,87422,1,0)
^169.32^1^1
"DATA",169.3,87422,1,1,0)
HUTCHINSON MELANOTIC FRECKLE, NOS
"DATA",169.3,87423,0)
LENTIGO MALIGNA MELANOMA^8742/3^^^6744^67440^^7
"DATA",169.3,87423,1,0)
^169.32^1^1
"DATA",169.3,87423,1,1,0)
MALIGNANT MELANOMA IN HUTCH MELANOTIC FRECKLE
"DATA",169.3,87432,0)
SUPERFICIAL SPREADING MELANOMA, IN SITU^8743/2^^^
"DATA",169.3,87433,0)
SUPERFICIAL SPREADING MELANOMA^8743/3^^^6744^67440^^7
"DATA",169.3,87433,1,0)
^169.32^^0
"DATA",169.3,87442,0)
ACRAL LENTIGINOUS MELANOMA, IN SITU^8744/2^^^
"DATA",169.3,87443,0)
ACRAL LENTIGINOUS MELANOMA, MALIGNANT^8744/3^^^6744^67440^^7
"DATA",169.3,87452,0)
DESMOPLASTIC MELANOMA IN SITU^8745/2^^^
"DATA",169.3,87453,0)
DESMOPLASTIC MELANOMA, MALIGNANT^8745/3^^^6744^67440^^7
"DATA",169.3,87453,1,0)
^169.32^2^2
"DATA",169.3,87453,1,1,0)
NEUROTROPIC MELANOMA, MALIGNANT
"DATA",169.3,87453,1,2,0)
DESMOPLASTIC MELANOMA, AMELANOTIC
"DATA",169.3,87462,0)
MUCOSAL LENTIGINOUS MELANOMA IN SITU^8746/2^^^
"DATA",169.3,87463,0)
MUCOSAL LENTIGINOUS MELANOMA^8746/3^^^
"DATA",169.3,87500,0)
INTRADERMAL NEVUS^8750/0^^^6744^67440^^7
"DATA",169.3,87500,1,0)
^169.32^1^1
"DATA",169.3,87500,1,1,0)
DERMAL NEVUS
"DATA",169.3,87600,0)
COMPOUND NEVUS^8760/0^^^6744^67440^^7
"DATA",169.3,87600,1,0)
^169.32^1^1
"DATA",169.3,87600,1,1,0)
DERMAL AND EPIDERMAL NEVUS
"DATA",169.3,87610,0)
SMALL CONGENITAL NEVUS^8761/0^^^^67440^^
"DATA",169.3,87611,0)
GIANT PIGMENTED NEVUS, NOS^8761/1^^^6744^67440^^7
"DATA",169.3,87611,1,0)
^169.32^1^1
"DATA",169.3,87611,1,1,0)
INTERMEDIATE AND GIANT CONGENITAL NEVUS
"DATA",169.3,87612,0)
MELANOMA IN SITU IN GIANT PIGMENTED NEVUS^8761/2^^^
"DATA",169.3,87613,0)
MALIGNANT MELANOMA IN GIANT PIGMENTED NEVUS^8761/3^^^6744^67440^^7
"DATA",169.3,87613,1,0)
^169.32^1^1
"DATA",169.3,87613,1,1,0)
MALIGNANT MELANOMA IN CONG MELANOCYTIC NEVUS
"DATA",169.3,87621,0)
PROLIFERATIVE DERMAL LESION CONGENITAL NEVUS^8762/1^^^^67440^^
"DATA",169.3,87700,0)
EPITHELIOID AND SPINDLE CELL NEVUS^8770/0^^^6744^67440^^7
"DATA",169.3,87700,1,0)
^169.32^4^4
"DATA",169.3,87700,1,1,0)
JUVENILE NEVUS
"DATA",169.3,87700,1,2,0)
JUVENILE MELANOMA
"DATA",169.3,87700,1,3,0)
SPITZ NEVUS
"DATA",169.3,87700,1,4,0)
PIGMENTED SPINDLE CELL NEVUS OF REED
"DATA",169.3,87702,0)
MIXED EPITHELIOID/SPINDLE CELL MELA IN SITU^8770/2^^^
"DATA",169.3,87703,0)
MIXED EPITHELIOID AND SPINDLE CELL MELANOMA^8770/3^^^^^^7
"DATA",169.3,87710,0)
EPITHELIOID CELL NEVUS^8771/0^^^6744^67440^^7
"DATA",169.3,87712,0)
EPITHELIOID CELL MELANOMA IN SITU^8771/2^^^
"DATA",169.3,87713,0)
EPITHELIOID CELL MELANOMA^8771/3^^^^^^7
"DATA",169.3,87720,0)
SPINDLE CELL NEVUS, NOS^8772/0^^^6744^67440^^7
"DATA",169.3,87722,0)
SPINDLE CELL MELANOMA IN SITU^8772/2^^^
"DATA",169.3,87723,0)
SPINDLE CELL MELANOMA, NOS^8772/3^^^^^^7
"DATA",169.3,87723,1,0)
^169.32^^0
"DATA",169.3,87732,0)
SPINDLE CELL MELANOMA IN SITU, TYPE A^8773/2^^^
"DATA",169.3,87733,0)
SPINDLE CELL MELANOMA, TYPE A^8773/3^^^6769^67690^^7
"DATA",169.3,87742,0)
SPINDLE CELL MELANOMA IN SITU, TYPE B^8774/2^^^
"DATA",169.3,87743,0)
SPINDLE CELL MELANOMA, TYPE B^8774/3^^^6769^67690^^7
"DATA",169.3,87800,0)
BLUE NEVUS, NOS^8780/0^^^6744^67440^^7
"DATA",169.3,87800,1,0)
^169.32^1^1
"DATA",169.3,87800,1,1,0)
JADASSOHN BLUE NEVUS
"DATA",169.3,87802,0)
BLUE NEVUS IN SITU^8780/2^^^
"DATA",169.3,87803,0)
BLUE NEVUS, MALIGNANT^8780/3^^^^67440^^7
"DATA",169.3,87900,0)
CELLULAR BLUE NEVUS^8790/0^^^6744^67440^^7
"DATA",169.3,88000,0)
SOFT TISSUE TUMOR, BENIGN^8800/0^^^^^^5
"DATA",169.3,88002,0)
SARCOMA IN SITU^8800/2^^^
"DATA",169.3,88003,0)
SARCOMA, NOS^8800/3^^^^^^5
"DATA",169.3,88003,1,0)
^169.32^3^3
"DATA",169.3,88003,1,1,0)
SOFT TISSUE SARCOMA
"DATA",169.3,88003,1,2,0)
SOFT TISSUE TUMOR, MALIGNANT
"DATA",169.3,88003,1,3,0)
MESENCHYMAL TUMOR, MALIGNANT
"DATA",169.3,88012,0)
SPINDLE CELL SARCOMA IN SITU^8801/2^^^
"DATA",169.3,88013,0)
SPINDLE CELL SARCOMA^8801/3^^^^^^5
"DATA",169.3,88013,1,0)
^169.32^1^1
"DATA",169.3,88013,1,1,0)
UNDIFFERENTIATED SPINDLE CELL SARCOMA
"DATA",169.3,88022,0)
GIANT CELL SARCOMA IN SITU^8802/2^^^
"DATA",169.3,88023,0)
GIANT CELL SARCOMA^8802/3^^^^^^5
"DATA",169.3,88023,1,0)
^169.32^2^2
"DATA",169.3,88023,1,1,0)
PLEOMORPHIC CELL SARCOMA
"DATA",169.3,88023,1,2,0)
UNDIFFERENTIATED PLEOMORPHIC SARCOMA
"DATA",169.3,88032,0)
SMALL CELL SARCOMA IN SITU^8803/2^^^
"DATA",169.3,88033,0)
SMALL CELL SARCOMA^8803/3^^^^^^5
"DATA",169.3,88033,1,0)
^169.32^2^2
"DATA",169.3,88033,1,1,0)
ROUND CELL SARCOMA
"DATA",169.3,88033,1,2,0)
UNDIFFERENTIATED ROUND CELL SARCOMA
"DATA",169.3,88042,0)
EPITHELIOID SARCOMA IN SITU^8804/2^^^
"DATA",169.3,88043,0)
EPITHELIOID SARCOMA^8804/3^^^^^^5
"DATA",169.3,88043,1,0)
^169.32^2^2
"DATA",169.3,88043,1,1,0)
EPITHELIOID CELL SARCOMA
"DATA",169.3,88043,1,2,0)
UNDEFFERENTIATED EPITHELIOID SARCOMA
"DATA",169.3,88052,0)
UNDIFFERENTIATED SARCOMA INS SITU^8805/2^^^
"DATA",169.3,88053,0)
UNDIFFERENTIATED SARCOMA^8805/3^^^
"DATA",169.3,88053,1,0)
^169.32^1^1
"DATA",169.3,88053,1,1,0)
UNDEFFERENTIATED UTERINE SARCOMA
"DATA",169.3,88062,0)
DESMOPLASTIC SMALL ROUND CELL TUMOR IN SITU^8806/2^^^
"DATA",169.3,88063,0)
DESMOPLASTIC SMALL ROUND CELL TUMOR^8806/3^^^
"DATA",169.3,88100,0)
FIBROMA, NOS^8810/0^^^^^^5
"DATA",169.3,88100,1,0)
^169.32^^0
"DATA",169.3,88101,0)
CELLULAR FIBROMA^8810/1^^^^67569^^
"DATA",169.3,88102,0)
FIBROSARCOMA IN SITU^8810/2^^^
"DATA",169.3,88103,0)
FIBROSARCOMA, NOS^8810/3^^^^^^5
"DATA",169.3,88110,0)
FIBROMYXOMA^8811/0^^^^^^5
"DATA",169.3,88110,1,0)
^169.32^2^2
"DATA",169.3,88110,1,1,0)
MYXOID FIBROMA
"DATA",169.3,88110,1,2,0)
MYXOFIBROMA, NOS
"DATA",169.3,88111,0)
MYXOINFLAMMATORY FIBROBLASTIC SARCOMA (mifs) (C49._)^8811/1
"DATA",169.3,88112,0)
FIBROMYXOSARCOMA IN SITU^8811/2^^^
"DATA",169.3,88113,0)
FIBROMYXOSARCOMA^8811/3^^^^^^5
"DATA",169.3,88120,0)
PERIOSTEAL FIBROMA^8812/0^67410^^^67400^^5
"DATA",169.3,88122,0)
PERIOSTEAL FIBROSARCOMA IN SITU^8812/2^^^
"DATA",169.3,88123,0)
PERIOSTEAL FIBROSARCOMA^8812/3^67410^^^67400^^5
"DATA",169.3,88123,1,0)
^169.32^1^1
"DATA",169.3,88123,1,1,0)
PERIOSTEAL SARCOMA, NOS
"DATA",169.3,88130,0)
FASCIAL FIBROMA^8813/0^^^^^^5
"DATA",169.3,88132,0)
FASCIAL FIBROSARCOMA IN SITU^8813/2^^^
"DATA",169.3,88133,0)
FASCIAL FIBROSARCOMA^8813/3^^^^^^5
"DATA",169.3,88133,1,0)
^169.32^^0
"DATA",169.3,88142,0)
INFANTILE FIBROSARCOMA IN SITU^8814/2^^^
"DATA",169.3,88143,0)
INFANTILE FIBROSARCOMA^8814/3^^^^^^5
"DATA",169.3,88143,1,0)
^169.32^2^1
"DATA",169.3,88143,1,2,0)
CONGENITAL FIBROSARCOMA
"DATA",169.3,88150,0)
SOLITARY FIBROUS TUMOR^8815/0^^^
"DATA",169.3,88150,1,0)
^169.32^2^2
"DATA",169.3,88150,1,1,0)
LOCALIZED FIBROUS TUMOR
"DATA",169.3,88150,1,2,0)
SOLITARY FIBROUS TUMOR/HEMANGIOPERICYTOMA GRADE 1 (CNS) (C71._)
"DATA",169.3,88151,0)
SOLITARY FIBROUS TUMOR/HEMANGIOPERICYTOMA GRADE 2 (CNS) (C71._)^8815/1
"DATA",169.3,88152,0)
SOLITARY FIBROUS TUMOR IN SITU^8815/2^^^
"DATA",169.3,88153,0)
SOLITARY FIBROUS TUMOR, MALIGNANT^8815/3^^^
"DATA",169.3,88153,1,0)
^169.32^1^1
"DATA",169.3,88153,1,1,0)
SOLITARY FIBROUS TUMOR/HEMANGIOPERICYTOMA GRADE 3 (CNS) (C71._)
"DATA",169.3,88200,0)
ELASTOFIBROMA^8820/0^^^^^^5
"DATA",169.3,88211,0)
AGGRESSIVE FIBROMATOSIS^8821/1^^^^^^5
"DATA",169.3,88211,1,0)
^169.32^3^3
"DATA",169.3,88211,1,1,0)
EXTRA-ABDOMINAL DESMOID
"DATA",169.3,88211,1,2,0)
DESMOID, NOS
"DATA",169.3,88211,1,3,0)
INVASIVE FIBROMA
"DATA",169.3,88212,0)
AGGRESSIVE FIBROMATOSIS IN SITU^8821/2^^^
"DATA",169.3,88213,0)
AGGRESSIVE FIBROMATOSIS, MALIGNANT^8821/3^^^
"DATA",169.3,88221,0)
ABDOMINAL FIBROMATOSIS^8822/1^^^^^^5
"DATA",169.3,88221,1,0)
^169.32^3^3
"DATA",169.3,88221,1,1,0)
ABDOMINAL DESMOID
"DATA",169.3,88221,1,2,0)
MESENTERIC FIBROMATOSIS
"DATA",169.3,88221,1,3,0)
RETROPERITONEAL FIBROMATOSIS
"DATA",169.3,88230,0)
DESMOPLASTIC FIBROMA^8823/0^^^^^^5
"DATA",169.3,88240,0)
MYOFIBROMA^8824/0^^^
"DATA",169.3,88241,0)
MYOFIBROMATOSIS^8824/1^^^^^^5
"DATA",169.3,88241,1,0)
^169.32^2^2
"DATA",169.3,88241,1,1,0)
CONGENTIAL GENERALIZED FIBROMATOSIS
"DATA",169.3,88241,1,2,0)
INFANTILE MYOFIBROMATOSIS
"DATA",169.3,88250,0)
MYOFIBROBLASTOMA^8825/0^^^
"DATA",169.3,88251,0)
MYOFIBROBLASTIC TUMOR, NOS^8825/1^^^
"DATA",169.3,88251,1,0)
^169.32^1^1
"DATA",169.3,88251,1,1,0)
INFLAMMATORY MYOFIBROBLASTIC TUMOR
"DATA",169.3,88253,0)
MYOFIBROBLASTIC SARCOMA^8825/3
"DATA",169.3,88253,1,0)
^169.32^1^1
"DATA",169.3,88253,1,1,0)
LOW-GRADE MYOFIBROBLASTIC SARCOMA (C01.9, C02._, C06.9, C49._)
"DATA",169.3,88260,0)
ANGIOMYOFIBROBLASTOMA^8826/0^^^
"DATA",169.3,88271,0)
MYOFIBROBLASTIC TUMOR, PERIBRONCHIAL^8827/1^^^^^^
"DATA",169.3,88271,1,0)
^169.32^1^1
"DATA",169.3,88271,1,1,0)
CONGENITAL PERIBRONCHIAL MYOFIBROBLASTIC TUM
"DATA",169.3,88300,0)
BENIGN FIBROUS HISTIOCYTOMA^8830/0^^^^^^5
"DATA",169.3,88300,1,0)
^169.32^3^3
"DATA",169.3,88300,1,1,0)
FIBROXANTHOMA, NOS
"DATA",169.3,88300,1,2,0)
XANTHOFIBROMA
"DATA",169.3,88300,1,3,0)
FIBROUS HISTIOCYTOMA, NOS
"DATA",169.3,88301,0)
ATYPICAL FIBROUS HISTIOCYTOMA^8830/1^^^^^^5
"DATA",169.3,88301,1,0)
^169.32^1^1
"DATA",169.3,88301,1,1,0)
ATYPICAL FIBROXANTHOMA
"DATA",169.3,88302,0)
FIBROUS HISTIOCYTOMA IN SITU^8830/2^^^
"DATA",169.3,88303,0)
MALIGNANT FIBROUS HISTIOCYTOMA^8830/3^^^^^^5
"DATA",169.3,88303,1,0)
^169.32^4^4
"DATA",169.3,88303,1,1,0)
FIBROXANTHOMA, MALIGNANT
"DATA",169.3,88303,1,2,0)
UNDIFFERENTIATED HIGH-GRADE PLEOMORPHIC SARCOMA OF BONE (C40._)
"DATA",169.3,88303,1,3,0)
MALIGNANT FIBROUS HISTIOCYTOMA (MFH) OF BONE
"DATA",169.3,88303,1,4,0)
UNDIFFERENTIATED HIGH-GRADE PLEOMORPHIC SARCOMA
"DATA",169.3,88310,0)
HISTIOCYTOMA, NOS^8831/0^^^
"DATA",169.3,88310,1,0)
^169.32^3^3
"DATA",169.3,88310,1,1,0)
JUVENILE HISTIOCYTOMA
"DATA",169.3,88310,1,2,0)
RETICULOHISTIOCYTOMA
"DATA",169.3,88310,1,3,0)
DEEP HISTIOCYTOMA
"DATA",169.3,88320,0)
DERMATOFIBROMA, NOS^8832/0^^^6744^67440^^5
"DATA",169.3,88320,1,0)
^169.32^4^4
"DATA",169.3,88320,1,1,0)
SCLEROSING HEMANGIOMA
"DATA",169.3,88320,1,2,0)
CUTANEOUS HISTIOCYTOMA, NOS
"DATA",169.3,88320,1,3,0)
SUBEPIDERMAL NODULAR FIBROSIS
"DATA",169.3,88320,1,4,0)
DERMATOFIBROMA LENTICULARE
"DATA",169.3,88321,0)
DERMATOFIBROMA PROTUBERANS^8832/1^^^
"DATA",169.3,88322,0)
DERMATOFIBROSARCOMA IN SITU^8832/2^^^
"DATA",169.3,88323,0)
DERMATOFIBROSARCOMA, NOS^8832/3^^^6744^67440^^5
"DATA",169.3,88323,1,0)
^169.32^2^2
"DATA",169.3,88323,1,1,0)
DERMATOFIBROSARCOMA PROTUBERANS, NOS
"DATA",169.3,88323,1,2,0)
FIBROSARCOMATOUS DERMATOFIBROSARCOMA PROTUBERANS
"DATA",169.3,88332,0)
PIGMENTED DERMATOFIBROSARCOMA PROTUBE IN SITU^8833/2^^^
"DATA",169.3,88333,0)
PIGMENTED DERMATOFIBROSARCOMA PROTUBERANS^8833/3^^^^67440^^5
"DATA",169.3,88333,1,0)
^169.32^1^1
"DATA",169.3,88333,1,1,0)
BEDNAR TUMOR
"DATA",169.3,88341,0)
GIANT CELL FIBROBLASTOMA^8834/1^^^
"DATA",169.3,88351,0)
PLEXIFORM FIBROHISTIOCYTIC TUMOR^8835/1^^^
"DATA",169.3,88361,0)
ANGIOMATOID FIBROUS HISTIOCYTOMA^8836/1^^^
"DATA",169.3,88400,0)
MYXOMA, NOS^8840/0^^^^^^5
"DATA",169.3,88402,0)
MYXOSARCOMA IN SITU^8840/2^^^
"DATA",169.3,88403,0)
MYXOSARCOMA^8840/3^^^^^^5
"DATA",169.3,88403,1,0)
^169.32^2^2
"DATA",169.3,88403,1,1,0)
SCLEROSING EPITHELIOID FIBROSARCOMA
"DATA",169.3,88403,1,2,0)
LOW-GRADE FIBROMYXOID SARCOMA
"DATA",169.3,88411,0)
ANGIOMYXOMA^8841/1^^^^^^5
"DATA",169.3,88411,1,0)
^169.32^1^1
"DATA",169.3,88411,1,1,0)
AGGRESSIVE ANGIOMYXOMA
"DATA",169.3,88420,0)
OSSIFYING FIBROMYXOID TUMOR^8842/0^^^
"DATA",169.3,88423,0)
PULMONARY MYXOID SARCOMA WITH EWSR1-CREB1 TRANSLOCATION (C34._)^8842/3
"DATA",169.3,88423,1,0)
^169.32^1^1
"DATA",169.3,88423,1,1,0)
OSSIFYING FIBROMYXOID TUMOR, MALIGNANT (C49._)
"DATA",169.3,88500,0)
LIPOMA, NOS^8850/0^^^^^^5
"DATA",169.3,88501,0)
ATYPICAL LIPOMA^8850/1^^^
"DATA",169.3,88501,1,0)
^169.32^2^2
"DATA",169.3,88501,1,1,0)
SUPERFICIAL WELL DIFFERENTATED LIPOSARCOMA
"DATA",169.3,88501,1,2,0)
WELL DIFF LIPOSARCOMA OF SUPERFIC SOFT TISSUE
"DATA",169.3,88502,0)
LIPOSARCOMA IN SITU^8850/2^^^
"DATA",169.3,88503,0)
LIPOSARCOMA, NOS^8850/3^^^^^^5
"DATA",169.3,88503,1,0)
^169.32^1^1
"DATA",169.3,88503,1,1,0)
FIBROLIPOSARCOMA
"DATA",169.3,88510,0)
FIBROLIPOMA^8851/0^^^^^^5
"DATA",169.3,88510,1,0)
^169.32^^0
"DATA",169.3,88512,0)
LIPOSARCOMA IN SITU, WELL DIFFERENTIATED^8851/2^^^
"DATA",169.3,88513,0)
LIPOSARCOMA, WELL DIFFERENTIATED^8851/3^^^^^^5
"DATA",169.3,88513,1,0)
^169.32^4^4
"DATA",169.3,88513,1,1,0)
LIPOSARCOMA, DIFFERENTIATED
"DATA",169.3,88513,1,2,0)
LIPOMA-LIKE LIPOSARCOMA
"DATA",169.3,88513,1,3,0)
INFLAMMATORY LIPOSARCOMA
"DATA",169.3,88513,1,4,0)
SCLEROSING LIPOSARCOMA
"DATA",169.3,88520,0)
FIBROMYXOLIPOMA^8852/0^^^^^^5
"DATA",169.3,88520,1,0)
^169.32^1^1
"DATA",169.3,88520,1,1,0)
MYXOLIPOMA
"DATA",169.3,88522,0)
MYXOID LIPOSARCOMA IN SITU^8852/2^^^
"DATA",169.3,88523,0)
MYXOID LIPOSARCOMA^8852/3^^^^^^5
"DATA",169.3,88523,1,0)
^169.32^1^1
"DATA",169.3,88523,1,1,0)
MYXOLIPOSARCOMA
"DATA",169.3,88532,0)
ROUND CELL LIPOSARCOMA IN SITU^8853/2^^^
"DATA",169.3,88533,0)
ROUND CELL LIPOSARCOMA^8853/3^^^^^^5
"DATA",169.3,88533,1,0)
^169.32^^0
"DATA",169.3,88540,0)
PLEOMORPHIC LIPOMA^8854/0^^^^^^5
"DATA",169.3,88542,0)
LIPOSARCOMA IN SITU, PLEOMORPHIC^8854/2^^^
"DATA",169.3,88543,0)
LIPOSARCOMA, PLEOMORPHIC^8854/3^^^^^^5
"DATA",169.3,88543,1,0)
^169.32^^0
"DATA",169.3,88552,0)
MIXED LIPOSARCOMA IN SITU^8855/2^^^
"DATA",169.3,88553,0)
MIXED LIPOSARCOMA^8855/3^^^^^^5
"DATA",169.3,88553,1,0)
^169.32^^0
"DATA",169.3,88560,0)
INTRAMUSCULAR LIPOMA^8856/0^^^^^^5
"DATA",169.3,88560,1,0)
^169.32^2^2
"DATA",169.3,88560,1,1,0)
INFILTRATING LIPOMA
"DATA",169.3,88560,1,2,0)
INFILTRATING ANGIOLIPOMA
"DATA",169.3,88570,0)
SPINDLE CELL LIPOMA^8857/0^^^^^^5
"DATA",169.3,88572,0)
FIBROBLASTIC LIPOSARCOMA IN SITU^8857/2^^^
"DATA",169.3,88573,0)
FIBROBLASTIC LIPOSARCOMA^8857/3^^^
"DATA",169.3,88582,0)
DEDIFFERENTIATED LIPOSARCOMA IN SITU^8858/2^^^
"DATA",169.3,88583,0)
DEDIFFERENTIATED LIPOSARCOMA^8858/3^^^^^^5
"DATA",169.3,88600,0)
ANGIOMYOLIPOMA^8860/0^^^^^^5
"DATA",169.3,88602,0)
ANGIOMYOLIPOSARCOMA IN SITU^8860/2^^^
"DATA",169.3,88603,0)
ANGIOMYOLIPOSARCOMA^8860/3^^^
"DATA",169.3,88610,0)
ANGIOLIPOMA, NOS^8861/0^^^^^^5
"DATA",169.3,88620,0)
CHONDROID LIPOMA^8862/0^^^
"DATA",169.3,88700,0)
MYELOLIPOMA^8870/0^^^^^^5
"DATA",169.3,88800,0)
HIBERNOMA^8880/0^^^^^^5
"DATA",169.3,88800,1,0)
^169.32^2^2
"DATA",169.3,88800,1,1,0)
FETAL FAT CELL LIPOMA
"DATA",169.3,88800,1,2,0)
BROWN FAT TUMOR
"DATA",169.3,88810,0)
LIPOBLASTOMATOSIS^8881/0^^^^^^5
"DATA",169.3,88810,1,0)
^169.32^3^3
"DATA",169.3,88810,1,1,0)
FETAL LIPOMA, NOS
"DATA",169.3,88810,1,2,0)
FETAL LIPOMATOSIS
"DATA",169.3,88810,1,3,0)
LIPOBLASTOMA
"DATA",169.3,88888,0)
NA^8888/8^^^^^^9
"DATA",169.3,88900,0)
LEIOMYOMA, NOS^8890/0^^^^^^5
"DATA",169.3,88900,1,0)
^169.32^5^5
"DATA",169.3,88900,1,1,0)
FIBROID UTERUS
"DATA",169.3,88900,1,2,0)
FIBROMYOMA
"DATA",169.3,88900,1,3,0)
LEIOMYOFIBROMA
"DATA",169.3,88900,1,4,0)
PLEXIFORM LEIOMYOMA
"DATA",169.3,88900,1,5,0)
LIPOLEIOMYOMA
"DATA",169.3,88901,0)
LEIOMYOMATOSIS, NOS^8890/1^^^^^^5
"DATA",169.3,88901,1,0)
^169.32^1^1
"DATA",169.3,88901,1,1,0)
INTRAVASCULAR LEIOMYOMATOSIS
"DATA",169.3,88902,0)
LEIOMYOSARCOMA IN SITU^8890/2^^^
"DATA",169.3,88903,0)
LEIOMYOSARCOMA, NOS^8890/3^^^^^^5
"DATA",169.3,88910,0)
EPITHELIOID LEIOMYOMA^8891/0^^^^^^5
"DATA",169.3,88910,1,0)
^169.32^1^1
"DATA",169.3,88910,1,1,0)
LEIOMYOBLASTOMA
"DATA",169.3,88912,0)
EPITHELIOID LEIOMYOSARCOMA IN SITU^8891/2^^^
"DATA",169.3,88913,0)
EPITHELIOID LEIOMYOSARCOMA^8891/3^^^^^^5
"DATA",169.3,88920,0)
CELLULAR LEIOMYOMA^8892/0^^^^^^5
"DATA",169.3,88930,0)
BIZARRE LEIOMYOMA^8893/0^^^^^^5
"DATA",169.3,88930,1,0)
^169.32^3^3
"DATA",169.3,88930,1,1,0)
SYMPLASTIC LEIOMYOMA
"DATA",169.3,88930,1,2,0)
ATYPICAL LEIOMYOMA
"DATA",169.3,88930,1,3,0)
PLEOMORPHIC LEIOMYOMA
"DATA",169.3,88940,0)
ANGIOMYOMA^8894/0^^^^^^5
"DATA",169.3,88940,1,0)
^169.32^2^2
"DATA",169.3,88940,1,1,0)
VASCULAR LEIOMYOMA
"DATA",169.3,88940,1,2,0)
ANGIOLEIOMYOMA
"DATA",169.3,88942,0)
ANGIOMYOSARCOMA IN SITU^8894/2^^^
"DATA",169.3,88943,0)
ANGIOMYOSARCOMA^8894/3^^^^^^5
"DATA",169.3,88950,0)
MYOMA^8895/0^^^^^^5
"DATA",169.3,88952,0)
MYOSARCOMA IN SITU^8895/2^^^
"DATA",169.3,88953,0)
MYOSARCOMA^8895/3^^^^^^5
"DATA",169.3,88962,0)
MYXOID LEIOMYOSARCOMA IN SITU^8896/2^^^
"DATA",169.3,88963,0)
MYXOID LEIOMYOSARCOMA^8896/3^^^^^^5
"DATA",169.3,88971,0)
SMOOTH MUSCLE TUMOR OF UNCERTAIN MALIG POTENT^8897/1^^^^^^5
"DATA",169.3,88971,1,0)
^169.32^1^1
"DATA",169.3,88971,1,1,0)
SMOOTH MUSCLE TUMOR, NOS
"DATA",169.3,88981,0)
METASTASIZING LEIOMYOMA^8898/1^^^
"DATA",169.3,89000,0)
RHABDOMYOMA, NOS^8900/0^^^^^^5
"DATA",169.3,89002,0)
RHABDOMYOSARCOMA IN SITU^8900/2^^^
"DATA",169.3,89003,0)
RHABDOMYOSARCOMA, NOS^8900/3^^^^^^5
"DATA",169.3,89003,1,0)
^169.32^1^1
"DATA",169.3,89003,1,1,0)
RHABDOSARCOMA
"DATA",169.3,89012,0)
PLEOMORPHIC RHABDOMYOSARCOMA IN SITU, ADULT^8901/2^^^
"DATA",169.3,89013,0)
PLEOMORPHIC RHABDOMYOSARCOMA, ADULT TYPE^8901/3^^^^^^5
"DATA",169.3,89013,1,0)
^169.32^1^1
"DATA",169.3,89013,1,1,0)
PLEOMORPHIC RHABDOMYOSARCOMA, NOS
"DATA",169.3,89022,0)
MIXED TYPE RHABDOMYOSARCOMA IN SITU^8902/2^^^
"DATA",169.3,89023,0)
MIXED TYPE RHABDOMYOSARCOMA^8902/3^^^^^^5
"DATA",169.3,89023,1,0)
^169.32^1^1
"DATA",169.3,89023,1,1,0)
MIXED EMBRYONAL AND ALVEOLAR RHABDOMYOSARCOMA
"DATA",169.3,89030,0)
FETAL RHABDOMYOMA^8903/0^^^^^^5
"DATA",169.3,89040,0)
ADULT RHABDOMYOMA^8904/0^^^^^^5
"DATA",169.3,89040,1,0)
^169.32^1^1
"DATA",169.3,89040,1,1,0)
GLYCOGENIC RHABDOMYOMA
"DATA",169.3,89050,0)
GENITAL RHABDOMYOMA^8905/0^67529^^^67510^^
"DATA",169.3,89102,0)
EMBRYONAL RHABDOMYOSARCOMA IN SITU^8910/2^^^
"DATA",169.3,89103,0)
EMBRYONAL RHABDOMYOSARCOMA, NOS^8910/3^^^^^^5
"DATA",169.3,89103,1,0)
^169.32^3^3
"DATA",169.3,89103,1,1,0)
EMBRYONAL RHABDOMYOSARCOMA, PLEOMORPHIC
"DATA",169.3,89103,1,2,0)
SARCOMA BOTRYOIDES
"DATA",169.3,89103,1,3,0)
BOTRYOID SARCOMA
"DATA",169.3,89122,0)
SPINDLE CELL RHABDOMYOSARCOMA IN SITU^8912/2^^^
"DATA",169.3,89123,0)
SPINDLE CELL RHABDOMYOSARCOMA^8912/3^^^
"DATA",169.3,89123,1,0)
^169.32^1^1
"DATA",169.3,89123,1,1,0)
SCLEROSING RHABDOMYOSARCOMA
"DATA",169.3,89202,0)
ALVEOLAR RHABDOMYOSARCOMA IN SITU^8920/2^^^
"DATA",169.3,89203,0)
ALVEOLAR RHABDOMYOSARCOMA^8920/3^^^^^^5
"DATA",169.3,89212,0)
RHABDOMYOSARCOMA W GANGLIONIC DIFF IN SITU^8921/2^^^
"DATA",169.3,89213,0)
RHABDOMYOSARCOMA W GANGLIONIC DIFFERENTIATION^8921/3^^^
"DATA",169.3,89213,1,0)
^169.32^1^1
"DATA",169.3,89213,1,1,0)
ECTOMESENCHYMOMA
"DATA",169.3,89300,0)
ENDOMETRIAL STROMAL NODULE^8930/0^^^^67541^^5
"DATA",169.3,89302,0)
ENDOMETRIAL STROMAL SARCOMA IN SITU^8930/2^^^
"DATA",169.3,89303,0)
ENDOMETRIAL STROMAL SARCOMA, NOS^8930/3^^^^67541^^5
"DATA",169.3,89303,1,0)
^169.32^2^2
"DATA",169.3,89303,1,1,0)
ENDOMETRIAL SARCOAM, NOS
"DATA",169.3,89303,1,2,0)
ENDOMETRIAL STROMAL SARCOMA, HIGH GRADE
"DATA",169.3,89312,0)
ENDOMETRIAL STROMAL SARCOMA IN SITU, LOW GRD^8931/2^^^
"DATA",169.3,89313,0)
ENDOMETRIAL STROMAL SARCOMA, LOW GRADE^8931/3^^^6754^67541^^5
"DATA",169.3,89313,1,0)
^169.32^4^4
"DATA",169.3,89313,1,1,0)
ENDOMETRIAL STROMATOSIS
"DATA",169.3,89313,1,2,0)
STROMAL ENDOMETRIOSIS
"DATA",169.3,89313,1,3,0)
STROMAL MYOSIS, NOS
"DATA",169.3,89313,1,4,0)
ENDOLYMPHATIC STROMAL MYOSIS
"DATA",169.3,89320,0)
ADENOMYOMA^8932/0^^^^^^5
"DATA",169.3,89320,1,0)
^169.32^1^1
"DATA",169.3,89320,1,1,0)
ATYPICAL POLYPOID ADENOMYOMA
"DATA",169.3,89332,0)
ADENOSARCOMA IN SITU^8933/2^^^
"DATA",169.3,89333,0)
ADENOSARCOMA^8933/3^^^^^^5
"DATA",169.3,89333,1,0)
^169.32^1^1
"DATA",169.3,89333,1,1,0)
MULLERIAN ADENOSARCOMA (C54._,C55.9)
"DATA",169.3,89342,0)
CARCINOFIBROMA IN SITU^8934/2^^^
"DATA",169.3,89343,0)
CARCINOFIBROMA^8934/3^^^
"DATA",169.3,89350,0)
STROMAL TUMOR, BENIGN^8935/0^^^
"DATA",169.3,89351,0)
STROMAL TUMOR, NOS^8935/1^^^
"DATA",169.3,89352,0)
STROMAL SARCOMA IN SITU^8935/2^^^
"DATA",169.3,89353,0)
STROMAL SARCOMA, NOS^8935/3^^^
"DATA",169.3,89360,0)
GASTROINTESTINAL STROMAL TUMOR, BENIGN^8936/0^^^
"DATA",169.3,89360,1,0)
^169.32^1^1
"DATA",169.3,89360,1,1,0)
GIST, BENIGN
"DATA",169.3,89361,0)
GASTROINTESTINAL STROMAL TUMOR, NOS^8936/1^^^
"DATA",169.3,89361,1,0)
^169.32^5^5
"DATA",169.3,89361,1,1,0)
GIST, NOS
"DATA",169.3,89361,1,2,0)
GASTROINTESTINAL STROMAL TUMOR, UNC MALIG POT
"DATA",169.3,89361,1,3,0)
GASTROINTESTINAL AUTONOMIC NERVE TUMOR
"DATA",169.3,89361,1,4,0)
GANT
"DATA",169.3,89361,1,5,0)
GASTROINTESTINAL PACEMAKER CELL TUMOR
"DATA",169.3,89362,0)
GASTROINTESTINAL STROMAL SARCOMA IN SITU^8936/2^^^
"DATA",169.3,89363,0)
GASTROINTESTINAL STROMAL SARCOMA^8936/3^^^
"DATA",169.3,89363,1,0)
^169.32^2^2
"DATA",169.3,89363,1,1,0)
GASTROINTESTINAL STROMAL TUMOR, MALIGNANT
"DATA",169.3,89363,1,2,0)
GIST, MALIGNANT
"DATA",169.3,89400,0)
PLEOMORPHIC ADENOMA^8940/0^^^6744^^^5
"DATA",169.3,89400,1,0)
^169.32^3^3
"DATA",169.3,89400,1,1,0)
MIXED TUMOR, NOS
"DATA",169.3,89400,1,2,0)
MIXED TUMOR, SALIVARY GLAND TYPE, NOS
"DATA",169.3,89400,1,3,0)
CHONDROID SYRINGOMA
"DATA",169.3,89402,0)
MIXED TUMOR, IN SITU^8940/2^^^
"DATA",169.3,89403,0)
MIXED TUMOR, MALIGNANT, NOS^8940/3^^^^^^5
"DATA",169.3,89403,1,0)
^169.32^2^2
"DATA",169.3,89403,1,1,0)
MIXED TUMOR, SALIVARY GLAND TYPE, MALIGNANT
"DATA",169.3,89403,1,2,0)
MALIGNANT CHONDROID SYRINGOMA
"DATA",169.3,89412,0)
CARCINOMA IN PLEOMORPHIC ADENOMA IN SITU^8941/2^^^
"DATA",169.3,89413,0)
CARCINOMA IN PLEOMORPHIC ADENOMA^8941/3^67080^^^67079^^3
"DATA",169.3,89502,0)
MULLERIAN MIXED TUMOR IN SITU^8950/2^^^
"DATA",169.3,89503,0)
MULLERIAN MIXED TUMOR^8950/3^^^^67540^^5
"DATA",169.3,89512,0)
MESODERMAL MIXED TUMOR IN SITU^8951/2^^^
"DATA",169.3,89513,0)
MESODERMAL MIXED TUMOR^8951/3^^^^^^5
"DATA",169.3,89590,0)
BENIGN CYSTIC NEPHROMA^8959/0^^^^67649^^
"DATA",169.3,89591,0)
CYSTIC PARTIALLY DIFF NEPHROBLASTOMA^8959/1^^^^67649^^
"DATA",169.3,89592,0)
CYSTIC NEPHROMA IN SITU^8959/2^^^
"DATA",169.3,89593,0)
MALIGNANT CYSTIC NEPHROMA^8959/3^^^^67649^^
"DATA",169.3,89593,1,0)
^169.32^1^1
"DATA",169.3,89593,1,1,0)
MALIGNANT MULTILOCULAR CYSTIC NEPHROMA
"DATA",169.3,89601,0)
MESOBLASTIC NEPHROMA^8960/1^^^^^^5
"DATA",169.3,89602,0)
NEPHROBLASTOMA IN SITU^8960/2^^^
"DATA",169.3,89603,0)
NEPHROBLASTOMA, NOS^8960/3^^^6764^67649^^5
"DATA",169.3,89603,1,0)
^169.32^4^2
"DATA",169.3,89603,1,3,0)
NEPHROMA, NOS
"DATA",169.3,89603,1,4,0)
WILMS TUMOR
"DATA",169.3,89632,0)
RHABDOID TUMOR IN SITU^8963/2^^^
"DATA",169.3,89633,0)
MALIGNANT RHABDOID TUMOR^8963/3^^^^^^5
"DATA",169.3,89633,1,0)
^169.32^2^2
"DATA",169.3,89633,1,1,0)
RHABDOID SARCOMA
"DATA",169.3,89633,1,2,0)
RHABDOID TUMOR, NOS
"DATA",169.3,89642,0)
CLEAR CELL SARCOMA OF KIDNEY IN SITU^8964/2^^^
"DATA",169.3,89643,0)
CLEAR CELL SARCOMA OF KIDNEY^8964/3^^^^67649^^5
"DATA",169.3,89650,0)
NEPHROGENIC ADENOFIBROMA^8965/0^^^^67649^^
"DATA",169.3,89660,0)
RENOMEDULLARY INTERSTITIAL CELL TUMOR^8966/0^^^^67649^^
"DATA",169.3,89660,1,0)
^169.32^1^1
"DATA",169.3,89660,1,1,0)
RENOMEDULLARY FIBROMA
"DATA",169.3,89670,0)
OSSIFYING RENAL TUMOR^8967/0^^^^67649^^
"DATA",169.3,89702,0)
HEPATOBLASTOMA IN SITU^8970/2^^^
"DATA",169.3,89703,0)
HEPATOBLASTOMA^8970/3^^^6722^67220^^5
"DATA",169.3,89703,1,0)
^169.32^1^1
"DATA",169.3,89703,1,1,0)
EMBRYONAL HEPATOMA
"DATA",169.3,89712,0)
PANCREATOBLASTOMA IN SITU^8971/2^^^
"DATA",169.3,89713,0)
PANCREATOBLASTOMA^8971/3^^^^67250^^5
"DATA",169.3,89722,0)
PULMONARY BLASTOMA IN SITU^8972/2^^^
"DATA",169.3,89723,0)
PULMONARY BLASTOMA^8972/3^^^6734^^^5
"DATA",169.3,89723,1,0)
^169.32^1^1
"DATA",169.3,89723,1,1,0)
PNEUMOBLASTOMA
"DATA",169.3,89732,0)
PLEUROPULMONARY BLASTOMA IN SITU^8973/2^^^
"DATA",169.3,89733,0)
PLEUROPULMONARY BLASTOMA^8973/3^^^
"DATA",169.3,89741,0)
SIALOBLASTOMA^8974/1^^^
"DATA",169.3,89751,0)
CALCIFYING NESTED EPITHELIAL STROMAL TUMOR (C22.0)^8975/1
"DATA",169.3,89802,0)
CARCINOSARCOMA IN SITU^8980/2^^^
"DATA",169.3,89803,0)
CARCINOSARCOMA, NOS^8980/3^^^^^^3
"DATA",169.3,89812,0)
CARCINOSARCOMA IN SITU, EMBRYONAL^8981/2^^^
"DATA",169.3,89813,0)
CARCINOSARCOMA, EMBRYONAL^8981/3^^^^^^3
"DATA",169.3,89820,0)
MYOEPITHELIOMA^8982/0^^^^^^5
"DATA",169.3,89820,1,0)
^169.32^2^2
"DATA",169.3,89820,1,1,0)
MYOEPITHELIAL TUMOR
"DATA",169.3,89820,1,2,0)
MYOEPITHELIAL ADENOMA
"DATA",169.3,89822,0)
MYOEPITHELIOMA IN SITU^8982/2^^^
"DATA",169.3,89823,0)
MALIGNANT MYOEPITHELIOMA^8982/3^^^
"DATA",169.3,89823,1,0)
^169.32^1^1
"DATA",169.3,89823,1,1,0)
MYOEPITHELIAL CARCINOMA
"DATA",169.3,89830,0)
ADENOMYOEPITHELIOMA^8983/0^^^^67500^^
"DATA",169.3,89833,0)
ADENOMYOEPITHELIOMA WITH CARCINOMA (C50._)^8983/3
"DATA",169.3,89900,0)
MESENCHYMOMA, BENIGN^8990/0^^^^^^5
"DATA",169.3,89901,0)
MESENCHYMOMA, NOS^8990/1^^^^^^5
"DATA",169.3,89901,1,0)
^169.32^1^1
"DATA",169.3,89901,1,1,0)
MIXED MESENCHYMAL TUMOR
"DATA",169.3,89902,0)
MESENCHYMOMA IN SITU^8990/2^^^
"DATA",169.3,89903,0)
MESENCHYMOMA, MALIGNANT^8990/3^^^^^^5
"DATA",169.3,89903,1,0)
^169.32^2^2
"DATA",169.3,89903,1,1,0)
MIXED MESENCHYMAL SARCOMA
"DATA",169.3,89903,1,2,0)
PHOSPHATURIC MESENCHYMAL TUMOR, MALIGNANT
"DATA",169.3,89912,0)
EMBRYONAL SARCOMA IN SITU^8991/2^^^
"DATA",169.3,89913,0)
EMBRYONAL SARCOMA^8991/3^^^^^^5
"DATA",169.3,90000,0)
BRENNER TUMOR, NOS^9000/0^^^6756^67569^^5
"DATA",169.3,90001,0)
BRENNER TUMOR, BORDERLINE MALIGNANCY^9000/1^^^6756^67569^^5
"DATA",169.3,90001,1,0)
^169.32^1^1
"DATA",169.3,90001,1,1,0)
BRENNER TUMOR, PROLIFERATING
"DATA",169.3,90002,0)
BRENNER TUMOR IN SITU^9000/2^^^
"DATA",169.3,90003,0)
BRENNER TUMOR, MALIGNANT^9000/3^^^^67569^^5
"DATA",169.3,90100,0)
FIBROADENOMA, NOS^9010/0^^^^67500^^5
"DATA",169.3,90110,0)
INTRACANALICULAR FIBROADENOMA^9011/0^^^6750^67500^^5
"DATA",169.3,90120,0)
PERICANALICULAR FIBROADENOMA^9012/0^^^6750^67500^^5
"DATA",169.3,90130,0)
ADENOFIBROMA, NOS^9013/0^^^6756^67569^^5
"DATA",169.3,90130,1,0)
^169.32^2^2
"DATA",169.3,90130,1,1,0)
CYSTADENOFIBROMA, NOS
"DATA",169.3,90130,1,2,0)
PAPILLARY ADENOFIBROMA
"DATA",169.3,90132,0)
ADENOFIBROMA IN SITU^9013/2^^^
"DATA",169.3,90133,0)
ADENOFIBROMA, MALIGNANT^9013/3^^^
"DATA",169.3,90133,1,0)
^169.32^1^1
"DATA",169.3,90133,1,1,0)
CYSTADENOFIBROMA, MALIGNANT
"DATA",169.3,90140,0)
SEROUS ADENOFIBROMA, NOS^9014/0^^^^^^5
"DATA",169.3,90140,1,0)
^169.32^1^1
"DATA",169.3,90140,1,1,0)
SEROUS CYSTADENOFIBROMA, NOS
"DATA",169.3,90141,0)
SEROUS ADENOFIBROMA OF BORDERLINE MALIGNANCY^9014/1^^^
"DATA",169.3,90141,1,0)
^169.32^1^1
"DATA",169.3,90141,1,1,0)
SEROUS CYSTADENOFIBROMA/BORDERLINE MALIGNANCY
"DATA",169.3,90142,0)
SEROUS ADENOCARCINOFIBROMA IN SITU^9014/2^^^
"DATA",169.3,90143,0)
SEROUS ADENOCARCINOFIBROMA^9014/3^^^
"DATA",169.3,90143,1,0)
^169.32^3^3
"DATA",169.3,90143,1,1,0)
MALIGNANT SEROUS ADENOFIBROMA
"DATA",169.3,90143,1,2,0)
SEROUS CYSTADENOCARCINOFIBROMA
"DATA",169.3,90143,1,3,0)
MALIGNANT SEROUS CYSTADENOFIBROMA
"DATA",169.3,90150,0)
MUCINOUS ADENOFIBROMA, NOS^9015/0^^^6756^67569^^5
"DATA",169.3,90150,1,0)
^169.32^1^1
"DATA",169.3,90150,1,1,0)
MUCINOUS CYSTADENOFIBROMA, NOS
"DATA",169.3,90151,0)
MUCINOUS ADENOFIBROMA/BORDERLINE MALIGNANCY^9015/1^^^
"DATA",169.3,90151,1,0)
^169.32^1^1
"DATA",169.3,90151,1,1,0)
MUCINOUS CYSTADENOFIBROMA OF BORDERLINE MALIG
"DATA",169.3,90152,0)
MUCINOUS ADENOCARCINOFIBROMA IN SITU^9015/2^^^
"DATA",169.3,90153,0)
MUCINOUS ADENOCARCINOFIBROMA^9015/3^^^
"DATA",169.3,90153,1,0)
^169.32^3^3
"DATA",169.3,90153,1,1,0)
MALIGNANT MUCINOUS ADEONFIBROMA
"DATA",169.3,90153,1,2,0)
MUCINOUS CYSTADENOCARCINOFIBROMA
"DATA",169.3,90153,1,3,0)
MALIGNANT MUCINOUS CYSTADENOFIBROMA
"DATA",169.3,90160,0)
GIANT FIBROADENOMA^9016/0^^^6750^67500^^5
"DATA",169.3,90200,0)
PHYLLODES TUMOR, BENIGN^9020/0^^^6750^67500^^5
"DATA",169.3,90200,1,0)
^169.32^1^1
"DATA",169.3,90200,1,1,0)
CYSTOSARCOMA PHYLLODES, BENIGN
"DATA",169.3,90201,0)
PHYLLODES TUMOR, BORDERLINE^9020/1^^^6750^67500^^5
"DATA",169.3,90201,1,0)
^169.32^2^2
"DATA",169.3,90201,1,1,0)
CYSTOSARCOMA PHYLLODES, NOS
"DATA",169.3,90201,1,2,0)
PHYLLODES TUMOR, NOS
"DATA",169.3,90202,0)
PHYLLODES TUMOR IN SITU ^9020/2^^^
"DATA",169.3,90203,0)
PHYLLODES TUMOR, MALIGNANT^9020/3^^^^67500^^5
"DATA",169.3,90203,1,0)
^169.32^2^2
"DATA",169.3,90203,1,1,0)
CYSTOSARCOMA PHYLLODES, MALIGNANT
"DATA",169.3,90203,1,2,0)
PERIDUCTAL STROMAL TUMOR, LOW GRADE (C50._)
"DATA",169.3,90300,0)
JUVENILE FIBROADENOMA^9030/0^^^6750^67500^^5
"DATA",169.3,90400,0)
SYNOVIOMA, BENIGN^9040/0^^^^^^5
"DATA",169.3,90402,0)
SYNOVIAL SARCOMA IN SITU^9040/2^^^
"DATA",169.3,90403,0)
SYNOVIAL SARCOMA, NOS^9040/3^^^^^^5
"DATA",169.3,90403,1,0)
^169.32^2^2
"DATA",169.3,90403,1,1,0)
SYNOVIOMA, NOS
"DATA",169.3,90403,1,2,0)
SYNOVIOMA, MALIGNANT
"DATA",169.3,90412,0)
SYNOVIAL SARCOMA IN SITU, SPINDLE CELL^9041/2^^^
"DATA",169.3,90413,0)
SYNOVIAL SARCOMA, SPINDLE CELL^9041/3^^^^^^5
"DATA",169.3,90413,1,0)
^169.32^1^1
"DATA",169.3,90413,1,1,0)
SYNOVIAL SARCOMA, MONOPHASIC FIBROUS
"DATA",169.3,90422,0)
SYNOVIAL SARCOMA IN SITU, EPITHELIOID CELL^9042/2^^^
"DATA",169.3,90423,0)
SYNOVIAL SARCOMA, EPITHELIOID CELL^9042/3^^^^^^5
"DATA",169.3,90432,0)
SYNOVIAL SARCOMA IN SITU, BIPHASIC^9043/2^^^
"DATA",169.3,90433,0)
SYNOVIAL SARCOMA, BIPHASIC^9043/3^^^^^^5
"DATA",169.3,90442,0)
CLEAR CELL SARCOMA IN SITU^9044/2^^^
"DATA",169.3,90443,0)
CLEAR CELL SARCOMA, NOS^9044/3^^^^^^5
"DATA",169.3,90443,1,0)
^169.32^2^2
"DATA",169.3,90443,1,1,0)
CLEAR CELL SARCOMA, TENDONS AND APONEUROSES
"DATA",169.3,90443,1,2,0)
MELANOMA, MALIGNANT, OF SOFT PARTS
"DATA",169.3,90453,0)
BIPHENOTYPICS SINONASAL SARCOMA (C30.0, C31.0-C31.3, C31.8, C31.9)^9045/3
"DATA",169.3,90500,0)
MESOTHELIOMA, BENIGN^9050/0^^^^^^5
"DATA",169.3,90502,0)
MESOTHELIOMA IN SITU^9050/2^^^
"DATA",169.3,90503,0)
MESOTHELIOMA, MALIGNANT^9050/3^^^^^^5
"DATA",169.3,90503,1,0)
^169.32^1^1
"DATA",169.3,90503,1,1,0)
MESOTHELIOMA, NOS
"DATA",169.3,90510,0)
FIBROUS MESOTHELIOMA, BENIGN^9051/0^^^^^^5
"DATA",169.3,90512,0)
FIBROUS MESOTHELIOMA IN SITU^9051/2^^^
"DATA",169.3,90513,0)
FIBROUS MESOTHELIOMA, MALIGNANT^9051/3^^^^^^5
"DATA",169.3,90513,1,0)
^169.32^4^4
"DATA",169.3,90513,1,1,0)
FIBROUS MESOTHELIOMA, NOS
"DATA",169.3,90513,1,2,0)
SPINDLED MESOTHELIOMA
"DATA",169.3,90513,1,3,0)
SARCOMATOID MESOTHELIOMA
"DATA",169.3,90513,1,4,0)
DESMOPLASTIC MESOTHELIOMA
"DATA",169.3,90520,0)
EPITHELIOID MESOTHELIOMA, BENIGN^9052/0^^^^^^5
"DATA",169.3,90520,1,0)
^169.32^2^2
"DATA",169.3,90520,1,1,0)
WELL DIFF PAPILLARY MESOTHELIOMA, BENIGN
"DATA",169.3,90520,1,2,0)
MESOTHELIAL PAPILLOMA
"DATA",169.3,90522,0)
EPITHELIOID MESOTHELIOMA IN SITU^9052/2^^^
"DATA",169.3,90523,0)
EPITHELIOID MESOTHELIOMA, MALIGNANT^9052/3^^^^^^5
"DATA",169.3,90523,1,0)
^169.32^1^1
"DATA",169.3,90523,1,1,0)
EPITHELIOID MESOTHELIOMA, NOS
"DATA",169.3,90532,0)
MESOTHELIOMA IN SITU, BIPHASIC^9053/2^^^
"DATA",169.3,90533,0)
MESOTHELIOMA, BIPHASIC, MALIGNANT^9053/3^^^^^^5
"DATA",169.3,90533,1,0)
^169.32^1^1
"DATA",169.3,90533,1,1,0)
MESOTHELIOMA, BIPHASIC, NOS
"DATA",169.3,90540,0)
ADENOMATOID TUMOR, NOS^9054/0^^^^^^5
"DATA",169.3,90550,0)
MULTICYSTIC MESOTHELIOMA, BENIGN^9055/0^^^
"DATA",169.3,90550,1,0)
^169.32^1^1
"DATA",169.3,90550,1,1,0)
CYSTIC MESOTHELIOMA, BENIGN
"DATA",169.3,90551,0)
CYSTIC MESOTHELIOMA, NOS^9055/1^^^6748^67480^^5
"DATA",169.3,90602,0)
DYSGERMINOMA IN SITU^9060/2^^^
"DATA",169.3,90603,0)
DYSGERMINOMA^9060/3^^^^^^2
"DATA",169.3,90612,0)
SEMINOMA, IN SITU^9061/2^^^
"DATA",169.3,90613,0)
SEMINOMA, NOS^9061/3^^^6762^67620^^2
"DATA",169.3,90622,0)
SEMINOMA IN SITU, ANAPLASTIC^9062/2^^^
"DATA",169.3,90623,0)
SEMINOMA, ANAPLASTIC^9062/3^^^6762^67620^^2
"DATA",169.3,90623,1,0)
^169.32^1^1
"DATA",169.3,90623,1,1,0)
SEMINOMA WITH HIGH MITOTIC INDEX
"DATA",169.3,90632,0)
SPERMATOCYTIC SEMINOMA IN SITU^9063/2^^^
"DATA",169.3,90633,0)
SPERMATOCYTIC SEMINOMA^9063/3^^^6762^67620^^2
"DATA",169.3,90633,1,0)
^169.32^1^1
"DATA",169.3,90633,1,1,0)
SPERMATOCYTOMA
"DATA",169.3,90642,0)
INTRATUBULAR MALIGNANT GERM CELLS^9064/2^^^^67620^^2
"DATA",169.3,90642,1,0)
^169.32^1^1
"DATA",169.3,90642,1,1,0)
INTRATUBULAR GERM CELL NEOPLASIA
"DATA",169.3,90643,0)
GERMINOMA^9064/3^^^^^^2
"DATA",169.3,90643,1,0)
^169.32^1^1
"DATA",169.3,90643,1,1,0)
GERM CELL TUMOR, NOS
"DATA",169.3,90652,0)
GERM CELL TUMOR IN SITUU, NONSEMINOMATOUS^9065/2^^^
"DATA",169.3,90653,0)
GERM CELL TUMOR, NONSEMINOMATOUS^9065/3^^^^67620^^
"DATA",169.3,90702,0)
EMBRYONAL CARCINOMA IN SITU^9070/2^^^
"DATA",169.3,90703,0)
EMBRYONAL CARCINOMA, NOS^9070/3^^^^^^3
"DATA",169.3,90703,1,0)
^169.32^1^1
"DATA",169.3,90703,1,1,0)
EMBRYONAL ADENOCARCINOMA
"DATA",169.3,90712,0)
YOLK SAC TUMOR IN SITU^9071/2^^^
"DATA",169.3,90713,0)
YOLK SAC TUMOR^9071/3^^^^^^3
"DATA",169.3,90713,1,0)
^169.32^5^5
"DATA",169.3,90713,1,1,0)
ENDODERMAL SINUS TUMOR
"DATA",169.3,90713,1,2,0)
POLYVESICULAR VITELLINE TUMOR
"DATA",169.3,90713,1,3,0)
ORCHIOBLASTOMA
"DATA",169.3,90713,1,4,0)
EMBRYONAL CARCINOMA, INFANTILE
"DATA",169.3,90713,1,5,0)
HEPATOID YOLK SAC TUMOR
"DATA",169.3,90722,0)
POLYEMBRYOMA IN SITU^9072/2^^^
"DATA",169.3,90723,0)
POLYEMBRYOMA^9072/3^^^^^^3
"DATA",169.3,90723,1,0)
^169.32^1^1
"DATA",169.3,90723,1,1,0)
EMBRYONAL CARCINOMA, POLYEMBRYONAL TYPE
"DATA",169.3,90731,0)
GONADOBLASTOMA^9073/1^^^^^^2
"DATA",169.3,90731,1,0)
^169.32^1^1
"DATA",169.3,90731,1,1,0)
GONOCYTOMA
"DATA",169.3,90732,0)
GONADOBLASTOMA IN SITU^9073/2^^^
"DATA",169.3,90733,0)
GONADOBLASTOMA, MALIGNANT^9073/3^^^
"DATA",169.3,90733,1,0)
^169.32^1^1
"DATA",169.3,90733,1,1,0)
GONOCYTOMA, MALIGNANT
"DATA",169.3,90800,0)
TERATOMA, BENIGN^9080/0^^^^^^2
"DATA",169.3,90800,1,0)
^169.32^5^5
"DATA",169.3,90800,1,1,0)
ADULT  CYSTIC TERATOMA
"DATA",169.3,90800,1,2,0)
ADULT TERATOMA, NOS
"DATA",169.3,90800,1,3,0)
CYSTIC TERATOMA, NOS
"DATA",169.3,90800,1,4,0)
TERATOMA, DIFFERENTIATED
"DATA",169.3,90800,1,5,0)
MATURE TERATOMA
"DATA",169.3,90801,0)
TERATOMA, NOS^9080/1^^^^^^2
"DATA",169.3,90801,1,0)
^169.32^1^1
"DATA",169.3,90801,1,1,0)
SOLID TERATOMA
"DATA",169.3,90802,0)
TERATOMA IN SITU^9080/2^^^
"DATA",169.3,90803,0)
TERATOMA, MALIGNANT, NOS^9080/3^^^^^^2
"DATA",169.3,90803,1,0)
^169.32^4^4
"DATA",169.3,90803,1,1,0)
EMBRYONAL TERATMA
"DATA",169.3,90803,1,2,0)
TERATOBLASTOMA, MALIGNANT
"DATA",169.3,90803,1,3,0)
IMMATURE TERATOMA, MALIGNANT
"DATA",169.3,90803,1,4,0)
IMMATURE TERATOMA, NOS
"DATA",169.3,90812,0)
TERATOCARCINOMA IN SITU^9081/2^^^
"DATA",169.3,90813,0)
TERATOCARCINOMA^9081/3^^^^^^3
"DATA",169.3,90813,1,0)
^169.32^1^1
"DATA",169.3,90813,1,1,0)
MIXED EMBRYONAL CARCINOMA AND TERATOMA
"DATA",169.3,90822,0)
TERATOMA IN SITU, UNDIFFERENTIATED^9082/2^^^
"DATA",169.3,90823,0)
MALIGNANT TERATOMA, UNDIFFERENTIATED^9082/3^^^^^^2
"DATA",169.3,90823,1,0)
^169.32^1^1
"DATA",169.3,90823,1,1,0)
MALIGNANT TERATOMA, ANAPLASTIC
"DATA",169.3,90832,0)
TERATOMA IN SITU, INTERMEDIATE^9083/2^^^
"DATA",169.3,90833,0)
MALIGNANT TERATOMA, INTERMEDIATE^9083/3^^^^^^2
"DATA",169.3,90840,0)
DERMOID CYST, NOS^9084/0^^^^^^2
"DATA",169.3,90840,1,0)
^169.32^1^1
"DATA",169.3,90840,1,1,0)
DERMOID, NOS
"DATA",169.3,90842,0)
DERMOID CYST IN SITU^9084/2^^^
"DATA",169.3,90843,0)
TERATOMA WITH MALIGNANT TRANSFORMATION^9084/3^^^^^^2
"DATA",169.3,90843,1,0)
^169.32^2^2
"DATA",169.3,90843,1,1,0)
DERMOID CYST WITH MALIGNANT TRANSFORMATION
"DATA",169.3,90843,1,2,0)
DERMOID CYST WITH SECONDARY TUMOR
"DATA",169.3,90852,0)
MIXED GERM CELL TUMOR IN SITU^9085/2^^^
"DATA",169.3,90853,0)
MIXED GERM CELL TUMOR^9085/3^^^^^^2
"DATA",169.3,90853,1,0)
^169.32^1^1
"DATA",169.3,90853,1,1,0)
MIXED TERATOMA AND SEMINOMA
"DATA",169.3,90863,0)
GERM CELL TUMORS WITH ASSOCIATED HEMATOLOGICAL MALIGNANCY (C37.9)^9086/3
"DATA",169.3,90900,0)
STRUMA OVARII, NOS^9090/0^^^6756^67569^^2
"DATA",169.3,90902,0)
STRUMA OVARII IN SITU^9090/2^^^
"DATA",169.3,90903,0)
STRUMA OVARII, MALIGNANT^9090/3^^^6756^67569^^2
"DATA",169.3,90911,0)
STRUMAL CARCINOID^9091/1^^^6756^67569^^2
"DATA",169.3,90911,1,0)
^169.32^1^1
"DATA",169.3,90911,1,1,0)
STRUMA OVARII AND CARCINOID
"DATA",169.3,90912,0)
STRUMAL CARCINOID IN SITU^9091/2^^^
"DATA",169.3,90913,0)
STRUMAL CARCINOID, MALIGNANT^9091/3^^^
"DATA",169.3,90913,1,0)
^169.32^1^1
"DATA",169.3,90913,1,1,0)
STRUMA OVARII AND CARCINOID, MALIGNANT
"DATA",169.3,91000,0)
HYDATIDIFORM MOLE, NOS^9100/0^^^6758^67589^^2
"DATA",169.3,91000,1,0)
^169.32^2^2
"DATA",169.3,91000,1,1,0)
HYDATID MOLE
"DATA",169.3,91000,1,2,0)
COMPLETE HYDATIDIFORM MOLE
"DATA",169.3,91001,0)
INVASIVE HYDATIDIFORM MOLE^9100/1^^^6758^67589^^2
"DATA",169.3,91001,1,0)
^169.32^4^4
"DATA",169.3,91001,1,1,0)
CHORIOADENOMA DESTRUENS
"DATA",169.3,91001,1,2,0)
CHORIOADENOMA
"DATA",169.3,91001,1,3,0)
INVASIVE MOLE, NOS
"DATA",169.3,91001,1,4,0)
MALIGNANT HYDATIDIFORM MOLE
"DATA",169.3,91002,0)
CHORIOCARCINOMA IN SITU^9100/2^^^
"DATA",169.3,91003,0)
CHORIOCARCINOMA, NOS^9100/3^^^^^^2
"DATA",169.3,91003,1,0)
^169.32^2^2
"DATA",169.3,91003,1,1,0)
CHORIONEPITHELIOMA
"DATA",169.3,91003,1,2,0)
CHORIOEPITHELIOMA
"DATA",169.3,91012,0)
CHORIOCARCINOMA W OTH GERM CELL ELEM IN SITU^9101/2^^^
"DATA",169.3,91013,0)
CHORIOCARCINOMA WITH OTHER GERM CELL ELEMENTS^9101/3^^^^^^3
"DATA",169.3,91013,1,0)
^169.32^2^2
"DATA",169.3,91013,1,1,0)
CHORIOCARCINOMA COMBINED WITH TERATOMA
"DATA",169.3,91013,1,2,0)
CHORIOCARCINOMA COMBINED WITH EMBRYONAL CA
"DATA",169.3,91022,0)
TERATOMA IN SITU, TROPHOBLASTIC^9102/2^^^
"DATA",169.3,91023,0)
MALIGNANT TERATOMA, TROPHOBLASTIC^9102/3^^^6762^^^2
"DATA",169.3,91030,0)
PARTIAL HYDATIDIFORM MOLE^9103/0^^^6758^67589^^2
"DATA",169.3,91041,0)
PLACENTAL SITE TROPHOBLASTIC TUMOR^9104/1^^^6758^67589^^2
"DATA",169.3,91043,0)
PLACENTAL SITE TROPHOBLASTIC TUMOR, MALIGNANT^9104/3^^^
"DATA",169.3,91052,0)
TROPHOBLASTIC TUMOR IN SITU, EPITHELIOID^9105/2^^^
"DATA",169.3,91053,0)
TROPHOBLASTIC TUMOR, EPITHELIOID^9105/3^^^
"DATA",169.3,91100,0)
MESONEPHROMA, BENIGN^9110/0^^^^^^3
"DATA",169.3,91100,1,0)
^169.32^3^2
"DATA",169.3,91100,1,1,0)
MESONEPHRIC ADENOMA
"DATA",169.3,91100,1,3,0)
WOLFFIAN DUCT ADENOMA
"DATA",169.3,91101,0)
MESONEPHRIC TUMOR, NOS^9110/1^^^
"DATA",169.3,91103,0)
MESONEPHROMA, MALIGNANT^9110/3^^^^^^3
"DATA",169.3,91103,1,0)
^169.32^4^4
"DATA",169.3,91103,1,1,0)
MESONEPHRIC ADENOCARCINOMA
"DATA",169.3,91103,1,2,0)
MESONEPHROMA, NOS
"DATA",169.3,91103,1,3,0)
WOLFFIAN DUCT CARCINOMA
"DATA",169.3,91103,1,4,0)
ADENOCARCINOMA OF RETE OVARII (C56.9)
"DATA",169.3,91200,0)
HEMANGIOMA, NOS^9120/0^^^6758^67589^^5
"DATA",169.3,91200,1,0)
^169.32^2^2
"DATA",169.3,91200,1,1,0)
ANGIOMA, NOS
"DATA",169.3,91200,1,2,0)
CHORIOANGIOMA
"DATA",169.3,91203,0)
HEMANGIOSARCOMA^9120/3^^^^^^5
"DATA",169.3,91203,1,0)
^169.32^1^1
"DATA",169.3,91203,1,1,0)
ANGIOSARCOMA
"DATA",169.3,91210,0)
CAVERNOUS HEMANGIOMA^9121/0^^^^^^5
"DATA",169.3,91220,0)
VENOUS HEMANGIOMA^9122/0^^^^^^5
"DATA",169.3,91230,0)
RACEMOSE HEMANGIOMA^9123/0^^^^^^5
"DATA",169.3,91230,1,0)
^169.32^1^1
"DATA",169.3,91230,1,1,0)
ARTERIOVENOUS HEMANGIOMA
"DATA",169.3,91243,0)
KUPFFER CELL SARCOMA^9124/3^^^6722^67220^^5
"DATA",169.3,91250,0)
EPITHELIOID HEMANGIOMA^9125/0^^^^^^5
"DATA",169.3,91250,1,0)
^169.32^1^1
"DATA",169.3,91250,1,1,0)
HISTIOCYTOID HEMANGIOMA
"DATA",169.3,91300,0)
HEMANGIOENDOTHELIOMA, BENIGN^9130/0^^^^^^5
"DATA",169.3,91301,0)
HEMANGIOENDOTHELIOMA, NOS^9130/1^^^^^^5
"DATA",169.3,91301,1,0)
^169.32^2^2
"DATA",169.3,91301,1,1,0)
ANGIOENDOTHELIOMA
"DATA",169.3,91301,1,2,0)
KAPOSIFORM HEMANGIOENDOTHELIOMA
"DATA",169.3,91303,0)
HEMANGIOENDOTHELIOMA, MALIGNANT^9130/3^^^^^^5
"DATA",169.3,91303,1,0)
^169.32^1^1
"DATA",169.3,91303,1,1,0)
HEMANGIOENDOTHELIAL SARCOMA
"DATA",169.3,91310,0)
CAPILLARY HEMANGIOMA^9131/0^^^^^^5
"DATA",169.3,91310,1,0)
^169.32^4^4
"DATA",169.3,91310,1,1,0)
HEMANGIOMA SIMPLEX
"DATA",169.3,91310,1,2,0)
INFANTILE HEMANGIOMA
"DATA",169.3,91310,1,3,0)
PLEXIFORM HEMANGIOMA
"DATA",169.3,91310,1,4,0)
JUVENILE HEMANGIOMA
"DATA",169.3,91320,0)
INTRAMUSCULAR HEMANGIOMA^9132/0^^^^^^5
"DATA",169.3,91331,0)
EPITHELIOID HEMANGIOENDOTHELIOMA, NOS^9133/1^^^^^^5
"DATA",169.3,91333,0)
EPITHELIOID HEMANGIOENDOTHELIOMA ^9133/3^^^^^^5
"DATA",169.3,91333,1,0)
^169.32^1^1
"DATA",169.3,91333,1,1,0)
INTRAVASCULAR BRONCHIAL ALVEOLAR TUMOR
"DATA",169.3,91351,0)
ENDOVASCULAR PAPILLARY ANGIOENDOTHELIOMA^9135/1^^^
"DATA",169.3,91351,1,0)
^169.32^1^1
"DATA",169.3,91351,1,1,0)
DABSKA TUMOR
"DATA",169.3,91361,0)
SPINDLE CELL HEMANGIOENDOTHELIOMA^9136/1^^^
"DATA",169.3,91361,1,0)
^169.32^1^1
"DATA",169.3,91361,1,1,0)
SPINDLE CELL ANGIOENDOTHELIOMA
"DATA",169.3,91373,0)
INTIMAL SARCOMA^9137/3
"DATA",169.3,91373,1,0)
^169.32^1^1
"DATA",169.3,91373,1,1,0)
PULMONARY ARTERY INTIMAL SARCOMA
"DATA",169.3,91403,0)
KAPOSI SARCOMA^9140/3^^^^^^5
"DATA",169.3,91403,1,0)
^169.32^1^1
"DATA",169.3,91403,1,1,0)
MULTIPLE HEMORRHAGIC SARCOMA
"DATA",169.3,91403,"E")
134^134^134
"DATA",169.3,91403,"L")
135^135^135
"DATA",169.3,91410,0)
ANGIOKERATOMA^9141/0^^^^^^5
"DATA",169.3,91420,0)
VERRUCOUS KERATOTIC HEMANGIOMA^9142/0^^^^^^5
"DATA",169.3,91500,0)
HEMANGIOPERICYTOMA, BENIGN^9150/0^^^^^^5
"DATA",169.3,91501,0)
HEMANGIOPERICYTOMA, NOS^9150/1^^^^^^5
"DATA",169.3,91501,1,0)
^169.32^1^1
"DATA",169.3,91501,1,1,0)
HEMANGIOPERICYTIC MENINGIOMA
"DATA",169.3,91503,0)
HEMANGIOPERICYTOMA, MALIGNANT^9150/3^^^^^^5
"DATA",169.3,91600,0)
ANGIOFIBROMA, NOS^9160/0^^^6711^^^5
"DATA",169.3,91600,1,0)
^169.32^5^5
"DATA",169.3,91600,1,1,0)
JUVENILE ANGIOFIBROMA
"DATA",169.3,91600,1,2,0)
FIBROUS PAPULE OF NOSE
"DATA",169.3,91600,1,3,0)
INVOLUTING NEVUS
"DATA",169.3,91600,1,4,0)
GIANT CELL ANGIOFIBROMA
"DATA",169.3,91600,1,5,0)
CELLULAR ANGIOFIBROMA
"DATA",169.3,91610,0)
ACQUIRED TUFTED HEMANGIOMA^9161/0^^^
"DATA",169.3,91611,0)
HEMANGIOBLASTOMA^9161/1^^^^^^5
"DATA",169.3,91611,1,0)
^169.32^1^1
"DATA",169.3,91611,1,1,0)
ANGIOBLASTOMA
"DATA",169.3,91700,0)
LYMPHANGIOMA, NOS^9170/0^^^^^^5
"DATA",169.3,91700,1,0)
^169.32^1^1
"DATA",169.3,91700,1,1,0)
LYMPHANGIOENDOTHELIOMA, NOS
"DATA",169.3,91703,0)
LYMPHANGIOSARCOMA^9170/3^^^^^^5
"DATA",169.3,91703,1,0)
^169.32^2^2
"DATA",169.3,91703,1,1,0)
LYMPHANGIOENDOTHELIAL SARCOMA
"DATA",169.3,91703,1,2,0)
LYMPHANGIOENDOTHELIOMA, MALIGNANT
"DATA",169.3,91710,0)
CAPILLARY LYMPHANGIOMA^9171/0^^^^^^5
"DATA",169.3,91720,0)
CAVERNOUS LYMPHANGIOMA^9172/0^^^^^^5
"DATA",169.3,91730,0)
CYSTIC LYMPHANGIOMA^9173/0^^^^^^5
"DATA",169.3,91730,1,0)
^169.32^2^2
"DATA",169.3,91730,1,1,0)
HYGROMA, NOS
"DATA",169.3,91730,1,2,0)
CYSTIC HYGROMA
"DATA",169.3,91740,0)
LYMPHANGIOMYOMA^9174/0^^^^^^5
"DATA",169.3,91741,0)
LYMPHANGIOMYOMATOSIS^9174/1^^^^^^5
"DATA",169.3,91741,1,0)
^169.32^1^1
"DATA",169.3,91741,1,1,0)
LYMPHANGIOLEIOMYOMATOSIS
"DATA",169.3,91750,0)
HEMOLYMPHANGIOMA^9175/0^^^^^^5
"DATA",169.3,91800,0)
OSTEOMA, NOS^9180/0^67410^^^67400^^5
"DATA",169.3,91802,0)
OSTEOSARCOMA IN SITU^9180/2^^^
"DATA",169.3,91803,0)
OSTEOSARCOMA, NOS^9180/3^67410^^6740^67400^^5
"DATA",169.3,91803,1,0)
^169.32^3^3
"DATA",169.3,91803,1,1,0)
OSTEOGENIC SARCOMA, NOS
"DATA",169.3,91803,1,2,0)
OSTEOCHONDROSARCOMA
"DATA",169.3,91803,1,3,0)
OSTEOBLASTIC SARCOMA
"DATA",169.3,91812,0)
CHONDROBLASTIC OSTEOSARCOMA IN SITU^9181/2^^^
"DATA",169.3,91813,0)
CHONDROBLASTIC OSTEOSARCOMA^9181/3^67410^^6740^67400^^5
"DATA",169.3,91813,1,0)
^169.32^^0
"DATA",169.3,91822,0)
FIBROBLASTIC OSTEOSARCOMA IN SITU^9182/2^^^
"DATA",169.3,91823,0)
FIBROBLASTIC OSTEOSARCOMA^9182/3^67410^^6740^67400^^5
"DATA",169.3,91823,1,0)
^169.32^2^1
"DATA",169.3,91823,1,2,0)
OSTEOFIBROSARCOMA
"DATA",169.3,91832,0)
TELANGIECTATIC OSTEOSARCOMA IN SITU^9183/2^^^
"DATA",169.3,91833,0)
TELANGIECTATIC OSTEOSARCOMA^9183/3^67410^^^67400^^5
"DATA",169.3,91833,1,0)
^169.32^^0
"DATA",169.3,91842,0)
OSTEOSARCOMA IN PAGET DISEASE OF BONE IN SITU^9184/2^^^
"DATA",169.3,91843,0)
OSTEOSARCOMA IN PAGET DISEASE OF BONE^9184/3^67410^^6740^67400^^5
"DATA",169.3,91843,1,0)
^169.32^^0
"DATA",169.3,91852,0)
SMALL CELL OSTEOSARCOMA IN SITU^9185/2^^^
"DATA",169.3,91853,0)
SMALL CELL OSTEOSARCOMA^9185/3^67410^^^67400^^5
"DATA",169.3,91853,1,0)
^169.32^1^1
"DATA",169.3,91853,1,1,0)
ROUND CELL OSTEOSARCOMA
"DATA",169.3,91862,0)
CENTRAL OSTEOSARCOMA IN SITU^9186/2^^^
"DATA",169.3,91863,0)
CENTRAL OSTEOSARCOMA^9186/3^67410^^^67400^^
"DATA",169.3,91863,1,0)
^169.32^2^2
"DATA",169.3,91863,1,1,0)
CONVENTIONAL CENTRAL OSTEOSARCOMA
"DATA",169.3,91863,1,2,0)
MEDULLARY OSTEOSARCOMA
"DATA",169.3,91872,0)
INTRAOSSEOUS WELL DIFF OSTEOSARCOMA IN SITU^9187/2^^^
"DATA",169.3,91873,0)
INTRAOSSEOUS WELL DIFFERENTIATED OSTEOSARCOMA^9187/3^67410^^^67400^^
"DATA",169.3,91873,1,0)
^169.32^3^3
"DATA",169.3,91873,1,1,0)
INTRAOSSEOUS LOW GRADE OSTEOSARCOMA
"DATA",169.3,91873,1,2,0)
LOW-GRADE INTRAMEDULLARY OSTEOSARCOMA (C40._, C41._)
"DATA",169.3,91873,1,3,0)
LOW-GRADE CENTRAL OSTEOSARCOMA (C40._, C41._)
"DATA",169.3,91910,0)
OSTEOID OSTEOMA, NOS^9191/0^67410^^6740^67400^^5
"DATA",169.3,91922,0)
PAROSTEAL OSTEOSARCOMA IN SITU^9192/2^^^
"DATA",169.3,91923,0)
PAROSTEAL OSTEOSARCOMA^9192/3^67410^^^67400^^
"DATA",169.3,91923,1,0)
^169.32^1^1
"DATA",169.3,91923,1,1,0)
JUXTACORTICAL OSTEOSARCOMA
"DATA",169.3,91932,0)
PERIOSTEAL OSTEOSARCOMA IN SITU^9193/2^^^
"DATA",169.3,91933,0)
PERIOSTEAL OSTEOSARCOMA^9193/3^67410^^^67400^^
"DATA",169.3,91942,0)
HIGH GRADE SURFACE OSTEOSARCOMA IN SITU^9194/2^^^
"DATA",169.3,91943,0)
HIGH GRADE SURFACE OSTEOSARCOMA^9194/3^67410^^^67400^^
"DATA",169.3,91952,0)
INTRACORTICAL OSTEOSARCOMA IN SITU^9195/2^^^
"DATA",169.3,91953,0)
INTRACORTICAL OSTEOSARCOMA^9195/3^67410^^^67400^^
"DATA",169.3,92000,0)
OSTEOBLASTOMA, NOS^9200/0^67410^^6740^67400^^5
"DATA",169.3,92000,1,0)
^169.32^1^1
"DATA",169.3,92000,1,1,0)
GIANT OSTEOID OSTEOMA
"DATA",169.3,92001,0)
AGGRESSIVE OSTEOBLASTOMA^9200/1^67410^^6740^67400^^5
"DATA",169.3,92002,0)
AGGRESSIVE OSTEOSARCOMA IN SITU^9200/2^^^
"DATA",169.3,92003,0)
AGGRESSIVE OSTEOSARCOMA, MALIGNANT^9200/3^^^
"DATA",169.3,92100,0)
OSTEOCHONDROMA^9210/0^67410^^6740^67400^^5
"DATA",169.3,92100,1,0)
^169.32^3^3
"DATA",169.3,92100,1,1,0)
CARTILAGINOUS EXOSTOSIS
"DATA",169.3,92100,1,2,0)
OSTEOCARTILAGINOUS EXOSTOSIS
"DATA",169.3,92100,1,3,0)
ECCHONDROMA
"DATA",169.3,92101,0)
OSTEOCHONDROMATOSIS, NOS^9210/1^67410^^6740^67400^^5
"DATA",169.3,92101,1,0)
^169.32^1^1
"DATA",169.3,92101,1,1,0)
ECCHONDROSIS
"DATA",169.3,92200,0)
CHONDROMA, NOS^9220/0^67410^^6740^67400^^5
"DATA",169.3,92200,1,0)
^169.32^1^1
"DATA",169.3,92200,1,1,0)
ENCHONDROMA
"DATA",169.3,92201,0)
CHONDROMATOSIS, NOS^9220/1^^^^^^5
"DATA",169.3,92202,0)
CHONDROSARCOMA IN SITU^9220/2^^^
"DATA",169.3,92203,0)
CHONDROSARCOMA, NOS^9220/3^67410^^6740^67400^^5
"DATA",169.3,92203,1,0)
^169.32^2^2
"DATA",169.3,92203,1,1,0)
FIBROCHONDROSARCOMA
"DATA",169.3,92203,1,2,0)
CHONDROSARCOMA GRADE 2/3
"DATA",169.3,92210,0)
JUXTACORTICAL CHONDROMA^9221/0^67410^^6740^67400^^5
"DATA",169.3,92210,1,0)
^169.32^1^1
"DATA",169.3,92210,1,1,0)
PERIOSTEAL CHONDROMA
"DATA",169.3,92212,0)
JUXTACORTICAL CHONDROMA IN SITU^9221/2^^^
"DATA",169.3,92213,0)
JUXTACORTICAL CHONDROSARCOMA^9221/3^67410^^^67400^^5
"DATA",169.3,92213,1,0)
^169.32^1^1
"DATA",169.3,92213,1,1,0)
PERIOSTEAL CHONDROSARCOMA
"DATA",169.3,92300,0)
CHONDROBLASTOMA, NOS^9230/0^67410^^6740^67400^^5
"DATA",169.3,92300,1,0)
^169.32^2^2
"DATA",169.3,92300,1,1,0)
CHONDROMATOUS GIANT CELL TUMOR
"DATA",169.3,92300,1,2,0)
CODMAN TUMOR
"DATA",169.3,92302,0)
CHONDROBLASTOMA IN SITU^9230/2^^^
"DATA",169.3,92303,0)
CHONDROBLASTOMA, MALIGNANT^9230/3^67410^^^67400^^5
"DATA",169.3,92312,0)
MYXOID CHONDROSARCOMA IN SITU^9231/2^^^
"DATA",169.3,92313,0)
MYXOID CHONDROSARCOMA^9231/3^^^^^^5
"DATA",169.3,92402,0)
MESENCHYMAL CHONDROSARCOMA IN SITU^9240/2^^^
"DATA",169.3,92403,0)
MESENCHYMAL CHONDROSARCOMA^9240/3^^^^^^5
"DATA",169.3,92403,1,0)
^169.32^^0
"DATA",169.3,92410,0)
CHONDROMYXOID FIBROMA^9241/0^67410^^6740^67400^^5
"DATA",169.3,92422,0)
CLEAR CELL CHONDROSARCOMA IN SITU^9242/2^^^
"DATA",169.3,92423,0)
CLEAR CELL CHONDROSARCOMA^9242/3^67410^^^67400^^
"DATA",169.3,92432,0)
DEDIFFERENTIATED CHONDROSARCOMA IN SITU^9243/2^^^
"DATA",169.3,92433,0)
DEDIFFERENTIATED CHONDROSARCOMA^9243/3^67410^^^67400^^
"DATA",169.3,92501,0)
GIANT CELL TUMOR OF BONE, NOS^9250/1^67410^^6740^67400^^5
"DATA",169.3,92501,1,0)
^169.32^1^1
"DATA",169.3,92501,1,1,0)
OSTEOCLASTOMA, NOS
"DATA",169.3,92502,0)
GIANT CELL TUMOR OF BONE IN SITU^9250/2^^^
"DATA",169.3,92503,0)
GIANT CELL TUMOR OF BONE, MALIGNANT^9250/3^67410^^6740^67400^^5
"DATA",169.3,92503,1,0)
^169.32^2^2
"DATA",169.3,92503,1,1,0)
GIANT CELL SARCOMA OF BONE
"DATA",169.3,92503,1,2,0)
OSTEOCLATOMA, MALIGNANT
"DATA",169.3,92511,0)
GIANT CELL TUMOR OF SOFT PARTS^9251/1^^^^^^5
"DATA",169.3,92512,0)
GIANT CELL TUMOR OF SOFT PARTS IN SITU^9251/2^^^
"DATA",169.3,92513,0)
MALIGNANT GIANT CELL TUMOR OF SOFT PARTS^9251/3^^^^^^5
"DATA",169.3,92520,0)
TENOSYNOVIAL GIANT CELL TUMOR^9252/0^^^^67490^^
"DATA",169.3,92520,1,0)
^169.32^2^2
"DATA",169.3,92520,1,1,0)
FIBROUS HISTIOCYTOMA OF TENDON SHEATH
"DATA",169.3,92520,1,2,0)
GIANT CELL TUMOR OF TENDON SHEATH
"DATA",169.3,92522,0)
TENOSYNOVIAL GIANT CELL TUMOR IN SITU^9252/2^^^
"DATA",169.3,92523,0)
MALIGNANT TENOSYNOVIAL GIANT CELL TUMOR^9252/3^^^^67490^^
"DATA",169.3,92523,1,0)
^169.32^1^1
"DATA",169.3,92523,1,1,0)
GIANT CELL TUMOR OF TENDON SHEATH, MALIGNANT
"DATA",169.3,92602,0)
EWING SARCOMA IN SITU^9260/2^^^
"DATA",169.3,92603,0)
EWING SARCOMA^9260/3^^^^^^5
"DATA",169.3,92603,1,0)
^169.32^1^1
"DATA",169.3,92603,1,1,0)
EWING TUMOR
"DATA",169.3,92612,0)
ADAMANTINOMA OF LONG BONES IN SITU^9261/2^^^
"DATA",169.3,92613,0)
ADAMANTINOMA OF LONG BONES^9261/3^^^6740^67400^^5
"DATA",169.3,92613,1,0)
^169.32^1^1
"DATA",169.3,92613,1,1,0)
TIBIAL ADAMANTINOMA
"DATA",169.3,92620,0)
OSSIFYING FIBROMA^9262/0^^^^^^5
"DATA",169.3,92620,1,0)
^169.32^2^2
"DATA",169.3,92620,1,1,0)
FIBRO-OSTEOMA
"DATA",169.3,92620,1,2,0)
OSTEOFIBROMA
"DATA",169.3,92700,0)
ODONTOGENIC TUMOR, BENIGN^9270/0^^^^^^3
"DATA",169.3,92701,0)
ODONTOGENIC TUMOR, NOS^9270/1^^^^^^3
"DATA",169.3,92702,0)
ODONTOGENIC TUMOR IN SITU^9270/2^^^
"DATA",169.3,92703,0)
ODONTOGENIC TUMOR, MALIGNANT^9270/3^^^^^^3
"DATA",169.3,92703,1,0)
^169.32^4^4
"DATA",169.3,92703,1,1,0)
ODONTOGENIC CARCINOMA
"DATA",169.3,92703,1,2,0)
ODONTOGENIC SARCOMA
"DATA",169.3,92703,1,3,0)
PRIMARY INTRAOSSEOUS CARCINOMA
"DATA",169.3,92703,1,4,0)
AMELOBLASTIC CARCINOMA
"DATA",169.3,92710,0)
AMELOBLASTIC FIBRODENTINOMA^9271/0^^^^^^5
"DATA",169.3,92710,1,0)
^169.32^1^1
"DATA",169.3,92710,1,1,0)
DENTINOMA
"DATA",169.3,92720,0)
CEMENTOMA, NOS^9272/0^^^^^^5
"DATA",169.3,92720,1,0)
^169.32^2^2
"DATA",169.3,92720,1,1,0)
PERIAPICAL CEMENTAL DYSPLASIA
"DATA",169.3,92720,1,2,0)
PERIAPICAL CEMENTO-OSSEOUS DYSPLASIA
"DATA",169.3,92730,0)
CEMENTOBLASTOMA, BENIGN^9273/0^^^^^^5
"DATA",169.3,92740,0)
CEMENTIFYING FIBROMA^9274/0^^^^^^5
"DATA",169.3,92740,1,0)
^169.32^1^1
"DATA",169.3,92740,1,1,0)
CEMENTO-OSSIFYING FIBROMA
"DATA",169.3,92750,0)
GIGANTIFORM CEMENTOMA^9275/0^^^^^^5
"DATA",169.3,92750,1,0)
^169.32^1^1
"DATA",169.3,92750,1,1,0)
FLORID OSSEOUS DYSPLASIA
"DATA",169.3,92800,0)
ODONTOMA, NOS^9280/0^^^^^^5
"DATA",169.3,92810,0)
COMPOUND ODONTOMA^9281/0^^^^^^5
"DATA",169.3,92820,0)
COMPLEX ODONTOMA^9282/0^^^^^^5
"DATA",169.3,92900,0)
AMELOBLASTIC FIBRO-ODONTOMA^9290/0^^^^^^5
"DATA",169.3,92900,1,0)
^169.32^1^1
"DATA",169.3,92900,1,1,0)
FIBROAMELOBLASTIC ODONTOMA
"DATA",169.3,92902,0)
AMELOBLASTIC ODONTOSARCOMA IN SITU^9290/2^^^
"DATA",169.3,92903,0)
AMELOBLASTIC ODONTOSARCOMA^9290/3^^^^^^5
"DATA",169.3,92903,1,0)
^169.32^2^2
"DATA",169.3,92903,1,1,0)
AMELOBLASTIC FIBRODENTINOSARCOMA
"DATA",169.3,92903,1,2,0)
AMELOBLASTIC FIBRO-ODONTOSARCOMA
"DATA",169.3,93000,0)
ADENOMATOID ODONTOGENIC TUMOR^9300/0^^^^^^5
"DATA",169.3,93000,1,0)
^169.32^1^1
"DATA",169.3,93000,1,1,0)
ADENOAMELOBLASTOMA
"DATA",169.3,93010,0)
CALCIFYING ODONTOGENIC CYST^9301/0^^^
"DATA",169.3,93020,0)
ODONTOGENIC GHOST CELL TUMOR^9302/0^^^^^^5
"DATA",169.3,93023,0)
GHOST CELL ODONTOGENIC CARCINOMA (C41.0, C41.1)^9302/3
"DATA",169.3,93100,0)
AMELOBLASTOMA, NOS^9310/0^^^
"DATA",169.3,93100,1,0)
^169.32^1^1
"DATA",169.3,93100,1,1,0)
ADAMANTINOMA, NOS
"DATA",169.3,93102,0)
AMELOBLASTOMA IN SITU^9310/2^^^
"DATA",169.3,93103,0)
AMELOBLASTOMA, MALIGNANT^9310/3^^^^^^5
"DATA",169.3,93103,1,0)
^169.32^1^1
"DATA",169.3,93103,1,1,0)
ADAMANTINOMA, MALIGNANT
"DATA",169.3,93110,0)
ODONTOAMELOBLASTOMA^9311/0^^^^^^5
"DATA",169.3,93120,0)
SQUAMOUS ODONTOGENIC TUMOR^9312/0^^^
"DATA",169.3,93200,0)
ODONTOGENIC MYXOMA^9320/0^^^^^^5
"DATA",169.3,93200,1,0)
^169.32^1^1
"DATA",169.3,93200,1,1,0)
ODONTOGENIC MYXOFIBROMA
"DATA",169.3,93210,0)
CENTRAL ODONTOGENIC FIBROMA^9321/0^^^^^^5
"DATA",169.3,93210,1,0)
^169.32^1^1
"DATA",169.3,93210,1,1,0)
ODONTOGENIC FIBROMA, NOS
"DATA",169.3,93220,0)
PERIPHERAL ODONTOGENIC FIBROMA^9322/0^^^^^^5
"DATA",169.3,93300,0)
AMELOBLASTIC FIBROMA^9330/0^^^^^^5
"DATA",169.3,93302,0)
AMELOBLASTIC FIBROSARCOMA IN SITU^9330/2^^^
"DATA",169.3,93303,0)
AMELOBLASTIC FIBROSARCOMA^9330/3^^^^^^5
"DATA",169.3,93303,1,0)
^169.32^2^2
"DATA",169.3,93303,1,1,0)
AMELOBLASTIC SARCOMA
"DATA",169.3,93303,1,2,0)
ODONTOGENIC FIBROSARCOMA
"DATA",169.3,93400,0)
CALCIFYING EPITHELIAL ODONTOGENIC TUMOR^9340/0^^^^^^5
"DATA",169.3,93400,1,0)
^169.32^1^1
"DATA",169.3,93400,1,1,0)
PINDBORG TUMOR
"DATA",169.3,93411,0)
CLEAR CELL ODONTOGENIC TUMOR^9341/1^^^
"DATA",169.3,93413,0)
CLEAR CELL ODONTOGENIC CARCINOMA (C41.0, C41.1)^9341/3
"DATA",169.3,93422,0)
ODONTOGENIC CARCINOSARCOMA IN SITU^9342/2^^^
"DATA",169.3,93423,0)
ODONTOGENIC CARCINOSARCOMA^9342/3^^^
"DATA",169.3,93501,0)
CRANIOPHARYNGIOMA^9350/1^^^6775^67752^^9
"DATA",169.3,93501,1,0)
^169.32^1^1
"DATA",169.3,93501,1,1,0)
RATHKE POUCH TUMOR
"DATA",169.3,93511,0)
CRANIOPHARYNGIOMA, ADAMANTINOMATOUS^9351/1^^^^67752^^
"DATA",169.3,93521,0)
CRANIOPHARYNGIOMA, PAPILLARY^9352/1^^^^67752^^
"DATA",169.3,93601,0)
PINEALOMA^9360/1^^^6775^67753^^9
"DATA",169.3,93602,0)
PINEALOMA IN SITU^9360/2^^^
"DATA",169.3,93603,0)
PINEALOMA, MALIGNANT^9360/3^^^
"DATA",169.3,93611,0)
PINEOCYTOMA^9361/1^^^6775^67753^^9
"DATA",169.3,93612,0)
PINEOCYTOMA IN SITU^9361/2^^^
"DATA",169.3,93613,0)
PINEOCYTOMA, MALIGNANT^9361/3^^^
"DATA",169.3,93622,0)
PINEOBLASTOMA IN SITU^9362/2^^^
"DATA",169.3,93623,0)
PINEOBLASTOMA^9362/3^^^6775^67753^^9
"DATA",169.3,93623,1,0)
^169.32^4^4
"DATA",169.3,93623,1,1,0)
MIXED PINEAL TUMOR
"DATA",169.3,93623,1,2,0)
MIXED PINEOCYTOMA-PINEOBLASTOMA
"DATA",169.3,93623,1,3,0)
PINEAL PARENCHYMAL TUMOR OF INTERMEDIATE DIFF
"DATA",169.3,93623,1,4,0)
TRANSITIONAL PINEAL TUMOR
"DATA",169.3,93630,0)
MELANOTIC NEUROECTODERMAL TUMOR^9363/0^^^^^^9
"DATA",169.3,93630,1,0)
^169.32^3^3
"DATA",169.3,93630,1,1,0)
RETINAL ANLAGE TUMOR
"DATA",169.3,93630,1,2,0)
MELANOAMELOBLASTOMA
"DATA",169.3,93630,1,3,0)
MELANOTIC PROGONOMA
"DATA",169.3,93642,0)
PERIPHERAL NEUROECTODERMAL TUMOR IN SITU^9364/2^^^
"DATA",169.3,93643,0)
PERIPHERAL NEUROECTODERMAL TUMOR^9364/3^^^^^^9
"DATA",169.3,93643,1,0)
^169.32^3^3
"DATA",169.3,93643,1,1,0)
NEUROECTODERMAL TUMOR, NOS
"DATA",169.3,93643,1,2,0)
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUM, NOS
"DATA",169.3,93643,1,3,0)
PPNET
"DATA",169.3,93652,0)
ASKIN TUMOR IN SITU^9365/2^^^
"DATA",169.3,93653,0)
ASKIN TUMOR ^9365/3^^^
"DATA",169.3,93702,0)
CHORDOMA IN SITU^9370/2^^^
"DATA",169.3,93703,0)
CHORDOMA, NOS^9370/3^^^^^^9
"DATA",169.3,93712,0)
CHONDROID CHORDOMA IN SITU^9371/2^^^
"DATA",169.3,93713,0)
CHONDROID CHORDOMA^9371/3^^^
"DATA",169.3,93722,0)
DEDIFFERENTIATED CHORDOMA IN SITU^9372/2^^^
"DATA",169.3,93723,0)
DEDIFFERENTIATED CHORDOMA^9372/3^^^
"DATA",169.3,93730,0)
PARACHORDOMA^9373/0^^^
"DATA",169.3,93801,0)
GLIOMA OF UNCERTAIN MALIGNANT POTENTIAL^9380/1^^^
"DATA",169.3,93802,0)
GLIOMA IN SITU^9380/2^^^
"DATA",169.3,93803,0)
GLIOMA, MALIGNANT^9380/3^^^6771^67710^^8
"DATA",169.3,93803,1,0)
^169.32^1^1
"DATA",169.3,93803,1,1,0)
GLIOMA, NOS
"DATA",169.3,93812,0)
GLIOMATOSIS CEREBRI IN SITU^9381/2^^^
"DATA",169.3,93813,0)
GLIOMATOSIS CEREBRI^9381/3^^^6771^67710^^8
"DATA",169.3,93822,0)
MIXED GLIOMA IN SITU^9382/2^^^
"DATA",169.3,93823,0)
MIXED GLIOMA^9382/3^^^6771^67710^^8
"DATA",169.3,93823,1,0)
^169.32^3^3
"DATA",169.3,93823,1,1,0)
OLIGOASTROCYTOMA
"DATA",169.3,93823,1,2,0)
ANAPLASTIC OLIGOASTROCYTOMA (C71._)
"DATA",169.3,93823,1,3,0)
OLIGOASTROCYTOMA, NOS (C71._)
"DATA",169.3,93831,0)
SUBEPENDYMOMA^9383/1^^^6771^67710^^8
"DATA",169.3,93831,1,0)
^169.32^3^3
"DATA",169.3,93831,1,1,0)
SUBEPENDYMAL GLIOMA
"DATA",169.3,93831,1,2,0)
SUBEPENDYMAL ASTROCYTOMA, NOS
"DATA",169.3,93831,1,3,0)
MIXED SUBEPENDYMOMA-EPENDYMOMA
"DATA",169.3,93841,0)
SUBEPENDYMAL GIANT CELL ASTROCYTOMA^9384/1^^^6771^67710^^8
"DATA",169.3,93853,0)
DIFFUSE MIDLINE GLIOMA, H3 K27M-MUTANT (C71._)^9385/3
"DATA",169.3,93900,0)
CHOROID PLEXUS PAPILLOMA, NOS^9390/0^^^6771^67715^^8
"DATA",169.3,93901,0)
ATYPICAL CHOROID PLEXUS PAPILLOMA^9390/1^^^^67715^^
"DATA",169.3,93902,0)
CHOROID PLEXUS CARCINOMA IN SITU^9390/2^^^
"DATA",169.3,93903,0)
CHOROID PLEXUS CARCINOMA^9390/3^^^6771^67715^^8
"DATA",169.3,93903,1,0)
^169.32^2^2
"DATA",169.3,93903,1,1,0)
CHOROID PLEXUS PAPILLOMA, ANAPLASTIC
"DATA",169.3,93903,1,2,0)
CHOROID PLEXUS PAPILLOMA, MALIGNANT
"DATA",169.3,93912,0)
EPENDYMOMA IN SITU^9391/2^^^
"DATA",169.3,93913,0)
EPENDYMOMA, NOS^9391/3^^^6771^67710^^8
"DATA",169.3,93913,1,0)
^169.32^4^4
"DATA",169.3,93913,1,1,0)
EPITHELIAL EPENDYMOMA
"DATA",169.3,93913,1,2,0)
CELLULAR EPENDYMOMA
"DATA",169.3,93913,1,3,0)
CLEAR CELL EPENDYMOMA
"DATA",169.3,93913,1,4,0)
TANYCYTIC EPENDYMOMA
"DATA",169.3,93922,0)
EPENDYMOMA IN SITU, ANAPLASTIC^9392/2^^^
"DATA",169.3,93923,0)
EPENDYMOMA, ANAPLASTIC^9392/3^^^6771^67710^^8
"DATA",169.3,93923,1,0)
^169.32^1^1
"DATA",169.3,93923,1,1,0)
EPENDYMOBLASTOMA
"DATA",169.3,93932,0)
PAPILLARY EPENDYMOMA IN SITU^9393/2^^^
"DATA",169.3,93933,0)
PAPILLARY EPENDYMOMA^9393/3^^^6771^67710^^8
"DATA",169.3,93941,0)
MYXOPAPILLARY EPENDYMOMA^9394/1^^^6771^67720^^8
"DATA",169.3,93942,0)
MYXOPAPILLARY EPENDYMOMA IN SITU^9394/2^^^
"DATA",169.3,93943,0)
MYXOPAPILLARY EPENDYMOMA, MALIGNANT^9394/3^^^
"DATA",169.3,93953,0)
PAPILLARY TUMOR OF PINEAL REGION (C75.3)^9395/3
"DATA",169.3,93963,0)
EPENDYMOMA, RELA FUSION-POSITIVE (C71._)^9396/3
"DATA",169.3,94002,0)
ASTROCYTOMA IN SITU^9400/2^^^
"DATA",169.3,94003,0)
ASTROCYTOMA, NOS^9400/3^^^6771^67710^^8
"DATA",169.3,94003,1,0)
^169.32^6^6
"DATA",169.3,94003,1,1,0)
ASTROGLIOMA
"DATA",169.3,94003,1,2,0)
ASTROCYTIC GLIOMA
"DATA",169.3,94003,1,3,0)
CYSTIC ASTROCYTOMA
"DATA",169.3,94003,1,4,0)
DIFFUSE ASTROCYTOMA
"DATA",169.3,94003,1,5,0)
DIFFUSE ASTROCYTOMA, IDH-WILDTYPE (C71._)
"DATA",169.3,94003,1,6,0)
DIFFUSE ASTROCYTOMA, IDH-MUTANT (C71._)
"DATA",169.3,94012,0)
ASTROCYTOMA IN SITU, ANAPLASTIC^9401/2^^^
"DATA",169.3,94013,0)
ASTROCYTOMA, ANAPLASTIC^9401/3^^^6771^67710^^8
"DATA",169.3,94013,1,0)
^169.32^2^2
"DATA",169.3,94013,1,1,0)
ANAPLASTIC ASTROCYTOMA, IDH-WILDTYPE (C71._)
"DATA",169.3,94013,1,2,0)
ANAPLASTIC ASTROCYTOMA, IDH-MUTANT (C71.)
"DATA",169.3,94102,0)
PROTOPLASMIC ASTROCYTOMA IN SITU^9410/2^^^
"DATA",169.3,94103,0)
PROTOPLASMIC ASTROCYTOMA^9410/3^^^6771^67710^^8
"DATA",169.3,94112,0)
GEMISTOCYTIC ASTROCYTOMA IN SITU^9411/2^^^
"DATA",169.3,94113,0)
GEMISTOCYTIC ASTROCYTOMA^9411/3^^^^67710^^8
"DATA",169.3,94113,1,0)
^169.32^2^1
"DATA",169.3,94113,1,2,0)
GEMISTOCYTOMA
"DATA",169.3,94121,0)
DESMOPLASTIC INFANTILE ASTROCYTOMA^9412/1^^^^67710^^
"DATA",169.3,94121,1,0)
^169.32^1^1
"DATA",169.3,94121,1,1,0)
DESMOPLASTIC INFANTILE GANGLIOGLIOMA
"DATA",169.3,94130,0)
DYSEMBRYOPLASTIC NEUROEPITHELIAL TUMOR^9413/0^^^
"DATA",169.3,94202,0)
FIBRILLARY ASTROCYTOMA IN SITU^9420/2^^^
"DATA",169.3,94203,0)
FIBRILLARY ASTROCYTOMA^9420/3^^^6771^67710^^8
"DATA",169.3,94203,1,0)
^169.32^2^1
"DATA",169.3,94203,1,2,0)
FIBROUS ASTROCYTOMA
"DATA",169.3,94211,0)
PILOCYTIC ASTROCYTOMA^9421/1^^^6771^67710^^8
"DATA",169.3,94211,1,0)
^169.32^4^3
"DATA",169.3,94211,1,2,0)
SPONGIOBLASTOMA, NOS
"DATA",169.3,94211,1,3,0)
PILOID ASTROCYTOMA
"DATA",169.3,94211,1,4,0)
JUVENILE ASTROCYTOMA
"DATA",169.3,94212,0)
JUVENILE ASTROCYTOMA IN SITU^9421/2^^^
"DATA",169.3,94213,0)
JUVENILE ASTROCYTOMA^9421/3^^^^67710^^
"DATA",169.3,94213,1,0)
^169.32^3^3
"DATA",169.3,94213,1,1,0)
PILOCYTIC ASTROCYTOMA
"DATA",169.3,94213,1,2,0)
PILOID ASTROCYTOMA
"DATA",169.3,94213,1,3,0)
SPONGIOBLASTOMA, NOS
"DATA",169.3,94232,0)
POLAR SPONGIOBLASTOMA IN SITU^9423/2^^^
"DATA",169.3,94233,0)
POLAR SPONGIOBLASTOMA^9423/3^^^6771^67710^^8
"DATA",169.3,94233,1,0)
^169.32^2^2
"DATA",169.3,94233,1,1,0)
SPONGIOBLASTOMA POLARE
"DATA",169.3,94233,1,2,0)
PRIMITIVE POLAR SPONGIOBLASTOMA
"DATA",169.3,94242,0)
PLEOMORPHIC XANTHOASTROCYTOMA IN SITU^9424/2^^^
"DATA",169.3,94243,0)
PLEOMORPHIC XANTHOASTROCYTOMA^9424/3^^^6771^67710^^8
"DATA",169.3,94243,1,0)
^169.32^1^1
"DATA",169.3,94243,1,1,0)
ANAPLASTIC PLEOMORPHIC XANTHROASTROCYTOMA (C71._)
"DATA",169.3,94253,0)
PILOMYXOID ASTROCYTOMA (C71._)^9425/3
"DATA",169.3,94302,0)
ASTROBLASTOMA IN SITU^9430/2^^^
"DATA",169.3,94303,0)
ASTROBLASTOMA^9430/3^^^6771^67710^^8
"DATA",169.3,94311,0)
ANGIOCENTRIC GLIOMA (C71._)^9431/1
"DATA",169.3,94321,0)
PITUICYTOMA (C75.1)^9432/1
"DATA",169.3,94402,0)
GLIOBLASTOMA IN SITU^9440/2^^^
"DATA",169.3,94403,0)
GLIOBLASTOMA, NOS^9440/3^^^6771^67710^^8
"DATA",169.3,94403,1,0)
^169.32^4^4
"DATA",169.3,94403,1,1,0)
GLIOBLASTOMA MULTIFORME
"DATA",169.3,94403,1,2,0)
SPONGIOBLASTOMA MULTIFORME
"DATA",169.3,94403,1,3,0)
GLIOBLASTOMA, IDH WILDTYPE (C71._)
"DATA",169.3,94403,1,4,0)
EPITHELIOID GLIOBLASTOMA (C71._)
"DATA",169.3,94412,0)
GIANT CELL GLIOBLASTOMA IN SITU^9441/2^^^
"DATA",169.3,94413,0)
GIANT CELL GLIOBLASTOMA^9441/3^^^6771^67710^^8
"DATA",169.3,94413,1,0)
^169.32^1^1
"DATA",169.3,94413,1,1,0)
MONSTROCELLULAR SARCOMA
"DATA",169.3,94421,0)
GLIOFIBROMA^9442/1^^^^67710^^
"DATA",169.3,94422,0)
GLIOSARCOMA IN SITU^9442/2^^^
"DATA",169.3,94423,0)
GLIOSARCOMA^9442/3^^^6771^67710^^8
"DATA",169.3,94423,1,0)
^169.32^1^1
"DATA",169.3,94423,1,1,0)
GLIOBLASTOMA WITH SARCOMATOUS COMPONENT
"DATA",169.3,94441,0)
CHORDOID GLIOMA^9444/1^^^^67710^^
"DATA",169.3,94441,1,0)
^169.32^1^1
"DATA",169.3,94441,1,1,0)
CHORDOID GLIOMA OF THIRD VENTRICLE
"DATA",169.3,94453,0)
GLIOBLASTOMA, IDH-MUTANT (C71._)^9445/3
"DATA",169.3,94502,0)
OLIGODENDROGLIOMA IN SITU^9450/2^^^
"DATA",169.3,94503,0)
OLIGODENDROGLIOMA, NOS^9450/3^^^6771^67710^^8
"DATA",169.3,94503,1,0)
^169.32^1^1
"DATA",169.3,94503,1,1,0)
OLIGODENDROGLIOMA, IDH-MUTANT AND 1P/19Q-CODELETED (C71._)
"DATA",169.3,94512,0)
OLIGODENDROGLIOMA IN SITU, ANAPLASTIC^9451/2^^^
"DATA",169.3,94513,0)
OLIGODENDROGLIOMA, ANAPLASTIC^9451/3^^^^67710^^8
"DATA",169.3,94513,1,0)
^169.32^1^1
"DATA",169.3,94513,1,1,0)
ANAPLASTIC OLIGODENDROGLIOMA, IDH-MUTANT AND 1P/19Q-CODELETED (C71._)
"DATA",169.3,94602,0)
OLIGODENDROBLASTOMA IN SITU^9460/2^^^
"DATA",169.3,94603,0)
OLIGODENDROBLASTOMA^9460/3^^^6771^67710^^8
"DATA",169.3,94702,0)
MEDULLOBLASTOMA IN SITU^9470/2^^^
"DATA",169.3,94703,0)
MEDULLOBLASTOMA, NOS^9470/3^^^6771^67716^^8
"DATA",169.3,94703,1,0)
^169.32^2^2
"DATA",169.3,94703,1,1,0)
MELANOTIC MEDULLOBLASTOMA
"DATA",169.3,94703,1,2,0)
MEDULLOBLASTOMA, CLASSIC (C71._)
"DATA",169.3,94712,0)
DESMOPLASTIC NODULAR MEDULLOBLASTOMA IN SITU^9471/2^^^
"DATA",169.3,94713,0)
DESMOPLASTIC NODULAR MEDULLOBLASTOMA^9471/3^^^6771^67716^^5
"DATA",169.3,94713,1,0)
^169.32^3^3
"DATA",169.3,94713,1,1,0)
DESMOPLASTIC MEDULLOBLASTOMA
"DATA",169.3,94713,1,2,0)
CIRCUMSCRIBED ARACHNOIDAL CEREBELLAR SARCOMA
"DATA",169.3,94713,1,3,0)
MEDULLOBLASTOMA, SHH-ACTIVATED ANS TP53-WILDTYPE (C71._)
"DATA",169.3,94722,0)
MEDULLOMYOBLASTOMA IN SITU^9472/2^^^
"DATA",169.3,94723,0)
MEDULLOMYOBLASTOMA^9472/3^^^6771^67716^^8
"DATA",169.3,94732,0)
PRIMITIVE NEUROECTODERMAL TUMOR IN SITU^9473/2^^^
"DATA",169.3,94733,0)
PRIMITIVE NEUROECTODERMAL TUMOR, NOS^9473/3^^^6771^^^8
"DATA",169.3,94733,1,0)
^169.32^4^4
"DATA",169.3,94733,1,1,0)
PNET, NOS
"DATA",169.3,94733,1,2,0)
CENTRAL PRIMITIVE NEUROECTODERMAL TUMOR, NOS
"DATA",169.3,94733,1,3,0)
CPNET
"DATA",169.3,94733,1,4,0)
SUPRATENTORIAL PNET
"DATA",169.3,94742,0)
LARGE CELL MEDULLOBLASTOMA IN SITU^9474/2^^^
"DATA",169.3,94743,0)
LARGE CELL MEDULLOBLASTOMA^9474/3^^^^67716^^
"DATA",169.3,94753,0)
MEDULLOBLASTOMA, WNT-ACTIVATED (C71._)^9475/3
"DATA",169.3,94763,0)
MEDULLOBLASTOMA, SHH-ACTIVATED AND TP53 MUTANT (C71._)^9476/3
"DATA",169.3,94773,0)
MEDULLOBLASTOMA, NON-WNT/NON-SHH (C71._)^9477/3
"DATA",169.3,94773,1,0)
^169.32^2^2
"DATA",169.3,94773,1,1,0)
MEDULLOBLASTOMA, GROUP 3 (C71._)
"DATA",169.3,94773,1,2,0)
MEDULLOBLASTOMA, GROUP 4 (C71._)
"DATA",169.3,94783,0)
EMBRYONAL TUMOR WITH MULTILAYERED ROSETTES, NOS (C71._)^9478/3
"DATA",169.3,94783,1,0)
^169.32^1^1
"DATA",169.3,94783,1,1,0)
EMBRYONAL TUMOR W/ MULTILAYERED ROSETTES C19MC-ALTERED
"DATA",169.3,94802,0)
CEREBELLAR SARCOMA IN SITU^9480/2^^^
"DATA",169.3,94803,0)
CEREBELLAR SARCOMA, NOS^9480/3^^^6771^67716^^5
"DATA",169.3,94900,0)
GANGLIONEUROMA^9490/0^^^^^^8
"DATA",169.3,94900,1,0)
^169.32^^0
"DATA",169.3,94902,0)
GANGLIONEUROBLASTOMA IN SITU^9490/2^^^
"DATA",169.3,94903,0)
GANGLIONEUROBLASTOMA^9490/3^^^^^^8
"DATA",169.3,94910,0)
GANGLIONEUROMATOSIS^9491/0^^^^^^8
"DATA",169.3,94920,0)
GANGLIOCYTOMA^9492/0^^^
"DATA",169.3,94930,0)
DYSPLASTIC GANGLIOCYTOMA OF CEREBELLUM^9493/0^^^^67716^^
"DATA",169.3,95002,0)
NEUROBLASTOMA IN SITU^9500/2^^^
"DATA",169.3,95003,0)
NEUROBLASTOMA, NOS^9500/3^^^^^^8
"DATA",169.3,95003,1,0)
^169.32^2^2
"DATA",169.3,95003,1,1,0)
SYMPATHICOBLASTOMA
"DATA",169.3,95003,1,2,0)
CENTRAL NEUROBLASTOMA
"DATA",169.3,95010,0)
MEDULLAEPITHELIOMA, BENIGN^9501/0^^^^67694^^
"DATA",169.3,95010,1,0)
^169.32^1^1
"DATA",169.3,95010,1,1,0)
DIKTYOMA, BENIGN
"DATA",169.3,95012,0)
MEDULLOEPITHELIOMA IN SITU^9501/2^^^
"DATA",169.3,95013,0)
MEDULLOEPITHELIOMA, NOS^9501/3^^^^^^8
"DATA",169.3,95013,1,0)
^169.32^1^1
"DATA",169.3,95013,1,1,0)
DIKTYOMA, MALIGNANT
"DATA",169.3,95020,0)
TERATOID MEDULLOEPITHELIOMA, BENIGN^9502/0^^^^67694^^
"DATA",169.3,95022,0)
TERATOID MEDULLOEPITHELIOMA IN SITU^9502/2^^^
"DATA",169.3,95023,0)
TERATOID MEDULLOEPITHELIOMA^9502/3^^^^^^8
"DATA",169.3,95032,0)
NEUROEPITHELIOMA  IN SITU^9503/2^^^
"DATA",169.3,95033,0)
NEUROEPITHELIOMA, NOS^9503/3^^^^^^8
"DATA",169.3,95042,0)
SPONGIONEUROBLASTOMA IN SITU^9504/2^^^
"DATA",169.3,95043,0)
SPONGIONEUROBLASTOMA^9504/3^^^^^^8
"DATA",169.3,95051,0)
GANGLIOGLIOMA, NOS^9505/1^^^^^^8
"DATA",169.3,95051,1,0)
^169.32^2^2
"DATA",169.3,95051,1,1,0)
GLIONEUROMA
"DATA",169.3,95051,1,2,0)
NEUROASTROCYTOMA
"DATA",169.3,95052,0)
GANGLIOGLIOMA IN SITU, ANAPLASTIC^9505/2^^^
"DATA",169.3,95053,0)
GANGLIOGLIOMA, ANAPLASTIC^9505/3^^^
"DATA",169.3,95061,0)
CENTRAL NEUROCYTOMA^9506/1^^^^^^8
"DATA",169.3,95061,1,0)
^169.32^5^5
"DATA",169.3,95061,1,1,0)
NEUROCYTOMA
"DATA",169.3,95061,1,2,0)
CEREBELLAR LIPONEUROCYTOMA
"DATA",169.3,95061,1,3,0)
LIPOMATOUS MEDULLOBLASTOMA
"DATA",169.3,95061,1,4,0)
NEUROLIPOCYTOMA
"DATA",169.3,95061,1,5,0)
MEDULLOCYTOMA
"DATA",169.3,95070,0)
PACINIAN TUMOR^9507/0^^^^^^8
"DATA",169.3,95082,0)
ATYPICAL TERATOID/RHABDOID TUMOR IN SITU^9508/2^^^
"DATA",169.3,95083,0)
ATYPICAL TERATOID/RHABDOID TUMOR^9508/3^^^^67710^^
"DATA",169.3,95083,1,0)
^169.32^2^2
"DATA",169.3,95083,1,1,0)
EMBRYONAL TUMOR WITH RHABDOID FEATURES
"DATA",169.3,95083,1,2,0)
CNS EMBRYONAL TUMOR WITH RHABDOID FEATURES (C71._)
"DATA",169.3,95091,0)
PAPILLARY GLIONEURONAL TUMOR (C71._)^9509/1
"DATA",169.3,95091,1,0)
^169.32^2^2
"DATA",169.3,95091,1,1,0)
DIFFUSE LEPTOMENINGEAL GLIONEURONAL TUMOR
"DATA",169.3,95091,1,2,0)
ROSETTE-FORMING GLIONEURONAL TUMOR (71._)
"DATA",169.3,95100,0)
RETINOCYTOMA^9510/0^^^^67692^^
"DATA",169.3,95100,"E")
^177^177
"DATA",169.3,95100,"L")
^178^178
"DATA",169.3,95102,0)
RETINOBLASTOMA IN SITU^9510/2^^^
"DATA",169.3,95103,0)
RETINOBLASTOMA, NOS^9510/3^^^6769^67692^^8
"DATA",169.3,95103,"E")
^177^177
"DATA",169.3,95103,"L")
^178^178
"DATA",169.3,95112,0)
RETINOBLASTOMA IN SITU, DIFFERENTIATED^9511/2^^^
"DATA",169.3,95113,0)
RETINOBLASTOMA, DIFFERENTIATED^9511/3^^^6769^67692^^8
"DATA",169.3,95113,"E")
^177^177
"DATA",169.3,95113,"L")
^178^178
"DATA",169.3,95122,0)
RETINOBLASTOMA IN SITU, UNDIFFERENTIATED^9512/2^^^
"DATA",169.3,95123,0)
RETINOBLASTOMA, UNDIFFERENTIATED^9512/3^^^^67692^^8
"DATA",169.3,95123,"E")
^177^177
"DATA",169.3,95123,"L")
^178^178
"DATA",169.3,95132,0)
RETINOBLASTOMA IN SITU, DIFFUSE^9513/2^^^
"DATA",169.3,95133,0)
RETINOBLASTOMA, DIFFUSE^9513/3^^^^67692^^
"DATA",169.3,95133,"E")
^177^177
"DATA",169.3,95133,"L")
^178^178
"DATA",169.3,95141,0)
RETINOBLASTOMA, SPONTANEOUSLY REGRESSED^9514/1^^^^67692^^
"DATA",169.3,95141,"E")
^177^177
"DATA",169.3,95141,"L")
^178^178
"DATA",169.3,95202,0)
OLFACTORY NEUROGENIC TUMOR IN SITU^9520/2^^^
"DATA",169.3,95203,0)
OLFACTORY NEUROGENIC TUMOR^9520/3^^^^^^8
"DATA",169.3,95212,0)
OLFACTORY NEUROCYTOMA IN SITU^9521/2^^^
"DATA",169.3,95213,0)
OLFACTORY NEUROCYTOMA^9521/3^^^6730^67300^^8
"DATA",169.3,95213,1,0)
^169.32^1^1
"DATA",169.3,95213,1,1,0)
ESTHESIONEUROCYTOMA
"DATA",169.3,95222,0)
OLFACTORY NEUROBLASTOMA IN SITU^9522/2^^^
"DATA",169.3,95223,0)
OLFACTORY NEUROBLASTOMA^9522/3^^^6730^67300^^8
"DATA",169.3,95223,1,0)
^169.32^1^1
"DATA",169.3,95223,1,1,0)
ESTHESIONEUROBLASTOMA
"DATA",169.3,95232,0)
OLFACTORY NEUROEPITHELIOMA IN SITU^9523/2^^^
"DATA",169.3,95233,0)
OLFACTORY NEUROEPITHELIOMA^9523/3^^^6730^67300^^8
"DATA",169.3,95233,1,0)
^169.32^1^1
"DATA",169.3,95233,1,1,0)
ESTHESIONEUROEPITHELIOMA
"DATA",169.3,95300,0)
MENINGIOMA, NOS^9530/0^^^^^^5
"DATA",169.3,95300,1,0)
^169.32^4^4
"DATA",169.3,95300,1,1,0)
MICROCYSTIC MENINGIOMA
"DATA",169.3,95300,1,2,0)
SECRETORY MENINGIOMA
"DATA",169.3,95300,1,3,0)
LYMPHOPLASMACYTE-RICH MENINGIOMA
"DATA",169.3,95300,1,4,0)
METAPLASTIC MENINGIOMA
"DATA",169.3,95301,0)
MENINGIOMATOSIS, NOS^9530/1^^^^^^5
"DATA",169.3,95301,1,0)
^169.32^2^2
"DATA",169.3,95301,1,1,0)
DIFFUSE MENINGIOMATOSIS
"DATA",169.3,95301,1,2,0)
MULTIPLE MENINGIOMAS
"DATA",169.3,95302,0)
MENINGIOMA IN SITU^9530/2^^^
"DATA",169.3,95303,0)
MENINGIOMA, MALIGNANT^9530/3^^^^^^5
"DATA",169.3,95303,1,0)
^169.32^4^4
"DATA",169.3,95303,1,1,0)
LEPTOMENINGEAL SARCOMA
"DATA",169.3,95303,1,2,0)
MENINGEAL SARCOMA
"DATA",169.3,95303,1,3,0)
MENINGOTHELIAL SARCOMA
"DATA",169.3,95303,1,4,0)
MENINGIOMA, ANAPLASTIC
"DATA",169.3,95310,0)
MENINGOTHELIAL MENINGIOMA^9531/0^^^^^^8
"DATA",169.3,95310,1,0)
^169.32^2^2
"DATA",169.3,95310,1,1,0)
ENDOTHELIOMATOUS MENINGIOMA
"DATA",169.3,95310,1,2,0)
SYNCYTIAL MENINGIOMA
"DATA",169.3,95312,0)
MENINGIOTHELIAL MENINGIOMA IN SITU^9531/2^^^
"DATA",169.3,95313,0)
MENINGIOTHELIAL MENINGIOMA, MALIGNANT^9531/3^^^
"DATA",169.3,95320,0)
FIBROUS MENINGIOMA^9532/0^^^^^^8
"DATA",169.3,95320,1,0)
^169.32^2^1
"DATA",169.3,95320,1,2,0)
FIBROBLASTIC MENINGIOMA
"DATA",169.3,95322,0)
FIBROUS MENINGIOMA IN SITU^9532/2^^^
"DATA",169.3,95323,0)
FIBROUS MENINGIOMA, MALIGNANT^9532/3^^^
"DATA",169.3,95330,0)
PSAMMOMATOUS MENINGIOMA^9533/0^^^^^^8
"DATA",169.3,95330,1,0)
^169.32^^0
"DATA",169.3,95340,0)
ANGIOMATOUS MENINGIOMA^9534/0^^^^^^8
"DATA",169.3,95350,0)
HEMANGIOBLASTIC MENINGIOMA^9535/0^^^^^^8
"DATA",169.3,95350,1,0)
^169.32^1^1
"DATA",169.3,95350,1,1,0)
ANGIOBLASIC MENINGIOMA
"DATA",169.3,95352,0)
HEMANGIOBLASTIC MENINGIOMA IN SITU^9535/2^^^
"DATA",169.3,95353,0)
HEMANGIOBLASTIC MENINGIOMA, MALIGNANT^9535/3^^^
"DATA",169.3,95370,0)
TRANSITIONAL MENINGIOMA^9537/0^^^^^^8
"DATA",169.3,95370,1,0)
^169.32^1^1
"DATA",169.3,95370,1,1,0)
MIXED MENINGIOMA
"DATA",169.3,95372,0)
TRANSITIONAL MENINGIOMA IN SITU^9537/2^^^
"DATA",169.3,95373,0)
TRANSITIONAL MENINGIOMA, MALIGNANT^9537/3^^^
"DATA",169.3,95381,0)
CLEAR CELL MENINGIOMA^9538/1^^^
"DATA",169.3,95381,1,0)
^169.32^1^1
"DATA",169.3,95381,1,1,0)
CHORDOID MEMINGIOMA
"DATA",169.3,95382,0)
PAPILLARY MENINGIOMA IN SITU^9538/2^^^
"DATA",169.3,95383,0)
PAPILLARY MENINGIOMA^9538/3^^^^^^8
"DATA",169.3,95383,1,0)
^169.32^1^1
"DATA",169.3,95383,1,1,0)
RHABDOID MENINGIOMA
"DATA",169.3,95391,0)
ATYPICAL MENINGIOMA^9539/1^^^
"DATA",169.3,95392,0)
MENINGEAL SARCOMATOSIS IN SITU^9539/2^^^
"DATA",169.3,95393,0)
MENINGEAL SARCOMATOSIS^9539/3^^^^^^5
"DATA",169.3,95400,0)
NEUROFIBROMA, NOS^9540/0^^^^^^5
"DATA",169.3,95401,0)
NEUROFIBROMATOSIS, NOS^9540/1^^^^^^5
"DATA",169.3,95401,1,0)
^169.32^3^3
"DATA",169.3,95401,1,1,0)
MULTIPLE NEUROFIBROMATOSIS
"DATA",169.3,95401,1,2,0)
VON RECKLINGHAUSEN DISEASE
"DATA",169.3,95401,1,3,0)
RECKLINGHAUSEN DISEASE
"DATA",169.3,95402,0)
PERIPHERAL NERVE SHEATH TUMOR IN SITU^9540/2^^^
"DATA",169.3,95403,0)
MALIGNANT PERIPHERAL NERVE SHEATH TUMOR^9540/3^^^^^^5
"DATA",169.3,95403,1,0)
^169.32^9^9
"DATA",169.3,95403,1,1,0)
NEUROGENIC SARCOMA
"DATA",169.3,95403,1,2,0)
NEUROSARCOMA
"DATA",169.3,95403,1,3,0)
MPNST, NOS
"DATA",169.3,95403,1,4,0)
NEUROFIBROSARCOMA
"DATA",169.3,95403,1,5,0)
MPNST WITH GLANDULAR DIFFERENTIATION
"DATA",169.3,95403,1,6,0)
EPITHELIOID MPNST
"DATA",169.3,95403,1,7,0)
MPNST WITH MESENCHYMAL DIFFERENTIATION
"DATA",169.3,95403,1,8,0)
MELANOTIC MPNST
"DATA",169.3,95403,1,9,0)
MELANOTIC PSAMMOMATOUS MPNST
"DATA",169.3,95410,0)
MELANOTIC NEUROFIBROMA^9541/0^^^^^^8
"DATA",169.3,95423,0)
EPITHELIOID MALIGNANT PERIPHERAL NERVE SHEATH TUMOR (C47.0-C47.6, C47.8, C47.9)^9542/3
"DATA",169.3,95423,1,0)
^169.32^^0
"DATA",169.3,95500,0)
PLEXIFORM NEUROFIBROMA^9550/0^^^^^^8
"DATA",169.3,95500,1,0)
^169.32^1^1
"DATA",169.3,95500,1,1,0)
PLEXIFORM NEUROMA
"DATA",169.3,95600,0)
NEURILEMMOMA, NOS^9560/0^^^^^^8
"DATA",169.3,95600,1,0)
^169.32^10^10
"DATA",169.3,95600,1,1,0)
ACOUSTIC NEUROMA
"DATA",169.3,95600,1,2,0)
SCHWANNOMA, NOS
"DATA",169.3,95600,1,3,0)
NEURINOMA
"DATA",169.3,95600,1,4,0)
PIGMENTED SCHWANNOMA
"DATA",169.3,95600,1,5,0)
MELANOTIC SCHWANNOMA
"DATA",169.3,95600,1,6,0)
PLEXIFORM SCHWANNOMA
"DATA",169.3,95600,1,7,0)
CELLULAR SCHWANNOMA
"DATA",169.3,95600,1,8,0)
DEGENERATED SCHWANNOMA
"DATA",169.3,95600,1,9,0)
ANCIENT SCHWANNOMA
"DATA",169.3,95600,1,10,0)
PSAMMOMATOUS SCHWANNOMA
"DATA",169.3,95601,0)
MELANOTIC SCHWANNOMA (C72.4, C72.5)^9560/1^^^^^^8
"DATA",169.3,95602,0)
NEURILEMMOMA IN SITU^9560/2^^^
"DATA",169.3,95603,0)
NEURILEMMOMA, MALIGNANT^9560/3^^^^^^8
"DATA",169.3,95603,1,0)
^169.32^3^3
"DATA",169.3,95603,1,1,0)
MALIGNANT SCHWANNOMA, NOS
"DATA",169.3,95603,1,2,0)
NEURILEMOSARCOMA
"DATA",169.3,95603,1,3,0)
MELANOTIC SCHWANNOMA, NOS
"DATA",169.3,95612,0)
PERI NRV SHEATH W RHABDOMYOBLAST DIFF IN SITU^9561/2^^^
"DATA",169.3,95613,0)
MAL PERI NERVE SHEATH W RHABDOMYOBLASTIC DIFF^9561/3^^^^^^8
"DATA",169.3,95613,1,0)
^169.32^3^3
"DATA",169.3,95613,1,1,0)
MPNST WITH RHABDOMYOBLASTIC DIFFERENTIATION
"DATA",169.3,95613,1,2,0)
TRITON TUMOR, MALIGNANT
"DATA",169.3,95613,1,3,0)
MALIGNANT SCHWANNOMA W RHABDOMYOBLASTIC DIFF
"DATA",169.3,95620,0)
NEUROTHEKEOMA^9562/0^^^^^^8
"DATA",169.3,95620,1,0)
^169.32^1^1
"DATA",169.3,95620,1,1,0)
NERVE SHEATH MYXOMA
"DATA",169.3,95700,0)
NEUROMA, NOS^9570/0^^^^^^8
"DATA",169.3,95710,0)
PERINEURIOMA, NOS^9571/0^^^
"DATA",169.3,95710,1,0)
^169.32^2^2
"DATA",169.3,95710,1,1,0)
INTRANEURAL PERINEURIOMA
"DATA",169.3,95710,1,2,0)
SOFT TISSUE PERINEURIOMA
"DATA",169.3,95712,0)
PERINEURIOMA IN SITU^9571/2^^^
"DATA",169.3,95713,0)
PERINEURIOMA, MALIGNANT^9571/3^^^
"DATA",169.3,95713,1,0)
^169.32^1^1
"DATA",169.3,95713,1,1,0)
PERINEURAL MPNST
"DATA",169.3,95800,0)
GRANULAR CELL TUMOR, NOS^9580/0^^^^^^8
"DATA",169.3,95800,1,0)
^169.32^1^1
"DATA",169.3,95800,1,1,0)
GRANULAR CELL MYOBLASTOMA, NOS
"DATA",169.3,95802,0)
GRANULAR CELL TUMOR IN SITU^9580/2^^^
"DATA",169.3,95803,0)
GRANULAR CELL TUMOR, MALIGNANT^9580/3^^^^^^8
"DATA",169.3,95803,1,0)
^169.32^1^1
"DATA",169.3,95803,1,1,0)
GRANULAR CELL MYOBLASTIC, MALIGNANT
"DATA",169.3,95812,0)
ALVEOLAR SOFT PART SARCOMA IN SITU^9581/2^^^
"DATA",169.3,95813,0)
ALVEOLAR SOFT PART SARCOMA^9581/3^^^^^^5
"DATA",169.3,95820,0)
GRANULAR CELL TUMOR OF THE SELLAR REGION^9582/0^^^^67751^^
"DATA",169.3,95903,0)
MALIGNANT LYMPHOMA, NOS^9590/3^^^^^^1
"DATA",169.3,95903,1,0)
^169.32^2^2
"DATA",169.3,95903,1,1,0)
LYMPHOMA, NOS
"DATA",169.3,95903,1,2,0)
MICROGLIOMA
"DATA",169.3,95903,"E")
136^136^136
"DATA",169.3,95903,"L")
137^137^137
"DATA",169.3,95913,0)
MALIGNANT LYMPHOMA, NON-HODGKIN, NOS^9591/3^^^^^^1
"DATA",169.3,95913,1,0)
^169.32^18^18
"DATA",169.3,95913,1,1,0)
NON-HODGKIN LYMPHOMA, NOS
"DATA",169.3,95913,1,2,0)
B CELL LYMPHOMA, NOS
"DATA",169.3,95913,1,3,0)
MALIGNANT LYMPHOMA, NON-CLEAVED CELL, NOS
"DATA",169.3,95913,1,4,0)
MALIGNANT LYMPHOMA, DIFFUSE, NOS
"DATA",169.3,95913,1,5,0)
MAL LYMPHOMA/LYMPHOCYTIC/INTERMD DIFF/NODULAR
"DATA",169.3,95913,1,6,0)
MAL LYMPHOMA, SMALL CELL, NONCLEAVED, DIFFUSE
"DATA",169.3,95913,1,7,0)
MAL LYMPHOMA, UNDIFFERENT CELL, NON-BURKITT
"DATA",169.3,95913,1,8,0)
MAL LYMPHOMA, UNDIFFERENTIATED CELL TYPE, NOS
"DATA",169.3,95913,1,9,0)
LYMPHOSARCOMA, NOS
"DATA",169.3,95913,1,10,0)
LYMPHOSARCOMA, DIFFUSE
"DATA",169.3,95913,1,11,0)
RETICULUM CELL SARCOMA
"DATA",169.3,95913,1,12,0)
RETICULUM CELL SARCOMA, DIFFUSE
"DATA",169.3,95913,1,13,0)
RETICULOSARCOMA, NOS
"DATA",169.3,95913,1,14,0)
RETICULOSARCOMA, DIFFUSE
"DATA",169.3,95913,1,15,0)
MAL LYMPHOMA, SMALL CLEAVED CELL, DIFFUSE
"DATA",169.3,95913,1,16,0)
MAL LYMPHOMA/LYMPHOCYTIC/POORLY DIFF/DIFFUSE
"DATA",169.3,95913,1,17,0)
MAL LYMPHOMA, SMALL CLEAVED CELL, NOS
"DATA",169.3,95913,1,18,0)
MAL LYMPHOMA, CLEAVED CELL, NOS
"DATA",169.3,95913,"E")
136^136^136
"DATA",169.3,95913,"L")
137^137^137
"DATA",169.3,95963,0)
COMPOSITE HODGKIN AND NON-HODGKIN LYMPHOMA^9596/3^^^
"DATA",169.3,95963,"E")
136^136^136
"DATA",169.3,95963,"L")
137^137^137
"DATA",169.3,95973,0)
PRIMARY CUTANEOUS FOLLICLE CENTRE LYMPHOMA^9597/3
"DATA",169.3,96313,0)
PAPILLARY TUMOR OF THE PINEAL REGION^9631/3^^^^^^9
"DATA",169.3,96503,0)
HODGKIN LYMPHOMA, NOS^9650/3^^^^^^1
"DATA",169.3,96503,1,0)
^169.32^2^2
"DATA",169.3,96503,1,1,0)
MALIGNANT LYMPHOMA, HODGKINS
"DATA",169.3,96503,1,2,0)
HODGKIN DISEASE, NOS
"DATA",169.3,96503,"E")
136^136^136
"DATA",169.3,96503,"L")
137^137^137
"DATA",169.3,96513,0)
HODGKIN LYMPHOMA, LYMPHOCYTE-RICH^9651/3^^^^^^1
"DATA",169.3,96513,1,0)
^169.32^4^4
"DATA",169.3,96513,1,1,0)
CLASSICAL HODGKIN LYMPHOMA, LYMPHOCYTE-RICH
"DATA",169.3,96513,1,2,0)
HODGKIN DISEASE, LYMPHOCYTE PREDOMINANCE, NOS
"DATA",169.3,96513,1,3,0)
HODGKIN DISEASE, LYMPHOCYTE-HISTIOCYTIC PRED
"DATA",169.3,96513,1,4,0)
HODGKIN DISEASE, LYMPHOCYTE PREDOM, DIFFUSE
"DATA",169.3,96513,"E")
136^136^136
"DATA",169.3,96513,"L")
137^137^137
"DATA",169.3,96523,0)
HODGKIN LYMPHOMA, MIXED CELLULARITY, NOS^9652/3^^^^^^1
"DATA",169.3,96523,1,0)
^169.32^1^1
"DATA",169.3,96523,1,1,0)
CLASSICAL HODGKIN LYMPHOMA, MIXED CELL, NOS
"DATA",169.3,96523,"E")
136^136^136
"DATA",169.3,96523,"L")
137^137^137
"DATA",169.3,96533,0)
HODGKIN LYMPHOMA, LYMPHOCYTE DEPLETION, NOS^9653/3^^^^^^1
"DATA",169.3,96533,1,0)
^169.32^1^1
"DATA",169.3,96533,1,1,0)
CLASS HODGKIN LYMPHOMA, LYMPHOCYTE DEPL, NOS
"DATA",169.3,96533,"E")
136^136^136
"DATA",169.3,96533,"L")
137^137^137
"DATA",169.3,96543,0)
HODGKIN LYMPHOMA, LYMPHOCYTE DEPL, DIFF FIBRO^9654/3^^^^^^1
"DATA",169.3,96543,1,0)
^169.32^1^1
"DATA",169.3,96543,1,1,0)
CLASS HODGKIN LYMPHOMA/LYMPHOCYTE DEP/DIF FIB
"DATA",169.3,96543,"E")
136^136^136
"DATA",169.3,96543,"L")
137^137^137
"DATA",169.3,96553,0)
HODGKIN LYMPHOMA, LYMPHOCYTE DEPL, RETICULAR^9655/3^^^^^^1
"DATA",169.3,96553,1,0)
^169.32^1^1
"DATA",169.3,96553,1,1,0)
CLASS HODGKIN LYMPHOMA/LYMPHOCYTE DEPL/RETIC
"DATA",169.3,96553,"E")
136^136^136
"DATA",169.3,96553,"L")
137^137^137
"DATA",169.3,96593,0)
HODGKIN LYMPHOMA, NODULAR LYMPHOCYTE PREDOMIN^9659/3^^^^^^1
"DATA",169.3,96593,1,0)
^169.32^3^3
"DATA",169.3,96593,1,1,0)
HODGKIN LYMPHOMA, LYMPHOCYTE PREDOM, NODULAR
"DATA",169.3,96593,1,2,0)
HODGKIN PARAGRANULOMA, NOS
"DATA",169.3,96593,1,3,0)
HODGKIN PARAGRANULOMA, NODULAR
"DATA",169.3,96593,"E")
136^136^136
"DATA",169.3,96593,"L")
137^137^137
"DATA",169.3,96613,0)
HODGKIN GRANULOMA^9661/3^^^^^^1
"DATA",169.3,96613,"E")
136^136^136
"DATA",169.3,96613,"L")
137^137^137
"DATA",169.3,96623,0)
HODGKIN SARCOMA^9662/3^^^^^^5
"DATA",169.3,96623,"E")
136^136^136
"DATA",169.3,96623,"L")
137^137^137
"DATA",169.3,96633,0)
HODGKIN LYMPHOMA, NODULAR SCLEROSIS, NOS^9663/3^^^^^^1
"DATA",169.3,96633,1,0)
^169.32^2^2
"DATA",169.3,96633,1,1,0)
CLASS HODGKIN LYMPHOMA/NODULAR SCLEROSIS, NOS
"DATA",169.3,96633,1,2,0)
HODGKIN DISEASE, NODULAR SCLEROSIS, NOS
"DATA",169.3,96633,"E")
136^136^136
"DATA",169.3,96633,"L")
137^137^137
"DATA",169.3,96643,0)
HODGKIN LYMPHOMA, NODUL SCLEROSIS, CELL PHASE^9664/3^^^^^^1
"DATA",169.3,96643,1,0)
^169.32^1^1
"DATA",169.3,96643,1,1,0)
CLASS HODGKIN LYMPHOMA/NOD SCLEROSIS/CELL PH
"DATA",169.3,96643,"E")
136^136^136
"DATA",169.3,96643,"L")
137^137^137
"DATA",169.3,96653,0)
HODGKIN LYMPHOMA, NODULAR SCLEROSIS, GRADE 1^9665/3^^^^^^1
"DATA",169.3,96653,1,0)
^169.32^3^3
"DATA",169.3,96653,1,1,0)
CLASS HODGKIN LYMPHOMA, NOD SCLEROSIS, GR 1
"DATA",169.3,96653,1,2,0)
HODGKIN DIS, NOD SCLEROSIS, LYMPHOCYTE PREDOM
"DATA",169.3,96653,1,3,0)
HODGKIN DIS, NOD SCLEROSIS, MIXED CELLULARITY
"DATA",169.3,96653,"E")
136^136^136
"DATA",169.3,96653,"L")
137^137^137
"DATA",169.3,96673,0)
HODGKIN LYMPHOMA, NODULAR SCLEROSIS, GRADE 2^9667/3^^^^^^1
"DATA",169.3,96673,1,0)
^169.32^3^3
"DATA",169.3,96673,1,1,0)
CLASS HODGKIN LYMPHOMA, NOD SCLEROSIS, GR 2
"DATA",169.3,96673,1,2,0)
HODGKIN DIS, NOD SCLEROSIS, LYMPHOCYTE DEPL
"DATA",169.3,96673,1,3,0)
HODGKIN DIS, NOD SCLEROSIS, SYNCYTIAL VARIANT
"DATA",169.3,96673,"E")
136^136^136
"DATA",169.3,96673,"L")
137^137^137
"DATA",169.3,96703,0)
MALIGNANT LYMPHOMA, SMALL B LYMPHOCYTIC, NOS^9670/3^^^^^^1
"DATA",169.3,96703,1,0)
^169.32^7^7
"DATA",169.3,96703,1,1,0)
MALIGNANT LYMPHOMA, SMALL LYMPHOCYTIC, NOS
"DATA",169.3,96703,1,2,0)
MAL LYMPHOMA, LYMPHOCYTIC, WELL DIFF, DIFFUSE
"DATA",169.3,96703,1,3,0)
MALIGNANT LYMPHOMA, LYMPHOCYTIC, NOS
"DATA",169.3,96703,1,4,0)
MALIGNANT LYMPHOMA, LYMPHOCYTIC, DIFFUSE, NOS
"DATA",169.3,96703,1,5,0)
MALIGNANT LYMPHOMA, SMALL CELL, NOS
"DATA",169.3,96703,1,6,0)
MALIGNANT LYMPHOMA, SML LYMPHOCYTIC, DIFFUSE
"DATA",169.3,96703,1,7,0)
MALIGNANT LYMPHOMA, SMALL CELL DIFFUSE
"DATA",169.3,96703,"E")
136^136^136
"DATA",169.3,96703,"L")
137^137^137
"DATA",169.3,96713,0)
MALIGNANT LYMPHOMA, LYMPHOPLASMACYTIC^9671/3^^^^^^1
"DATA",169.3,96713,1,0)
^169.32^4^4
"DATA",169.3,96713,1,1,0)
MALIGNANT LYMPHOMA, LYMPHOPLASMACYTOID
"DATA",169.3,96713,1,2,0)
IMMUNOCYTOMA
"DATA",169.3,96713,1,3,0)
MALIGNANT LYMPHOMA, PLASMACYTOID
"DATA",169.3,96713,1,4,0)
PLASMACYTIC LYMPHOMA
"DATA",169.3,96713,"E")
136^136^136
"DATA",169.3,96713,"L")
137^137^137
"DATA",169.3,96733,0)
MANTLE CELL LYMPHOMA^9673/3^^^^^^1
"DATA",169.3,96733,1,0)
^169.32^5^5
"DATA",169.3,96733,1,1,0)
MANTLE ZONE LYMPHOMA
"DATA",169.3,96733,1,2,0)
MANTLE CELL LYMPHOMA
"DATA",169.3,96733,1,3,0)
MAL LYMPHOMA/LYMPHOCYTIC/INTERM DIFF/DIFFUSE
"DATA",169.3,96733,1,4,0)
MALIGNANT LYMPHOMA, CENTROCYTIC
"DATA",169.3,96733,1,5,0)
MALIGNANT LYMPHOMATOUS POLYPOSIS
"DATA",169.3,96733,"E")
136^136^136
"DATA",169.3,96733,"L")
137^137^137
"DATA",169.3,96753,0)
MALIGNANT LYMPHOMA, MIXED SMALL/LARGE, DIFF^9675/3^^^^^^1
"DATA",169.3,96753,1,0)
^169.32^4^4
"DATA",169.3,96753,1,1,0)
MAL LYMPHOMA, MIXED LYMPHO-HISTIOCYTIC, DIFF
"DATA",169.3,96753,1,2,0)
MALIGNANT LYMPHOMA, MIXED CELL TYPE, DIFFUSE
"DATA",169.3,96753,1,3,0)
MALIGNANT LYMPHOMA, CENTROBLASTIC-CYTIC, NOS
"DATA",169.3,96753,1,4,0)
MALIGNANT LYMPHOMA, CENTROBLASTIC-CYTIC, DIFF
"DATA",169.3,96753,"E")
136^136^136
"DATA",169.3,96753,"L")
137^137^137
"DATA",169.3,96783,0)
PRIMARY EFFUSION LYMPHOMA ^9678/3^^^
"DATA",169.3,96783,"E")
136^136^136
"DATA",169.3,96783,"L")
137^137^137
"DATA",169.3,96793,0)
MEDIASTINAL LARGE B-CELL LYMPHOMA^9679/3^^^^67383^^
"DATA",169.3,96793,1,0)
^169.32^1^1
"DATA",169.3,96793,1,1,0)
THYMIC LARGE B-CELL LYMPHOMA
"DATA",169.3,96793,"E")
136^136^136
"DATA",169.3,96793,"L")
137^137^137
"DATA",169.3,96803,0)
MALIGNANT LYMPHOMA, LRGE B-CELL, DIFFUSE, NOS^9680/3^^^^^^1
"DATA",169.3,96803,1,0)
^169.32^25^25
"DATA",169.3,96803,1,1,0)
DIFFUSE LARGE B-CELL LYMPHOMA, NOS
"DATA",169.3,96803,1,2,0)
MALIGNANT LYMPHOMA, LARGE CELL, NOS
"DATA",169.3,96803,1,3,0)
MALIGNANT LYMPHOMA, LARGE B-CELL, NOS
"DATA",169.3,96803,1,4,0)
MALIGNANT LYMPHOMA, HISTIOCYTIC, NOS
"DATA",169.3,96803,1,5,0)
MALIGNANT LYMPHOMA, HISTIOCYTIC, DIFFUSE
"DATA",169.3,96803,1,6,0)
MALIG LYMPHOMA, LRGE CELL, CLEAVED/NONCLEAVED
"DATA",169.3,96803,1,7,0)
MALIGNANT LYMPHOMA, LARGE CELL, DIFFUSE, NOS
"DATA",169.3,96803,1,8,0)
MALIGNANT LYMPHOMA, LARGE CLEAVED CELL, NOS
"DATA",169.3,96803,1,9,0)
MALIGNANT LYMPHOMA, LARGE CELL, CLEAVED, DIFF
"DATA",169.3,96803,1,10,0)
MALIGNANT LYMPHOMA, LARGE CELL, CLEAVED, NOS
"DATA",169.3,96803,1,11,0)
MALIGNANT LYMPHOMA/LARGE CELL/NONCLEAVED/DIFF
"DATA",169.3,96803,1,12,0)
MALIGNANT LYMPHOMA/LARGE CELL/NONCLEAVED/NOS
"DATA",169.3,96803,1,13,0)
MALIGNANT LYMPHOMA, NONCLEAVED, DIFFUSE, NOS
"DATA",169.3,96803,1,14,0)
MALIGNANT LYMPHOMA, NONCLEAVED, NOS
"DATA",169.3,96803,1,15,0)
MAL LYMPH, LRG B-CELL, DIFF, CENTROBLAST, NOS
"DATA",169.3,96803,1,16,0)
MALIGNANT LYMPHOMA, CENTROBLASTIC, NOS
"DATA",169.3,96803,1,17,0)
MALIGNANT LYMPHOMA, CENTROBLASTIC, DIFFUSE
"DATA",169.3,96803,1,18,0)
INTRAVASCULAR LARGE B-CELL LYMPHOMA
"DATA",169.3,96803,1,19,0)
INTRAVASCULAR B-CELL LYMPHOMA
"DATA",169.3,96803,1,20,0)
ANGIOENDOTHELIOMATOSIS
"DATA",169.3,96803,1,21,0)
ANGIOTROPIC LYMPHOMA
"DATA",169.3,96803,1,22,0)
T-CELL LARGE B-CELL LYMPHOMA
"DATA",169.3,96803,1,23,0)
HISTIOCYTE-RICH LARGE B-CELL LYMPHOMA
"DATA",169.3,96803,1,24,0)
T-CELL/HISTIOCYTE-RICH LARGE B-CELL LYMPHOMA
"DATA",169.3,96803,1,25,0)
ANAPLASTIC LARGE B-CELL LYMPHOMA
"DATA",169.3,96803,"E")
136^136^136
"DATA",169.3,96803,"L")
137^137^137
"DATA",169.3,96843,0)
MALIG LYMPHOMA, LRG B-CELL, DIFF, IMMUNO, NOS^9684/3^^^^^^1
"DATA",169.3,96843,1,0)
^169.32^4^4
"DATA",169.3,96843,1,1,0)
MALIGNANT LYMPHOMA, IMMUNOBLASTIC, NOS
"DATA",169.3,96843,1,2,0)
IMMUNOBLASTIC SARCOMA
"DATA",169.3,96843,1,3,0)
MALIGNANT LYMPHOMA, LARGE CELL, IMMUNOBLASTIC
"DATA",169.3,96843,1,4,0)
PLASMABLASTIC LYMPHOMA
"DATA",169.3,96843,"E")
136^136^136
"DATA",169.3,96843,"L")
137^137^137
"DATA",169.3,96873,0)
BURKITT LYMPHOMA, NOS^9687/3^^^^^^1
"DATA",169.3,96873,1,0)
^169.32^4^4
"DATA",169.3,96873,1,1,0)
BURKITT TUMOR
"DATA",169.3,96873,1,2,0)
MALIGNANT LYMPHOMA, UNDIFFERENT, BURKITT TYPE
"DATA",169.3,96873,1,3,0)
MALIGNANT LYMPHOMA, SM NONCLEAV, BURKITT TYPE
"DATA",169.3,96873,1,4,0)
BURKITT-LIKE LYMPHOMA
"DATA",169.3,96873,"E")
136^136^136
"DATA",169.3,96873,"L")
137^137^137
"DATA",169.3,96883,0)
T-CELL/HISTIOCYTE RICH LARGE B-CELL LYMPHOMA^9688/3
"DATA",169.3,96893,0)
SPLENIC MARGINAL ZONE B-CELL LYMPHOMA^9689/3^^^^67422^^
"DATA",169.3,96893,1,0)
^169.32^2^2
"DATA",169.3,96893,1,1,0)
SPLENIC MARGINAL ZONE LYMPHOMA, NOS
"DATA",169.3,96893,1,2,0)
SPLENIC LYMPHOMA WITH VILLOUS LYMPHOCYTES
"DATA",169.3,96893,"E")
136^136^136
"DATA",169.3,96893,"L")
137^137^137
"DATA",169.3,96903,0)
FOLLICULAR LYMPHOMA, NOS^9690/3^^^^^^1
"DATA",169.3,96903,1,0)
^169.32^6^6
"DATA",169.3,96903,1,1,0)
MALIGNANT LYMPHOMA, FOLLICULAR, NOS
"DATA",169.3,96903,1,2,0)
MALIGNANT LYMPHOMA, FOLLICLE CENT, FOLLICULAR
"DATA",169.3,96903,1,3,0)
MALIGNANT LYMPHOMA, FOLLICLE CENTER, NOS
"DATA",169.3,96903,1,4,0)
MALIGNANT LYMPHOMA, CENTROBLASTIC-CYTIC, FOLL
"DATA",169.3,96903,1,5,0)
MALIGNANT LYMPHOMA, NODULAR, NOS
"DATA",169.3,96903,1,6,0)
MALIGNANT LYMPHOMA, LYMPHOCYTIC, NODULAR, NOS
"DATA",169.3,96903,"E")
136^136^136
"DATA",169.3,96903,"L")
137^137^137
"DATA",169.3,96913,0)
FOLLICULAR LYMPHOMA, GRADE 2^9691/3^^^^^^1
"DATA",169.3,96913,1,0)
^169.32^5^5
"DATA",169.3,96913,1,1,0)
MAL LYMPHOMA, MIXED SM CLEAVED/LRG CELL, FOLL
"DATA",169.3,96913,1,2,0)
MAL LYMPHOMA, MIXED LYMPHO-HISTIOCYTIC, NOD
"DATA",169.3,96913,1,3,0)
MIXED CELL TYPE, NOD
"DATA",169.3,96913,1,4,0)
MALIG LYMPHOMA, MIXED CELL TYPE, FOLLICULAR
"DATA",169.3,96913,1,5,0)
MALIGNANT LYMPHOMA, MIXED CELL TYPE, NODULAR
"DATA",169.3,96913,"E")
136^136^136
"DATA",169.3,96913,"L")
137^137^137
"DATA",169.3,96953,0)
FOLLICULAR LYMPHOMA, GRADE 1^9695/3^^^^^^1
"DATA",169.3,96953,1,0)
^169.32^3^3
"DATA",169.3,96953,1,1,0)
MALIGNANT LYMPHOMA, SM CLEAVED CELL, FOLLICUL
"DATA",169.3,96953,1,2,0)
FOLLICULAR LYMPHOMA, SMALL CLEAVED CELL
"DATA",169.3,96953,1,3,0)
MALIG LYMPHOMA, LYMPHOCYTIC, POOR DIFF, NODUL
"DATA",169.3,96953,"E")
136^136^136
"DATA",169.3,96953,"L")
137^137^137
"DATA",169.3,96983,0)
FOLLICULAR LYMPHOMA, GRADE 3^9698/3^^^^^^1
"DATA",169.3,96983,1,0)
^169.32^7^7
"DATA",169.3,96983,1,1,0)
MALIGNANT LYMPHOMA, LRG CELL, FOLLICULAR, NOS
"DATA",169.3,96983,1,2,0)
MALIGNANT LYMPHOMA, LRG CELL, NONCLEAVED, FOL
"DATA",169.3,96983,1,3,0)
MALIGNANT LYMPHOMA, HISTIOCYTIC, NODULAR
"DATA",169.3,96983,1,4,0)
MALIGNANT LYMPHOMA, NONCLEAVED, FOLLICUL, NOS
"DATA",169.3,96983,1,5,0)
MALIGNANT LYMPHOMA, LARGE CLEAVED, FOLLICULAR
"DATA",169.3,96983,1,6,0)
MALIGNANT LYMPHOMA, CENTROBLASTIC, FOLLICULAR
"DATA",169.3,96983,1,7,0)
MALIG LYMPHOMA, LYMPHOCYTIC, WELL DIFF, NODUL
"DATA",169.3,96983,"E")
136^136^136
"DATA",169.3,96983,"L")
137^137^137
"DATA",169.3,96993,0)
MARGINAL ZONE B-CELL LYMPHOMA, NOS^9699/3^^^
"DATA",169.3,96993,1,0)
^169.32^9^9
"DATA",169.3,96993,1,1,0)
MARGINAL ZONE LYMPHOMA, NOS
"DATA",169.3,96993,1,2,0)
MUCOSAL-ASSOCIATED LYMPHOID TISSUE LYMPHOMA
"DATA",169.3,96993,1,3,0)
MALT LYMPHOMA
"DATA",169.3,96993,1,4,0)
BRONCHIAL-ASSOCIATED LYMPHOID TISSUE LYMPHOMA
"DATA",169.3,96993,1,5,0)
BALT LYMPHOMA
"DATA",169.3,96993,1,6,0)
SKIN-ASSOCIATED LYMPHOID TISSUE LYMPHOMA
"DATA",169.3,96993,1,7,0)
SALT LYMPHOMA
"DATA",169.3,96993,1,8,0)
NODAL MARGINAL ZONE LYMPHOMA
"DATA",169.3,96993,1,9,0)
MONOCYTOID B-CELL LYMPHOMA
"DATA",169.3,96993,"E")
136^136^136
"DATA",169.3,96993,"L")
137^137^137
"DATA",169.3,97003,0)
MYCOSIS FUNGOIDES^9700/3^^^6744^67440^^1
"DATA",169.3,97003,1,0)
^169.32^1^1
"DATA",169.3,97003,1,1,0)
PAGETOID RETICULOSIS
"DATA",169.3,97003,"E")
138^138^230
"DATA",169.3,97003,"L")
139^148^148
"DATA",169.3,97013,0)
SEZARY SYNDROME^9701/3^^^^^^1
"DATA",169.3,97013,1,0)
^169.32^1^1
"DATA",169.3,97013,1,1,0)
SEZARY DISEASE
"DATA",169.3,97013,"E")
138^138^230
"DATA",169.3,97013,"L")
139^148^148
"DATA",169.3,97023,0)
MATURE T-CELL LYMPHOMA, NOS^9702/3^^^^^^1
"DATA",169.3,97023,1,0)
^169.32^8^8
"DATA",169.3,97023,1,1,0)
PERIPHERAL T-CELL LYMPHOMA, NOS
"DATA",169.3,97023,1,2,0)
T-CELL LYMPHOMA, NOS
"DATA",169.3,97023,1,3,0)
PERIPH T-CELL LYMPH, PLEOMORPHIC SM CELL
"DATA",169.3,97023,1,4,0)
PERIPH T-CELL LYMPH, PLEOMORPHIC MED/LRG CELL
"DATA",169.3,97023,1,5,0)
PERIPH T-CELL LYMPH, LARGE CELL
"DATA",169.3,97023,1,6,0)
T-ZONE LYMPHOMA
"DATA",169.3,97023,1,7,0)
LYMPHOEPITHELIOD LYMPHOMA
"DATA",169.3,97023,1,8,0)
LENNERT LYMPHOMA
"DATA",169.3,97023,"E")
136^136^136
"DATA",169.3,97023,"L")
137^137^137
"DATA",169.3,97053,0)
ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA^9705/3^^^^^^1
"DATA",169.3,97053,1,0)
^169.32^2^2
"DATA",169.3,97053,1,1,0)
PERIPHERAL T-CELL LYMPHOMA, AILD
"DATA",169.3,97053,1,2,0)
ANGIOIMMUNOBLASTIC LYMPHOMA
"DATA",169.3,97053,"E")
136^136^136
"DATA",169.3,97053,"L")
137^137^137
"DATA",169.3,97083,0)
SUBCUTANEOUS PANNICULISTIC T-CELL LYMPHOMA^9708/3^^^^^^1
"DATA",169.3,97083,"E")
136^136^136
"DATA",169.3,97083,"L")
137^137^137
"DATA",169.3,97093,0)
CUTANEOUS T-CELL LYMPHOMA, NOS^9709/3^^^6744^67440^^1
"DATA",169.3,97093,1,0)
^169.32^1^1
"DATA",169.3,97093,1,1,0)
CUTANEOUS LYMPHOMA, NOS
"DATA",169.3,97093,"E")
136^136^136
"DATA",169.3,97093,"L")
137^137^137
"DATA",169.3,97123,0)
INTRAVASCULAR LARGE B-CELL LYMPHOMA^9712/3
"DATA",169.3,97143,0)
ANAPLASTIC LRG CELL LYMPH, T & NULL CELL TYPE^9714/3^^^^^^1
"DATA",169.3,97143,1,0)
^169.32^3^3
"DATA",169.3,97143,1,1,0)
LARGE CELL LYMPHOMA
"DATA",169.3,97143,1,2,0)
ANAPLASTIC LARGE CELL LYMPHOMA, NOS
"DATA",169.3,97143,1,3,0)
ANAPLASTIC LARGE CELL LYMPHOMA, CD30+
"DATA",169.3,97143,"E")
136^136^136
"DATA",169.3,97143,"L")
137^137^137
"DATA",169.3,97163,0)
HEPATOSPLENIC GAMMA-DELTA CELL LYMPHOMA^9716/3^^^^^^1
"DATA",169.3,97163,"E")
136^136^136
"DATA",169.3,97163,"L")
137^137^137
"DATA",169.3,97173,0)
INTESTINAL T-CELL LYMPHOMA^9717/3^^^^^^1
"DATA",169.3,97173,1,0)
^169.32^2^2
"DATA",169.3,97173,1,1,0)
ENTEROPATHY TYPE INTESTINAL T-CELL LYMPHOMA
"DATA",169.3,97173,1,2,0)
ENTEROPATHY ASSOCIATED T-CELL LYMPHOMA
"DATA",169.3,97173,"E")
136^136^136
"DATA",169.3,97173,"L")
137^137^137
"DATA",169.3,97183,0)
PRIM CUTANEOUS CD30+ T-CELL LYMPHOPROLIF DIS^9718/3^^^^67440^^
"DATA",169.3,97183,1,0)
^169.32^3^3
"DATA",169.3,97183,1,1,0)
LYMPHOMATOID PAPULOSIS
"DATA",169.3,97183,1,2,0)
PRIMARY CUTANEOUS ANAPLASTIC LARGE CELL LYMPH
"DATA",169.3,97183,1,3,0)
PRIMARY CUTANEOUS CD30+ LARGE T-CELL LYMPHOMA
"DATA",169.3,97183,"E")
136^136^136
"DATA",169.3,97183,"L")
137^137^137
"DATA",169.3,97193,0)
NK/T-CELL LYMPHOMA, NASAL AND NASAL-TYPE^9719/3^^^
"DATA",169.3,97193,1,0)
^169.32^5^5
"DATA",169.3,97193,1,1,0)
T/NK-CELL LYMPHOMA
"DATA",169.3,97193,1,2,0)
ANGIOCENTRIC T-CELL LYMPHOMA
"DATA",169.3,97193,1,3,0)
MALIGNANT RETICULOSIS, NOS
"DATA",169.3,97193,1,4,0)
MALIGNANT MIDLINE RETICULOSIS
"DATA",169.3,97193,1,5,0)
POLYMORPHIC RETICULOSIS
"DATA",169.3,97193,"E")
136^136^136
"DATA",169.3,97193,"L")
137^137^137
"DATA",169.3,97243,0)
SYSTEMIC EBV POSITIVE T-CELL LYMPHOPROLIFERATIVE DISEASE OF CHILDHOOD^9724/3
"DATA",169.3,97253,0)
HYDROA VACCINIFORME-LIKE LYMPHOMA^9725/3
"DATA",169.3,97263,0)
PRIMARY CUTANEOUS GAMMA-DELTA T-CELL LYMPHOMA^9726/3
"DATA",169.3,97273,0)
PRECURSOR CELL LYMPHOBLASTIC LYMPHOMA, NOS^9727/3^^^
"DATA",169.3,97273,1,0)
^169.32^3^3
"DATA",169.3,97273,1,1,0)
MALIGNANT LYMPHOMA, LYMPHOBLASTIC, NOS
"DATA",169.3,97273,1,2,0)
MALIGNANT LYMPHOMA, CONVOLUTED CELL
"DATA",169.3,97273,1,3,0)
LYMPHOBLASTOMA
"DATA",169.3,97273,"E")
136^136^136
"DATA",169.3,97273,"L")
137^137^137
"DATA",169.3,97283,0)
PRECURSOR B-CELL LYMPHOBLASTIC LYMPHOMA^9728/3^^^
"DATA",169.3,97283,"E")
136^136^136
"DATA",169.3,97283,"L")
137^137^137
"DATA",169.3,97293,0)
PRECURSOR T-CELL LYMPHOBLASTIC LYMPHOMA^9729/3^^^
"DATA",169.3,97293,"E")
136^136^136
"DATA",169.3,97293,"L")
137^137^137
"DATA",169.3,97313,0)
PLASMACYTOMA, NOS^9731/3^^^^^^1
"DATA",169.3,97313,1,0)
^169.32^4^4
"DATA",169.3,97313,1,1,0)
PLASMACYTOMA OF BONE
"DATA",169.3,97313,1,2,0)
PLASMA CELL TUMOR
"DATA",169.3,97313,1,3,0)
SOLITARY MYELOMA
"DATA",169.3,97313,1,4,0)
SOLITARY PLASMACYTOMA
"DATA",169.3,97313,"E")
^^
"DATA",169.3,97313,"L")
^^
"DATA",169.3,97323,0)
MULTIPLE MYELOMA^9732/3^^^6742^67421^^1
"DATA",169.3,97323,1,0)
^169.32^3^3
"DATA",169.3,97323,1,1,0)
MYELOMA, NOS
"DATA",169.3,97323,1,2,0)
MYELOMATOSIS
"DATA",169.3,97323,1,3,0)
PLASMA CELL MYELOMA
"DATA",169.3,97333,0)
PLASMA CELL LEUKEMIA^9733/3^^^^67421^^
"DATA",169.3,97333,1,0)
^169.32^1^1
"DATA",169.3,97333,1,1,0)
PLASMACYTIC LEUKEMIA
"DATA",169.3,97343,0)
PLASMACYTOMA, EXTRAMEDULLARY^9734/3^^^
"DATA",169.3,97353,0)
PLASMABLASTIC LYMPHOMA^9735/3
"DATA",169.3,97373,0)
ALK POSITIVE LARGE B-CELL LYMPHOMA^9737/3
"DATA",169.3,97383,0)
LARGE B-CELL LYMPHOMA ARISING IN HHV8-ASSOCIATED MULTICENTRIC CASTLEMAN DISEASE^9738/3
"DATA",169.3,97401,0)
MASTOCTTOMA, NOS^9740/1^^^^^^5
"DATA",169.3,97401,1,0)
^169.32^1^1
"DATA",169.3,97401,1,1,0)
MAST CELL TUMOR NOS
"DATA",169.3,97403,0)
MAST CELL SARCOMA^9740/3^^^^^^5
"DATA",169.3,97403,1,0)
^169.32^2^2
"DATA",169.3,97403,1,1,0)
MALIGNANT MAST CELL TUMOR
"DATA",169.3,97403,1,2,0)
MALIGNANT MASTOCYTOMA
"DATA",169.3,97411,0)
INDOLENT SYSTEMIC MASTOCYTOSIS^9741/1
"DATA",169.3,97413,0)
MALIGNANT MASTOCYTOSIS^9741/3^^^^^^1
"DATA",169.3,97413,1,0)
^169.32^2^1
"DATA",169.3,97413,1,2,0)
SYSTEMIC TISSUE MAST CELL DISEASE
"DATA",169.3,97423,0)
MAST CELL LEUKEMIA^9742/3^^^^67421^^
"DATA",169.3,97503,0)
MALIGNANT HISTIOCYTOSIS^9750/3^^^^^^1
"DATA",169.3,97503,1,0)
^169.32^1^1
"DATA",169.3,97503,1,1,0)
HISTIOCYTIC MEDULLARY RETICULOSIS
"DATA",169.3,97511,0)
LANGERHANS CELL HISTIOCYTOSIS, NOS (<2010 CASES)^9751/1^^^
"DATA",169.3,97511,1,0)
^169.32^2^2
"DATA",169.3,97511,1,1,0)
LANGERHANS CELL GRANULOMATOSIS
"DATA",169.3,97511,1,2,0)
HISTIOCYTOSIS X, NOS
"DATA",169.3,97513,0)
LANGERHANS CELL HISTIOCYTOSIS, NOS^9751/3
"DATA",169.3,97513,1,0)
^169.32^2^2
"DATA",169.3,97513,1,1,0)
LANGERHANS CELL GRANULOMATOSIS
"DATA",169.3,97513,1,2,0)
HISTIOCYTOSIS X, NOS
"DATA",169.3,97521,0)
LANGERHANS CELL HISTIOCYTOSIS, UNIFOCAL^9752/1^^^
"DATA",169.3,97521,1,0)
^169.32^3^3
"DATA",169.3,97521,1,1,0)
LANGERHANS CELL GRANULOMATOSIS, UNIFOCAL
"DATA",169.3,97521,1,2,0)
LANGERHANS CELL HISTIOCYTOSIS, MONO-OSTOTIC
"DATA",169.3,97521,1,3,0)
EOSINOPHILIC GRANULOMA
"DATA",169.3,97531,0)
LANGERHANS CELL HISTIOCYTOSIS, MULTIFOCAL^9753/1^^^
"DATA",169.3,97531,1,0)
^169.32^2^2
"DATA",169.3,97531,1,1,0)
LANGERHANS CELL HISTIOCYTOSIS, POLY-OSTOTIC
"DATA",169.3,97531,1,2,0)
HAND-SCHULLER-CHRISTIAN DISEASE
"DATA",169.3,97543,0)
LANGERHANS CELL HISTIOCYTOSIS, DISSEMINATED^9754/3^^^
"DATA",169.3,97543,1,0)
^169.32^4^4
"DATA",169.3,97543,1,1,0)
LANGERHANS CELL HISTIOCYTOSIS, GENERALIZED
"DATA",169.3,97543,1,2,0)
LETTERER-SIWE DISEASE
"DATA",169.3,97543,1,3,0)
ACUTE PROGRESSIVE HISTIOCYTOSIS X
"DATA",169.3,97543,1,4,0)
NONLIPID RETICULOENDOTHELIOSIS
"DATA",169.3,97553,0)
HISTIOCYTIC SARCOMA^9755/3^^^
"DATA",169.3,97553,1,0)
^169.32^1^1
"DATA",169.3,97553,1,1,0)
TRUE HISTIOCYTIC LYMPHOMA
"DATA",169.3,97555,0)
TEST CHECK TEST ONE TWO THREE^9755/5
"DATA",169.3,97555,1,0)
^169.32^2^2
"DATA",169.3,97555,1,1,0)
HISTIOCYTOSIS X, NOS
"DATA",169.3,97555,1,2,0)
LANGERHANS CELL GRANULOMATOSIS
"DATA",169.3,97563,0)
LANGERHANS CELL SARCOMA^9756/3^^^
"DATA",169.3,97573,0)
INTERDIGITATING DENDRITIC CELL SARCOMA^9757/3^^^
"DATA",169.3,97573,1,0)
^169.32^2^2
"DATA",169.3,97573,1,1,0)
INTERDIGITATING CELL SARCOMA
"DATA",169.3,97573,1,2,0)
DENDRITIC CELL SARCOMA, NOS
"DATA",169.3,97583,0)
FOLLICULAR DENDRITIC CELL SARCOMA^9758/3^^^
"DATA",169.3,97583,1,0)
^169.32^1^1
"DATA",169.3,97583,1,1,0)
FOLLICULAR DENDRITIC CELL TUMOR
"DATA",169.3,97593,0)
FIBROBLASTIC RETICULAR CELL TUMOR^9759/3
"DATA",169.3,97603,0)
IMMUNIOPROLIFERATIVE DISEASE, NOS^9760/3^^^^^^1
"DATA",169.3,97613,0)
WALDENSTROM MACROGLOBULINEMIA^9761/3^^^6742^67420^^1
"DATA",169.3,97613,1,0)
^169.32^^0
"DATA",169.3,97623,0)
HEAVY CHAIN DISEASE, NOS^9762/3^^^^^^1
"DATA",169.3,97623,1,0)
^169.32^4^4
"DATA",169.3,97623,1,1,0)
ALPHA HEAVY CHAIN DISEASE
"DATA",169.3,97623,1,2,0)
MU HEAVY CHAIN DISEASE
"DATA",169.3,97623,1,3,0)
GAMMA HEAVY CHAIN DISEASE
"DATA",169.3,97623,1,4,0)
FRANKLIN DISEASE
"DATA",169.3,97643,0)
IMMUNOPROLIFERATIVE SMALL INTESTINAL DISEASE^9764/3^^^6717^^^1
"DATA",169.3,97643,1,0)
^169.32^1^1
"DATA",169.3,97643,1,1,0)
MEDITERRANEAN LYMPHOMA
"DATA",169.3,97651,0)
MONOCLONAL GAMMOPATHY OF UNDETERMINED SIG^9765/1^^^^^^1
"DATA",169.3,97651,1,0)
^169.32^2^2
"DATA",169.3,97651,1,1,0)
MGUS
"DATA",169.3,97651,1,2,0)
MONOCLONAL GAMMOPATHY, NOS
"DATA",169.3,97661,0)
ANGIOCENTRIC IMMUNOPROLIFERATIVE LESION^9766/1^^^^^^1
"DATA",169.3,97661,1,0)
^169.32^1^1
"DATA",169.3,97661,1,1,0)
LYMPHOID GRANULOMATOSIS
"DATA",169.3,97671,0)
ANGIOIMMUNOBLASTIC LYMPHADENOPATHY^9767/1^^^^^^1
"DATA",169.3,97681,0)
T-GAMMA LYMPHOPROLIFERATIVE DISEASE^9768/1^^^^^^1
"DATA",169.3,97691,0)
IMMUNOGLOBULIN DEPOSITION DISEASE^9769/1^^^
"DATA",169.3,97691,1,0)
^169.32^2^2
"DATA",169.3,97691,1,1,0)
SYSTEMIC LIGHT CHAIN DISEASE
"DATA",169.3,97691,1,2,0)
PRIMARY AMYLOIDOSIS
"DATA",169.3,98003,0)
LEUKEMIA, NOS^9800/3^^^^^^6
"DATA",169.3,98003,1,0)
^169.32^4^4
"DATA",169.3,98003,1,1,0)
SUBACUTE LEUKEMIA, NOS
"DATA",169.3,98003,1,2,0)
CHRONIC LEUKEMIA, NOS
"DATA",169.3,98003,1,3,0)
ALEUKEMIC LEUKEMIA, NOS
"DATA",169.3,98003,1,4,0)
LEUKEMIA
"DATA",169.3,98013,0)
ACUTE LEUKEMIA, NOS^9801/3^^^^^^6
"DATA",169.3,98013,1,0)
^169.32^4^4
"DATA",169.3,98013,1,1,0)
BLAST CELL LEUKEMIA
"DATA",169.3,98013,1,2,0)
UNDIFFERENTIATED LEUKEMIA
"DATA",169.3,98013,1,3,0)
STEM CELL LEUKEMIA
"DATA",169.3,98013,1,4,0)
LEUKEMIA
"DATA",169.3,98053,0)
ACUTE BIPHENOTYPIC LEUKEMIA^9805/3^^^
"DATA",169.3,98053,1,0)
^169.32^3^3
"DATA",169.3,98053,1,1,0)
ACUTE MIXED LINEAGE LEUKEMIA
"DATA",169.3,98053,1,2,0)
ACUTE BILINEAL LEUKEMIA
"DATA",169.3,98053,1,3,0)
LEUKEMIA
"DATA",169.3,98063,0)
MIXED PHENOTYPE ACUTE LEUKEMIA WITH T(9;22)(Q34;Q11.2); BCR-ABL1^9806/3
"DATA",169.3,98063,1,0)
^169.32^1^1
"DATA",169.3,98063,1,1,0)
LEUKEMIA
"DATA",169.3,98073,0)
MIXED PHENOTYPE ACUTE LEUKEMIA WITH T(V;11Q23); MLL REARRANGED^9807/3
"DATA",169.3,98073,1,0)
^169.32^1^1
"DATA",169.3,98073,1,1,0)
LEUKEMIA
"DATA",169.3,98083,0)
MIXED PHENOTYPE ACUTE LEUKEMIA, B/MYELOID, NOS^9808/3
"DATA",169.3,98083,1,0)
^169.32^1^1
"DATA",169.3,98083,1,1,0)
LEUKEMIA
"DATA",169.3,98093,0)
MIXED PHENOTYPE ACUTE LEUKEMIA, T/MYELOID, NOS^9809/3
"DATA",169.3,98093,1,0)
^169.32^1^1
"DATA",169.3,98093,1,1,0)
LEUKEMIA
"DATA",169.3,98113,0)
B LYMPHOBLASTIC LEUKEMIA/LYMPHOMA, NOS^9811/3
"DATA",169.3,98113,1,0)
^169.32^1^1
"DATA",169.3,98113,1,1,0)
LEUKEMIA
"DATA",169.3,98123,0)
B LYMPHOBLASTIC LEUKEMIA/LYMPHOMA WITH T(9;22)(Q34;Q11.2); BCR-ABL1^9812/3
"DATA",169.3,98123,1,0)
^169.32^1^1
"DATA",169.3,98123,1,1,0)
LEUKEMIA
"DATA",169.3,98133,0)
B LYMPHOBLASTIC LEUKEMIA/LYMPHOMA WITH T(V;11Q23); MLL REARRANGED^9813/3
"DATA",169.3,98133,1,0)
^169.32^1^1
"DATA",169.3,98133,1,1,0)
LEUKEMIA
"DATA",169.3,98143,0)
B LYMPHOBLASTIC LEUKEMIA/LYMPHOMA WITH T(12;21)(P13;Q22); TEL-AML1 (ETV6-RUNX1)^9814/3
"DATA",169.3,98143,1,0)
^169.32^1^1
"DATA",169.3,98143,1,1,0)
LEUKEMIA
"DATA",169.3,98153,0)
B LYMPHOBLASTIC LEUKEMIA/LYMPHOMA WITH HYPERDIPLOIDY^9815/3
"DATA",169.3,98153,1,0)
^169.32^1^1
"DATA",169.3,98153,1,1,0)
LEUKEMIA
"DATA",169.3,98163,0)
B LYMPHOBLASTIC LEUKEMIA/LYMPHOMA WITH HYPODIPLOIDY (HYPODIPLOID ALL)^9816/3
"DATA",169.3,98163,1,0)
^169.32^1^1
"DATA",169.3,98163,1,1,0)
LEUKEMIA
"DATA",169.3,98173,0)
B LYMPHOBLASTIC LEUKEMIA/LYMPHOMA WITH T(5;14)(Q31;Q32); IL3-IGH^9817/3
"DATA",169.3,98173,1,0)
^169.32^1^1
"DATA",169.3,98173,1,1,0)
LEUKEMIA
"DATA",169.3,98183,0)
B LYMPHOBLASTIC LEUKEMIA/LYMPHOMA WITH T(1;19)(Q23;P13.3); E2A PBX1 (TCF3 PBX1)^9818/3
"DATA",169.3,98183,1,0)
^169.32^1^1
"DATA",169.3,98183,1,1,0)
LEUKEMIA
"DATA",169.3,98203,0)
LYMPHOID LEUKEMIA, NOS^9820/3^^^^^^6
"DATA",169.3,98203,1,0)
^169.32^10^10
"DATA",169.3,98203,1,1,0)
LYMPHOCYTIC LEUKEMIA, NOS
"DATA",169.3,98203,1,2,0)
LYMPHATIC LEUKEMIA, NOS
"DATA",169.3,98203,1,3,0)
SUBACUTE LYMPHOID LEUKEMIA
"DATA",169.3,98203,1,4,0)
SUBACUTE LYMPHOCYCTIC LEUKEMIA
"DATA",169.3,98203,1,5,0)
SUBACUTE LYMPHATIC LEUKEMIA
"DATA",169.3,98203,1,6,0)
ALEUKEMIC LYMPHOID LEUKEMIA
"DATA",169.3,98203,1,7,0)
ALEUKEMIC LYMPHOCYCTIC LEUKEMIA
"DATA",169.3,98203,1,8,0)
ALEUKEMIC LYMPHATIC LEUKEMIA
"DATA",169.3,98203,1,9,0)
LYMPHOSARCOMA CELL LEUKEMIA
"DATA",169.3,98203,1,10,0)
LEUKEMIA
"DATA",169.3,98233,0)
B-CELL CHRON LYMPHOCYTIC LEUK/SMALL LYMPHOMA^9823/3^^^^^^6
"DATA",169.3,98233,1,0)
^169.32^5^5
"DATA",169.3,98233,1,1,0)
CHRONIC LYMPHOCYTIC LEUKEMIA, B-CELL TYPE
"DATA",169.3,98233,1,2,0)
CHRONIC LYMPHOCYTIC LEUKEMIA
"DATA",169.3,98233,1,3,0)
CHRONIC LYMPHOID LEUKEMIA
"DATA",169.3,98233,1,4,0)
CHRONIC LYMPHATIC LEUKEMIA
"DATA",169.3,98233,1,5,0)
LEUKEMIA
"DATA",169.3,98263,0)
BURKITT CELL LEUKEMIA^9826/3^^^^^^6
"DATA",169.3,98263,1,0)
^169.32^7^7
"DATA",169.3,98263,1,1,0)
ACUTE LEUKEMIA, BURKITT TYPE
"DATA",169.3,98263,1,2,0)
B-ALL
"DATA",169.3,98263,1,3,0)
BURKITT CELL LEUKEMIA
"DATA",169.3,98263,1,4,0)
FAB L3
"DATA",169.3,98263,1,5,0)
ACUTE LYMPHOBLASTIC LEUKEMIA, MATURE
"DATA",169.3,98263,1,6,0)
B-CELL TYPE
"DATA",169.3,98263,1,7,0)
LEUKEMIA
"DATA",169.3,98273,0)
ADULT T-CELL LEUKEMIA/LYMPHOMA (HTLV-1 POS)^9827/3^^^^^^1
"DATA",169.3,98273,1,0)
^169.32^4^4
"DATA",169.3,98273,1,1,0)
ADULT T-CELL LYMPHOMA/LEUKEMIA
"DATA",169.3,98273,1,2,0)
ADULT T-CELL LYMPHOMA
"DATA",169.3,98273,1,3,0)
ADULT T-CELL LEUKEMIA
"DATA",169.3,98273,1,4,0)
LEUKEMIA
"DATA",169.3,98311,0)
T-CELL LARGE GRANULAR LYMPHOCYTIC LEUKEMIA^9831/1^^^
"DATA",169.3,98311,1,0)
^169.32^4^4
"DATA",169.3,98311,1,1,0)
T-CELL LARGE GRANULAR LYMPHOCYTOSIS
"DATA",169.3,98311,1,2,0)
NK-CELL LARGE GRANULAR LYMPHOCYTIC LEUKEMIA
"DATA",169.3,98311,1,3,0)
LARGE GRANULAR LYMPHOCYTOSIS, NOS
"DATA",169.3,98311,1,4,0)
LEUKEMIA
"DATA",169.3,98313,0)
CHRONIC LYMPHOPROLIFERATIVE DISORDER OF NK-CELLS^9831/3
"DATA",169.3,98313,1,0)
^169.32^1^1
"DATA",169.3,98313,1,1,0)
LEUKEMIA
"DATA",169.3,98323,0)
PROLYMPHOCYTIC LEUKEMIA, NOS^9832/3^^^
"DATA",169.3,98323,1,0)
^169.32^1^1
"DATA",169.3,98323,1,1,0)
LEUKEMIA
"DATA",169.3,98333,0)
PROLYMPHOCYTIC LEUKEMIA, B-CELL TYPE^9833/3^^^
"DATA",169.3,98333,1,0)
^169.32^1^1
"DATA",169.3,98333,1,1,0)
LEUKEMIA
"DATA",169.3,98343,0)
PROLYMPHOCYTIC LEUKEMIA, T-CELL TYPE^9834/3^^^
"DATA",169.3,98343,1,0)
^169.32^1^1
"DATA",169.3,98343,1,1,0)
LEUKEMIA
"DATA",169.3,98353,0)
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA, NOS^9835/3^^^
"DATA",169.3,98353,1,0)
^169.32^12^12
"DATA",169.3,98353,1,1,0)
PRECURSOR CELL LYMPHOBLASTIC LEUK, NOT PHENO
"DATA",169.3,98353,1,2,0)
ACUTE LYMPHOBLASTIC LEUKEMIA, PRECURSOR-CELL
"DATA",169.3,98353,1,3,0)
ACUTE LYMPHOBLASTIC LEUKEMIA-LYMPHOMA, NOS
"DATA",169.3,98353,1,4,0)
FAB L1
"DATA",169.3,98353,1,5,0)
ACUTE LYMPHOBLASTIC LEUKEMIA, L2 TYPE, NOS
"DATA",169.3,98353,1,6,0)
FAB L2
"DATA",169.3,98353,1,7,0)
ACUTE LYMPHOBLASTIC LEUKEMIA, NOS
"DATA",169.3,98353,1,8,0)
ACUTE LYMPHOCTIC LEUKEMIA
"DATA",169.3,98353,1,9,0)
ACUTE LYMPHOID LEUKEMIA
"DATA",169.3,98353,1,10,0)
ACUTE LYMPHATIC LEUKEMIA
"DATA",169.3,98353,1,11,0)
LYMPHOBLASTIC LEUKEMIA, NOS
"DATA",169.3,98353,1,12,0)
LEUKEMIA
"DATA",169.3,98363,0)
PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA^9836/3^^^
"DATA",169.3,98363,1,0)
^169.32^7^7
"DATA",169.3,98363,1,1,0)
PRO-B ALL
"DATA",169.3,98363,1,2,0)
COMMON PRECURSOR B ALL
"DATA",169.3,98363,1,3,0)
PRE-B ALL
"DATA",169.3,98363,1,4,0)
PRE-PRE-B ALL
"DATA",169.3,98363,1,5,0)
COMMON ALL
"DATA",169.3,98363,1,6,0)
C-ALL
"DATA",169.3,98363,1,7,0)
LEUKEMIA
"DATA",169.3,98373,0)
T LYMPHOBLASTIC LEUKEMIA/LYMPHOMA^9837/3^^^
"DATA",169.3,98373,1,0)
^169.32^5^5
"DATA",169.3,98373,1,1,0)
PRO-T ALL
"DATA",169.3,98373,1,2,0)
PRE-T ALL
"DATA",169.3,98373,1,3,0)
CORTICAL T ALL
"DATA",169.3,98373,1,4,0)
MATURE T ALL
"DATA",169.3,98373,1,5,0)
LEUKEMIA
"DATA",169.3,98403,0)
ACUTE MYELOID LEUKEMIA, M6 TYPE^9840/3^^^^^^6
"DATA",169.3,98403,1,0)
^169.32^11^11
"DATA",169.3,98403,1,1,0)
ERYTHREMIC MYELOSIS, NOS
"DATA",169.3,98403,1,2,0)
FAB M6
"DATA",169.3,98403,1,3,0)
ACUTE ERYTHROID LEUKEMIA
"DATA",169.3,98403,1,4,0)
M6A
"DATA",169.3,98403,1,5,0)
M6B
"DATA",169.3,98403,1,6,0)
ERYTHROLEUKEMIA
"DATA",169.3,98403,1,7,0)
AML M6
"DATA",169.3,98403,1,8,0)
ACUTE ERYTHREMIA
"DATA",169.3,98403,1,9,0)
DI GUGLIELMO DISEASE
"DATA",169.3,98403,1,10,0)
ACUTE ERYTHREMIC MYELOSIS
"DATA",169.3,98403,1,11,0)
LEUKEMIA
"DATA",169.3,98603,0)
MYELOID LEUKEMIA, NOS^9860/3^^^^^^6
"DATA",169.3,98603,1,0)
^169.32^17^17
"DATA",169.3,98603,1,1,0)
NON-LYMPHOCYTIC LEUKEMIA, NOS
"DATA",169.3,98603,1,2,0)
GRANULOCYTIC LEUKEMIA, NOS
"DATA",169.3,98603,1,3,0)
MYELOGENOUS LEUKEMIA, NOS
"DATA",169.3,98603,1,4,0)
MYELOMONOCYTIC LEUKEMIA, NOS
"DATA",169.3,98603,1,5,0)
MYELOCYTIC LEUKEMIA, NOS
"DATA",169.3,98603,1,6,0)
SUBACUTE MYELOID LEUKEMIA
"DATA",169.3,98603,1,7,0)
SUBACUTE GRANULOCYTIC LEUKEMIA
"DATA",169.3,98603,1,8,0)
SUBACUTE MYELOGENOUS LEUKEMIA
"DATA",169.3,98603,1,9,0)
ALEUKEMIC MYELOID LEUKEMIA
"DATA",169.3,98603,1,10,0)
ALEUKEMIC GRANULOCYTIC LEUKEMIA
"DATA",169.3,98603,1,11,0)
ALEUKEMIC MYELOGENOUS LEUKEMIA
"DATA",169.3,98603,1,12,0)
EOSINOPHILIC LEUKEMIA
"DATA",169.3,98603,1,13,0)
MONOCYTIC LEUKEMIA, NOS
"DATA",169.3,98603,1,14,0)
SUBACUTE MONOCYTIC LEUKEMIA
"DATA",169.3,98603,1,15,0)
CHRONIC MONOCYTIC LEUKEMIA
"DATA",169.3,98603,1,16,0)
ALEUKEMIC MONOCYTIC LEUKEMIA
"DATA",169.3,98603,1,17,0)
LEUKEMIA
"DATA",169.3,98613,0)
ACUTE MYELOID LEUKEMIA, NOS^9861/3^^^^^^6
"DATA",169.3,98613,1,0)
^169.32^5^5
"DATA",169.3,98613,1,1,0)
ACUTE NON-LYMPHOCYTIC LEUKEMIA
"DATA",169.3,98613,1,2,0)
ACUTE GRANULOCYTIC LEUKEMIA
"DATA",169.3,98613,1,3,0)
ACUTE MYELOGENOUS LEUKEMIA
"DATA",169.3,98613,1,4,0)
ACUTE MYELOCYTIC LEUKEMIA
"DATA",169.3,98613,1,5,0)
LEUKEMIA
"DATA",169.3,98633,0)
CHRONIC MYELOID LEUKEMIA, NOS^9863/3^^^^^^6
"DATA",169.3,98633,1,0)
^169.32^4^4
"DATA",169.3,98633,1,1,0)
CHRONIC GRANULOCYTIC LEUKEMIA, NOS
"DATA",169.3,98633,1,2,0)
CHRONIC MYELOGENOUS LEUKEMIA, NOS
"DATA",169.3,98633,1,3,0)
CHRONIC MYELOCYTIC LEUKEMIA, NOS
"DATA",169.3,98633,1,4,0)
LEUKEMIA
"DATA",169.3,98653,0)
ACUTE MYELOID LEUKEMIA WITH T(6;9)(P23;Q34) DEK-NUP214^9865/3
"DATA",169.3,98653,1,0)
^169.32^1^1
"DATA",169.3,98653,1,1,0)
LEUKEMIA
"DATA",169.3,98663,0)
ACUTE PROMYELOCYTIC LEUKEMIA^9866/3^^^^^^6
"DATA",169.3,98663,1,0)
^169.32^6^6
"DATA",169.3,98663,1,1,0)
ACUTE PROMYELOCYTIC LEUKEMIA, PML/RAR-ALPHA
"DATA",169.3,98663,1,2,0)
ACUTE MYELOID LEUKEMIA
"DATA",169.3,98663,1,3,0)
FAB M3
"DATA",169.3,98663,1,4,0)
ACUTE MYELOID LEUKEMIA, PML/RAR-ALPHA
"DATA",169.3,98663,1,5,0)
ACUTE PROMYELOCYTIC LEUKEMIA, NOS
"DATA",169.3,98663,1,6,0)
LEUKEMIA
"DATA",169.3,98673,0)
ACUTE MYELOMONOCYTIC LEUKEMIA^9867/3^^^^^^6
"DATA",169.3,98673,1,0)
^169.32^4^2
"DATA",169.3,98673,1,3,0)
FAB M4
"DATA",169.3,98673,1,4,0)
LEUKEMIA
"DATA",169.3,98693,0)
ACUTE MYELOID LEUKEMIA WITH INV(3)(Q21Q26.2) OR T(3;3)(Q21;Q26.2); RPN1EVI1^9869/3
"DATA",169.3,98693,1,0)
^169.32^1^1
"DATA",169.3,98693,1,1,0)
LEUKEMIA
"DATA",169.3,98703,0)
ACUTE BASOPHILIC LEUKEMIA^9870/3^^^^^^6
"DATA",169.3,98703,1,0)
^169.32^1^1
"DATA",169.3,98703,1,1,0)
LEUKEMIA
"DATA",169.3,98713,0)
ACUTE MYELOID LEUK/ABNORM MARROW EOSINOPHIL^9871/3^^^^^^6
"DATA",169.3,98713,1,0)
^169.32^6^6
"DATA",169.3,98713,1,1,0)
ACUTE MYELOID LEUKEMIA, INV(16)(P13;Q22)
"DATA",169.3,98713,1,2,0)
ACUTE MYELOID LEUKEMIA, T(16;16)(P13;Q11)
"DATA",169.3,98713,1,3,0)
ACUTE MYELOID LEUKEMIA, CBF-BETA/MYH11
"DATA",169.3,98713,1,4,0)
ACUTE MYELOMONOCYTIC/ABNORM MARR EOSINOPHILS
"DATA",169.3,98713,1,5,0)
FAB M4EO
"DATA",169.3,98713,1,6,0)
LEUKEMIA
"DATA",169.3,98723,0)
ACUTE MYELOID LEUKEMIA, MINIMAL DIFF^9872/3^^^^^^6
"DATA",169.3,98723,1,0)
^169.32^3^3
"DATA",169.3,98723,1,1,0)
FAB M0
"DATA",169.3,98723,1,2,0)
ACUTE MYELOBLASTIC LEUKEMIA
"DATA",169.3,98723,1,3,0)
LEUKEMIA
"DATA",169.3,98733,0)
ACUTE MYELOID LEUKEMIA WITHOUT MATURATION^9873/3^^^^^^6
"DATA",169.3,98733,1,0)
^169.32^2^2
"DATA",169.3,98733,1,1,0)
FAB M1
"DATA",169.3,98733,1,2,0)
LEUKEMIA
"DATA",169.3,98743,0)
ACUTE MYELOID LEUKEMIA WITH MATURATION^9874/3^^^^^^6
"DATA",169.3,98743,1,0)
^169.32^2^2
"DATA",169.3,98743,1,1,0)
FAB M2, NOS
"DATA",169.3,98743,1,2,0)
LEUKEMIA
"DATA",169.3,98753,0)
CHRONIC MYELOGENOUS LEUKEMIA, BCR/ABL +^9875/3^^^
"DATA",169.3,98753,1,0)
^169.32^6^6
"DATA",169.3,98753,1,1,0)
CHRONIC MYELOGENOUS LEUK, PHILA CHROMOSOME +
"DATA",169.3,98753,1,2,0)
CHRONIC MYELOGENOUS LEUKEMIA
"DATA",169.3,98753,1,3,0)
CHRONIC GRANULOCYTIC LEUK, PHILA CHROMOSOME +
"DATA",169.3,98753,1,4,0)
CHRONIC GRANULOCYTIC LEUKEMIA
"DATA",169.3,98753,1,5,0)
CHRONIC GRANULOCYTIC LEUKEMIA, BCR/ABL
"DATA",169.3,98753,1,6,0)
LEUKEMIA
"DATA",169.3,98763,0)
ATYPICAL CML, BCR/ABL NEGATIVE ^9876/3^^^
"DATA",169.3,98763,1,0)
^169.32^2^2
"DATA",169.3,98763,1,1,0)
ATYPICAL CML, PHILA CHROMOSOME (PH1) NEGATIVE
"DATA",169.3,98763,1,2,0)
LEUKEMIA
"DATA",169.3,98913,0)
ACUTE MONOCYTIC LEUKEMIA^9891/3^^^^^^6
"DATA",169.3,98913,1,0)
^169.32^4^4
"DATA",169.3,98913,1,1,0)
ACUTE MONOBLASTIC LEUKEMIA
"DATA",169.3,98913,1,2,0)
MOMBLASTIC LEUKEMIA, NOS
"DATA",169.3,98913,1,3,0)
FAB M5
"DATA",169.3,98913,1,4,0)
LEUKEMIA
"DATA",169.3,98953,0)
ACUTE MYELOID LEUK W MULTILINEAGE DYSPLASIA^9895/3^^^
"DATA",169.3,98953,1,0)
^169.32^3^3
"DATA",169.3,98953,1,1,0)
ACUTE MYELOID LEUK W PRI MYELODYSPLAST SYN
"DATA",169.3,98953,1,2,0)
ACUTE MYELOID LEUK W/O PRI MYELODYSPLAST SYN
"DATA",169.3,98953,1,3,0)
LEUKEMIA
"DATA",169.3,98963,0)
ACUTE MYELOID LEUKEMIA^9896/3^^^
"DATA",169.3,98963,1,0)
^169.32^4^4
"DATA",169.3,98963,1,1,0)
ACUTE MYELOID LEUKEMIA, AML1(CBF-ALPHA)/ETO
"DATA",169.3,98963,1,2,0)
FAB M2, T(8;21)(Q22;Q22)
"DATA",169.3,98963,1,3,0)
FAB M2, AML1(CBF-ALPHA)/ETO
"DATA",169.3,98963,1,4,0)
LEUKEMIA
"DATA",169.3,98973,0)
ACUTE MYELOID LEUKEMIA, 11Q23 ABNORMALITIES^9897/3^^^
"DATA",169.3,98973,1,0)
^169.32^2^2
"DATA",169.3,98973,1,1,0)
ACUTE MYELOID LEUKEMIA, MLL
"DATA",169.3,98973,1,2,0)
LEUKEMIA
"DATA",169.3,98983,0)
MYELOID LEUKEMIA ASSOCIATED WITH DOWN SYNDROME^9898/3
"DATA",169.3,98983,1,0)
^169.32^1^1
"DATA",169.3,98983,1,1,0)
LEUKEMIA
"DATA",169.3,99103,0)
ACUTE MEGAKARYOBLASTIC LEUKEMIA^9910/3^^^6742^67421^^6
"DATA",169.3,99103,1,0)
^169.32^5^3
"DATA",169.3,99103,1,1,0)
MEGAKARYOCYTIC LEUKEMIA
"DATA",169.3,99103,1,4,0)
FAB M7
"DATA",169.3,99103,1,5,0)
LEUKEMIA
"DATA",169.3,99113,0)
ACUTE MYELOID LEUKEMIA (MEGAKARYOBLASTIC) WITH T(1;22)(P13;Q13); RBM15-MKL1^9911/3
"DATA",169.3,99113,1,0)
^169.32^1^1
"DATA",169.3,99113,1,1,0)
LEUKEMIA
"DATA",169.3,99203,0)
THERAPY-RELATED ACUTE MYELOID LEUKEMIA, NOS^9920/3^^^^^^6
"DATA",169.3,99203,1,0)
^169.32^3^3
"DATA",169.3,99203,1,1,0)
THERAPY-RELATED AML, ALKYLATING AGENT RELATED
"DATA",169.3,99203,1,2,0)
THERAPY-RELATED AML, EPIPODOPHYLLOTOXIN-REL
"DATA",169.3,99203,1,3,0)
LEUKEMIA
"DATA",169.3,99303,0)
MYELOID SARCOMA^9930/3^^^^^^5
"DATA",169.3,99303,1,0)
^169.32^3^3
"DATA",169.3,99303,1,1,0)
GRANULOCYTIC SARCOMA
"DATA",169.3,99303,1,2,0)
CHLOROMA
"DATA",169.3,99303,1,3,0)
LEUKEMIA
"DATA",169.3,99313,0)
ACUTE PANMYELOSIS WITH MYELOFIBROSIS^9931/3^^^6742^67421^^6
"DATA",169.3,99313,1,0)
^169.32^5^5
"DATA",169.3,99313,1,1,0)
ACUTE PANMYELOSIS, NOS
"DATA",169.3,99313,1,2,0)
ACUTE MYELOFIBROSIS
"DATA",169.3,99313,1,3,0)
ACUTE MYELOSCLEROSIS, NOS
"DATA",169.3,99313,1,4,0)
MALIGNANT MYELOSCLEROSIS
"DATA",169.3,99313,1,5,0)
LEUKEMIA
"DATA",169.3,99403,0)
HAIRY CELL LEUKEMIA^9940/3^^^6742^67421^^6
"DATA",169.3,99403,1,0)
^169.32^3^3
"DATA",169.3,99403,1,1,0)
HAIRY CELL LEUKEMIA VARIANT
"DATA",169.3,99403,1,2,0)
LEUKEMIC RETICULOENDOTHELIOSIS
"DATA",169.3,99403,1,3,0)
LEUKEMIA
"DATA",169.3,99453,0)
CHRONIC MYELOMONOCYTIC LEUKEMIA, NOS^9945/3^^^
"DATA",169.3,99453,1,0)
^169.32^4^4
"DATA",169.3,99453,1,1,0)
CHRONIC MYELOMONOCYTIC LEUKEMIA, TYPE II
"DATA",169.3,99453,1,2,0)
CHRONIC MYELOMONOCYTIC LEUK IN TRANSFORMATION
"DATA",169.3,99453,1,3,0)
CHRONIC MYELOMONOCYTIC LEUKEMIA, TYPE I
"DATA",169.3,99453,1,4,0)
LEUKEMIA
"DATA",169.3,99463,0)
JUVENILE MYELOMONOCYTIC LEUKEMIA^9946/3^^^
"DATA",169.3,99463,1,0)
^169.32^2^2
"DATA",169.3,99463,1,1,0)
JUVENILE CHRONIC MYELOMONOCYTIC LEUKEMIA
"DATA",169.3,99463,1,2,0)
LEUKEMIA
"DATA",169.3,99483,0)
AGGRESSIVE NK-CELL LEUKEMIA^9948/3^^^
"DATA",169.3,99483,1,0)
^169.32^1^1
"DATA",169.3,99483,1,1,0)
LEUKEMIA
"DATA",169.3,99503,0)
POLYCYTHEMIA VERA^9950/3^^^^^^6
"DATA",169.3,99503,1,0)
^169.32^3^3
"DATA",169.3,99503,1,1,0)
POLYCYTHEMIA RUBRA VERA
"DATA",169.3,99503,1,2,0)
PROLIFERATIVE POLYCYTHEMIA
"DATA",169.3,99503,1,3,0)
CHRONIC ERYTHREMIA
"DATA",169.3,99603,0)
CHRONIC MYELOPROLIFERATIVE DISEASE, NOS^9960/3^^^^^^6
"DATA",169.3,99603,1,0)
^169.32^1^1
"DATA",169.3,99603,1,1,0)
CHRONIC MYELOPROLIFERATIVE DISORDER
"DATA",169.3,99613,0)
MYELOSCLEROSIS WITH MYELOID METAPLASIA^9961/3^^^^^^6
"DATA",169.3,99613,1,0)
^169.32^5^5
"DATA",169.3,99613,1,1,0)
MEGAKARYOCYTIC MYELOSCLEROSIS
"DATA",169.3,99613,1,2,0)
MYELOFIBROSIS WITH MYELOID METAPLASIA
"DATA",169.3,99613,1,3,0)
MYELOFIBROSIS OF MYELOPROLIFERATIVE DISEASE
"DATA",169.3,99613,1,4,0)
CHRONIC IDIOPATHIC MYELOFIBROSIS
"DATA",169.3,99613,1,5,0)
AGNOGENIC MYELOID METAPLASIA
"DATA",169.3,99623,0)
ESSENTIAL THROMBOCYTHEMIA^9962/3^^^^^^6
"DATA",169.3,99623,1,0)
^169.32^3^3
"DATA",169.3,99623,1,1,0)
IDIOPATHIC THROMBOCYTHEMIA
"DATA",169.3,99623,1,2,0)
ESSENTIAL HEMORRHAGIC THROMBOCYTHEMIA
"DATA",169.3,99623,1,3,0)
IDIOPATHIC HEMORRHAGIC THROMBOCYTHEMIA
"DATA",169.3,99633,0)
CHRONIC NEUTROPHILIC LEUKEMIA^9963/3^^^
"DATA",169.3,99643,0)
HYPEREOSINOPHILIC SYNDROME^9964/3^^^
"DATA",169.3,99643,1,0)
^169.32^1^1
"DATA",169.3,99643,1,1,0)
CHRONIC EOSINOPHILIC LEUKEMIA
"DATA",169.3,99653,0)
MYELOID AND LYMPHOID NEOPLASMS WITH PDGFRB REARRANGEMENT^9965/3
"DATA",169.3,99663,0)
MYELOID AND LYMPHOID NEOPLASMS WITH PDGFRB ARRANGEMENT^9966/3
"DATA",169.3,99673,0)
MYELOID AND LYMPHOID NEOPLASM WITH FGFR1 ABNORMALITIES^9967/3
"DATA",169.3,99701,0)
LYMPHOPROLIFERATIVE DISORDER, NOS^9970/1^^^^^^1
"DATA",169.3,99701,1,0)
^169.32^1^1
"DATA",169.3,99701,1,1,0)
LYMPHOPROLIFERATIVE DISEASE, NOS
"DATA",169.3,99713,0)
POLYMORPHIC PTLD^9971/3
"DATA",169.3,99751,0)
MYELOPROLIFERATIVE DISEASE, NOS^9975/1^^^
"DATA",169.3,99753,0)
MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASM, UNCLASSIFIABLE^9975/3
"DATA",169.3,99803,0)
REFRACTORY ANEMIA^9980/3^^^^^^6
"DATA",169.3,99803,1,0)
^169.32^1^1
"DATA",169.3,99803,1,1,0)
REFRACTORY ANEMIA WITHOUT SIDEROBLASTS
"DATA",169.3,99823,0)
REFRACTORY ANEMIA WITH SIDEROBLASTS^9982/3^^^^^^6
"DATA",169.3,99823,1,0)
^169.32^2^2
"DATA",169.3,99823,1,1,0)
REFRACTORY ANEMIA WITH RINGED SIDEROBLASTS
"DATA",169.3,99823,1,2,0)
RARS
"DATA",169.3,99833,0)
REFRACTORY ANEMIA WITH EXCESS BLASTS^9983/3^^^^^^6
"DATA",169.3,99833,1,0)
^169.32^3^3
"DATA",169.3,99833,1,1,0)
RAEB
"DATA",169.3,99833,1,2,0)
RAEB I
"DATA",169.3,99833,1,3,0)
RAEB II
"DATA",169.3,99843,0)
REFRACTORY ANEMIA W EXCESS BLASTS IN TRANS^9984/3^^^^^^6
"DATA",169.3,99843,1,0)
^169.32^1^1
"DATA",169.3,99843,1,1,0)
RAEB-T
"DATA",169.3,99853,0)
REFRACTORY CYTOPENIA W MULTILINEAGE DYSPLASIA^9985/3^^^
"DATA",169.3,99863,0)
MYELODYSPLASTIC SYNDROME W 5Q DELETION SYND^9986/3^^^
"DATA",169.3,99873,0)
THERAPY-RELATED MYELODYSPLASTIC SYNDROME, NOS^9987/3^^^
"DATA",169.3,99873,1,0)
^169.32^2^2
"DATA",169.3,99873,1,1,0)
TX-REL MYELODYSPLASTIC SYN/ALKYLATING AGENT
"DATA",169.3,99873,1,2,0)
TX-REL MYELODYSPLASTIC SYN/EPIDOPOPHYLLOTOXIN
"DATA",169.3,99893,0)
MYELODYSPLASTIC SYNDROME, NOS^9989/3^^^
"DATA",169.3,99893,1,0)
^169.32^2^2
"DATA",169.3,99893,1,1,0)
PRELEUKEMIA
"DATA",169.3,99893,1,2,0)
PRELEUKEMIC SYNDROME
"DATA",169.3,99913,0)
REFRACTORY NEUTROPENIA^9991/3
"DATA",169.3,99923,0)
REFRACTORY THROMBOCYTOPENIA^9992/3
"DATA",169.3,99999,0)
UNKNOWN^9999/9^^^^^^9
"FIA",165.5)
ONCOLOGY PRIMARY
"FIA",165.5,0)
^ONCO(165.5,
"FIA",165.5,0,0)
165.5IsP
"FIA",165.5,0,1)
y^y^p^^^^n^^n
"FIA",165.5,0,10)

"FIA",165.5,0,11)

"FIA",165.5,0,"RLRO")

"FIA",165.5,0,"VR")
2.2^ONC
"FIA",165.5,165.5)
1
"FIA",165.5,165.5,24.3)

"FIA",165.5,165.5,24.4)

"FIA",165.5,165.5,24.5)

"FIA",165.5,165.5,285)

"FIA",165.5,165.5,286)

"FIA",165.5,165.5285)
0
"FIA",165.5,165.5286)
0
"FIA",169.3)
ICD-O-3 MORPHOLOGY
"FIA",169.3,0)
^ONCO(169.3,
"FIA",169.3,0,0)
169.3
"FIA",169.3,0,1)
y^y^f^^n^^y^r^n
"FIA",169.3,0,10)

"FIA",169.3,0,11)

"FIA",169.3,0,"RLRO")

"FIA",169.3,0,"VR")
2.2^ONC
"FIA",169.3,169.3)
0
"FIA",169.3,169.32)
0
"INI")
ONCUPLPR
"INIT")
ONC2PS09
"KRN",.402,1256,-1)
0^1
"KRN",.402,1256,0)
ONCO ABSTRACT-I^3180322.1446^^165.5^^^3180503
"KRN",.402,1256,"%D",0)
^.4021^2^2^3140508^^^^
"KRN",.402,1256,"%D",1,0)
Template for complete abstract for fields in Primary file: data relevant
"KRN",.402,1256,"%D",2,0)
to particular cancer only as opposed to specific to Patient.
"KRN",.402,1256,"DR",1,165.5)
@0;D MEN^ONCOAIP;.01;.05;.06;.07;S Y="@0";@1;D PAT^ONCOAIP;.03//^S X=$P($G(^ONCO(160.19,IIN,0)),U,2);S FACPNT=$P($G(^ONCO(165.5,DA,0)),U,3) D FNPI^ONCNPI;11;8;8.2;9;8.1;16;10;147//^S X="000000";
"KRN",.402,1256,"DR",1,165.5,1)
I $P($G(^ONCO(165.5,DA,0)),U,16)'="",$P($G(^ONCO(165.5,DA,0)),U,16)<3070000 S Y=2.1;2.2;S PHYPNT=$P($G(^ONCO(165.5,DA,0)),U,13) D PNPI^ONCNPI;2.1;S PHYPNT=$P($G(^ONCO(165.5,DA,0)),U,12) D PNPI^ONCNPI;2;
"KRN",.402,1256,"DR",1,165.5,2)
S PHYPNT=$P($G(^ONCO(165.5,DA,0)),U,11) D PNPI^ONCNPI;2.3;S PHYPNT=$P($G(^ONCO(165.5,DA,0)),U,14) D PNPI^ONCNPI;2.4;S PHYPNT=$P($G(^ONCO(165.5,DA,0)),U,15) D PNPI^ONCNPI;18;1.2;W ! D PAUSE^ONCOPA2A I PAUSE=U S Y="@0";
"KRN",.402,1256,"DR",1,165.5,3)
D PHCDSP^ONCPHC;148//^S X=PHCDEF;I X=1 S Y="@11";148.1////@;148.2////@;148.3////@;148.4////@;S Y="@12";@11;W !;148.1//^S X=PHCDEF(1);148.2//^S X=PHCDEF(2);148.3//^S X=PHCDEF(3);148.4//^S X=PHCDEF(4);@12;
"KRN",.402,1256,"DR",1,165.5,4)
W ! D PAUSE^ONCOPA2A I PAUSE=U S Y="@0";S Y=$S(ONCOANS="A":"@2",1:"@0");@2;D CAN^ONCOAIP;.04;S COC=$E($$GET1^DIQ(165.5,DA,.04,"E"),1,2);
"KRN",.402,1256,"DR",1,165.5,5)
I (+COC<10)!(+COC>14) S $P(^ONCO(165.5,DA,2.2),U,4)="",$P(^ONCO(165.5,DA,2.2),U,5)="",$P(^ONCO(165.5,DA,2.2),U,6)="",Y="@20";171;172;173;@20;I COC="00" S RFDEF="NONE" S Y=6;
"KRN",.402,1256,"DR",1,165.5,6)
I (COC=10)!(COC=11)!(COC=12)!(COC=13)!(COC=14) S RFDEF="NONE",TFDEF="NONE";6//^S X=$G(RFDEF);K RFDEF;S FACPNT=$P($G(^ONCO(165.5,DA,0)),U,18) D FNPI^ONCNPI;I (COC=20)!(COC=21)!(COC=22) S TFDEF="NONE";7//^S X=$G(TFDEF);K TFDEF;
"KRN",.402,1256,"DR",1,165.5,7)
S FACPNT=$P($G(^ONCO(165.5,DA,0)),U,19) D FNPI^ONCNPI;237;S FEEB=$$GET1^DIQ(165.5,DA,237,"I");I FEEB'=1 S Y="@155";237.1;@155;155;3;I $P($G(^ONCO(165.5,DA,0)),U,16)<3100000 S Y="@14";233;@14;
"KRN",.402,1256,"DR",1,165.5,8)
I $P($G(^ONCO(165.5,DA,0)),U,16)<3070000!($P($G(^ONCO(165.5,DA,0)),U,16)>3121231) S Y="@15";159;I X=0 S $P(^ONCO(165.5,DA,24),U,13)="8888888" W !,"DATE OF CONCLUSIVE DX: 88/88/8888" S Y="@15";
"KRN",.402,1256,"DR",1,165.5,9)
I X=1 S $P(^ONCO(165.5,DA,24),U,13)="0000000" W !,"DATE OF CONCLUSIVE DX: 00/00/0000" S Y="@15";I X=9 S $P(^ONCO(165.5,DA,24),U,13)="9999999" W !,"DATE OF CONCLUSIVE DX: 99/99/9999" S Y="@15";193;@15;
"KRN",.402,1256,"DR",1,165.5,10)
I (COC="00")!(COC=10)!(COC=11)!(COC=12)!(COC=13)!(COC=14) S DFDEF=$E(RH,1,30);5//^S X=$G(DFDEF);K DFDEF;238;20;S PS=X;D PAIR^ONCOAIP;S Y=$$TOP^ONCOAIT;21.5;S Y=100;21.51;S Y=100;21.52;100;28;
"KRN",.402,1256,"DR",1,165.5,11)
I $P($G(^ONCO(165.5,DA,0)),U,16)>3001231 S Y=22.3;22;D DEFH3^ONCOHICD;22.3//^S X=$G(H3DEF);K H3DEF;W !,"HISTOLOGY CODE: ",$$GET1^DIQ(165.5,D0,22.1);D HISTXT^ONCOAIP;S X=X;101;D ^ONCSUBS;240;@623;I $G(TOP)'=67619 S Y=24;
"KRN",.402,1256,"DR",1,165.5,12)
I $G(TOP)=67619,$P($G(^ONCO(165.5,D0,0)),U,16)>3101231 S $P(^ONCO(165.5,D0,"CS"),U,8)=988;623;250;684;96;102;I X=9 S Y="@156";156;S Y=24;@156;156////0000000;W !,"DRE DATE: 00/00/0000";28;24;24.3;24.4;24.5;
"KRN",.402,1256,"DR",1,165.5,13)
I $P($G(^ONCO(165.5,DA,0)),U,16)<3100000 S Y="@157";24.1;24.2;S:($E($$HIST^ONCFUNC(D0),1,4)'=8935)&($E($$HIST^ONCFUNC(D0),1,4)'=8936) Y="@157";239;@157;
"KRN",.402,1256,"DR",1,165.5,14)
I $P($G(^ONCO(165.5,DA,0)),U,16)<3070000!($P($G(^ONCO(165.5,DA,0)),U,16)>3121231) S Y=83;I ($P($G(^ONCO(165.5,D0,2)),U,1)=67809)!($$LEUKEMIA^ONCOAIP2(D0))!($$LYMPHOMA^ONCFUNC(D0)) D NA^ONCMPH;194;D MTRAOP^ONCMPH;195;196;83;26;
"KRN",.402,1256,"DR",1,165.5,15)
I ($$GET1^DIQ(165.5,D0,.01,"E")'="LIVER")&($G(TOP)'=67220) S Y="@251";1010;@251;I $P($G(^ONCO(165.5,DA,0)),U,16)>3021231 S Y="@27";D TMARKER^ONCOU55 I TM1=0 S Y="@21";D TM^ONCOTM(D0,1);@2510;I $G(TM2)=0 S Y="@22";D TM^ONCOTM(D0,2);
"KRN",.402,1256,"DR",1,165.5,16)
@2520;I $G(TM3)=0 S Y="@23";D TM^ONCOTM(D0,3);@2530;S Y="@27";@21;25.1///9;W !,"TUMOR MARKER 1: Unknown or no information";@22;25.2///9;W !,"TUMOR MARKER 2: Unknown or no information";@23;25.3///9;
"KRN",.402,1256,"DR",1,165.5,17)
W !,"TUMOR MARKER 3: Unknown or no information";S Y="@27";25.1;25.2;25.3;@27;120;I X=0 S Y="@1210";I X=9 S Y="@1219";121;S Y="@28";@1210;121////0000000;W !,"DATE OF CANCER CONF: 00/00/0000";S Y="@28";@1219;121////9999999;
"KRN",.402,1256,"DR",1,165.5,18)
W !,"DATE OF CANCER CONF: 99/99/9999";@28;21;W ! D PAUSE^ONCOPA2A I PAUSE=U S Y="@0";I (+COC<10)!(+COC>14) S Y="@105";S PS=$P($G(^ONCO(165.5,D0,2)),U,1);I $E($G(PS),3,4)=34 S Y="@174";
"KRN",.402,1256,"DR",1,165.5,19)
I ($E($G(PS),3,4)=18)!($G(PS)=67199)!($G(PS)=67209) S Y="@180";S Y="@105";@174;D ^ONCSYMP;174;I (X=0)!(X=9) S PIECE=18 D STUFF^ONCSYMP S Y=186;174.1;186;I (X=0)!(X=9) S PIECE=33 D STUFF^ONCSYMP S Y=187;186.1;187;
"KRN",.402,1256,"DR",1,165.5,20)
I (X=0)!(X=9) S PIECE=35 D STUFF^ONCSYMP S Y=188;187.1;188;I (X=0)!(X=9) S PIECE=37 D STUFF^ONCSYMP S Y=189;188.1;189;I (X=0)!(X=9) S PIECE=39 D STUFF^ONCSYMP S Y=190;189.1;190;175;I (X=0)!(X=9) S PIECE=19 D STUFF^ONCSYMP S Y=176;
"KRN",.402,1256,"DR",1,165.5,21)
175.1;176;I (X=0)!(X=9) S PIECE=20 D STUFF^ONCSYMP S Y=177;176.1;177;I (X=0)!(X=9) S PIECE=21 D STUFF^ONCSYMP S Y=178;177.1;178;I (X=0)!(X=9) S PIECE=22 D STUFF^ONCSYMP S Y=179;178.1;179;
"KRN",.402,1256,"DR",1,165.5,22)
I (X=0)!(X=9) S PIECE=23 D STUFF^ONCSYMP S Y="@105";179.1;S Y="@105";@180;D COLON^ONCSYMP;191;711;712;809;713;192;180;I (X=0)!(X=9) S PIECE=24 D STUFF^ONCSYMP S Y=181;180.1;181;I (X=0)!(X=9) S PIECE=25 D STUFF^ONCSYMP S Y=182;
"KRN",.402,1256,"DR",1,165.5,23)
181.1;182;I (X=0)!(X=9) S PIECE=27 D STUFF^ONCSYMP S Y=183;182.1;183;I (X=0)!(X=9) S PIECE=28 D STUFF^ONCSYMP S Y=185;183.1;185;I (X=0)!(X=9) S PIECE=30 D STUFF^ONCSYMP S Y=184;185.1;184;
"KRN",.402,1256,"DR",1,165.5,24)
I (X=0)!(X=9) S PIECE=31 D STUFF^ONCSYMP S Y=179;184.1;179;I (X=0)!(X=9) S PIECE=23 D STUFF^ONCSYMP S Y="@105";179.1;@105;S SECTION="Cancer Identification" D SECTION^ONCOAIP;W !;104;S FLDNUM=104,NODE=10,LIMIT=1000 D ^ONCTEXT;W !;
"KRN",.402,1256,"DR",1,165.5,25)
105;S FLDNUM=105,NODE=11,LIMIT=1000 D ^ONCTEXT;W !;106;S FLDNUM=106,NODE=12,LIMIT=1000 D ^ONCTEXT;W !;116;S FLDNUM=116,NODE=22,LIMIT=1000 D ^ONCTEXT;W !;103;S FLDNUM=103,NODE=9,LIMIT=1000 D ^ONCTEXT;W !;107;
"KRN",.402,1256,"DR",1,165.5,26)
S FLDNUM=107,NODE=13,LIMIT=1000 D ^ONCTEXT;W !;285;S FLDNUM=285,NODE=22.1,LIMIT=1000 D ^ONCTEXT;W !;286;S FLDNUM=286,NODE=22.2,LIMIT=1000 D ^ONCTEXT;W !;S Y=$S(ONCOANS="A":"@3",1:"@0");@3;D EXT^ONCOAIP;@31;D MO^ONCOAIP2;41;
"KRN",.402,1256,"DR",1,165.5,27)
I $G(AWHFLG)=0 S Y=30 K AWHFLG;227;I $G(ONCSKP39)=1 S Y=39 K ONCSKP39;I $P($G(^ONCO(165.5,DA,0)),U,16)>3151231 S Y=29.4;29;I $P($G(^ONCO(165.5,DA,0)),U,16)<3160101 S Y="@295";29.4;29.5;29.3;@295;
"KRN",.402,1256,"DR",1,165.5,28)
I $P($G(^ONCO(165.5,DA,0)),U,16)<3040000 S Y=30;29.2;30;I $P($G(^ONCO(165.5,DA,0)),U,16)<3040000 S Y="@305";30.2;29.1;@305;D PGPE^ONCOAIP2;30.1;
"KRN",.402,1256,"DR",1,165.5,29)
I X=99,$P($G(^ONCO(165.5,D0,0)),U,16)>3031231 S $P(^ONCO(165.5,D0,"CS"),U,7)=970 F SSF=3,4,5 S $P(^ONCO(165.5,D0,"CS2"),U,SSF)=998;@231;D LN^ONCOAIP2;31;S L=X;I $$LYMPHOMA^ONCFUNC(D0) S $P(^ONCO(165.5,D0,2),U,12,13)="99^99";S X=X;
"KRN",.402,1256,"DR",1,165.5,30)
I $P($G(^ONCO(165.5,DA,0)),U,16)<3040000 S Y=33;31.1;32.1;33;I X=0 S Y="@24";I X=99 S Y="@25";32;S Y="@26";@24;32////98;W !,"REGIONAL LYMPH NODES POSITIVE: No nodes were examined";S Y="@26";@25;32////99;
"KRN",.402,1256,"DR",1,165.5,31)
W !,"REGIONAL LYMPH NODES POSITIVE: Unknown if nodes +, NA, not stated";@26;35;I (X'="")&(X'=7) S Y="@310";34;S:X=0 Y="@32";34.1;S:X=0 Y="@33";34.2;S Y="@34";@310;34////0;W !,"SITE OF DISTANT METASTASIS #1: None";@32;34.1////0;
"KRN",.402,1256,"DR",1,165.5,32)
W !,"SITE OF DISTANT METASTASIS #2: None";@33;34.2////0;W !,"SITE OF DISTANT METASTASIS #3: None";@34;I $P($G(^ONCO(165.5,DA,0)),U,16)<3040000 S Y="@341";34.3;
"KRN",.402,1256,"DR",1,165.5,33)
I $P($G(^ONCO(165.5,DA,0)),U,16)<3151231,X="00" S $P(^ONCO(165.5,DA,"CS1"),U,20)=0 W !,"METS AT DX-BONE:  None";I $P($G(^ONCO(165.5,DA,0)),U,16)<3151231,X=98 S $P(^ONCO(165.5,DA,"CS1"),U,20)=8 W !,"METS AT DX-BONE:  NA";
"KRN",.402,1256,"DR",1,165.5,34)
I $P($G(^ONCO(165.5,DA,0)),U,16)<3151231,X="00" S $P(^ONCO(165.5,DA,"CS1"),U,21)=0 W !,"METS AT DX-BRAIN: None";I $P($G(^ONCO(165.5,DA,0)),U,16)<3151231,X=98 S $P(^ONCO(165.5,DA,"CS1"),U,21)=8 W !,"METS AT DX-BRAIN: NA";
"KRN",.402,1256,"DR",1,165.5,35)
I $P($G(^ONCO(165.5,DA,0)),U,16)<3151231,X="00" S $P(^ONCO(165.5,DA,"CS1"),U,22)=0 W !,"METS AT DX-LIVER: None";I $P($G(^ONCO(165.5,DA,0)),U,16)<3151231,X=98 S $P(^ONCO(165.5,DA,"CS1"),U,22)=8 W !,"METS AT DX-LIVER: NA";
"KRN",.402,1256,"DR",1,165.5,36)
I $P($G(^ONCO(165.5,DA,0)),U,16)<3151231,X="00" S $P(^ONCO(165.5,DA,"CS1"),U,23)=0 W !,"METS AT DX-LUNG:  None";I $P($G(^ONCO(165.5,DA,0)),U,16)<3151231,X=98 S $P(^ONCO(165.5,DA,"CS1"),U,23)=8 W !,"METS AT DX-LUNG:  NA";
"KRN",.402,1256,"DR",1,165.5,37)
I $P($G(^ONCO(165.5,DA,0)),U,16)<3151231,X="00" S $P(^ONCO(165.5,DA,"CS1"),U,24)=0 W !,"METS AT DX-DISTANT LN:  None";
"KRN",.402,1256,"DR",1,165.5,38)
I $P($G(^ONCO(165.5,DA,0)),U,16)<3151231,X=98 S $P(^ONCO(165.5,DA,"CS1"),U,24)=8 W !,"METS AT DX-DISTANT LN:  NA";
"KRN",.402,1256,"DR",1,165.5,39)
I $P($G(^ONCO(165.5,DA,0)),U,16)<3151231,X="00" S $P(^ONCO(165.5,DA,"CS1"),U,25)=0 W !,"METS AT DX-OTHER:  None" S Y=34.4;
"KRN",.402,1256,"DR",1,165.5,40)
I $P($G(^ONCO(165.5,DA,0)),U,16)<3151231,X=98 S $P(^ONCO(165.5,DA,"CS1"),U,25)=8 W !,"METS AT DX-OTHER:  NA" S Y=34.4;34.31;34.32;34.33;34.34;34.35;34.36;34.4;@341;D ^ONCOTN;@69;I $P($G(^ONCO(165.5,DA,0)),U,16)>3069999 S Y="@300";
"KRN",.402,1256,"DR",1,165.5,41)
69;@300;D BLOOD^ONCOAIP2;30.5;@301;W !;S:$E($$HIST^ONCFUNC(D0),1,3)'=951 Y=37.1;69.1;37.1;D CN2^ONCOTN;37.2;37.3;I '$$GTT^ONCOU55(D0) S Y="@38";134;@38;I '$$T^ONCOU55(D0) S Y="@39";136;@39;38;241;19;280;280.1;280.2;W !;69.4;85;
"KRN",.402,1256,"DR",1,165.5,42)
D CN4^ONCOTN;86;87;I '$$GTT^ONCOU55(D0) S Y="@311";135;@311;I '$$T^ONCOU55(D0) S Y="@312";136;@312;88;242;89;W !;149;S Y="@313";@376;D CTNM88^ONCOTN;38;241;19;W !;D PTNM88^ONCOTN;88;242;89;W !;@313;39;W !;65;S:X="" Y="@82";66;@82;
"KRN",.402,1256,"DR",1,165.5,43)
248;249;W !;25;S X=X;44;W ! D PAUSE^ONCOPA2A I PAUSE=U S Y="@0";I $P($G(^ONCO(165.5,DA,0)),U,16)<3040000 S Y="@399";@292;D ^ONCCS2;D ^ONCPCS;29.2;30.2;29.1;31.1;32.1;33;I X=0 S Y="@241";I X=99 S Y="@252";32;S Y="@261";@241;
"KRN",.402,1256,"DR",1,165.5,44)
32////98;W !,"REGIONAL LYMPH NODES POSITIVE: No nodes were examined";S Y="@261";@252;32////99;W !,"REGIONAL LYMPH NODES POSITIVE: Unknown if nodes +, NA, not stated";@261;34.3;
"KRN",.402,1256,"DR",1,165.5,45)
I $P($G(^ONCO(165.5,DA,0)),U,16)<3151231,X="00" S $P(^ONCO(165.5,DA,"CS1"),U,20)=0 W !,"METS AT DX-BONE:  None";I $P($G(^ONCO(165.5,DA,0)),U,16)<3151231,X=98 S $P(^ONCO(165.5,DA,"CS1"),U,20)=8 W !,"METS AT DX-BONE:  NA";
"KRN",.402,1256,"DR",1,165.5,46)
I $P($G(^ONCO(165.5,DA,0)),U,16)<3151231,X="00" S $P(^ONCO(165.5,DA,"CS1"),U,21)=0 W !,"METS AT DX-BRAIN: None";I $P($G(^ONCO(165.5,DA,0)),U,16)<3151231,X=98 S $P(^ONCO(165.5,DA,"CS1"),U,21)=8 W !,"METS AT DX-BRAIN: NA";
"KRN",.402,1256,"DR",1,165.5,47)
I $P($G(^ONCO(165.5,DA,0)),U,16)<3151231,X="00" S $P(^ONCO(165.5,DA,"CS1"),U,22)=0 W !,"METS AT DX-LIVER: None";I $P($G(^ONCO(165.5,DA,0)),U,16)<3151231,X=98 S $P(^ONCO(165.5,DA,"CS1"),U,22)=8 W !,"METS AT DX-LIVER: NA";
"KRN",.402,1256,"DR",1,165.5,48)
I $P($G(^ONCO(165.5,DA,0)),U,16)<3151231,X="00" S $P(^ONCO(165.5,DA,"CS1"),U,23)=0 W !,"METS AT DX-LUNG:  None";I $P($G(^ONCO(165.5,DA,0)),U,16)<3151231,X=98 S $P(^ONCO(165.5,DA,"CS1"),U,23)=8 W !,"METS AT DX-LUNG:  NA";
"KRN",.402,1256,"DR",1,165.5,49)
I $P($G(^ONCO(165.5,DA,0)),U,16)<3151231,X="00" S $P(^ONCO(165.5,DA,"CS1"),U,24)=0 W !,"METS AT DX-DISTANT LN:  None";
"KRN",.402,1256,"DR",1,165.5,50)
I $P($G(^ONCO(165.5,DA,0)),U,16)<3151231,X=98 S $P(^ONCO(165.5,DA,"CS1"),U,24)=8 W !,"METS AT DX-DISTANT LN:  NA";
"KRN",.402,1256,"DR",1,165.5,51)
I $P($G(^ONCO(165.5,DA,0)),U,16)<3151231,X="00" S $P(^ONCO(165.5,DA,"CS1"),U,25)=0 W !,"METS AT DX-OTHER:  None" S Y="@344";
"KRN",.402,1256,"DR",1,165.5,52)
I $P($G(^ONCO(165.5,DA,0)),U,16)<3151231,X=98 S $P(^ONCO(165.5,DA,"CS1"),U,25)=8 W !,"METS AT DX-OTHER:  NA" S Y="@344";34.31;34.32;34.33;34.34;34.35;34.36;@344;34.4;44.1;44.2;44.3;44.4;44.5;44.6;44.7;44.8;44.9;44.101;44.11;44.12;
"KRN",.402,1256,"DR",1,165.5,53)
44.13;44.14;44.15;44.16;44.17;44.18;44.19;44.201;44.21;44.22;44.23;44.24;44.25;I $P($G(^ONCO(165.5,DA,"CS3")),U,2)'=1 S Y="@398";247;@398;D ^ONCCS;D PAUSE^ONCOPA2A I PAUSE=U S Y="@0";@399;S Y=$S(ONCOANS="A":"@4",1:"@0");@4;
"KRN",.402,1256,"DR",1,165.5,54)
D NCDS^ONCPTX;S X=X;58.1;I X="" S TXNUL=1,$P(^ONCO(165.5,D0,3),U,31)="",Y="@35";I (X=0)!(X="00") D NCDS^ONCNTX S Y="@35";I (X=9)!(X="09") D NCDS^ONCUTX S Y="@35";58.3;@35;58.4;I X="" S $P(^ONCO(165.5,D0,3.1),U,6)="",Y="@36";
"KRN",.402,1256,"DR",1,165.5,55)
I (X=0)!(X="00") D NCDSATF^ONCNTX1 S Y="@36";I (X=9)!(X="09") D NCDSATF^ONCUTX1 S Y="@36";58.5;@36;W !;281;228;229;230;231;232;245;W !;I $P($G(^ONCO(165.5,DA,0)),U,16)<3100000 S Y="@124";235;I (X=1)!(X=9) D DNTDEL^ONCOCC S Y="@41";
"KRN",.402,1256,"DR",1,165.5,56)
@124;124;I (X="0000000")!(X=9999999) S Y="@41";I X="" D CHKTS^ONCODSR;D NTX^ONCOAIP;@41;I $P($G(^ONCO(165.5,DA,0)),U,16)>3021231 S Y="@429";D ROADS^ONCPTX;58.2;D SPSR^ONCATF;I X="" S TXNUL=1,$P(^ONCO(165.5,D0,3),U,38)="",Y="@426";
"KRN",.402,1256,"DR",1,165.5,57)
S X=X;S SPS=$P($G(^ONCO(165.5,D0,3)),U,38);I SPS=("00")!(SPS=1) D SURR^ONCNTX S TXNO=1,Y="@426";S TPX=$P($G(^ONCO(165.5,D0,2)),U,1);S SGRP=$P($G(^ONCO(164,TPX,0)),U,16);I $E(TPX,3,4)=77 S SGRP=67422;
"KRN",.402,1256,"DR",1,165.5,58)
I $G(^ONCO(164,SGRP,"SPS",SPS,0))[99 D SURR^ONCUTX S TXUNK=1 S Y="@426";D SATFDFR^ONCOCC;74;@426;D DSPSPSR^ONCATF;W !;50.2//^S X=$G(SPSDF);@427;W !;D CHKPRMR^ONCUTX1;138;D SCPR^ONCATF;S X=X;S SCOPE=$P($G(^ONCO(165.5,D0,3)),U,40);
"KRN",.402,1256,"DR",1,165.5,59)
I SCOPE="" S $P(^ONCO(165.5,D0,3),U,42)="",TXNUL=1,Y="@1381";I SCOPE=1 D NODER^ONCNTX S TXNO=1,Y="@1381";S TPX=$P($G(^ONCO(165.5,D0,2)),U,1) I TPX="" S Y="@428";S SGRP=$P($G(^ONCO(164,TPX,0)),U,16) I SGRP="" S Y="@428";
"KRN",.402,1256,"DR",1,165.5,60)
I $G(^ONCO(164,SGRP,"SC5",SCOPE,0))["Unknown" D NODER^ONCUTX S TXUNK=1,Y="@1381";140;D NUMND^ONCATF;@1381;D DSPSCPR^ONCATF;W !;D SCOPER^ONCOCC;138.1//^S X=$G(SCPDF);S X=X;S SCPATF=$P($G(^ONCO(165.5,D0,3.1)),U,9);
"KRN",.402,1256,"DR",1,165.5,61)
I SCPATF="" S $P(^ONCO(165.5,D0,3.1),U,11)="",Y="@139";I SCPATF=1 D NODATFR^ONCNTX1 S Y="@139";S TPX=$P($G(^ONCO(165.5,D0,2)),U,1) I TPX="" S Y="@428";S SGRP=$P($G(^ONCO(164,TPX,0)),U,16) I SGRP="" S Y="@428";
"KRN",.402,1256,"DR",1,165.5,62)
I $G(^ONCO(164,SGRP,"SC5",SCPATF,0))["Unknown" D NODATFR^ONCUTX1 S Y="@139";D NUMN^ONCOCC;140.1//^S X=$G(NUMDF);@139;W !;139;D SOSNR^ONCATF;S X=X;S SOSN=$P($G(^ONCO(165.5,D0,3)),U,41) I SOSN="" S TXNUL=1,Y="@1391";
"KRN",.402,1256,"DR",1,165.5,63)
I SOSN=1 D SOSNR^ONCNTX S TXNO=1,Y="@1391";S TPX=$P($G(^ONCO(165.5,D0,2)),U,1) I TPX="" S Y="@428";S SGRP=$P($G(^ONCO(164,TPX,0)),U,16) I SGRP="" S Y="@428";I $G(^ONCO(164,SGRP,"SO5",SOSN,0))["Unknown" S TXUNK=1;@1391;
"KRN",.402,1256,"DR",1,165.5,64)
D DSPSOSR^ONCATF;D SOSNR^ONCOCC;139.1//^S X=$G(SOSNDF);S X=X;@428;W ! D PAUSE^ONCOPA2A I PAUSE=U S Y="@0";@429;D FORDS^ONCPTX;S X=X;58.6;D SPS^ONCATF;I X="" S TXNUL=1,$P(^ONCO(165.5,D0,3.1),U,29)="",Y="@42";S X=X;
"KRN",.402,1256,"DR",1,165.5,65)
S SPS=$P($G(^ONCO(165.5,D0,3.1)),U,29);I SPS="00"!(SPS=1) D SUR^ONCNTX,SA^ONCNTX,SM^ONCNTX,DSD^ONCNTX S TXNO=1,Y="@42";S TPX=$P($G(^ONCO(165.5,D0,2)),U,1);S SGRP=$P($G(^ONCO(164,TPX,0)),U,16);
"KRN",.402,1256,"DR",1,165.5,66)
I $G(^ONCO(164,SGRP,"SPS",SPS,0))[99 D SUR^ONCUTX S TXUNK=1,Y="@42";50;435;14;D SPSDT^ONCATF;D SATFDEF^ONCOCC;59;@42;D DSPSPS^ONCATF;W !;58.7//^S X=$G(SPSDF);I X="" S $P(^ONCO(165.5,D0,3.1),U,8)="",Y="@43";S X=X;
"KRN",.402,1256,"DR",1,165.5,67)
S SPSATF=$P($G(^ONCO(165.5,D0,3.1)),U,30) I SPSATF="" S $P(^ONCO(165.5,D0,3.1),U,8)="",Y="@43";I SPSATF="00"!(SPSATF=1) D SURATF^ONCNTX1 S Y="@43";S TPX=$P($G(^ONCO(165.5,D0,2)),U,1) I TPX="" S Y="@44";
"KRN",.402,1256,"DR",1,165.5,68)
S SGRP=$P($G(^ONCO(164,TPX,0)),U,16) I SGRP="" S Y="@44";I $G(^ONCO(164,SGRP,"SPS",SPSATF,0))[99 D SURATF^ONCUTX1 S Y="@43";234;50.3//^S X=$G(SPSDTDF);I $P($G(^ONCO(165.5,DA,0)),U,16)<3100000 S Y="@43";@43;W !;D RFNS^ONCATF1;58;
"KRN",.402,1256,"DR",1,165.5,69)
@431;W !;D CHKPRMF^ONCUTX1;138.4;D SCP^ONCATF;S X=X;S SCOPE=$P($G(^ONCO(165.5,D0,3.1)),U,31) I SCOPE="" S $P(^ONCO(165.5,D0,3.1),U,22)="",$P(^ONCO(165.5,D0,3),U,42)="",TXNUL=1,Y="@45";I SCOPE=0 D NODE^ONCNTX S TXNO=1,Y="@45";
"KRN",.402,1256,"DR",1,165.5,70)
I SCOPE=9 D NODE^ONCUTX S TXUNK=1,Y="@45";138.2;D SCPDT^ONCATF;@45;D DSPSCP^ONCATF;W !;D SCOPE^ONCOCC;138.5//^S X=$G(SCPDF);S X=X;
"KRN",.402,1256,"DR",1,165.5,71)
S SCPATF=$P($G(^ONCO(165.5,D0,3.1)),U,32) I SCPATF="" S $P(^ONCO(165.5,D0,3.1),U,23)="",$P(^ONCO(165.5,D0,3.1),U,11)="",Y="@46";I SCPATF=0 D NODEATF^ONCNTX1 S Y="@46";I SCPATF=9 D NODEATF^ONCUTX1 S Y="@46";138.3//^S X=$G(SCPDTDF);
"KRN",.402,1256,"DR",1,165.5,72)
@46;W !;139.4;D SOSN^ONCATF;S X=X;S SOSN=$P($G(^ONCO(165.5,D0,3.1)),U,33) I SOSN="" S $P(^ONCO(165.5,D0,3.1),U,24)="",TXNUL=1,Y="@47";I SOSN=0 D SOSN^ONCNTX S TXNO=1,Y="@47";I SOSN=9 D SOSN^ONCUTX S TXUNK=1,Y="@47";139.2;
"KRN",.402,1256,"DR",1,165.5,73)
D SOSNDT^ONCATF;@47;S:(SOSN=3)!(SOSN=4) Y="@4725";139.6////0;139.7////0000000;W !!,"METS SITE RESECTED: 0";W !,"METS SITE RESECTED DATE: 00/00/0000";S Y="@475";@4725;139.6;139.7;@475;D DSPSOSN^ONCATF;W !;D SOSN^ONCOCC;
"KRN",.402,1256,"DR",1,165.5,74)
139.5//^S X=$G(SOSNDF);S X=X;S SOSNATF=$P($G(^ONCO(165.5,D0,3.1)),U,34) I SOSNATF="" S $P(^ONCO(165.5,D0,3.1),U,25)="",Y="@48";I SOSNATF=0 D SOSNATF^ONCNTX1 S Y="@48";I SOSNATF=9 D SOSNATF^ONCUTX1 S Y="@48";
"KRN",.402,1256,"DR",1,165.5,75)
139.3//^S X=$G(SOSNDTDF);@48;W !;170;I $P($G(^ONCO(165.5,DA,0)),U,16)>3021231 S Y=108;D DEFAULT^ONCTXSM;23//^S X=$G(RRDF);W !;108;S FLDNUM=108,NODE=14,LIMIT=1000 D ^ONCTEXT;W !;@44;46;
"KRN",.402,1256,"DR",1,165.5,76)
I (X=1)!(X=9) S $P(^ONCO(165.5,DA,7),U,20)="" S Y="@441";47;@441;W ! D PAUSE^ONCOPA2A I PAUSE=U S Y="@0";D RAD^ONCPTX;51.2;D RAD^ONCATF1;S R=$S(X&(X<7):1,1:0);I X="" S $P(^ONCO(165.5,D0,3),U,4)="",TXNUL=1,Y="@49";
"KRN",.402,1256,"DR",1,165.5,77)
I (X=0)!(X=7) D RAD1^ONCNTX,RAD2^ONCNTX S TXNO=1,Y="@49";I (X=8)!(X=9) D RAD^ONCUTX S TXUNK=1,Y="@49";51;D RADDT^ONCATF1;D RATFDEF^ONCOCC;126;125;363;
"KRN",.402,1256,"DR",1,165.5,78)
I X'="" S RTMCODE=$P($G(^ONCO(166.13,X,0)),U,1) I (RTMCODE>49)&(RTMCODE<63) S $P(^ONCO(165.5,DA,"THY1"),U,43)=88888 W !,"REGIONAL DOSE: cGy: NA, brachytherapy/radioisotopes administered" S Y=363.1;442;363.1;
"KRN",.402,1256,"DR",1,165.5,79)
I X'="" S RTMCODE=$P($G(^ONCO(166.13,X,0)),U,1) I (RTMCODE>49)&(RTMCODE<63) S $P(^ONCO(165.5,DA,"THY1"),U,44)=88888 W !,"BOOST DOSE: cGy: NA, brachytherapy/radioisotopes administered" S Y=56;443;56;361;@49;D DSPRAD^ONCATF1;W !;
"KRN",.402,1256,"DR",1,165.5,80)
51.4//^S X=$G(RADDF);I X="" S $P(^ONCO(165.5,D0,3.1),U,13)="",Y="@411";I (X=0)!(X=7) D RADATF^ONCNTX1 S Y="@411";I (X=8)!(X=9) D RADATF^ONCUTX1 S Y="@411";51.5//^S X=$G(RADDTDF);@411;D RS^ONCOAIP;S X=X;W !;51.3;D RFNR^ONCATF1;W !;
"KRN",.402,1256,"DR",1,165.5,81)
75;S RFNR=X D ^ONCRFNR W:$G(RFNRMSG)'="" !!,RFNRMSG;W ! D PAUSE^ONCOPA2A I PAUSE=U S Y="@0";S RVAR=$P($G(^ONCO(165.5,D0,3)),U,6);I RVAR=""!(RVAR=0)!(RVAR=9) S Y="@413";@412;W !;109;S FLDNUM=109,NODE=15,LIMIT=1000 D ^ONCTEXT;@413;
"KRN",.402,1256,"DR",1,165.5,82)
D ST^ONCPTX;53.2;D CHEM^ONCATF1;I X="" S $P(^ONCO(165.5,D0,3),U,11)="",TXNUL=1,Y="@414";I (X="00")!(X=82)!(X=85)!(X=86)!(X=87) D CHE^ONCNTX S TXNO=1,Y="@414";I (X=88)!(X=99) S XX=X D CHE^ONCUTX S TXUNK=1,Y="@414";53;
"KRN",.402,1256,"DR",1,165.5,83)
D CHEMDT^ONCATF1;D CATFDEF^ONCOCC;@414;D DSPCHEM^ONCATF1;W !;53.3//^S X=$G(CHEMDF);I X="" S $P(^ONCO(165.5,D0,3.1),U,15)="",Y="@415";I (X="00")!(X=82)!(X=85)!(X=86)!(X=87) D CMATFDT^ONCNTX1 S Y="@415";
"KRN",.402,1256,"DR",1,165.5,84)
I (X=88)!(X=99) D CHEMATF^ONCUTX1 S Y="@415";53.4//^S X=$G(CHMDTDF);@415;S CVAR=$P($G(^ONCO(165.5,D0,3)),U,13);I (CVAR="")!(CVAR="00")!(CVAR=99)!(CVAR=82)!(CVAR=85)!(CVAR=86)!(X=87) S Y="@416";W !;1423;I X="" S Y="@4151";1423.1;
"KRN",.402,1256,"DR",1,165.5,85)
I X="" S Y="@4151";1423.2;I X="" S Y="@4151";1423.3;I X="" S Y="@4151";1423.4;@4151;W !;111;S FLDNUM=111,NODE=17,LIMIT=1000 D ^ONCTEXT;@416;W !;54.2;D HT^ONCATF1;I X="" S $P(^ONCO(165.5,D0,3),U,14)="",TXNUL=1,Y="@417";
"KRN",.402,1256,"DR",1,165.5,86)
I (X="00")!(X=82)!(X=85)!(X=86)!(X=87) D HOR^ONCNTX1 S TXNO=1,Y="@417";I (X=88)!(X=99) S XX=X D HOR^ONCUTX S TXUNK=1,Y="@417";54;D HTDT^ONCATF1;D HATFDEF^ONCOCC;@417;D DSPHT^ONCATF1;W !;54.3//^S X=$G(HTDF);
"KRN",.402,1256,"DR",1,165.5,87)
I X="" S $P(^ONCO(165.5,D0,3.1),U,17)="",Y="@418";I (X="00")!(X=82)!(X=85)!(X=86)!(X=87) D HTATFDT^ONCNTX1 S Y="@418";I (X=88)!(X=99) D HTATF^ONCUTX1 S Y="@418";54.4//^S X=$G(HTDTDF);@418;W !;S HVAR=$P($G(^ONCO(165.5,D0,3)),U,16);
"KRN",.402,1256,"DR",1,165.5,88)
I (HVAR="")!(HVAR="00")!(HVAR=99)!(HVAR=82)!(HVAR=85)!(HVAR=86)!(X=87) S Y="@419";112;S FLDNUM=112,NODE=18,LIMIT=1000 D ^ONCTEXT;@419;55.2;D IMM^ONCATF1;I X="" S $P(^ONCO(165.5,D0,3),U,17)="",TXNUL=1,Y="@420";
"KRN",.402,1256,"DR",1,165.5,89)
I (X="00")!(X=82)!(X=85)!(X=86)!(X=87) D IMM^ONCNTX1 S TXNO=1,Y="@420";I (X=88)!(X=99) S XX=X D IMM^ONCUTX S TXUNK=1,Y="@420";55;D IMMDT^ONCATF1;D IATFDEF^ONCOCC;@420;D DSPIMM^ONCATF1;W !;55.3//^S X=$G(IMMDF);
"KRN",.402,1256,"DR",1,165.5,90)
I X="" S $P(^ONCO(165.5,D0,3.1),U,19)="",Y="@421";I (X="00")!(X=82)!(X=85)!(X=86)!(X=87) D IMATFDT^ONCNTX1 S Y="@421";I (X=88)!(X=99) D IMMATF^ONCUTX1 S Y="@421";55.4//^S X=$G(IMMDTDF);@421;W !;
"KRN",.402,1256,"DR",1,165.5,91)
S IVAR=$P($G(^ONCO(165.5,D0,3)),U,19);I (IVAR="")!(IVAR="00")!(IVAR=99)!(IVAR=82)!(IVAR=85)!(IVAR=86)!(X=87) S Y="@422";114;S FLDNUM=114,NODE=20,LIMIT=1000 D ^ONCTEXT;@422;153;D HTEP^ONCATF1;
"KRN",.402,1256,"DR",1,165.5,92)
I X="" S $P(^ONCO(165.5,D0,3.1),U,35)="",TXNUL=1,Y="@4201";S HE=$P(^ONCO(167,X,0),U,1);I (HE="00")!(HE=82)!(HE=85)!(HE=86)!(HE=87) D HTEP^ONCNTX1 S TXNO=1,Y="@4201";I (HE=88)!(HE=99) D HTEP^ONCUTX S TXUNK=1,Y="@4201";153.1;
"KRN",.402,1256,"DR",1,165.5,93)
D HTEPDT^ONCATF1;D HEATFDEF^ONCOCC;@4201;D DSPHTEP^ONCATF1;W !;153.2//^S X=$G(HTEPDF);I X="" S $P(^ONCO(165.5,D0,3.2),U,3)="",Y="@42015";S HEATF=$P(^ONCO(167,X,0),U,1);
"KRN",.402,1256,"DR",1,165.5,94)
I (HEATF="00")!(HEATF=82)!(HEATF=85)!(HEATF=86)!(HEATF=87) D HEATFDT^ONCNTX1 S Y="@42015";I (HEATF=88)!(HEATF=99) D HTEPATF^ONCUTX1 S Y="@42015";153.3//^S X=$G(HTEPDTDF);@42015;W !;
"KRN",.402,1256,"DR",1,165.5,95)
I $P($G(^ONCO(165.5,DA,0)),U,16)<3060000 S Y="@4202";D SSS^ONCOAIP1;S X=X;W !;15;@4202;W ! D PAUSE^ONCOPA2A I PAUSE=U S Y="@0";D OTH^ONCPTX;57.2;D OTH^ONCATF1;I X="" S $P(^ONCO(165.5,D0,3),U,23)="",TXNUL=1,Y="@423";
"KRN",.402,1256,"DR",1,165.5,96)
I (X=0)!(X=7) D OTH^ONCNTX1 S TXNO=$S(X=0:1,1:""),Y="@423";I (X=8)!(X=9) D OTH^ONCUTX S TXUNK=$S(X=9:1,1:""),Y="@423";57;D OTHDT^ONCATF1;D OATFDEF^ONCOCC;@423;D DSPOTH^ONCATF1;W !;57.3//^S X=$G(OTHDF);
"KRN",.402,1256,"DR",1,165.5,97)
I X="" S $P(^ONCO(165.5,D0,3.1),U,21)="" S Y="@424";I X=0!(X=7) D OTHATF^ONCNTX1 S Y="@424";I X=8!(X=9) D OTHATF^ONCUTX1 S Y="@424";57.4//^S X=$G(OTHDTDF);@424;W !;S OVAR=$P($G(^ONCO(165.5,D0,3)),U,25);
"KRN",.402,1256,"DR",1,165.5,98)
I OVAR=""!(OVAR=0)!(OVAR=9) S Y="@425";115;S FLDNUM=115,NODE=21,LIMIT=1000 D ^ONCTEXT;@425;D PRO^ONCPTX;12;@13;D PP^ONCATF1;D PATFDEF^ONCOCC;13//^S X=$G(PPDF);279;346;I X=9 D PRO^ONCUTX S Y="@113";
"KRN",.402,1256,"DR",1,165.5,99)
I (X=0)!(X=2)!(X=3)!(X=4)!(X=5)!(X=6)!(X=7)!(X=8) D PRO^ONCNTX1 S Y="@113";560;133;@113;W !;113;S FLDNUM=113,NODE=19,LIMIT=1000 D ^ONCTEXT;S Y=$S(ONCOANS="A":"@5",1:"@0");@5;D ^ONCOPCE;S Y=$S(ONCOANS="A":"@9",1:"@0");@6;
"KRN",.402,1256,"DR",1,165.5,100)
D ORF^ONCOAIP;205;206;207;208;209;210;211;212;213;214;215;216;217;218;219;220;221;222;223;224;225;226;S Y="@0";@7;D AB^ONCOAIP;91;I $G(EDIT)="YES" S Y="@0";S:$P(^ONCO(165.5,D0,7),U,4)="" Y="@83";W !!?5,"Selected for QA=>",!;63;
"KRN",.402,1256,"DR",1,165.5,101)
S:X="N" Y="@83";64;64.1;64.2;@83;S Y="";62;@999999;62;S Y=$S(ONCOANS=8:"@8",1:"");@8;D EDTMOD^ONCOAIP2;999.26;999.27;999.28;999.29;W !;999.1;999.2;999.3;999.4;999.5;999.6;999.7;999.8;999.9;999.11;999.12;999.13;999.14;999.15;999.16;
"KRN",.402,1256,"DR",1,165.5,102)
999.17;999.18;999.19;999.21;999.22;999.23;999.24;999.25;S Y="@0";@9;D UDFMOD^ONCOAIP2;284;284.1;284.2;284.3;284.4;284.5;284.6;284.7;284.8;284.9;S Y=$S(ONCOANS="A":"@7",1:"@0");
"MBREQ")
0
"ORD",7,.402)
.402;7;;;EDEOUT^DIFROMSO(.402,DA,"",XPDA);FPRE^DIFROMSI(.402,"",XPDA);EPRE^DIFROMSI(.402,DA,$E("N",$G(XPDNEW)),XPDA,"",OLDA);;EPOST^DIFROMSI(.402,DA,"",XPDA);DEL^DIFROMSK(.402,"",%)
"ORD",7,.402,0)
INPUT TEMPLATE
"PKG",14,-1)
1^1
"PKG",14,0)
ONCOLOGY^ONC^Oncology treatment tracking & tumor registry package.
"PKG",14,20,0)
^9.402P^^
"PKG",14,22,0)
^9.49I^1^1
"PKG",14,22,1,0)
2.2
"PKG",14,22,1,"PAH",1,0)
9^3180504
"QUES","XPF1",0)
Y
"QUES","XPF1","??")
^D REP^XPDH
"QUES","XPF1","A")
Shall I write over your |FLAG| File
"QUES","XPF1","B")
YES
"QUES","XPF1","M")
D XPF1^XPDIQ
"QUES","XPF2",0)
Y
"QUES","XPF2","??")
^D DTA^XPDH
"QUES","XPF2","A")
Want my data |FLAG| yours
"QUES","XPF2","B")
YES
"QUES","XPF2","M")
D XPF2^XPDIQ
"QUES","XPI1",0)
YO
"QUES","XPI1","??")
^D INHIBIT^XPDH
"QUES","XPI1","A")
Want KIDS to INHIBIT LOGONs during the install
"QUES","XPI1","B")
NO
"QUES","XPI1","M")
D XPI1^XPDIQ
"QUES","XPM1",0)
PO^VA(200,:EM
"QUES","XPM1","??")
^D MG^XPDH
"QUES","XPM1","A")
Enter the Coordinator for Mail Group '|FLAG|'
"QUES","XPM1","B")

"QUES","XPM1","M")
D XPM1^XPDIQ
"QUES","XPO1",0)
Y
"QUES","XPO1","??")
^D MENU^XPDH
"QUES","XPO1","A")
Want KIDS to Rebuild Menu Trees Upon Completion of Install
"QUES","XPO1","B")
NO
"QUES","XPO1","M")
D XPO1^XPDIQ
"QUES","XPZ1",0)
Y
"QUES","XPZ1","??")
^D OPT^XPDH
"QUES","XPZ1","A")
Want to DISABLE Scheduled Options, Menu Options, and Protocols
"QUES","XPZ1","B")
NO
"QUES","XPZ1","M")
D XPZ1^XPDIQ
"QUES","XPZ2",0)
Y
"QUES","XPZ2","??")
^D RTN^XPDH
"QUES","XPZ2","A")
Want to MOVE routines to other CPUs
"QUES","XPZ2","B")
NO
"QUES","XPZ2","M")
D XPZ2^XPDIQ
"RTN")
8
"RTN","ONC2PS09")
0^7^B2237612
"RTN","ONC2PS09",1,0)
ONC2PS09 ;Hines OIFO/RTK - Post-Install Routine for Patch ONC*2.2*9 ;03/27/18
"RTN","ONC2PS09",2,0)
 ;;2.2;ONCOLOGY;**9**;Jul 31, 2013;Build 3
"RTN","ONC2PS09",3,0)
 ;
"RTN","ONC2PS09",4,0)
 ;N RC
"RTN","ONC2PS09",5,0)
 ;DC production server.
"RTN","ONC2PS09",6,0)
 ;S RC=$$UPDCSURL^ONCSAPIU("http://127.0.0.1:22/cgi_bin/oncsrv.exe")
"RTN","ONC2PS09",7,0)
 ;DC test server, comment out for final release.
"RTN","ONC2PS09",8,0)
 ;S RC=$$UPDCSURL^ONCSAPIU("http://127.0.0.1:22/cgi_bin/oncsrv.exe")
"RTN","ONC2PS09",9,0)
 ;
"RTN","ONC2PS09",10,0)
 D XRF1693
"RTN","ONC2PS09",11,0)
 Q
"RTN","ONC2PS09",12,0)
 ;
"RTN","ONC2PS09",13,0)
 ;Re-Index the "B", "C" and "D" cross-references on File #169.3
"RTN","ONC2PS09",14,0)
XRF1693 ;
"RTN","ONC2PS09",15,0)
 D BMES^XPDUTL("Re-indexing 'B', 'C' and 'D' cross-references of File #169.3...")
"RTN","ONC2PS09",16,0)
 N DIK
"RTN","ONC2PS09",17,0)
 S DIK="^ONCO(169.3,",DIK(1)=".01^B"
"RTN","ONC2PS09",18,0)
 D ENALL2^DIK ;Kill existing "B" cross-reference.
"RTN","ONC2PS09",19,0)
 D ENALL^DIK ;Re-create "B" cross-reference.
"RTN","ONC2PS09",20,0)
 S DIK="^ONCO(169.3,",DIK(1)="1^D"
"RTN","ONC2PS09",21,0)
 D ENALL2^DIK ;Kill existing "D" cross-reference.
"RTN","ONC2PS09",22,0)
 D ENALL^DIK ;Re-create "D" cross-reference.
"RTN","ONC2PS09",23,0)
 ;next do x-ref on .01 of SYNONYM (field #2) subfile
"RTN","ONC2PS09",24,0)
 S IEN=0 F  S IEN=$O(^ONCO(169.3,IEN)) Q:IEN'>0  D
"RTN","ONC2PS09",25,0)
 .I '$D(^ONCO(169.3,IEN,1)) Q
"RTN","ONC2PS09",26,0)
 .S DIK="^ONCO(169.3,IEN,1,",DIK(1)=".01^C",DA(1)=IEN D ENALL2^DIK
"RTN","ONC2PS09",27,0)
 .S DIK="^ONCO(169.3,IEN,1,",DIK(1)=".01^C",DA(1)=IEN D ENALL^DIK
"RTN","ONC2PS09",28,0)
 ;
"RTN","ONC2PS09",29,0)
 D BMES^XPDUTL("Done Re-indexing the File #169.3 cross-references...")
"RTN","ONC2PS09",30,0)
 ;
"RTN","ONC2PS09",31,0)
 Q
"RTN","ONCACD1")
0^1^B70408549
"RTN","ONCACD1",1,0)
ONCACD1 ;Hines OIFO/GWB - Extract NAACCR/STATE/VACCR data ;09/06/11
"RTN","ONCACD1",2,0)
 ;;2.2;ONCOLOGY;**1,4,5,8,9**;Jul 31, 2013;Build 3
"RTN","ONCACD1",3,0)
 ;
"RTN","ONCACD1",4,0)
 ;P5 added in RQRS the Analytic Cases selection.
"RTN","ONCACD1",5,0)
 ;P8 allows BLANK in TNM Clin/Path data fields & others.
"RTN","ONCACD1",6,0)
 ;P9 discard in State Extract -  COC=34 & Analytic=NO
"RTN","ONCACD1",7,0)
EN1 ;Entry point
"RTN","ONCACD1",8,0)
 K ^TMP($J)
"RTN","ONCACD1",9,0)
 N EXPORT,PAGE,STOPDT,OIEN,ZTREQ
"RTN","ONCACD1",10,0)
 S PAGE=1,OIEN=0
"RTN","ONCACD1",11,0)
 S EXPORT="YES"
"RTN","ONCACD1",12,0)
 D SETUP
"RTN","ONCACD1",13,0)
 I 'DEVICE W $C(26) H 30
"RTN","ONCACD1",14,0)
 Q
"RTN","ONCACD1",15,0)
 ;
"RTN","ONCACD1",16,0)
SETUP ;Loop through appropriate cross-reference
"RTN","ONCACD1",17,0)
 I 'DEVICE S X=0 X ^%ZOSF("RM") ;Disable autowrap
"RTN","ONCACD1",18,0)
 N BLANK,DCLC,FDNUM,IEN,NC,NINE,TPG,ZERO,ZNINE,X
"RTN","ONCACD1",19,0)
 S BLANK=" "
"RTN","ONCACD1",20,0)
 S (IEN,ZERO)=0
"RTN","ONCACD1",21,0)
 S NINE=9,ZNINE="09"
"RTN","ONCACD1",22,0)
 S OUT=$G(OUT,0)
"RTN","ONCACD1",23,0)
 ;
"RTN","ONCACD1",24,0)
 ;NCDB EXTRACT
"RTN","ONCACD1",25,0)
 ;Loop through DATE DX (165.5,3) "ADX" cross-reference
"RTN","ONCACD1",26,0)
 S ONCDT=DATE
"RTN","ONCACD1",27,0)
 I STEXT=0 F  S ONCDT=$O(^ONCO(165.5,"ADX",ONCDT)) Q:(ONCDT>DATE1)!(ONCDT="")  S IEN=0 F  S IEN=$O(^ONCO(165.5,"ADX",ONCDT,IEN)) Q:IEN=""  I $$DIV^ONCFUNC(IEN)=DUZ(2) D  Q:OUT
"RTN","ONCACD1",28,0)
 .I $G(NCDB)=2 S DCLC=$P($G(^ONCO(165.5,IEN,7)),U,21) Q:(DCLC<SDT)!(DCLC>EDT)
"RTN","ONCACD1",29,0)
 .I $G(NCDB)=3 S ACCN=$P($G(^ONCO(165.5,IEN,0)),U,5) Q:(ACCN<SDT)!(ACCN>EDT)
"RTN","ONCACD1",30,0)
 .D LOOP
"RTN","ONCACD1",31,0)
 ;
"RTN","ONCACD1",32,0)
 ;VACCR/STATE EXTRACT
"RTN","ONCACD1",33,0)
 ;Loop through DATE CASE COMPLETED (165.5,90) "AAD" cross-reference
"RTN","ONCACD1",34,0)
 I STEXT=1,($G(ONCLDT)=1) S SDT=SDT-1 F  S SDT=$O(^ONCO(165.5,"AAD",SDT)) Q:(SDT<1)!(SDT>EDT)!(OUT=1)  F  S IEN=$O(^ONCO(165.5,"AAD",SDT,IEN)) Q:IEN<1  I $$DIV^ONCFUNC(IEN)=DUZ(2) D  Q:OUT
"RTN","ONCACD1",35,0)
 .Q:$G(^ONCO(165.5,IEN,0))=""
"RTN","ONCACD1",36,0)
 .D LOOP
"RTN","ONCACD1",37,0)
 ;Loop through DATE CASE LAST CHANGED (165.5,198) "AAE" cross-reference
"RTN","ONCACD1",38,0)
 I STEXT=1,($G(ONCLDT)=2) S SDT=SDT-1 F  S SDT=$O(^ONCO(165.5,"AAE",SDT)) Q:(SDT<1)!(SDT>EDT)!(OUT=1)  F  S IEN=$O(^ONCO(165.5,"AAE",SDT,IEN)) Q:IEN<1  I $$DIV^ONCFUNC(IEN)=DUZ(2) D  Q:OUT
"RTN","ONCACD1",39,0)
 .Q:$G(^ONCO(165.5,IEN,0))=""
"RTN","ONCACD1",40,0)
 .D LOOP
"RTN","ONCACD1",41,0)
 ;Loop through ACCESSION NUMBER (165.5,.05) "AA" cross-reference
"RTN","ONCACD1",42,0)
 I STEXT=1,($G(ONCLDT)=3) S SDT=SDT-1 F  S SDT=$O(^ONCO(165.5,"AA",SDT)) Q:(SDT<1)!(SDT>EDT)!(OUT=1)  F  S IEN=$O(^ONCO(165.5,"AA",SDT,IEN)) Q:IEN<1  I $$DIV^ONCFUNC(IEN)=DUZ(2) D  Q:OUT
"RTN","ONCACD1",43,0)
 .Q:$G(^ONCO(165.5,IEN,0))=""
"RTN","ONCACD1",44,0)
 .D LOOP
"RTN","ONCACD1",45,0)
 ;
"RTN","ONCACD1",46,0)
 ;VACCR/STATE EXTRACT
"RTN","ONCACD1",47,0)
 ;Loop through DATE CASE LAST CHANGED (165.5,198) "AAE" cross-reference
"RTN","ONCACD1",48,0)
 I STEXT=2 S SDT=SDT-1 F  S SDT=$O(^ONCO(165.5,"AAE",SDT)) Q:(SDT<1)!(SDT>EDT)!(OUT=1)  F  S IEN=$O(^ONCO(165.5,"AAE",SDT,IEN)) Q:IEN<1  I $$DIV^ONCFUNC(IEN)=DUZ(2) D  Q:OUT
"RTN","ONCACD1",49,0)
 .Q:$G(^ONCO(165.5,IEN,0))=""
"RTN","ONCACD1",50,0)
 .D LOOP
"RTN","ONCACD1",51,0)
 ;
"RTN","ONCACD1",52,0)
 ;RQRS EXTRACT
"RTN","ONCACD1",53,0)
 ;Loop through DATE DX (165.5,3) "ADX" cross-reference
"RTN","ONCACD1",54,0)
 I STEXT=3,($G(ONCLDT)=1) S SDT=SDT-1 F  S SDT=$O(^ONCO(165.5,"ADX",SDT)) Q:(SDT<1)!(SDT>EDT)!(OUT=1)  F  S IEN=$O(^ONCO(165.5,"ADX",SDT,IEN)) Q:IEN<1  I $$DIV^ONCFUNC(IEN)=DUZ(2) D  Q:OUT
"RTN","ONCACD1",55,0)
 .Q:$G(^ONCO(165.5,IEN,0))=""
"RTN","ONCACD1",56,0)
 .S TPG=$P($G(^ONCO(165.5,IEN,2)),U,1)
"RTN","ONCACD1",57,0)
 .S NC=0
"RTN","ONCACD1",58,0)
 .F FDNUM=.03,.05,.06,3,20,22.3 I $$GET1^DIQ(165.5,IEN,FDNUM,"I")="" S NC=1
"RTN","ONCACD1",59,0)
 .Q:NC=1
"RTN","ONCACD1",60,0)
 .S ONCCLCA=$E($$GET1^DIQ(165.5,IEN,.04),1,2)
"RTN","ONCACD1",61,0)
 .I ($G(ONCR12)=2),((ONCCLCA=0)!(ONCCLCA>0)&(ONCCLCA<23)) D LOOP Q
"RTN","ONCACD1",62,0)
 .I ($G(ONCR12)=1),(($E(TPG,3,4)=50)!($E(TPG,3,4)=18)!($E(TPG,3,4)=20))&(TPG'=67181) D LOOP  ; screen out 67181 (appendix) cases - p2.2*4
"RTN","ONCACD1",63,0)
 ;
"RTN","ONCACD1",64,0)
 ;Loop through DATE CASE LAST CHANGED (165.5,198) "AAE" cross-reference
"RTN","ONCACD1",65,0)
 ;Quit if "ADX" is before 2008 - p2.2*4
"RTN","ONCACD1",66,0)
 I STEXT=3,($G(ONCLDT)=2) S SDT=SDT-1 F  S SDT=$O(^ONCO(165.5,"AAE",SDT)) Q:(SDT<1)!(SDT>EDT)!(OUT=1)  F  S IEN=$O(^ONCO(165.5,"AAE",SDT,IEN)) Q:IEN<1  I $$DIV^ONCFUNC(IEN)=DUZ(2) D  Q:OUT
"RTN","ONCACD1",67,0)
 .Q:$G(^ONCO(165.5,IEN,0))=""
"RTN","ONCACD1",68,0)
 .Q:$P($G(^ONCO(165.5,IEN,0)),U,16)<3080101
"RTN","ONCACD1",69,0)
 .S TPG=$P($G(^ONCO(165.5,IEN,2)),U,1)
"RTN","ONCACD1",70,0)
 .S NC=0
"RTN","ONCACD1",71,0)
 .F FDNUM=.03,.05,.06,3,20,22.3 I $$GET1^DIQ(165.5,IEN,FDNUM,"I")="" S NC=1
"RTN","ONCACD1",72,0)
 .Q:NC=1
"RTN","ONCACD1",73,0)
 .S ONCCLCA=$E($$GET1^DIQ(165.5,IEN,.04),1,2)
"RTN","ONCACD1",74,0)
 .I ($G(ONCR12)=2),((ONCCLCA=0)!(ONCCLCA>0)&(ONCCLCA<23)) D LOOP Q
"RTN","ONCACD1",75,0)
 .I ($G(ONCR12)=1),($E(TPG,3,4)=50)!($E(TPG,3,4)=18)!($E(TPG,3,4)=20)&(TPG'=67181) D LOOP
"RTN","ONCACD1",76,0)
 ;
"RTN","ONCACD1",77,0)
 ;Loop through ACCESSION NUMBER (165.5,.05) "AA" cross-reference
"RTN","ONCACD1",78,0)
 I STEXT=3,($G(ONCLDT)=3) S SDT=SDT-1 F  S SDT=$O(^ONCO(165.5,"AA",SDT)) Q:(SDT<1)!(SDT>EDT)!(OUT=1)  F  S IEN=$O(^ONCO(165.5,"AA",SDT,IEN)) Q:IEN<1  I $$DIV^ONCFUNC(IEN)=DUZ(2) D  Q:OUT
"RTN","ONCACD1",79,0)
 .Q:$G(^ONCO(165.5,IEN,0))=""
"RTN","ONCACD1",80,0)
 .Q:$P($G(^ONCO(165.5,IEN,0)),U,16)<3080101
"RTN","ONCACD1",81,0)
 .S TPG=$P($G(^ONCO(165.5,IEN,2)),U,1)
"RTN","ONCACD1",82,0)
 .S NC=0
"RTN","ONCACD1",83,0)
 .F FDNUM=.03,.05,.06,3,20,22.3 I $$GET1^DIQ(165.5,IEN,FDNUM,"I")="" S NC=1
"RTN","ONCACD1",84,0)
 .Q:NC=1
"RTN","ONCACD1",85,0)
 .S ONCCLCA=$E($$GET1^DIQ(165.5,IEN,.04),1,2)
"RTN","ONCACD1",86,0)
 .I ($G(ONCR12)=2),((ONCCLCA=0)!(ONCCLCA>0)&(ONCCLCA<23)) D LOOP Q
"RTN","ONCACD1",87,0)
 .I ($G(ONCR12)=1),($E(TPG,3,4)=50)!($E(TPG,3,4)=18)!($E(TPG,3,4)=20)&(TPG'=67181) D LOOP
"RTN","ONCACD1",88,0)
 Q
"RTN","ONCACD1",89,0)
 ;
"RTN","ONCACD1",90,0)
LOOP ;Apply extract selection rules
"RTN","ONCACD1",91,0)
 ;P#9
"RTN","ONCACD1",92,0)
 I ($G(EXTRACT)=2),($E($$GET1^DIQ(165.5,IEN,.04),1,2)=34),($G(ACO)=0) Q
"RTN","ONCACD1",93,0)
 N LINE,RULES,VALID,JUMP
"RTN","ONCACD1",94,0)
 S RULES=0
"RTN","ONCACD1",95,0)
 F  S RULES=$O(^ONCO(160.16,EXTRACT,"RULES",RULES)) Q:RULES<1  D
"RTN","ONCACD1",96,0)
 .S LINE=^ONCO(160.16,EXTRACT,"RULES",RULES,0)
"RTN","ONCACD1",97,0)
 .X LINE
"RTN","ONCACD1",98,0)
 Q:'VALID
"RTN","ONCACD1",99,0)
 S ^TMP($J,IEN)=""
"RTN","ONCACD1",100,0)
 D OUTPUT(IEN,EXTRACT,JUMP,.OUT)
"RTN","ONCACD1",101,0)
 I 'DEVICE W !
"RTN","ONCACD1",102,0)
 Q
"RTN","ONCACD1",103,0)
 ;
"RTN","ONCACD1",104,0)
OUTPUT(IEN,EXTRACT,JUMP,OUT) ;Output
"RTN","ONCACD1",105,0)
 S ACD160=$P(^ONCO(165.5,IEN,0),U,2)
"RTN","ONCACD1",106,0)
 I DEVICE D HEAD(IEN,.OUT) Q:OUT
"RTN","ONCACD1",107,0)
 N POS S POS=0
"RTN","ONCACD1",108,0)
 F  S POS=$O(^ONCO(160.16,EXTRACT,"FIELD","B",POS)) Q:POS<1  D  Q:OUT
"RTN","ONCACD1",109,0)
 .N NODE S NODE=0
"RTN","ONCACD1",110,0)
 .F  S NODE=$O(^ONCO(160.16,EXTRACT,"FIELD","B",POS,NODE)) Q:NODE<1  D  Q:OUT
"RTN","ONCACD1",111,0)
 ..N STRING,DEFAULT,FILL,LEN
"RTN","ONCACD1",112,0)
 ..Q:$G(^ONCO(160.16,EXTRACT,"FIELD",NODE,0))=""
"RTN","ONCACD1",113,0)
 ..D DISPLAY(DEVICE,$P(^ONCO(160.16,EXTRACT,"FIELD",NODE,0),U,1)_U_$P(^ONCO(160.16,EXTRACT,"FIELD",NODE,0),U,4),.OUT)
"RTN","ONCACD1",114,0)
 ..Q:OUT
"RTN","ONCACD1",115,0)
 ..S LEN=$P(^ONCO(160.16,EXTRACT,"FIELD",NODE,0),U,2)
"RTN","ONCACD1",116,0)
 ..S STRING=$TR(^ONCO(160.16,EXTRACT,"FIELD",NODE,1),"~","^")
"RTN","ONCACD1",117,0)
 ..S DEFAULT=$P(^ONCO(160.16,EXTRACT,"FIELD",NODE,2),U,1)
"RTN","ONCACD1",118,0)
 ..S FILL=$P(^ONCO(160.16,EXTRACT,"FIELD",NODE,3),U,1)
"RTN","ONCACD1",119,0)
 ..D DATA(IEN,ACD160,STRING,DEFAULT,FILL,LEN,JUMP,NODE,POS)
"RTN","ONCACD1",120,0)
 ..;=========================================================
"RTN","ONCACD1",121,0)
 ..; This Code supports the PCE Extracts (currently disabled)
"RTN","ONCACD1",122,0)
 ..;=========================================================
"RTN","ONCACD1",123,0)
 ..I $G(^ONCO(160.16,EXTRACT,0))["ZZNCDB" D
"RTN","ONCACD1",124,0)
 ...I $O(^ONCO(160.16,EXTRACT,"FIELD","B",POS))>1 Q  ;QUIT if not end
"RTN","ONCACD1",125,0)
 ...N EXTRACT,NODE,POS
"RTN","ONCACD1",126,0)
 ...S EXTRACT=100,JUMP=0
"RTN","ONCACD1",127,0)
 ...;S:$D(^ONCO(165.5,"APCE","BLA",IEN)) EXTRACT=1
"RTN","ONCACD1",128,0)
 ...; ^==== Bladder 95,90,85
"RTN","ONCACD1",129,0)
 ...;S:$D(^ONCO(165.5,"APCE","THY",IEN)) EXTRACT=2
"RTN","ONCACD1",130,0)
 ...; ^==== Thyroid 96,91,86
"RTN","ONCACD1",131,0)
 ...;S:$D(^ONCO(165.5,"APCE","STS",IEN)) EXTRACT=3
"RTN","ONCACD1",132,0)
 ...; ^==== Soft Tissue 96,91,86
"RTN","ONCACD1",133,0)
 ...;S:$D(^ONCO(165.5,"APCE","COL",IEN)) EXTRACT=4
"RTN","ONCACD1",134,0)
 ...; ^==== Colorectal 97,92,87
"RTN","ONCACD1",135,0)
 ...;S:$D(^ONCO(165.5,"APCE","NHL",IEN)) EXTRACT=5
"RTN","ONCACD1",136,0)
 ...; ^==== Non-Hodgkins 97,92,87
"RTN","ONCACD1",137,0)
 ...;S:$D(^ONCO(165.5,"APCE","BRE",IEN)) EXTRACT=6
"RTN","ONCACD1",138,0)
 ...; ^==== Breast 98,93,88
"RTN","ONCACD1",139,0)
 ...;S:$D(^ONCO(165.5,"APCE","PRO2",IEN)) EXTRACT=7
"RTN","ONCACD1",140,0)
 ...; ^==== Prostate 98,93,88
"RTN","ONCACD1",141,0)
 ...;S:$D(^ONCO(165.5,"APCE","MEL",IEN)) EXTRACT=8
"RTN","ONCACD1",142,0)
 ...; ^==== Melanoma 99,94,89
"RTN","ONCACD1",143,0)
 ...;S:$D(^ONCO(165.5,"APCE","HEP",IEN)) EXTRACT=9
"RTN","ONCACD1",144,0)
 ...; ^==== Hepatocellular Cancers 00,95,90
"RTN","ONCACD1",145,0)
 ...;S:$D(^ONCO(165.5,"APCE","CNS",IEN)) EXTRACT=10
"RTN","ONCACD1",146,0)
 ...; ^==== Primary Intracranial/CNS Tumors 00,95,90
"RTN","ONCACD1",147,0)
 ...;S:$D(^ONCO(165.5,"APCE","LNG",IEN)) EXTRACT=11
"RTN","ONCACD1",148,0)
 ...; ^==== Lung (NSCLC) 01,96,91
"RTN","ONCACD1",149,0)
 ...;S:$D(^ONCO(165.5,"APCE","GAS",IEN)) EXTRACT=12
"RTN","ONCACD1",150,0)
 ...; ^==== Gastric Cancers 01,96,91
"RTN","ONCACD1",151,0)
 ...S POS=0
"RTN","ONCACD1",152,0)
 ...F  S POS=$O(^ONCO(160.17,EXTRACT,"FIELD","B",POS)) Q:POS<1  D  Q:OUT
"RTN","ONCACD1",153,0)
 ....N NODE S NODE=0
"RTN","ONCACD1",154,0)
 ....F  S NODE=$O(^ONCO(160.17,EXTRACT,"FIELD","B",POS,NODE)) Q:NODE<1  D  Q:OUT
"RTN","ONCACD1",155,0)
 .....N DEFAULT,FILL,LEN,STRING
"RTN","ONCACD1",156,0)
 .....Q:$G(^ONCO(160.17,EXTRACT,"FIELD",NODE,0))=""
"RTN","ONCACD1",157,0)
 .....D DISPLAY(DEVICE,$P(^ONCO(160.17,EXTRACT,"FIELD",NODE,0),U,1)_U_$P(^ONCO(160.17,EXTRACT,"FIELD",NODE,0),U,4),.OUT)
"RTN","ONCACD1",158,0)
 .....Q:OUT
"RTN","ONCACD1",159,0)
 .....S STRING=$TR(^ONCO(160.17,EXTRACT,"FIELD",NODE,1),"~","^")
"RTN","ONCACD1",160,0)
 .....S DEFAULT=^ONCO(160.17,EXTRACT,"FIELD",NODE,2)
"RTN","ONCACD1",161,0)
 .....S FILL=^ONCO(160.17,EXTRACT,"FIELD",NODE,3)
"RTN","ONCACD1",162,0)
 .....S LEN=$P(^ONCO(160.17,EXTRACT,"FIELD",NODE,0),U,2)
"RTN","ONCACD1",163,0)
 .....D DATA(IEN,ACD160,STRING,DEFAULT,FILL,LEN,JUMP,NODE,POS)
"RTN","ONCACD1",164,0)
 Q
"RTN","ONCACD1",165,0)
 ;
"RTN","ONCACD1",166,0)
HEAD(IEN,OUT) ;Preview End-of-Page
"RTN","ONCACD1",167,0)
 N FLG
"RTN","ONCACD1",168,0)
 I IEN=OIEN S FLG=0
"RTN","ONCACD1",169,0)
 I IEN'=OIEN S OIEN=IEN,FLG=1
"RTN","ONCACD1",170,0)
 I 'FLG Q:$Y+4<IOSL
"RTN","ONCACD1",171,0)
 I PAGE'=1 D  Q:OUT
"RTN","ONCACD1",172,0)
 .Q:$E(IOST,1,2)'="C-"
"RTN","ONCACD1",173,0)
 .N DIR,Y
"RTN","ONCACD1",174,0)
 .S DIR(0)="E" D ^DIR
"RTN","ONCACD1",175,0)
 .I 'Y S OUT=1 Q
"RTN","ONCACD1",176,0)
 D HEADER
"RTN","ONCACD1",177,0)
 Q
"RTN","ONCACD1",178,0)
 ;
"RTN","ONCACD1",179,0)
HEADER ;Preview Header
"RTN","ONCACD1",180,0)
 I PAGE'=1 W @IOF
"RTN","ONCACD1",181,0)
 I PAGE=1,$E(IOST,1,2)="C-" W @IOF
"RTN","ONCACD1",182,0)
 I STEXT=3 W !,"RQRS EXTRACT",?70,"Page: ",PAGE S PAGE=PAGE+1
"RTN","ONCACD1",183,0)
 E  W !,$P(^ONCO(160.16,EXTRACT,0),U),?70,"Page: ",PAGE S PAGE=PAGE+1
"RTN","ONCACD1",184,0)
 W !,"Patient: ",$$GET1^DIQ(160,ACD160,.01,"E")
"RTN","ONCACD1",185,0)
 W ?55,"SSN: ",$$GET1^DIQ(160,ACD160,2,"E")
"RTN","ONCACD1",186,0)
 W !,"Col#",?5,"Item name",?51,"Value",!
"RTN","ONCACD1",187,0)
 F I=1:1:79 W "="
"RTN","ONCACD1",188,0)
 Q
"RTN","ONCACD1",189,0)
 ;
"RTN","ONCACD1",190,0)
DISPLAY(DEVICE,WRITE,OUT) ; Display preview
"RTN","ONCACD1",191,0)
 Q:'DEVICE
"RTN","ONCACD1",192,0)
 N DOTS,COL,ITEM
"RTN","ONCACD1",193,0)
 I DEVICE,($Y+5)>IOSL D HEAD(0,.OUT) Q:OUT
"RTN","ONCACD1",194,0)
 S COL=$P(WRITE,U,1)
"RTN","ONCACD1",195,0)
 S COL=$S($L(COL)=1:"   "_COL,$L(COL)=2:"  "_COL,$L(COL)=3:" "_COL,1:COL)
"RTN","ONCACD1",196,0)
 S ITEM=$P(WRITE,U,2),ITEM=$E(ITEM,1,45)
"RTN","ONCACD1",197,0)
 S DOTS=(46-$L(ITEM))
"RTN","ONCACD1",198,0)
 W !,COL,?5,ITEM
"RTN","ONCACD1",199,0)
 F I=1:1:DOTS W "."
"RTN","ONCACD1",200,0)
 Q
"RTN","ONCACD1",201,0)
 ;
"RTN","ONCACD1",202,0)
DATA(IEN,ACD160,STRING,DEFAULT,FILL,LEN,JUMP,NODE,POS) ;Compute extract value
"RTN","ONCACD1",203,0)
 N ACDANS,EXIT S EXIT=0
"RTN","ONCACD1",204,0)
 I JUMP'="0" D
"RTN","ONCACD1",205,0)
 .I POS<$P(JUMP,U) Q
"RTN","ONCACD1",206,0)
 .I POS>$P(JUMP,U,2) Q
"RTN","ONCACD1",207,0)
 .N I
"RTN","ONCACD1",208,0)
 .S EXIT=1
"RTN","ONCACD1",209,0)
 .F I=1:1:LEN W BLANK
"RTN","ONCACD1",210,0)
 Q:EXIT
"RTN","ONCACD1",211,0)
 X STRING
"RTN","ONCACD1",212,0)
 ;
"RTN","ONCACD1",213,0)
 ;If value = "", extract DEFAULT value
"RTN","ONCACD1",214,0)
 I ACDANS="" D  Q
"RTN","ONCACD1",215,0)
 .N I,X S X=""
"RTN","ONCACD1",216,0)
 .I DEFAULT=8 D  Q
"RTN","ONCACD1",217,0)
 ..F I=1:1:LEN W DEFAULT
"RTN","ONCACD1",218,0)
 .I @DEFAULT="09" W @DEFAULT Q
"RTN","ONCACD1",219,0)
 .F I=1:1:LEN W @DEFAULT
"RTN","ONCACD1",220,0)
 ;
"RTN","ONCACD1",221,0)
 ;If value too long, truncate to LENGTH (160.161,1)
"RTN","ONCACD1",222,0)
 ;If value too short, pad with FILL (160.161,6)
"RTN","ONCACD1",223,0)
 I $L(ACDANS)=LEN W ACDANS Q
"RTN","ONCACD1",224,0)
 I $L(ACDANS)>LEN W $E(ACDANS,1,LEN) Q
"RTN","ONCACD1",225,0)
 E  D  Q
"RTN","ONCACD1",226,0)
 .N JUST,STUFF,I,REM,CAL
"RTN","ONCACD1",227,0)
 .S JUST=$P(FILL,","),STUFF=$P(FILL,",",2)
"RTN","ONCACD1",228,0)
 .S REM=LEN-$L(ACDANS)
"RTN","ONCACD1",229,0)
 .I JUST="R" W ACDANS
"RTN","ONCACD1",230,0)
 .F I=1:1:REM W @STUFF
"RTN","ONCACD1",231,0)
 .I JUST="L" W ACDANS
"RTN","ONCACD1",232,0)
 Q
"RTN","ONCACD1",233,0)
 ;
"RTN","ONCACD1",234,0)
CLEANUP ;Cleanup
"RTN","ONCACD1",235,0)
 K DATE,EDT,NCDB,SDT,STEXT
"RTN","ONCODIS")
0^2^B825697
"RTN","ONCODIS",1,0)
ONCODIS ;Hines OIFO/GWB - OncoTrax Banner ;09/13/11
"RTN","ONCODIS",2,0)
 ;;2.2;ONCOLOGY;**1,4,7,5,8,6,9**;Jul 31, 2013;Build 3
"RTN","ONCODIS",3,0)
 ;
"RTN","ONCODIS",4,0)
MAIN ;OncoTrax Banner
"RTN","ONCODIS",5,0)
 S RC=$$CHKVER^ONCSAPIV()
"RTN","ONCODIS",6,0)
 D LOGO
"RTN","ONCODIS",7,0)
 K I,RC
"RTN","ONCODIS",8,0)
 Q
"RTN","ONCODIS",9,0)
 ;
"RTN","ONCODIS",10,0)
LOGO ;Display banner
"RTN","ONCODIS",11,0)
 W @IOF W !!!!!! F I=1:1:9 W !,?22,$P($T(DISP+I),";",3)
"RTN","ONCODIS",12,0)
 W !!,?22,"Department of Veterans Affairs"
"RTN","ONCODIS",13,0)
 W !?22,"OncoTraX V2.2 P9 Test Build #3" Q
"RTN","ONCODIS",14,0)
DISP ;
"RTN","ONCODIS",15,0)
 ;;VVVV            VVAA
"RTN","ONCODIS",16,0)
 ;; VVVV          VVAAAA
"RTN","ONCODIS",17,0)
 ;;  VVVV        VVAAAAAA
"RTN","ONCODIS",18,0)
 ;;   VVVV      VVAA  AAAA
"RTN","ONCODIS",19,0)
 ;;    VVVV    VVAA    AAAA
"RTN","ONCODIS",20,0)
 ;;     VVVV  VVAA      AAAA
"RTN","ONCODIS",21,0)
 ;;      VVVVVVAA        AAAA
"RTN","ONCODIS",22,0)
 ;;       VVVVAA   AAAAAAAAAAA
"RTN","ONCODIS",23,0)
 ;;        VVAA     AAAAAAAAAAA
"RTN","ONCOPA1")
0^5^B60892840
"RTN","ONCOPA1",1,0)
ONCOPA1 ;Hines OIFO/GWB - [PA Print Complete Abstract (132c)] ;09/22/11
"RTN","ONCOPA1",2,0)
 ;;2.2;ONCOLOGY;**1,5,6,9**;Jul 31, 2013;Build 3
"RTN","ONCOPA1",3,0)
 ;
"RTN","ONCOPA1",4,0)
 ;Replaces print templates ONCOX1-X11.
"RTN","ONCOPA1",5,0)
 ;
"RTN","ONCOPA1",6,0)
 K IOP,%ZIS S %ZIS="MQ" W ! D ^%ZIS K %ZIS,IOP G:POP EXIT
"RTN","ONCOPA1",7,0)
 I $D(IO("Q")) S ONCOLST="ONCOIEN^PTIEN^STARS^LENGTH^TITLE^PRTPCE^ONCODA^ESPD" D TASK G EXIT
"RTN","ONCOPA1",8,0)
 U IO D PRINT D ^%ZISC K %ZIS,IOP G EXIT
"RTN","ONCOPA1",9,0)
 ;
"RTN","ONCOPA1",10,0)
PRINT ;Print
"RTN","ONCOPA1",11,0)
 Q:$G(ONCOIEN)=""
"RTN","ONCOPA1",12,0)
 W @IOF
"RTN","ONCOPA1",13,0)
 S (IEN,D0)=ONCOIEN,PTIEN=$P($G(^ONCO(165.5,IEN,0)),U,2)
"RTN","ONCOPA1",14,0)
 S PG=0,EX="",LINE=$S($E(IOST,1,2)="C-":IOSL-2,1:IOSL-6)
"RTN","ONCOPA1",15,0)
 S STARS="******************************************************************************"
"RTN","ONCOPA1",16,0)
 S DATEDX=$P($G(^ONCO(165.5,IEN,0)),U,16)
"RTN","ONCOPA1",17,0)
 D NOW^%DTC S Y=% K % D DD^%DT S PRTDATE=Y
"RTN","ONCOPA1",18,0)
 K DIQ S DIC="^ONCO(160,",DIQ(0)="C"
"RTN","ONCOPA1",19,0)
 S DR=".111:.131;2;7:10;13;18.9:21;22.9:29;38:44;48;50;51;52;61;55;56;62;63;64;65;66;67;68;1006"
"RTN","ONCOPA1",20,0)
 S DA=PTIEN,DIQ="ONCAB" D EN^DIQ1
"RTN","ONCOPA1",21,0)
 K DIQ S DIC="^ONCO(165.5,",DIQ(0)="C"
"RTN","ONCOPA1",22,0)
 S DR=".01:.07;1.2;2:2.4;3;3.5:19;20.1;22:35.1;37:40.2;41;49:59;62:67;70:71.3;74:79;83;85:92;95;100;101;108;117:130;132;133;137:146;200;346;363;363.1;442;443;560;787;50.2;361;623;684;1010;153:153.3;435;149;151;154:156;170;171:192;711:713;809"
"RTN","ONCOPA1",23,0)
 S DA=ONCOIEN,DIQ="ONCAB" D EN^DIQ1
"RTN","ONCOPA1",24,0)
 K DIQ S DIC="^ONCO(165.5,",DIQ(0)="IE"
"RTN","ONCOPA1",25,0)
 S DR="29.2;30.2;29.1;31.1;32.1;32;33;34.3;34.4;44.1:44.9;160:168;148:148.4;15;21;25;44;46;47;96;102;159;193;194;195;196;2.2;227:235;1423:1423.4;157.1;24.1:24.5;237;34.31:34.6;241;242;245;250;279:281"
"RTN","ONCOPA1",26,0)
 S DA=ONCOIEN,DIQ="ONCAB" D EN^DIQ1
"RTN","ONCOPA1",27,0)
 K DIQ S DIC="^ONCO(165.5,",DIQ(0)="C"
"RTN","ONCOPA1",28,0)
 S DR="72",DA=ONCOIEN,DR(165.572)=".01;.02;.03;.031;.032",DIQ="ONCAB"
"RTN","ONCOPA1",29,0)
 F SR=0:0 S SR=$O(^ONCO(165.5,IEN,23,SR)) Q:SR'>0  D
"RTN","ONCOPA1",30,0)
 .S DA(165.572)=SR D EN^DIQ1 Q
"RTN","ONCOPA1",31,0)
 K DIQ S DIC="^ONCO(165.5,",DIQ(0)="C"
"RTN","ONCOPA1",32,0)
 S DR="60",DA=ONCOIEN,DR(165.51)=".01:2;33:37",DIQ="ONCAB"
"RTN","ONCOPA1",33,0)
 F SCT=0:0 S SCT=$O(^ONCO(165.5,IEN,4,SCT)) Q:SCT'>0  D
"RTN","ONCOPA1",34,0)
 .S DA(165.51)=SCT D EN^DIQ1 Q
"RTN","ONCOPA1",35,0)
 K DIQ S DIC="^ONCO(160,",DIQ(0)="C"
"RTN","ONCOPA1",36,0)
 S DR="44",DA=PTIEN,DR(160.044)=".01:1",DIQ="ONCAB"
"RTN","ONCOPA1",37,0)
 F CHST=0:0 S CHST=$O(^ONCO(160,PTIEN,9,CHST)) Q:CHST'>0  D
"RTN","ONCOPA1",38,0)
 .S DA(160.044)=CHST D EN^DIQ1 Q
"RTN","ONCOPA1",39,0)
 I $G(ESPD)=1 D
"RTN","ONCOPA1",40,0)
 .S ONCAB(165.5,IEN,.02)="XXXXX,XXXXX"
"RTN","ONCOPA1",41,0)
 .S ONCAB(160,PTIEN,2)="XXX-XX-XXXX"
"RTN","ONCOPA1",42,0)
 .S ONCAB(160,PTIEN,.119)="XXXXXXXXXX"
"RTN","ONCOPA1",43,0)
 .S $P(ONCAB(160,PTIEN,.116),",",1)="XXXXX"
"RTN","ONCOPA1",44,0)
 .S ONCAB(160,PTIEN,.131)="XXX-XXX-XXXX"
"RTN","ONCOPA1",45,0)
 .S ONCAB(165.5,IEN,8)="XXXXXXXXXX"
"RTN","ONCOPA1",46,0)
 .S ONCAB(165.5,IEN,8.2)="XXXXXXXXXX"
"RTN","ONCOPA1",47,0)
 .S ONCAB(165.5,IEN,8.1)="XXXXX"
"RTN","ONCOPA1",48,0)
 S PATNAME=$G(ONCAB(165.5,IEN,.02)),SSAN=$G(ONCAB(160,PTIEN,2))
"RTN","ONCOPA1",49,0)
 S NAME="CANCER REGISTRY ABSTRACT" D FORMAT
"RTN","ONCOPA1",50,0)
 S CRA=TITLE W !!,TITLE
"RTN","ONCOPA1",51,0)
 W !!?21,$E(ONCAB(165.5,IEN,.03),1,26)
"RTN","ONCOPA1",52,0)
 W "    ACOS #:  ",ONCAB(165.5,IEN,67)
"RTN","ONCOPA1",53,0)
 W ?76,"Print Date:  ",PRTDATE D P Q:EX=U
"RTN","ONCOPA1",54,0)
 W !,"      Patient Name:  ",ONCAB(165.5,IEN,.02),?76,"SSN:  ",ONCAB(160,PTIEN,2) D P Q:EX=U
"RTN","ONCOPA1",55,0)
 S DOB="",VRBLPTR=$P($G(^ONCO(160,PTIEN,0)),U,1) I VRBLPTR'="" D
"RTN","ONCOPA1",56,0)
 .S FILE=U_$P(VRBLPTR,";",2)_$P(VRBLPTR,";",1)_",0)"
"RTN","ONCOPA1",57,0)
 .S Y=$S($D(@FILE):$P(@FILE,U,3),1:"") I Y'="" D DD^%DT S DOB=Y Q
"RTN","ONCOPA1",58,0)
 W !,"      Home Address:  ",ONCAB(160,PTIEN,.119) D P Q:EX=U
"RTN","ONCOPA1",59,0)
 W !,"                     ",ONCAB(160,PTIEN,.118) D P Q:EX=U
"RTN","ONCOPA1",60,0)
 W !,"            County:  ",ONCAB(160,PTIEN,.12) D P Q:EX=U
"RTN","ONCOPA1",61,0)
 W !,"               Sex:  ",$E(ONCAB(160,PTIEN,10),1,14),?44,"Race:  ",$E(ONCAB(160,PTIEN,8),1,21),?76,"Ethnicity:  ",ONCAB(160,PTIEN,9) D P Q:EX=U
"RTN","ONCOPA1",62,0)
 W !,"     Date of Birth:  ",DOB
"RTN","ONCOPA1",63,0)
 W ?38," Age at DX:  ",ONCAB(165.5,IEN,4) D P Q:EX=U
"RTN","ONCOPA1",64,0)
 ;
"RTN","ONCOPA1",65,0)
CI ;Cancer Identification
"RTN","ONCOPA1",66,0)
 S NAME="CANCER IDENTIFICATION" D FORMAT
"RTN","ONCOPA1",67,0)
 W !!,TITLE
"RTN","ONCOPA1",68,0)
 S NODE2=$G(^ONCO(165.5,IEN,2))
"RTN","ONCOPA1",69,0)
 S COC=$E($$GET1^DIQ(165.5,IEN,.04),1,2)
"RTN","ONCOPA1",70,0)
 W !!,"       Accession Number: ",ONCAB(165.5,IEN,.05),?38,"Accession Year:  ",ONCAB(165.5,IEN,.07),?76,"Sequence Number:  ",ONCAB(165.5,IEN,.06) D P Q:EX=U
"RTN","ONCOPA1",71,0)
 W !,"                    Date Dx: ",ONCAB(165.5,IEN,3) D P Q:EX=U
"RTN","ONCOPA1",72,0)
 I DATEDX>3061231 D
"RTN","ONCOPA1",73,0)
 .W !,"   Ambiguous Terminology Dx: ",ONCAB(165.5,IEN,159,"E") D P Q:EX=U
"RTN","ONCOPA1",74,0)
 .W !,"      Date of Conclusive Dx: ",ONCAB(165.5,IEN,193,"E") D P Q:EX=U
"RTN","ONCOPA1",75,0)
 W !,"                Dx Facility: ",ONCAB(165.5,IEN,5) D P Q:EX=U
"RTN","ONCOPA1",76,0)
 W !,"      Date of First Contact: ",ONCAB(165.5,IEN,155) D P Q:EX=U
"RTN","ONCOPA1",77,0)
 I DATEDX>3091231 D
"RTN","ONCOPA1",78,0)
 .W !,"           Inpatient Status: ",ONCAB(165.5,IEN,233,"E") D P Q:EX=U
"RTN","ONCOPA1",79,0)
 W !,"              Class of Case: ",ONCAB(165.5,IEN,.04) D P Q:EX=U
"RTN","ONCOPA1",80,0)
 W !,"     Date of First Symptoms: ",ONCAB(165.5,IEN,171) D P Q:EX=U
"RTN","ONCOPA1",81,0)
 W !,"  Date Start Workup Ordered: ",ONCAB(165.5,IEN,172) D P Q:EX=U
"RTN","ONCOPA1",82,0)
 W !,"        Date Workup Started: ",ONCAB(165.5,IEN,173) D P Q:EX=U
"RTN","ONCOPA1",83,0)
 W !,"   Type of Reporting Source: ",ONCAB(165.5,IEN,1.2) D P Q:EX=U
"RTN","ONCOPA1",84,0)
 W !,"                    Site/Gp: ",ONCAB(165.5,IEN,.01) D P Q:EX=U
"RTN","ONCOPA1",85,0)
 W !,"          Primary Site Code: ",ONCAB(165.5,IEN,20.1),"  "
"RTN","ONCOPA1",86,0)
 S TOP=$P(NODE2,U,1) I TOP'="" W $P(^ONCO(164,TOP,0),U,1) D P Q:EX=U
"RTN","ONCOPA1",87,0)
 W !,"    Text-Primary Site Title: ",ONCAB(165.5,IEN,100) D P Q:EX=U
"RTN","ONCOPA1",88,0)
 I DATEDX>3061231 D
"RTN","ONCOPA1",89,0)
 .W !,"   Mult Tum Rpt as One Prim: ",ONCAB(165.5,IEN,194,"E") D P Q:EX=U
"RTN","ONCOPA1",90,0)
 .W !,"    Date of Multiple Tumors: ",ONCAB(165.5,IEN,195,"E") D P Q:EX=U
"RTN","ONCOPA1",91,0)
 .W !,"       Multiplicity Counter: ",ONCAB(165.5,IEN,196,"E") D P Q:EX=U
"RTN","ONCOPA1",92,0)
 W !,"                 Laterality: ",ONCAB(165.5,IEN,28) D P Q:EX=U
"RTN","ONCOPA1",93,0)
 S HIST=$$HIST^ONCFUNC(IEN,.HSTFLD)
"RTN","ONCOPA1",94,0)
 W !,"                  Histology: ",ONCAB(165.5,IEN,HSTFLD) D P Q:EX=U
"RTN","ONCOPA1",95,0)
 W !,"       Text-Histology Title: ",ONCAB(165.5,IEN,101) D P Q:EX=U
"RTN","ONCOPA1",96,0)
 W:TOP=67619 !,"       Gleason Score (Clin): ",ONCAB(165.5,IEN,623)
"RTN","ONCOPA1",97,0)
 W:TOP=67619 !,"       Gleason Score (Path): ",ONCAB(165.5,IEN,250,"E")
"RTN","ONCOPA1",98,0)
 W:TOP=67619 !,"                        PSA: ",ONCAB(165.5,IEN,684)
"RTN","ONCOPA1",99,0)
 W:TOP=67619 !,"                   PSA Date: ",ONCAB(165.5,IEN,96,"E")
"RTN","ONCOPA1",100,0)
 W:TOP=67619 !,"                    DRE +/-: ",ONCAB(165.5,IEN,102,"E")
"RTN","ONCOPA1",101,0)
 W:TOP=67619 !,"                   DRE Date: ",ONCAB(165.5,IEN,156)
"RTN","ONCOPA1",102,0)
 W !,"      Grade/Differentiation: ",ONCAB(165.5,IEN,24),"  "
"RTN","ONCOPA1",103,0)
 S GR=$P(NODE2,U,5) I GR'="" W $P(^ONCO(164.43,GR,0),U,2) D P Q:EX=U
"RTN","ONCOPA1",104,0)
 I DATEDX>3091231 D
"RTN","ONCOPA1",105,0)
 .W !,"          Grade Path System: ",ONCAB(165.5,IEN,24.1,"E") D P Q:EX=U
"RTN","ONCOPA1",106,0)
 .W !,"           Grade Path Value: ",ONCAB(165.5,IEN,24.2,"E") D P Q:EX=U
"RTN","ONCOPA1",107,0)
 I DATEDX>3171231 D
"RTN","ONCOPA1",108,0)
 .W !,"             Grade Clinical: ",ONCAB(165.5,IEN,24.3,"E") D P Q:EX=U
"RTN","ONCOPA1",109,0)
 .W !,"         Grade Pathological: ",ONCAB(165.5,IEN,24.4,"E") D P Q:EX=U
"RTN","ONCOPA1",110,0)
 .W !,"         Grade Post-Therapy: ",ONCAB(165.5,IEN,24.5,"E") D P Q:EX=U
"RTN","ONCOPA1",111,0)
 W !,"        AFIP/JPC Submission: ",ONCAB(165.5,IEN,83) D P Q:EX=U
"RTN","ONCOPA1",112,0)
 W !,"    Diagnostic Confirmation: ",ONCAB(165.5,IEN,26) D P Q:EX=U
"RTN","ONCOPA1",113,0)
 W:TOP=67220 !,"                Hepatitis C: ",ONCAB(165.5,IEN,1010)
"RTN","ONCOPA1",114,0)
 S TM1=$$PRINT^ONCOTM(IEN,1)
"RTN","ONCOPA1",115,0)
 I TM1["UMOR" S $E(TM1,2,5)="umor" I TM1["ARKER" S $E(TM1,8,12)="arker"
"RTN","ONCOPA1",116,0)
 S TM2=$$PRINT^ONCOTM(IEN,2)
"RTN","ONCOPA1",117,0)
 I TM2["UMOR" S $E(TM2,2,5)="umor" I TM2["ARKER" S $E(TM2,8,12)="arker"
"RTN","ONCOPA1",118,0)
 S TM3=$$PRINT^ONCOTM(IEN,3)
"RTN","ONCOPA1",119,0)
 I TM3["UMOR" S $E(TM3,2,5)="umor" I TM3["ARKER" S $E(TM3,8,12)="arker"
"RTN","ONCOPA1",120,0)
 S LEN=$L(TM1) W !?(27-LEN),TM1,": ",ONCAB(165.5,IEN,25.1) D P Q:EX=U
"RTN","ONCOPA1",121,0)
 S LEN=$L(TM2) W !?(27-LEN),TM2,": ",ONCAB(165.5,IEN,25.2) D P Q:EX=U
"RTN","ONCOPA1",122,0)
 S LEN=$L(TM3) W !?(27-LEN),TM3,": ",ONCAB(165.5,IEN,25.3) D P Q:EX=U
"RTN","ONCOPA1",123,0)
 W !,"     Facility Referred From: ",ONCAB(165.5,IEN,6) D P Q:EX=U
"RTN","ONCOPA1",124,0)
 W !,"       Facility Referred To: ",ONCAB(165.5,IEN,7) D P Q:EX=U
"RTN","ONCOPA1",125,0)
 W !,"                  Fee Basis: ",ONCAB(165.5,IEN,237,"E") D P Q:EX=U
"RTN","ONCOPA1",126,0)
 W !,"Presentation at Cancer Conf: ",ONCAB(165.5,IEN,120) D P Q:EX=U
"RTN","ONCOPA1",127,0)
 W !,"  Date of Cancer Conference: ",ONCAB(165.5,IEN,121) D P Q:EX=U
"RTN","ONCOPA1",128,0)
 W !,"         Casefinding Source: ",ONCAB(165.5,IEN,21,"E")
"RTN","ONCOPA1",129,0)
 ;
"RTN","ONCOPA1",130,0)
 I $E(IOST,1,2)="C-" W ! K DIR S DIR(0)="E",DIR("A")="Enter RETURN to continue with this abstract" D ^DIR Q:'Y  D HDR G PA1A
"RTN","ONCOPA1",131,0)
 D P Q:EX=U
"RTN","ONCOPA1",132,0)
PA1A D ^ONCOPA1A
"RTN","ONCOPA1",133,0)
 ;
"RTN","ONCOPA1",134,0)
EXIT ;KILL variables
"RTN","ONCOPA1",135,0)
 K CHST,CMIEN,CNTR,COC,CRA,D0,DA,DATEDX,DIC,DIQ,DIR,DOB,DR,DTE,DXDT,EX
"RTN","ONCOPA1",136,0)
 K FHDT,FHIEN,FHZN,FILE,FLG,FM,FOLH,FR,GR,HIST,HSTFLD,IC,ICDCD,IEN,LEN
"RTN","ONCOPA1",137,0)
 K LENGTH,LINE,NAME,NF,NODE2,NOK,NUM,ONCAB,ONCOIEN,ONCOLST,OTHPRI,PATH
"RTN","ONCOPA1",138,0)
 K PATNAME,PG,POP,PRI,PRTDATE,PRTPCE,PRZN,PTIEN,QS,RCDT,REG,REG1,RK,RK1
"RTN","ONCOPA1",139,0)
 K SCT,SITE,SR,SSAN,ST,STARS,TITLE,TM1,TM2,TM3,TOP,TPX,TSIEN,TSTAT,UF
"RTN","ONCOPA1",140,0)
 K VRBLPTR,VS,Y,ZN
"RTN","ONCOPA1",141,0)
 Q
"RTN","ONCOPA1",142,0)
 ;
"RTN","ONCOPA1",143,0)
P ;Enter RETURN to continue
"RTN","ONCOPA1",144,0)
 I $Y>(IOSL-10) D  Q:EX=U  W !
"RTN","ONCOPA1",145,0)
 .I $E(IOST,1,2)="C-" W ! K DIR S DIR(0)="E",DIR("A")="Enter RETURN to continue with this abstract" D ^DIR I 'Y S EX=U Q
"RTN","ONCOPA1",146,0)
 .D HDR Q
"RTN","ONCOPA1",147,0)
 Q
"RTN","ONCOPA1",148,0)
 ;
"RTN","ONCOPA1",149,0)
FORMAT ;
"RTN","ONCOPA1",150,0)
 S LENGTH=$L(NAME),NUM=(((132-LENGTH)/2)\1)-10
"RTN","ONCOPA1",151,0)
 S TITLE="     "_$E(STARS,1,NUM)_"     "_NAME_"     "_$E(STARS,1,NUM)
"RTN","ONCOPA1",152,0)
 Q
"RTN","ONCOPA1",153,0)
 ;
"RTN","ONCOPA1",154,0)
TASK ;Report Queued
"RTN","ONCOPA1",155,0)
 K ZTUCI,ZTDTH,ZTIO,ZTSAVE
"RTN","ONCOPA1",156,0)
 S ZTRTN="PRINT^ONCOPA1",ZTREQ="@",ZTSAVE("ZTREQ")=""
"RTN","ONCOPA1",157,0)
 S ZTDESC="Print Complete Abstract"
"RTN","ONCOPA1",158,0)
 F RK=1:1 S RK1=$P(ONCOLST,U,RK) Q:RK1=""  S ZTSAVE(RK1)=""
"RTN","ONCOPA1",159,0)
 D ^%ZTLOAD D ^%ZISC U IO W !,"Report Queued",!
"RTN","ONCOPA1",160,0)
 K ZTDESC,ZTREQ,ZTRTN,ZTSAVE,ZTSK
"RTN","ONCOPA1",161,0)
 Q
"RTN","ONCOPA1",162,0)
 ;
"RTN","ONCOPA1",163,0)
HDR ;Header
"RTN","ONCOPA1",164,0)
 W @IOF S PG=PG+1
"RTN","ONCOPA1",165,0)
 W CRA,!
"RTN","ONCOPA1",166,0)
 W ?5," Patient Name:  ",PATNAME,?84,"SSN:  ",SSAN,!
"RTN","ONCOPA1",167,0)
 Q
"RTN","ONCOPA1",168,0)
 ;
"RTN","ONCOPA1",169,0)
MULT ;Entry point for option ABS...MA...3).
"RTN","ONCOPA1",170,0)
 ;Also called from PCEPRT2^ONCOGEN.
"RTN","ONCOPA1",171,0)
 I $D(IO("Q")) S ONCOLST="ONCOIEN^PTIEN^STARS^LENGTH^TITLE^PRTPCE^ONCODA^ESPD" D TASK G EXIT
"RTN","ONCOPA1",172,0)
 U IO D PRINT K %ZIS,IOP G EXIT
"RTN","ONCOPA1",173,0)
 Q
"RTN","ONCOPA1",174,0)
 ;
"RTN","ONCOPA1",175,0)
CLEANUP ;Cleanup
"RTN","ONCOPA1",176,0)
 K ESPD
"RTN","ONCOTNS")
0^4^B19790752
"RTN","ONCOTNS",1,0)
ONCOTNS ;Hines OIFO/GWB - AJCC TNM STAGING ;07/29/05
"RTN","ONCOTNS",2,0)
 ;;2.2;ONCOLOGY;**1,9**;Jul 31, 2013;Build 3
"RTN","ONCOTNS",3,0)
 ;CLINICAL STAGE GROUP   (165.5,38)
"RTN","ONCOTNS",4,0)
 ;PATHOLOGIC STAGE GROUP (165.5,88)
"RTN","ONCOTNS",5,0)
 ;OTHER STAGE GROUP      (165.5,117)
"RTN","ONCOTNS",6,0)
 ;
"RTN","ONCOTNS",7,0)
IN ;Input transform 
"RTN","ONCOTNS",8,0)
 N ONCOS S ONCOS=$P($G(^ONCO(165.5,D0,0)),U,1)
"RTN","ONCOTNS",9,0)
 N ONCOH S ONCOH=$$HIST^ONCFUNC(D0)
"RTN","ONCOTNS",10,0)
 I STGIND="X" G IN1
"RTN","ONCOTNS",11,0)
 I $$LYMPHOMA^ONCFUNC(D0)!(ONCOS=62)!(ONCOS=63) D
"RTN","ONCOTNS",12,0)
 .S STGIND="L"
"RTN","ONCOTNS",13,0)
 ;
"RTN","ONCOTNS",14,0)
IN1 S DIC="^ONCO(164.45,",DIC(0)="EMQ",DIC("S")="I $P(^(0),U,3)[STGIND"
"RTN","ONCOTNS",15,0)
 D ^DIC
"RTN","ONCOTNS",16,0)
 I (X["(A)")!(X["(B)") D
"RTN","ONCOTNS",17,0)
 .W !!,"Enter systemic symptom suffixes at the LYMPH NODES prompt."
"RTN","ONCOTNS",18,0)
 I Y=-1 K X Q
"RTN","ONCOTNS",19,0)
 S X=$P(^ONCO(164.45,+Y,0),U,2)
"RTN","ONCOTNS",20,0)
 Q
"RTN","ONCOTNS",21,0)
 ;
"RTN","ONCOTNS",22,0)
INNUM S X=$S(X["NA":88,X["Unk":99,X["Occ":"OC",X="0a":"0A",X="0is":"0IS",1:X)
"RTN","ONCOTNS",23,0)
 I X="IIIE+S" S X="3ES" Q
"RTN","ONCOTNS",24,0)
 I X="V" S X=5 Q
"RTN","ONCOTNS",25,0)
 I $E(X,1,2)="IV" S X=4_$E(X,3,99) Q
"RTN","ONCOTNS",26,0)
 I $E(X,1,3)="III" S X=3_$E(X,4,99) Q
"RTN","ONCOTNS",27,0)
 I $E(X,1,2)="II" S X=2_$E(X,3,99) Q
"RTN","ONCOTNS",28,0)
 I $E(X,1)="I" S X=1_$E(X,2,99) Q
"RTN","ONCOTNS",29,0)
 Q
"RTN","ONCOTNS",30,0)
 ;
"RTN","ONCOTNS",31,0)
HP ;HELP
"RTN","ONCOTNS",32,0)
 N ONCOI,ONCOX,ONCOXS,ONCOH,ONCOS,SG1,SG2,SGT
"RTN","ONCOTNS",33,0)
 S ONCOI=0,ONCOXS=""
"RTN","ONCOTNS",34,0)
 I STGIND="X" G HP1
"RTN","ONCOTNS",35,0)
 N ONCOS S ONCOS=$P($G(^ONCO(165.5,D0,0)),U,1)
"RTN","ONCOTNS",36,0)
 N ONCOH S ONCOH=$$HIST^ONCFUNC(D0)
"RTN","ONCOTNS",37,0)
 I $$LYMPHOMA^ONCFUNC(D0)!(ONCOS=62)!(ONCOS=63) D
"RTN","ONCOTNS",38,0)
 .S STGIND="L"
"RTN","ONCOTNS",39,0)
HP1 W !,"Select one of the following:",!
"RTN","ONCOTNS",40,0)
 F  S ONCOXS=$O(^ONCO(164.45,"B",ONCOXS)) Q:ONCOXS=""  D
"RTN","ONCOTNS",41,0)
 .S ONCOI=$O(^ONCO(164.45,"B",ONCOXS,0)),ONCOX=^ONCO(164.45,ONCOI,0)
"RTN","ONCOTNS",42,0)
 .S SG1=$P(ONCOX,U,1),SG2=$P(ONCOX,U,2),SGT=$P(ONCOX,U,3)
"RTN","ONCOTNS",43,0)
 .W:SGT[STGIND !?5,SG1,?10,SG2
"RTN","ONCOTNS",44,0)
 Q
"RTN","ONCOTNS",45,0)
OT ;Output transform 
"RTN","ONCOTNS",46,0)
 I Y'="" D
"RTN","ONCOTNS",47,0)
 .S STG=$O(^ONCO(164.45,"B",Y,""))
"RTN","ONCOTNS",48,0)
 .I STG'="" S Y=$P($G(^ONCO(164.45,STG,0)),U,2)
"RTN","ONCOTNS",49,0)
 .S ONCS=$P($G(^ONCO(165.5,D0,0)),U,1)
"RTN","ONCOTNS",50,0)
 .S ONCH=$$HIST^ONCFUNC(D0)
"RTN","ONCOTNS",51,0)
 .I $$LYMPHOMA^ONCFUNC(D0)!(ONCS=62)!(ONCS=63) D
"RTN","ONCOTNS",52,0)
 ..Q  ;due to p6 update to Clin/Path Stg Grp don't need LN suffix anymore
"RTN","ONCOTNS",53,0)
 ..S SSIN=$P($G(^ONCO(165.5,D0,2)),U,11),SSOT=""
"RTN","ONCOTNS",54,0)
 ..I SSIN=0 S SSOT="(A)"
"RTN","ONCOTNS",55,0)
 ..I (SSIN=1)!(SSIN=2)!(SSIN=3) S SSOT="(B)"
"RTN","ONCOTNS",56,0)
 ..I SSIN'=9 S Y=Y_" "_SSOT
"RTN","ONCOTNS",57,0)
 K STG,ONCS,ONCH,SSIN,SSOT Q
"RTN","ONCOTNS",58,0)
RS S XX=$G(^ONCO(165.5,D0,2)),TX=$P(XX,U) G EX:TX="",EX:$P(^ONCO(164,+TX,0),U,11)="" S N=$E(Y),N=$S(N=1:"I",N=2:"II",N=3:"III",N=4:"IV",1:N),Y=N_$E(Y,2,4),Y=Y_" (T"_$P(XX,U,25)_" N"_$P(XX,U,26)_" M"_$P(XX,U,27)_")" G EX
"RTN","ONCOTNS",59,0)
 ;
"RTN","ONCOTNS",60,0)
OT1 ;'COMPUTED EXPRESSION' for AJJC STAGE (165.5,40) and BEST STAGE (165.5,40.1)
"RTN","ONCOTNS",61,0)
 S PATHSG=$P($G(^ONCO(165.5,D0,2.1)),U,4)
"RTN","ONCOTNS",62,0)
 S PATHT=$P($G(^ONCO(165.5,D0,2.1)),U,1)
"RTN","ONCOTNS",63,0)
 S PATHN=$P($G(^ONCO(165.5,D0,2.1)),U,2)
"RTN","ONCOTNS",64,0)
 S PATHM=$P($G(^ONCO(165.5,D0,2.1)),U,3)
"RTN","ONCOTNS",65,0)
 S CLINSG=$P($G(^ONCO(165.5,D0,2)),U,20)
"RTN","ONCOTNS",66,0)
 S CLINT=$P($G(^ONCO(165.5,D0,2)),U,25)
"RTN","ONCOTNS",67,0)
 S CLINN=$P($G(^ONCO(165.5,D0,2)),U,26)
"RTN","ONCOTNS",68,0)
 S CLINM=$P($G(^ONCO(165.5,D0,2)),U,27)
"RTN","ONCOTNS",69,0)
 S (AJSG,HIERT,HIERN,HIERM,HIERFLG)=""
"RTN","ONCOTNS",70,0)
 S AJSG=PATHSG,HIERFLG="P"
"RTN","ONCOTNS",71,0)
 I "88^99"[PATHSG,CLINSG<6,CLINSG'="" S AJSG=CLINSG,HIERFLG="C"
"RTN","ONCOTNS",72,0)
 I PATHSG="",CLINSG'="" S AJSG=CLINSG,HIERFLG="C"
"RTN","ONCOTNS",73,0)
 I "88^99"[PATHSG!(PATHSG="") D
"RTN","ONCOTNS",74,0)
 .I CLINSG<6,CLINSG'="" Q
"RTN","ONCOTNS",75,0)
 .I PATHT'="X",PATHT'=88,PATHT'="" Q
"RTN","ONCOTNS",76,0)
 .I PATHN'="X",PATHN'=88,PATHN'="" Q
"RTN","ONCOTNS",77,0)
 .I PATHM'="X",PATHM'=88,PATHM'="" Q
"RTN","ONCOTNS",78,0)
 .I CLINT'="X",CLINT'=88,CLINT'="" S HIERFLG="C" Q
"RTN","ONCOTNS",79,0)
 .I CLINN'="X",CLINN'=88,CLINN'="" S HIERFLG="C" Q
"RTN","ONCOTNS",80,0)
 .I CLINM'="X",CLINM'=88,CLINM'="" S HIERFLG="C" Q
"RTN","ONCOTNS",81,0)
 I HIERFLG="P" D
"RTN","ONCOTNS",82,0)
 .S HIERT=$P($G(^ONCO(165.5,D0,2.1)),U,1)
"RTN","ONCOTNS",83,0)
 .S HIERN=$P($G(^ONCO(165.5,D0,2.1)),U,2)
"RTN","ONCOTNS",84,0)
 .S HIERM=$P($G(^ONCO(165.5,D0,2.1)),U,3)
"RTN","ONCOTNS",85,0)
 .S HIERTNM=$$GET1^DIQ(165.5,D0,89.1)
"RTN","ONCOTNS",86,0)
 I HIERFLG="C" D
"RTN","ONCOTNS",87,0)
 .S HIERT=$P($G(^ONCO(165.5,D0,2)),U,25)
"RTN","ONCOTNS",88,0)
 .S HIERN=$P($G(^ONCO(165.5,D0,2)),U,26)
"RTN","ONCOTNS",89,0)
 .S HIERM=$P($G(^ONCO(165.5,D0,2)),U,27)
"RTN","ONCOTNS",90,0)
 .S HIERTNM=$$GET1^DIQ(165.5,D0,37)
"RTN","ONCOTNS",91,0)
 I AJSG'="" S Y=AJSG D OT S X=Y
"RTN","ONCOTNS",92,0)
 K AJSG,CLINM,CLINN,CLINT,CLINSG,PATHM,PATHN,PATHT,PATHSG Q
"RTN","ONCOTNS",93,0)
 ;
"RTN","ONCOTNS",94,0)
STGBY ;STAGED BY (165.5,40.2)
"RTN","ONCOTNS",95,0)
 D OT1
"RTN","ONCOTNS",96,0)
 I HIERFLG'="" S Y=$S(HIERFLG="C":$P($G(^ONCO(165.5,D0,3)),U,32),1:$P($G(^ONCO(165.5,D0,2.1)),U,5))
"RTN","ONCOTNS",97,0)
 D STGBOT S X=Y
"RTN","ONCOTNS",98,0)
 Q
"RTN","ONCOTNS",99,0)
 ;
"RTN","ONCOTNS",100,0)
STGBOT ;STAGED BY (165.5,40.2) OUTPUT TRANSFORM
"RTN","ONCOTNS",101,0)
 I Y'="" D
"RTN","ONCOTNS",102,0)
 .I Y=0 S Y="Not staged" Q
"RTN","ONCOTNS",103,0)
 .I Y=1 S Y="Managing MD" Q
"RTN","ONCOTNS",104,0)
 .I Y=2 S Y="Pathologist" Q
"RTN","ONCOTNS",105,0)
 .I Y=3 S Y="Pathologist & managing MD" Q
"RTN","ONCOTNS",106,0)
 .I Y=4 S Y="Committee chair, liaison MD, registry advisor" Q
"RTN","ONCOTNS",107,0)
 .I Y=5 S Y="Registrar" Q
"RTN","ONCOTNS",108,0)
 .I Y=6 S Y="Registrar & MD" Q
"RTN","ONCOTNS",109,0)
 .I Y=7 S Y="Another facility" Q
"RTN","ONCOTNS",110,0)
 .I Y=8 S Y="NA" Q
"RTN","ONCOTNS",111,0)
 .I Y=9 S Y="Unknown" Q
"RTN","ONCOTNS",112,0)
 Q
"RTN","ONCOTNS",113,0)
 ;
"RTN","ONCOTNS",114,0)
TR ;Translate code
"RTN","ONCOTNS",115,0)
 S XS=$P(XX,U,20),XG=$P(XX,U,28),X=XG_$E(XS,2,5)
"RTN","ONCOTNS",116,0)
EX ;EXIT
"RTN","ONCOTNS",117,0)
 K ST,SC,XD0,ONCOX,XX,ONCOYR
"RTN","ONCPCI")
0^6^B27235694
"RTN","ONCPCI",1,0)
ONCPCI ;Hines OIFO/GWB - Patient Identification/Cancer Identification screen display ;09/22/11
"RTN","ONCPCI",2,0)
 ;;2.2;ONCOLOGY;**1,9**;Jul 31, 2013;Build 3
"RTN","ONCPCI",3,0)
 ;
"RTN","ONCPCI",4,0)
PI ;Patient Identification
"RTN","ONCPCI",5,0)
 K DASH S $P(DASH,"-",80)="-"
"RTN","ONCPCI",6,0)
 N DI,DIC,DR,DA,DIQ,ONC,TM1,TM2,TM3,DOTS1,DOTS2,DOTS3
"RTN","ONCPCI",7,0)
 S DIC="^ONCO(165.5,"
"RTN","ONCPCI",8,0)
 S DR=".03;1.2;2;2.1;2.2;2.3;2.4;8;8.1;8.2;9;10;11;16;18;147"
"RTN","ONCPCI",9,0)
 S DA=D0,DIQ="ONC" D EN^DIQ1
"RTN","ONCPCI",10,0)
 F I=.03,1.2,2,2.1,2.2,2.3,2.4,8,8.1,8.2,9,10,11,16,18 S X=ONC(165.5,D0,I) D UCASE S ONC(165.5,D0,I)=X
"RTN","ONCPCI",11,0)
 W !," Reporting Facility...........: ",ONC(165.5,D0,.03)
"RTN","ONCPCI",12,0)
 W !," Marital Status at Dx.........: ",ONC(165.5,D0,11)
"RTN","ONCPCI",13,0)
 W !," Patient Address at Dx........: ",ONC(165.5,D0,8)
"RTN","ONCPCI",14,0)
 W !," Patient Address at Dx - Supp.: ",ONC(165.5,D0,8.2)
"RTN","ONCPCI",15,0)
 W !," City/town at Dx..............: ",ONC(165.5,D0,8.1)
"RTN","ONCPCI",16,0)
 W !," State at Dx..................: ",ONC(165.5,D0,16)
"RTN","ONCPCI",17,0)
 W !," Postal Code at Dx............: ",ONC(165.5,D0,9)
"RTN","ONCPCI",18,0)
 W !," County at Dx.................: ",ONC(165.5,D0,10)
"RTN","ONCPCI",19,0)
 W !," Census Tract.................: ",ONC(165.5,D0,147)
"RTN","ONCPCI",20,0)
 I DATEDX>3061231 D
"RTN","ONCPCI",21,0)
 .W !," Managing Physician...........: ",ONC(165.5,D0,2.2)
"RTN","ONCPCI",22,0)
 W !," Following Physician..........: ",ONC(165.5,D0,2.1)
"RTN","ONCPCI",23,0)
 W !," Primary Surgeon..............: ",ONC(165.5,D0,2)
"RTN","ONCPCI",24,0)
 W !," Physician #3.................: ",ONC(165.5,D0,2.3)
"RTN","ONCPCI",25,0)
 W !," Physician #4       ..........: ",ONC(165.5,D0,2.4)
"RTN","ONCPCI",26,0)
 W !," Primary Payer at Dx..........: ",ONC(165.5,D0,18)
"RTN","ONCPCI",27,0)
 W !," Type of Reporting Source.....: ",ONC(165.5,D0,1.2)
"RTN","ONCPCI",28,0)
 W !,DASH
"RTN","ONCPCI",29,0)
 K DASH,I,X
"RTN","ONCPCI",30,0)
 Q
"RTN","ONCPCI",31,0)
 ;
"RTN","ONCPCI",32,0)
CI ;Cancer Identification
"RTN","ONCPCI",33,0)
 K DASH S $P(DASH,"-",80)="-"
"RTN","ONCPCI",34,0)
 N DI,DIC,DR,DA,DIQ,ONC,TM1,TM2,TM3,DOTS1,DOTS2,DOTS3
"RTN","ONCPCI",35,0)
 S DIC="^ONCO(165.5,"
"RTN","ONCPCI",36,0)
 S DR=".04;6;7;155;3;28;22;22.1;22.3;24:24.5;26;25.1;25.2;25.3;83;623;684;120;121;1010;5;171;172;173;21;96;102;156;159;193;194;195;196;233;237;237.1;238;250"
"RTN","ONCPCI",37,0)
 S DA=D0,DIQ="ONC" D EN^DIQ1
"RTN","ONCPCI",38,0)
 F I=.04,28,24,25.1,25.2,25.3,26,83,120,684,1010,5,21,102,159,194,24.1,24.2,24.3,24.4,24.5,233,237,237.1,238 S X=ONC(165.5,D0,I) D UCASE S ONC(165.5,D0,I)=X
"RTN","ONCPCI",39,0)
 S COC=$E($$GET1^DIQ(165.5,D0,.04,"E"),1,2)
"RTN","ONCPCI",40,0)
 S TM1=$$PRINT^ONCOTM(D0,1)
"RTN","ONCPCI",41,0)
 K DOTS1 S $P(DOTS1,".",25-$L(TM1))="."
"RTN","ONCPCI",42,0)
 S TM2=$$PRINT^ONCOTM(D0,2)
"RTN","ONCPCI",43,0)
 K DOTS2 S $P(DOTS2,".",25-$L(TM2))="."
"RTN","ONCPCI",44,0)
 S TM3=$$PRINT^ONCOTM(D0,3)
"RTN","ONCPCI",45,0)
 K DOTS3 S $P(DOTS3,".",25-$L(TM3))="."
"RTN","ONCPCI",46,0)
 S TXT=ONC(165.5,D0,.04),LEN=48 D TXT
"RTN","ONCPCI",47,0)
 W !," Class of Case................: ",TXT1 W:TXT2'="" !,?35,TXT2
"RTN","ONCPCI",48,0)
 I (COC=10)!(COC=11)!(COC=12)!(COC=13)!(COC=14) D
"RTN","ONCPCI",49,0)
 .W !," Date of First Symptoms.......: ",ONC(165.5,D0,171)
"RTN","ONCPCI",50,0)
 .W !," Date Workup Ordered/Started..: ",ONC(165.5,D0,172),"  ",ONC(165.5,D0,173)
"RTN","ONCPCI",51,0)
 S TXT=ONC(165.5,D0,6),LEN=46 D TXT
"RTN","ONCPCI",52,0)
 W !," Facility referred from.......: ",TXT1 W:TXT2'="" !,?32,TXT2
"RTN","ONCPCI",53,0)
 S TXT=ONC(165.5,D0,7),LEN=46 D TXT
"RTN","ONCPCI",54,0)
 W !," Facility referred to.........: ",TXT1 W:TXT2'="" !,?32,TXT2
"RTN","ONCPCI",55,0)
 W !," Fee Basis....................: ",ONC(165.5,D0,237)
"RTN","ONCPCI",56,0)
 I ONC(165.5,D0,237)="YES",$G(ONC(165.5,D0,237.1))'="" W " (",ONC(165.5,D0,237.1),")"
"RTN","ONCPCI",57,0)
 W !," Date of First Contact........: ",ONC(165.5,D0,155)
"RTN","ONCPCI",58,0)
 W !," Date Dx......................: ",ONC(165.5,D0,3)
"RTN","ONCPCI",59,0)
 I DATEDX>3091231 D
"RTN","ONCPCI",60,0)
 .W !," Inpatient Status.............: ",ONC(165.5,D0,233)
"RTN","ONCPCI",61,0)
 I DATEDX>3061231 D
"RTN","ONCPCI",62,0)
 .W !," Ambiguous Terminology Dx.....: ",ONC(165.5,D0,159)
"RTN","ONCPCI",63,0)
 .W !," Date of Conclusive Dx........: ",ONC(165.5,D0,193)
"RTN","ONCPCI",64,0)
 S TXT=ONC(165.5,D0,5),LEN=46 D TXT
"RTN","ONCPCI",65,0)
 W !," Dx Facility..................: ",TXT1 W:TXT2'="" !,?32,TXT2
"RTN","ONCPCI",66,0)
 W:ONC(165.5,D0,238)'="" !," Outside Slides Reviewed......: ",ONC(165.5,D0,238)
"RTN","ONCPCI",67,0)
 S HIST=$$HIST^ONCFUNC(D0,.HSTFLD,.HISTNAM)
"RTN","ONCPCI",68,0)
 S TXT=ONC(165.5,D0,HSTFLD),LEN=46 D TXT
"RTN","ONCPCI",69,0)
 W !," Histology/Behavior Code......: ",ONC(165.5,D0,22.1)_" "_TXT1 W:TXT2'="" !,?32,TXT2
"RTN","ONCPCI",70,0)
 W:$G(TOP)=67619 !," Gleason Score (Clinical).....: ",ONC(165.5,D0,623)
"RTN","ONCPCI",71,0)
 W:$G(TOP)=67619 !," Gleason Score (Pathologic)...: ",ONC(165.5,D0,250)
"RTN","ONCPCI",72,0)
 W:$G(TOP)=67619 !," PSA..........................: ",ONC(165.5,D0,96)," ",ONC(165.5,D0,684)
"RTN","ONCPCI",73,0)
 W:$G(TOP)=67619 !," DRE +/-......................: ",ONC(165.5,D0,156)," ",ONC(165.5,D0,102)
"RTN","ONCPCI",74,0)
 S TXT=ONC(165.5,D0,28),LEN=46 D TXT
"RTN","ONCPCI",75,0)
 W !," Laterality...................: ",TXT1 W:TXT2'="" !,?32,TXT2
"RTN","ONCPCI",76,0)
 W !," Grade/Differentiation........: ",ONC(165.5,D0,24)
"RTN","ONCPCI",77,0)
 I DATEDX>3091231 D
"RTN","ONCPCI",78,0)
 .W:ONC(165.5,D0,24.1)'="" !," Grade Path System............: ",ONC(165.5,D0,24.1)
"RTN","ONCPCI",79,0)
 .W:ONC(165.5,D0,24.2)'="" !," Grade Path Value.............: ",ONC(165.5,D0,24.2)
"RTN","ONCPCI",80,0)
 I DATEDX>2171231 D  ;might only want these for 2018> but now 1918>
"RTN","ONCPCI",81,0)
 .W:ONC(165.5,D0,24.3)'="" !," Grade Clinical...............: ",ONC(165.5,D0,24.3)
"RTN","ONCPCI",82,0)
 .W:ONC(165.5,D0,24.4)'="" !," Grade Pathological...........: ",ONC(165.5,D0,24.4)
"RTN","ONCPCI",83,0)
 .W:ONC(165.5,D0,24.5)'="" !," Grade Post-Therapy...........: ",ONC(165.5,D0,24.5)
"RTN","ONCPCI",84,0)
 I DATEDX>3061231 D
"RTN","ONCPCI",85,0)
 .W !," Mult Tum Rpt as One Prim.....: ",ONC(165.5,D0,194)
"RTN","ONCPCI",86,0)
 .W !," Date of Multiple Tumors......: ",ONC(165.5,D0,195)
"RTN","ONCPCI",87,0)
 .W !," Multiplicity Counter.........: ",ONC(165.5,D0,196)
"RTN","ONCPCI",88,0)
 W !," AFIP/JPC submission..........: ",ONC(165.5,D0,83)
"RTN","ONCPCI",89,0)
 W !," Diagnostic Confirmation......: ",ONC(165.5,D0,26)
"RTN","ONCPCI",90,0)
 W:($$GET1^DIQ(165.5,D0,.01,"E")="LIVER")!($G(TOP)=67220) !," Hepatitis C..................: ",ONC(165.5,D0,1010)
"RTN","ONCPCI",91,0)
 ;I DATEDX<3030000 D
"RTN","ONCPCI",92,0)
 ;.W !," ",TM1,DOTS1,"....: ",ONC(165.5,D0,25.1)
"RTN","ONCPCI",93,0)
 ;.W !," ",TM2,DOTS2,"....: ",ONC(165.5,D0,25.2)
"RTN","ONCPCI",94,0)
 ;.W !," ",TM3,DOTS3,"....: ",ONC(165.5,D0,25.3)
"RTN","ONCPCI",95,0)
 W !," Presentation at Cancer Conf..: ",ONC(165.5,D0,121)," ",ONC(165.5,D0,120)
"RTN","ONCPCI",96,0)
 W !," Casefinding Source...........: ",ONC(165.5,D0,21)
"RTN","ONCPCI",97,0)
 W !,DASH
"RTN","ONCPCI",98,0)
 K DASH,HIST,HSTFLD,HISTNAM,LEN,LOS,NOP,TXT,TXT1,TXT2,X
"RTN","ONCPCI",99,0)
 Q
"RTN","ONCPCI",100,0)
 ;
"RTN","ONCPCI",101,0)
TXT ;Text formatting
"RTN","ONCPCI",102,0)
 S (TXT1,TXT2)="",LOS=$L(TXT) I LOS<LEN S TXT1=TXT Q
"RTN","ONCPCI",103,0)
 S NOP=$L($E(TXT,1,LEN)," ")
"RTN","ONCPCI",104,0)
 S TXT1=$P(TXT," ",1,NOP-1),TXT2=$P(TXT," ",NOP,999)
"RTN","ONCPCI",105,0)
 Q
"RTN","ONCPCI",106,0)
 ;
"RTN","ONCPCI",107,0)
UCASE ;Mixed case to uppercase conversion
"RTN","ONCPCI",108,0)
 S X=$TR(X,"abcdefghijklmnopqrstuvwxyz","ABCDEFGHIJKLMNOPQRSTUVWXYZ")
"RTN","ONCPCI",109,0)
 Q
"RTN","ONCPCI",110,0)
 ;
"RTN","ONCPCI",111,0)
CLEANUP ;Cleanup
"RTN","ONCPCI",112,0)
 K COC,D0,DATEDX,TOP
"RTN","ONCPSD")
0^8^B8425456
"RTN","ONCPSD",1,0)
ONCPSD ;Hines OIFO/GWB - STAGE OF DISEASE AT DIAGNOSIS PRINT ;10/05/11
"RTN","ONCPSD",2,0)
 ;;2.2;ONCOLOGY;**1,6,9**;Jul 31, 2013;Build 3
"RTN","ONCPSD",3,0)
 ;
"RTN","ONCPSD",4,0)
PRT N DIC,DR,DA,DIQ,I,LEN,LOS,NOP,ONC,TXT,TXT1,TXT2,X
"RTN","ONCPSD",5,0)
 S DIC="^ONCO(165.5,"
"RTN","ONCPSD",6,0)
 S DR="34;34.1;34.2;35;37;89.1;38;88;19;89;39;149;151;29;29.3;29.4;29.5;30;31;32;33;65;66;25;44;241;242;280"
"RTN","ONCPSD",7,0)
 S DA=D0,DIQ="ONC" D EN^DIQ1
"RTN","ONCPSD",8,0)
 F I=34,34.1,34.2,35,38,88,19,89,39,149,151,29,29.3,29.4,29.5,30,31,32,33,280 S X=ONC(165.5,D0,I) D UCASE S ONC(165.5,D0,I)=X
"RTN","ONCPSD",9,0)
 I $P($G(^ONCO(165.5,D0,0)),U,16)<3160101 W !," Tumor Size...................: ",ONC(165.5,D0,29)
"RTN","ONCPSD",10,0)
 I $P($G(^ONCO(165.5,D0,0)),U,16)>3151231 D
"RTN","ONCPSD",11,0)
 .W !," Tumor Size Clinical..........: ",$E(ONC(165.5,D0,29.4),1,48)
"RTN","ONCPSD",12,0)
 .W !," Tumor Size Pathologic........: ",$E(ONC(165.5,D0,29.5),1,48)
"RTN","ONCPSD",13,0)
 .W !," Tumor Size Summary...........: ",$E(ONC(165.5,D0,29.3),1,48)
"RTN","ONCPSD",14,0)
 .Q
"RTN","ONCPSD",15,0)
 S TXT=ONC(165.5,D0,30),LEN=46 D TXT
"RTN","ONCPSD",16,0)
 W !," Extension....................: ",TXT1 W:TXT2'="" !,?32,TXT2
"RTN","ONCPSD",17,0)
 W !," Lymph Nodes..................: ",ONC(165.5,D0,31)
"RTN","ONCPSD",18,0)
 W !," Regional Lymph Nodes Examined: ",ONC(165.5,D0,33)
"RTN","ONCPSD",19,0)
 W !," Regional Lymph Nodes Positive: ",ONC(165.5,D0,32)
"RTN","ONCPSD",20,0)
 W !," SEER Summary Stage 2000......: ",ONC(165.5,D0,35)
"RTN","ONCPSD",21,0)
 W !," Site of Distant Metastasis #1: ",ONC(165.5,D0,34)
"RTN","ONCPSD",22,0)
 W !," Site of Distant Metastasis #2: ",ONC(165.5,D0,34.1)
"RTN","ONCPSD",23,0)
 W !," Site of Distant Metastasis #3: ",ONC(165.5,D0,34.2)
"RTN","ONCPSD",24,0)
 W !," Clinical Stage Discussion....: ",ONC(165.5,D0,280)
"RTN","ONCPSD",25,0)
 W !
"RTN","ONCPSD",26,0)
 W !," Clinical Staging",?22,"TNM edition: ",$$TNMED^ONCOU55(D0),?41,"Pathologic Staging"
"RTN","ONCPSD",27,0)
 W !," ----------------",?41,"------------------"
"RTN","ONCPSD",28,0)
 W !," TNM........: ",ONC(165.5,D0,37)," ",$P($G(^ONCO(165.5,D0,24)),U,5),?41,"TNM........: ",ONC(165.5,D0,89.1)," ",$P($G(^ONCO(165.5,D0,24)),U,5)
"RTN","ONCPSD",29,0)
 W !," Stage Group: ",ONC(165.5,D0,38)," ",$E($P(ONC(165.5,D0,241),"(",1),1,19),?41,"Stage Group: ",ONC(165.5,D0,88)," ",$E($P(ONC(165.5,D0,242),"(",1),1,19)
"RTN","ONCPSD",30,0)
 W !," Staged By..: ",$E(ONC(165.5,D0,19),1,25),?41,"Staged By..: ",$E(ONC(165.5,D0,89),1,25)
"RTN","ONCPSD",31,0)
 W !
"RTN","ONCPSD",32,0)
 W !," Other Staging System: ",ONC(165.5,D0,39),?41,"TNM Form Assigned..: ",ONC(165.5,D0,25)
"RTN","ONCPSD",33,0)
 W !," Physician's Stage...: ",ONC(165.5,D0,65),?41,"TNM Form Completed.: ",ONC(165.5,D0,44)
"RTN","ONCPSD",34,0)
 W !,DASHES
"RTN","ONCPSD",35,0)
 Q
"RTN","ONCPSD",36,0)
TXT S (TXT1,TXT2)="",LOS=$L(TXT) I LOS<LEN S TXT1=TXT Q
"RTN","ONCPSD",37,0)
 S NOP=$L($E(TXT,1,LEN)," ")
"RTN","ONCPSD",38,0)
 S TXT1=$P(TXT," ",1,NOP-1),TXT2=$P(TXT," ",NOP,999)
"RTN","ONCPSD",39,0)
 Q
"RTN","ONCPSD",40,0)
 ;
"RTN","ONCPSD",41,0)
UCASE S X=$TR(X,"abcdefghijklmnopqrstuvwxyz","ABCDEFGHIJKLMNOPQRSTUVWXYZ")
"RTN","ONCPSD",42,0)
 Q
"RTN","ONCPSD",43,0)
 ;
"RTN","ONCPSD",44,0)
CLEANUP ;Cleanup
"RTN","ONCPSD",45,0)
 K D0,DASHES
"RTN","ONCUPLPR")
0^3^B1000520
"RTN","ONCUPLPR",1,0)
ONCUPLPR ;Hines OIFO/GWB - PRE-INSTALL ROUTINE FOR NAACCR UPLOAD
"RTN","ONCUPLPR",2,0)
 ;;2.2;ONCOLOGY;**6,9**;Jul 31, 2013;Build 3
"RTN","ONCUPLPR",3,0)
 ;
"RTN","ONCUPLPR",4,0)
 ;Kill ONCOLOGY DATA EXTRACT FORMAT (160.16) data
"RTN","ONCUPLPR",5,0)
 ;K ^ONCO(160.1600)
"RTN","ONCUPLPR",6,0)
 ;
"RTN","ONCUPLPR",7,0)
 ;Kill ICD-O-3 MORPHOLOGY (169.3) data
"RTN","ONCUPLPR",8,0)
 ; data will be brought in with patch install
"RTN","ONCUPLPR",9,0)
 K ^ONCO(169.3)
"RTN","ONCUPLPR",10,0)
 ;delete an entry in file #160.16
"RTN","ONCUPLPR",11,0)
 N DIK,DA,ONCI
"RTN","ONCUPLPR",12,0)
 F ONCI=804,805,806 D
"RTN","ONCUPLPR",13,0)
 .S DA(1)=2,DA=ONCI
"RTN","ONCUPLPR",14,0)
 .S DIK="^ONCO(160.16,"_DA(1)_",""FIELD""," D ^DIK
"RTN","ONCUPLPR",15,0)
 ;delete bad entry
"RTN","ONCUPLPR",16,0)
 K ^ONCO(160.16,2,"FIELD","C","State/Requestor Items",541)
"RTN","ONCUPLPR",17,0)
 K ^ONCO(160.16,2,"FIELD","B",2370,807)
"RTN","ONCUPLPR",18,0)
 ;
"RTN","ONCUPLPR",19,0)
DIK ;update entries in state
"RTN","ONCUPLPR",20,0)
 N DA,DIE
"RTN","ONCUPLPR",21,0)
 S DIC(0)="EL"
"RTN","ONCUPLPR",22,0)
 S DA(1)=2,DA=807
"RTN","ONCUPLPR",23,0)
 S DIE="^ONCO(160.16,"_DA(1)_",""FIELD"","
"RTN","ONCUPLPR",24,0)
 S DR=".01///^S X=2340;1///^S X=1000;3///^S X=""State/Requestor Items""" D ^DIE
"RTN","ONCUPLPR",25,0)
 ;
"RTN","ONCUPLPR",26,0)
 Q
"SEC","^DIC",169.3,169.3,0,"AUDIT")
@
"SEC","^DIC",169.3,169.3,0,"DD")
@
"SEC","^DIC",169.3,169.3,0,"DEL")
@
"SEC","^DIC",169.3,169.3,0,"LAYGO")
@
"SEC","^DIC",169.3,169.3,0,"RD")
@
"SEC","^DIC",169.3,169.3,0,"WR")
@
"UP",165.5,165.5285,-1)
165.5^22.1
"UP",165.5,165.5285,0)
165.5285
"UP",165.5,165.5286,-1)
165.5^22.2
"UP",165.5,165.5286,0)
165.5286
"VER")
8.0^22.2
"^DD",165.5,165.5,24.3,0)
GRADE CLINICAL^FJ1X^^2.3;12^K:$L(X)>1!($L(X)<1)!("1234589ABCDELHMS"'[X) X
"^DD",165.5,165.5,24.3,3)
Answer must be 1 character in length.  Allowable values are: 1,2,3,4,5,8,9,A,B,C,D,E,L,H,M,S
"^DD",165.5,165.5,24.3,21,0)
^.001^3^3^3180321^^^
"^DD",165.5,165.5,24.3,21,1,0)
This data item records the grade of a solid primary tumor before any
"^DD",165.5,165.5,24.3,21,2,0)
treatment (surgical resection or initiation of any treatment including
"^DD",165.5,165.5,24.3,21,3,0)
neoadjuvant).
"^DD",165.5,165.5,24.3,"DT")
3180321
"^DD",165.5,165.5,24.4,0)
GRADE PATHOLOGICAL^FJ1X^^2.3;13^K:$L(X)>1!($L(X)<1)!("1234589ABCDELHMS"'[X) X
"^DD",165.5,165.5,24.4,3)
Answer must be 1 character in length.  Allowable values are: 1,2,3,4,5,8,9,A,B,C,D,E,L,H,M,S
"^DD",165.5,165.5,24.4,21,0)
^.001^2^2^3180321^^
"^DD",165.5,165.5,24.4,21,1,0)
This data item records the grade of a solid primary tumor that has been
"^DD",165.5,165.5,24.4,21,2,0)
resected and for which no neoadjuvant therapy was administered.
"^DD",165.5,165.5,24.4,"DT")
3180321
"^DD",165.5,165.5,24.5,0)
GRADE POST-THERAPY^FJ1X^^2.3;14^K:$L(X)>1!($L(X)<1)!("1234589ABCDELHMS"'[X) X
"^DD",165.5,165.5,24.5,3)
Answer must be 1 character in length.  Allowable values are: 1,2,3,4,5,8,9,A,B,C,D,E,L,H,M,S
"^DD",165.5,165.5,24.5,21,0)
^.001^2^2^3180321^^
"^DD",165.5,165.5,24.5,21,1,0)
This data item records the grade of a solid primary tumor that has been
"^DD",165.5,165.5,24.5,21,2,0)
resected following neoadjuvant therapy.
"^DD",165.5,165.5,24.5,"DT")
3180321
"^DD",165.5,165.5,285,0)
TEXT-STAGING^165.5285^^22.1;0
"^DD",165.5,165.5,285,21,0)
^^4^4^3180409^
"^DD",165.5,165.5,285,21,1,0)
 
"^DD",165.5,165.5,285,21,2,0)
Text area for information related to the new NAACCR 2018 staging
"^DD",165.5,165.5,285,21,3,0)
guidelines for the primary site.
"^DD",165.5,165.5,285,21,4,0)
 
"^DD",165.5,165.5,286,0)
TEXT-SITE SPECIFIC DATA ITEMS^165.5286^^22.2;0
"^DD",165.5,165.5,286,21,0)
^^5^5^3180409^
"^DD",165.5,165.5,286,21,1,0)
 
"^DD",165.5,165.5,286,21,2,0)
Text area for information related to the Site Specific Data Items (SSDI)
"^DD",165.5,165.5,286,21,3,0)
for the primary site.  The SSDI are a new data item introduced in
"^DD",165.5,165.5,286,21,4,0)
NAACCR 2018.
"^DD",165.5,165.5,286,21,5,0)
 
"^DD",165.5,165.5285,0)
TEXT-STAGING SUB-FIELD^^.01^1
"^DD",165.5,165.5285,0,"DT")
3180409
"^DD",165.5,165.5285,0,"NM","TEXT-STAGING")

"^DD",165.5,165.5285,0,"UP")
165.5
"^DD",165.5,165.5285,.01,0)
TEXT-STAGING^Wx^^0;1^Q
"^DD",165.5,165.5285,.01,3)
Enter any text relating to the staging of the primary.
"^DD",165.5,165.5285,.01,21,0)
^.001^1^1^3180409^^
"^DD",165.5,165.5285,.01,21,1,0)
This field will store any text relating to the staging of the primary.
"^DD",165.5,165.5285,.01,"DT")
3180409
"^DD",165.5,165.5286,0)
TEXT-SITE SPECIFIC DATA ITEMS SUB-FIELD^^.01^1
"^DD",165.5,165.5286,0,"DT")
3180409
"^DD",165.5,165.5286,0,"NM","TEXT-SITE SPECIFIC DATA ITEMS")

"^DD",165.5,165.5286,0,"UP")
165.5
"^DD",165.5,165.5286,.01,0)
TEXT-SITE SPECIFIC DATA ITEMS^Wx^^0;1^Q
"^DD",165.5,165.5286,.01,3)
Enter text relating to the Site Specific Data items for the primary.
"^DD",165.5,165.5286,.01,21,0)
^.001^1^1^3180409^^
"^DD",165.5,165.5286,.01,21,1,0)
This field will store any text relating to the site specific data items for the primary.
"^DD",165.5,165.5286,.01,"DT")
3180409
"^DD",169.3,169.3,0)
FIELD^^4.1^14
"^DD",169.3,169.3,0,"DDA")
N
"^DD",169.3,169.3,0,"DT")
3180124
"^DD",169.3,169.3,0,"IX","AC",169.3,4)

"^DD",169.3,169.3,0,"IX","AC",169.3,4.1)

"^DD",169.3,169.3,0,"IX","B",169.3,.01)

"^DD",169.3,169.3,0,"IX","C",169.32,.01)

"^DD",169.3,169.3,0,"IX","D",169.3,1)

"^DD",169.3,169.3,0,"NM","ICD-O-3 MORPHOLOGY")

"^DD",169.3,169.3,0,"PT",164.23,.01)

"^DD",169.3,169.3,0,"PT",165.5,22.3)

"^DD",169.3,169.3,.001,0)
NUMBER^NJ5,0^^ ^K:+X'=X!(X>99999)!(X<80000)!(X?.E1"."1N.N) X
"^DD",169.3,169.3,.001,3)
Type a Number between 80000 and 99999, 0 Decimal Digits
"^DD",169.3,169.3,.001,"DT")
3001117
"^DD",169.3,169.3,.01,0)
NAME^RF^^0;1^K:$L(X)>80!($L(X)<2)!'(X'?1P.E) X
"^DD",169.3,169.3,.01,1,0)
^.1
"^DD",169.3,169.3,.01,1,1,0)
169.3^B
"^DD",169.3,169.3,.01,1,1,1)
S ^ONCO(169.3,"B",$E(X,1,30),DA)=""
"^DD",169.3,169.3,.01,1,1,2)
K ^ONCO(169.3,"B",$E(X,1,30),DA)
"^DD",169.3,169.3,.01,3)
Answer must be 2-80 characters in length.
"^DD",169.3,169.3,.01,21,0)
^.001^3^3^3100817^^
"^DD",169.3,169.3,.01,21,1,0)
 
"^DD",169.3,169.3,.01,21,2,0)
Identifies the ICD-O (International Classification of Diseases for 
"^DD",169.3,169.3,.01,21,3,0)
Oncology (Third Edition)) terms.
"^DD",169.3,169.3,.01,"DT")
3091029
"^DD",169.3,169.3,1,0)
CODE^F^^0;2^K:$L(X)>6!($L(X)<3) X
"^DD",169.3,169.3,1,1,0)
^.1
"^DD",169.3,169.3,1,1,1,0)
169.3^D
"^DD",169.3,169.3,1,1,1,1)
S ^ONCO(169.3,"D",$E(X,1,30),DA)=""
"^DD",169.3,169.3,1,1,1,2)
K ^ONCO(169.3,"D",$E(X,1,30),DA)
"^DD",169.3,169.3,1,1,1,"%D",0)
^^1^1^3001120^
"^DD",169.3,169.3,1,1,1,"%D",1,0)
Indexes file by CODE.
"^DD",169.3,169.3,1,1,1,"DT")
3001120
"^DD",169.3,169.3,1,3)
Answer must be 3-6 characters in length.
"^DD",169.3,169.3,1,"DT")
3001120
"^DD",169.3,169.3,2,0)
SYNONYM/EQUIVALENT TERM^169.32^^1;0
"^DD",169.3,169.3,2,21,0)
^.001^4^4^3180124^^^^
"^DD",169.3,169.3,2,21,1,0)

"^DD",169.3,169.3,2,21,2,0)
This field contains the synonyms and equivalent terms for this
"^DD",169.3,169.3,2,21,3,0)
morphology.
"^DD",169.3,169.3,2,21,4,0)

"^DD",169.3,169.3,2,"DT")
3010131
"^DD",169.3,169.3,3,0)
ICDO-SITE^P164.08'^ONCO(164.08,^0;5^Q
"^DD",169.3,169.3,3,21,0)
^^1^1^3001120^
"^DD",169.3,169.3,3,21,1,0)
POINTS TO THE ICDO SITE FILE.
"^DD",169.3,169.3,3,"DT")
3001120
"^DD",169.3,169.3,4,0)
TOPOGRAPHY 1^P164'^ONCO(164,^0;6^Q
"^DD",169.3,169.3,4,1,0)
^.1
"^DD",169.3,169.3,4,1,1,0)
169.3^AC
"^DD",169.3,169.3,4,1,1,1)
S ^ONCO(169.3,"AC",$E(X,1,4),DA)=""
"^DD",169.3,169.3,4,1,1,2)
K ^ONCO(169.3,"AC",$E(X,1,4),DA)
"^DD",169.3,169.3,4,1,1,"DT")
3010131
"^DD",169.3,169.3,4,21,0)
^.001^4^4^3010131^^^^
"^DD",169.3,169.3,4,21,1,0)

"^DD",169.3,169.3,4,21,2,0)
This field indicates a usual primary site (ICD-O TOPOGRPAHY) for this
"^DD",169.3,169.3,4,21,3,0)
morphology.
"^DD",169.3,169.3,4,21,4,0)

"^DD",169.3,169.3,4,"DT")
3010131
"^DD",169.3,169.3,4.1,0)
TOPOGRAPHY 2^P164'^ONCO(164,^0;3^Q
"^DD",169.3,169.3,4.1,1,0)
^.1
"^DD",169.3,169.3,4.1,1,1,0)
169.3^AC
"^DD",169.3,169.3,4.1,1,1,1)
S ^ONCO(169.3,"AC",$E(X,1,4),DA)=""
"^DD",169.3,169.3,4.1,1,1,2)
K ^ONCO(169.3,"AC",$E(X,1,4),DA)
"^DD",169.3,169.3,4.1,1,1,"DT")
3010131
"^DD",169.3,169.3,4.1,21,0)
^^4^4^3010131^
"^DD",169.3,169.3,4.1,21,1,0)

"^DD",169.3,169.3,4.1,21,2,0)
This field indicates a usual primary site (ICD-O TOPOGRPAHY) for this
"^DD",169.3,169.3,4.1,21,3,0)
morphology.
"^DD",169.3,169.3,4.1,21,4,0)

"^DD",169.3,169.3,4.1,"DT")
3010131
"^DD",169.3,169.3,43,0)
EXTENSION CODE SET-1ST ED^*P164.5'^ONCO(164.5,^E;1^S DIC("S")="I $P(^(0),U,5)=""E"",$P(^(0),U,2)'>1" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
"^DD",169.3,169.3,43,12)
A first edition extension code set may be selected.
"^DD",169.3,169.3,43,12.1)
S DIC("S")="I $P(^(0),U,5)=""E"",$P(^(0),U,2)'>1"
"^DD",169.3,169.3,43,21,0)
^.001^3^3^3010406^^^^
"^DD",169.3,169.3,43,21,1,0)
This field identifies the set of codes used to characterize extension
"^DD",169.3,169.3,43,21,2,0)
for this topography in the first edition of SEER Extent of Disease Codes
"^DD",169.3,169.3,43,21,3,0)
and Coding Instructions.
"^DD",169.3,169.3,43,"DT")
3010406
"^DD",169.3,169.3,43.01,0)
EXTENSION CODE SET-2ND ED^*P164.5'^ONCO(164.5,^E;2^S DIC("S")="I $P(^(0),U,5)=""E"",$P(^(0),U,2)'>2" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
"^DD",169.3,169.3,43.01,12)
A first or second edition extension code set may be selected.
"^DD",169.3,169.3,43.01,12.1)
S DIC("S")="I $P(^(0),U,5)=""E"",$P(^(0),U,2)'>2"
"^DD",169.3,169.3,43.01,21,0)
^.001^3^3^3001120^^
"^DD",169.3,169.3,43.01,21,1,0)
This field identifies the set of codes used to characterize extension
"^DD",169.3,169.3,43.01,21,2,0)
for this topography in the second edition of SEER Extent of Disease Codes
"^DD",169.3,169.3,43.01,21,3,0)
and Coding Instructions.
"^DD",169.3,169.3,43.01,"DT")
3001120
"^DD",169.3,169.3,43.02,0)
EXTENSION CODE SET-3RD ED^*P164.5'^ONCO(164.5,^E;3^S DIC("S")="I $P(^(0),U,5)=""E"",$P(^(0),U,2)'>3" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
"^DD",169.3,169.3,43.02,12)
A first, second or third edition extension code set may be selected.
"^DD",169.3,169.3,43.02,12.1)
S DIC("S")="I $P(^(0),U,5)=""E"",$P(^(0),U,2)'>3"
"^DD",169.3,169.3,43.02,21,0)
^.001^3^3^3001120^^^^
"^DD",169.3,169.3,43.02,21,1,0)
This field identifies the set of codes used to characterize extension
"^DD",169.3,169.3,43.02,21,2,0)
for this topography in the third edition of SEER Extent of Disease Codes
"^DD",169.3,169.3,43.02,21,3,0)
and Coding Instructions.
"^DD",169.3,169.3,43.02,"DT")
3001120
"^DD",169.3,169.3,53,0)
LYMPH NODE CODE SET-1ST ED^*P164.5'^ONCO(164.5,^L;1^S DIC("S")="I $P(^(0),U,5)=""L"",$P(^(0),U,2)'>1" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
"^DD",169.3,169.3,53,12)
A first edition lymph node code set may be selected.
"^DD",169.3,169.3,53,12.1)
S DIC("S")="I $P(^(0),U,5)=""L"",$P(^(0),U,2)'>1"
"^DD",169.3,169.3,53,21,0)
^.001^4^4^3001120^^^
"^DD",169.3,169.3,53,21,1,0)
This field identifies the set of codes used to
"^DD",169.3,169.3,53,21,2,0)
characterize lymph node involvement for this
"^DD",169.3,169.3,53,21,3,0)
topography in the first edition of SEER Extent
"^DD",169.3,169.3,53,21,4,0)
of Disease Codes and Coding Instructions.
"^DD",169.3,169.3,53,"DT")
3001120
"^DD",169.3,169.3,53.01,0)
LYMPH NODE CODE SET-2ND ED^*P164.5'^ONCO(164.5,^L;2^S DIC("S")="I $P(^(0),U,5)=""L"",$P(^(0),U,2)'>2" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
"^DD",169.3,169.3,53.01,12)
A first or second edition lymph node code set may be selected.
"^DD",169.3,169.3,53.01,12.1)
S DIC("S")="I $P(^(0),U,5)=""L"",$P(^(0),U,2)'>2"
"^DD",169.3,169.3,53.01,21,0)
^.001^4^4^3001120^^
"^DD",169.3,169.3,53.01,21,1,0)
This field identifies the set of codes used to
"^DD",169.3,169.3,53.01,21,2,0)
characterize lymph node involvement for this
"^DD",169.3,169.3,53.01,21,3,0)
topography in the second edition of SEER Extent
"^DD",169.3,169.3,53.01,21,4,0)
of Disease Codes and Coding Instructions.
"^DD",169.3,169.3,53.01,"DT")
3001120
"^DD",169.3,169.3,53.02,0)
LYMPH NODE CODE SET-3RD ED^*P164.5'^ONCO(164.5,^L;3^S DIC("S")="I $P(^(0),U,5)=""L"",$P(^(0),U,2)'>3" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
"^DD",169.3,169.3,53.02,12)
A first, second or third edition lymph node code set may be selected.
"^DD",169.3,169.3,53.02,12.1)
S DIC("S")="I $P(^(0),U,5)=""L"",$P(^(0),U,2)'>3"
"^DD",169.3,169.3,53.02,21,0)
^.001^4^4^3001120^^
"^DD",169.3,169.3,53.02,21,1,0)
This field identifies the set of codes used to
"^DD",169.3,169.3,53.02,21,2,0)
characterize lymph node involvement for this
"^DD",169.3,169.3,53.02,21,3,0)
topography in the third edition of SEER Extent
"^DD",169.3,169.3,53.02,21,4,0)
of Disease Codes and Coding Instructions.
"^DD",169.3,169.3,53.02,"DT")
3001120
"^DD",169.3,169.3,71,0)
HISTOPATHOLOGIC TYPE^S^1:Lymphoid;2:Embryonal;3:Epithelial;4:Reticuloendothelial;5:Sarcoma;6:Hematogenous;7:Melanoma;8:Nerve;9:Other;^0;8^Q
"^DD",169.3,169.3,71,21,0)
^^2^2^3001120^
"^DD",169.3,169.3,71,21,1,0)
The HISTOPATHOLOGIC TYPE is the category (type) of morphology according to
"^DD",169.3,169.3,71,21,2,0)
cell type.
"^DD",169.3,169.3,71,"DT")
3001120
"^DD",169.3,169.32,0)
SYNONYM/EQUIVALENT TERM SUB-FIELD^^.01^1
"^DD",169.3,169.32,0,"DT")
3180124
"^DD",169.3,169.32,0,"NM","SYNONYM/EQUIVALENT TERM")

"^DD",169.3,169.32,0,"UP")
169.3
"^DD",169.3,169.32,.01,0)
SYNONYM/EQUIVALENT TERM^MFXJ70^^0;1^K:X[""""!(X'?.ANP)!(X<0) X I $D(X) K:$L(X)>70!($L(X)<3) X
"^DD",169.3,169.32,.01,1,0)
^.1
"^DD",169.3,169.32,.01,1,1,0)
169.3^C
"^DD",169.3,169.32,.01,1,1,1)
S ^ONCO(169.3,"C",$E(X,1,30),DA(1),DA)=""
"^DD",169.3,169.32,.01,1,1,2)
K ^ONCO(169.3,"C",$E(X,1,30),DA(1),DA)
"^DD",169.3,169.32,.01,1,1,"DT")
3001122
"^DD",169.3,169.32,.01,3)
Answer must be 3-70 characters in length.
"^DD",169.3,169.32,.01,21,0)
^.001^4^4^3180124^^^^
"^DD",169.3,169.32,.01,21,1,0)

"^DD",169.3,169.32,.01,21,2,0)
This field contains a synonym or equivalent term for this
"^DD",169.3,169.32,.01,21,3,0)
morphology.
"^DD",169.3,169.32,.01,21,4,0)

"^DD",169.3,169.32,.01,"DT")
3180124
"^DIC",169.3,169.3,0)
ICD-O-3 MORPHOLOGY^169.3
"^DIC",169.3,169.3,0,"GL")
^ONCO(169.3,
"^DIC",169.3,169.3,"%",0)
^1.005^^0
"^DIC",169.3,169.3,"%D",0)
^^2^2^3010523^
"^DIC",169.3,169.3,"%D",1,0)
This file contains the International Classification of Diseases for Oncology,
"^DIC",169.3,169.3,"%D",2,0)
Third Edition (ICD-O-3) morphology codes and code descriptions.
"^DIC",169.3,"B","ICD-O-3 MORPHOLOGY",169.3)

**END**
**END**
